Ligand source activities (1 row/activity)





Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Potency)
# tested GPCRs
(Potency)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
445643 104164 69 None -1 7 Human 5.0 pAC50 = 5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 803 7 3 12 4.6 C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC 10.1038/s41467-023-40064-9
CHEMBL269732 104164 69 None -1 7 Human 5.0 pAC50 = 5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 803 7 3 12 4.6 C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC 10.1038/s41467-023-40064-9
2398 7741 62 None -7413 36 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
2801 7741 62 None -7413 36 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
701 7741 62 None -7413 36 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
CHEMBL415 7741 62 None -7413 36 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
DB01242 7741 62 None -7413 36 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
5022 8432 76 None -239 9 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 4 1 4 3.2 O=c1[nH]c2c(n1CCN1CCN(CC1)c1cccc(c1)C(F)(F)F)cccc2 10.1038/s41467-023-40064-9
6918248 8432 76 None -239 9 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 4 1 4 3.2 O=c1[nH]c2c(n1CCN1CCN(CC1)c1cccc(c1)C(F)(F)F)cccc2 10.1038/s41467-023-40064-9
8182 8432 76 None -239 9 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 4 1 4 3.2 O=c1[nH]c2c(n1CCN1CCN(CC1)c1cccc(c1)C(F)(F)F)cccc2 10.1038/s41467-023-40064-9
CHEMBL231068 8432 76 None -239 9 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 4 1 4 3.2 O=c1[nH]c2c(n1CCN1CCN(CC1)c1cccc(c1)C(F)(F)F)cccc2 10.1038/s41467-023-40064-9
DB04908 8432 76 None -239 9 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 4 1 4 3.2 O=c1[nH]c2c(n1CCN1CCN(CC1)c1cccc(c1)C(F)(F)F)cccc2 10.1038/s41467-023-40064-9
2247 7293 81 None -812 42 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
249 7293 81 None -812 42 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
2603 7293 81 None -812 42 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
CHEMBL296419 7293 81 None -812 42 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
DB00637 7293 81 None -812 42 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
2710 91083 31 None -25 9 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 300 3 0 2 3.7 CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1 10.1038/s41467-023-40064-9
CHEMBL22150 91083 31 None -25 9 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 300 3 0 2 3.7 CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1 10.1038/s41467-023-40064-9
DB08936 91083 31 None -25 9 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 300 3 0 2 3.7 CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1 10.1038/s41467-023-40064-9
3351 101777 52 None -1 6 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 388 5 0 5 2.8 O=C(COc1ccc(Cl)cc1)N1CCN(Cc2ccc3c(c2)OCO3)CC1 10.1038/s41467-023-40064-9
CHEMBL254857 101777 52 None -1 6 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 388 5 0 5 2.8 O=C(COc1ccc(Cl)cc1)N1CCN(Cc2ccc3c(c2)OCO3)CC1 10.1038/s41467-023-40064-9
9823820 25938 102 None 1 2 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 6 3 5 4.1 COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O 10.1038/s41467-023-40064-9
CHEMBL1289601 25938 102 None 1 2 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 6 3 5 4.1 COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O 10.1038/s41467-023-40064-9
3035016 19366 50 None 1 3 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 483 3 5 10 0.6 CC(=O)[C@]1(N)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](O)[C@H](O)CO2)C1)C(=O)c1ccccc1C3=O 10.1038/s41467-023-40064-9
CHEMBL1186894 19366 50 None 1 3 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 483 3 5 10 0.6 CC(=O)[C@]1(N)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](O)[C@H](O)CO2)C1)C(=O)c1ccccc1C3=O 10.1038/s41467-023-40064-9
3627 50903 18 None -162 9 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 314 3 0 2 4.1 CN1CCCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1 10.1038/s41467-023-40064-9
CHEMBL1515447 50903 18 None -162 9 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 314 3 0 2 4.1 CN1CCCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1 10.1038/s41467-023-40064-9
196122 119365 55 None -1 4 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 478 13 1 6 4.5 CCOC1O[C@H]([C@@H](COCc2ccccc2)OCc2ccccc2)[C@H](OCc2ccccc2)[C@H]1O 10.1038/s41467-023-40064-9
CHEMBL3301681 119365 55 None -1 4 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 478 13 1 6 4.5 CCOC1O[C@H]([C@@H](COCc2ccccc2)OCc2ccccc2)[C@H](OCc2ccccc2)[C@H]1O 10.1038/s41467-023-40064-9
98941 53724 17 None -58 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 457 7 0 4 6.3 COc1ccc2c(c1)OC(C)(C)C(c1ccccc1)C2c1ccc(OCCN2CCCC2)cc1 10.1038/s41467-023-40064-9
CHEMBL154126 53724 17 None -58 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 457 7 0 4 6.3 COc1ccc2c(c1)OC(C)(C)C(c1ccccc1)C2c1ccc(OCCN2CCCC2)cc1 10.1038/s41467-023-40064-9
4150 7575 39 None -19 15 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 6 2 2 5.8 CCCCCc1cc(O)c(c(c1)O)[C@@H]1C=C(C)CC[C@H]1C(=C)C 10.1038/s41467-023-40064-9
5288 7575 39 None -19 15 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 6 2 2 5.8 CCCCCc1cc(O)c(c(c1)O)[C@@H]1C=C(C)CC[C@H]1C(=C)C 10.1038/s41467-023-40064-9
644019 7575 39 None -19 15 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 6 2 2 5.8 CCCCCc1cc(O)c(c(c1)O)[C@@H]1C=C(C)CC[C@H]1C(=C)C 10.1038/s41467-023-40064-9
CHEMBL190461 7575 39 None -19 15 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 6 2 2 5.8 CCCCCc1cc(O)c(c(c1)O)[C@@H]1C=C(C)CC[C@H]1C(=C)C 10.1038/s41467-023-40064-9
DB09061 7575 39 None -19 15 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 6 2 2 5.8 CCCCCc1cc(O)c(c(c1)O)[C@@H]1C=C(C)CC[C@H]1C(=C)C 10.1038/s41467-023-40064-9
9818306 21191 15 None -1 5 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 1 1 3 3.8 CC(=O)Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12 10.1038/s41467-023-40064-9
CHEMBL1200430 21191 15 None -1 5 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 1 1 3 3.8 CC(=O)Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12 10.1038/s41467-023-40064-9
5568 204279 29 None -4365 13 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 352 4 0 3 5.3 CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21 10.1038/s41467-023-40064-9
66069 204279 29 None -4365 13 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 352 4 0 3 5.3 CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21 10.1038/s41467-023-40064-9
CHEMBL1201102 204279 29 None -4365 13 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 352 4 0 3 5.3 CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21 10.1038/s41467-023-40064-9
CHEMBL570 204279 29 None -4365 13 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 352 4 0 3 5.3 CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21 10.1038/s41467-023-40064-9
DB00508 204279 29 None -4365 13 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 352 4 0 3 5.3 CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21 10.1038/s41467-023-40064-9
64143 205643 62 None -2 10 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 567 9 4 6 4.7 Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C 10.1038/s41467-023-40064-9
CHEMBL584 205643 62 None -2 10 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 567 9 4 6 4.7 Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C 10.1038/s41467-023-40064-9
2520 210787 70 None -120 20 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
CHEMBL1280 210787 70 None -120 20 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
CHEMBL6966 210787 70 None -120 20 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
10180 105645 47 None -25 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 6 1 4 4.5 CCN(CC)CCNc1ccc(C)c2sc3ccccc3c(=O)c12 10.1038/s41467-023-40064-9
CHEMBL279014 105645 47 None -25 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 6 1 4 4.5 CCN(CC)CCNc1ccc(C)c2sc3ccccc3c(=O)c12 10.1038/s41467-023-40064-9
6077 157477 31 None -4570 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 5 0 4 4.4 CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL39560 157477 31 None -4570 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 5 0 4 4.4 CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2 10.1038/s41467-023-40064-9
1662 195484 80 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 162 4 3 3 -0.3 CC(O)(CC(=O)O)CC(=O)O 10.1038/s41467-023-40064-9
CHEMBL50444 195484 80 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 162 4 3 3 -0.3 CC(O)(CC(=O)O)CC(=O)O 10.1038/s41467-023-40064-9
24795069 95823 42 None -9 3 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 418 7 1 6 3.6 COc1cc2c(cc1OC)[C@H]1C[C@@H](OC(=O)[C@@H](N)C(C)C)[C@H](CC(C)C)CN1CC2 10.1038/s41467-023-40064-9
CHEMBL2364639 95823 42 None -9 3 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 418 7 1 6 3.6 COc1cc2c(cc1OC)[C@H]1C[C@@H](OC(=O)[C@@H](N)C(C)C)[C@H](CC(C)C)CN1CC2 10.1038/s41467-023-40064-9
4822 51806 47 None -1995 10 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 293 0 0 2 4.7 CN1CCC(=C2c3ccccc3Sc3ccccc32)CC1 10.1038/s41467-023-40064-9
CHEMBL152408 51806 47 None -1995 10 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 293 0 0 2 4.7 CN1CCC(=C2c3ccccc3Sc3ccccc32)CC1 10.1038/s41467-023-40064-9
3280 55223 28 None -8 8 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 10 0 5 5.4 CCOc1ccc(Cc2nccc3cc(OCC)c(OCC)cc23)cc1OCC 10.1038/s41467-023-40064-9
CHEMBL1555736 55223 28 None -8 8 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 10 0 5 5.4 CCOc1ccc(Cc2nccc3cc(OCC)c(OCC)cc23)cc1OCC 10.1038/s41467-023-40064-9
10071196 9898 79 None -1023 9 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.1038/s41467-023-40064-9
5142 9898 79 None -1023 9 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.1038/s41467-023-40064-9
8423 9898 79 None -1023 9 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.1038/s41467-023-40064-9
CHEMBL2111101 9898 79 None -1023 9 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.1038/s41467-023-40064-9
DB05316 9898 79 None -1023 9 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.1038/s41467-023-40064-9
49843517 85069 41 None -42 8 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 590 13 2 6 8.5 CCCCCCO[C@@H](C)c1cccc(-c2csc(NC(=O)c3cc(Cl)c(/C=C(\C)C(=O)O)c(Cl)c3)n2)c1OC 10.1038/s41467-023-40064-9
CHEMBL2107831 85069 41 None -42 8 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 590 13 2 6 8.5 CCCCCCO[C@@H](C)c1cccc(-c2csc(NC(=O)c3cc(Cl)c(/C=C(\C)C(=O)O)c(Cl)c3)n2)c1OC 10.1038/s41467-023-40064-9
444795 146777 105 None -40 6 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 300 5 1 1 5.6 CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1 10.1038/s41467-023-40064-9
CHEMBL38 146777 105 None -40 6 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 300 5 1 1 5.6 CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1 10.1038/s41467-023-40064-9
3735 213010 76 None -1 3 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 571 4 2 2 3.7 CCC(Cc1c(I)cc(I)c(N)c1I)C(=O)O 10.1038/s41467-023-40064-9
CHEMBL867 213010 76 None -1 3 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 571 4 2 2 3.7 CCC(Cc1c(I)cc(I)c(N)c1I)C(=O)O 10.1038/s41467-023-40064-9
2583 10548 118 None -9120 16 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
592 10548 118 None -9120 16 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
65999 10548 118 None -9120 16 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
CHEMBL1017 10548 118 None -9120 16 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
DB00966 10548 118 None -9120 16 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
65863 21237 57 None -8 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 436 6 0 4 7.0 Clc1ccc(C(Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1201196 21237 57 None -8 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 436 6 0 4 7.0 Clc1ccc(C(Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1 10.1038/s41467-023-40064-9
208898 72973 78 None -22 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 556 18 1 6 7.0 CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1 10.1038/s41467-023-40064-9
CHEMBL184412 72973 78 None -22 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 556 18 1 6 7.0 CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1 10.1038/s41467-023-40064-9
DB04855 72973 78 None -22 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 556 18 1 6 7.0 CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1 10.1038/s41467-023-40064-9
2444 21250 26 None -10 8 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 333 6 0 2 4.1 CN(C)CCOC(c1ccccc1)c1ccc(Br)cc1 10.1038/s41467-023-40064-9
CHEMBL1201245 21250 26 None -10 8 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 333 6 0 2 4.1 CN(C)CCOC(c1ccccc1)c1ccc(Br)cc1 10.1038/s41467-023-40064-9
DB01237 21250 26 None -10 8 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 333 6 0 2 4.1 CN(C)CCOC(c1ccccc1)c1ccc(Br)cc1 10.1038/s41467-023-40064-9
2749 7132 40 None -512 10 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 4 0 3 4.5 CN(CC(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
5574 7132 40 None -512 10 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 4 0 3 4.5 CN(CC(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
7237 7132 40 None -512 10 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 4 0 3 4.5 CN(CC(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
CHEMBL829 7132 40 None -512 10 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 4 0 3 4.5 CN(CC(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
DB01246 7132 40 None -512 10 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 4 0 3 4.5 CN(CC(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
50905713 109173 76 None 1 2 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 416 4 2 6 4.5 C[C@H](Nc1ncnc2nc[nH]c12)c1cc2cccc(Cl)c2c(=O)n1-c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL3039502 109173 76 None 1 2 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 416 4 2 6 4.5 C[C@H](Nc1ncnc2nc[nH]c12)c1cc2cccc(Cl)c2c(=O)n1-c1ccccc1 10.1038/s41467-023-40064-9
24821094 73868 93 None 1 8 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 440 5 1 7 4.2 C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1 10.1038/s41467-023-40064-9
CHEMBL1873475 73868 93 None 1 8 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 440 5 1 7 4.2 C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1 10.1038/s41467-023-40064-9
8569 29415 91 None -1 4 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 244 3 2 4 2.3 COc1ccc(C(=O)c2ccccc2O)c(O)c1 10.1038/s41467-023-40064-9
CHEMBL1326877 29415 91 None -1 4 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 244 3 2 4 2.3 COc1ccc(C(=O)c2ccccc2O)c(O)c1 10.1038/s41467-023-40064-9
62867 9903 35 None -5248 9 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 475 8 1 6 4.0 OCCC1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
7557 9903 35 None -5248 9 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 475 8 1 6 4.0 OCCC1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
CHEMBL398880 9903 35 None -5248 9 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 475 8 1 6 4.0 OCCC1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
DB01621 9903 35 None -5248 9 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 475 8 1 6 4.0 OCCC1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
6917906 74547 21 None -7 5 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 887 35 10 12 1.7 CCCCCCCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O)C(N)=O)C(=O)O 10.1038/s41467-023-40064-9
CHEMBL1908331 74547 21 None -7 5 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 887 35 10 12 1.7 CCCCCCCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O)C(N)=O)C(=O)O 10.1038/s41467-023-40064-9
37464 25993 26 None -4466 8 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 291 6 2 3 3.5 CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1 10.1038/s41467-023-40064-9
CHEMBL1290 25993 26 None -4466 8 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 291 6 2 3 3.5 CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1 10.1038/s41467-023-40064-9
DB01359 25993 26 None -4466 8 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 291 6 2 3 3.5 CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1 10.1038/s41467-023-40064-9
60151560 174221 39 None -1 5 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 439 11 1 5 5.3 CCO[C@@H](Cc1ccc(OCCn2c(C)ccc2-c2ccc(SC)cc2)cc1)C(=O)O 10.1038/s41467-023-40064-9
CHEMBL4297530 174221 39 None -1 5 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 439 11 1 5 5.3 CCO[C@@H](Cc1ccc(OCCn2c(C)ccc2-c2ccc(SC)cc2)cc1)C(=O)O 10.1038/s41467-023-40064-9
133 9274 52 None -41686 28 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C 10.1038/s41467-023-40064-9
1723 9274 52 None -41686 28 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C 10.1038/s41467-023-40064-9
28693 9274 52 None -41686 28 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C 10.1038/s41467-023-40064-9
CHEMBL19215 9274 52 None -41686 28 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C 10.1038/s41467-023-40064-9
DB13520 9274 52 None -41686 28 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C 10.1038/s41467-023-40064-9
124087 8171 114 None -380 27 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
7157 8171 114 None -380 27 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
814 8171 114 None -380 27 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
CHEMBL1172 8171 114 None -380 27 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
DB00967 8171 114 None -380 27 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
3157 8252 71 None -22387 22 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
7170 8252 71 None -22387 22 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
954 8252 71 None -22387 22 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
CHEMBL707 8252 71 None -22387 22 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
DB00590 8252 71 None -22387 22 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
2107 9829 50 None -5248 9 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 365 4 1 5 4.0 N#Cc1ccc2c(c1)N(CCCN1CCC(CC1)O)c1c(S2)cccc1 10.1038/s41467-023-40064-9
4747 9829 50 None -5248 9 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 365 4 1 5 4.0 N#Cc1ccc2c(c1)N(CCCN1CCC(CC1)O)c1c(S2)cccc1 10.1038/s41467-023-40064-9
9216 9829 50 None -5248 9 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 365 4 1 5 4.0 N#Cc1ccc2c(c1)N(CCCN1CCC(CC1)O)c1c(S2)cccc1 10.1038/s41467-023-40064-9
CHEMBL251940 9829 50 None -5248 9 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 365 4 1 5 4.0 N#Cc1ccc2c(c1)N(CCCN1CCC(CC1)O)c1c(S2)cccc1 10.1038/s41467-023-40064-9
DB01608 9829 50 None -5248 9 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 365 4 1 5 4.0 N#Cc1ccc2c(c1)N(CCCN1CCC(CC1)O)c1c(S2)cccc1 10.1038/s41467-023-40064-9
3356 9060 73 None -165 2 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1038/s41467-023-40064-9
4326 9060 73 None -165 2 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1038/s41467-023-40064-9
9867642 9060 73 None -165 2 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1038/s41467-023-40064-9
CHEMBL426559 9060 73 None -165 2 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1038/s41467-023-40064-9
DB11629 9060 73 None -165 2 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1038/s41467-023-40064-9
2805 168669 38 None -51 9 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 329 6 0 2 4.9 Clc1ccc(C(OCCN2CCCCC2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL415087 168669 38 None -51 9 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 329 6 0 2 4.9 Clc1ccc(C(OCCN2CCCCC2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL343448 218479 43 None - 1 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL None None None C/C=C1\NC(=O)[C@H]2CSSCC/C=C/[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@H](C(C)C)NC1=O 10.1038/s41467-023-40064-9
8609 21216 66 None -1 4 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 229 2 2 4 2.2 Nc1ccc(C(=O)Oc2ccccc2)c(O)c1 10.1038/s41467-023-40064-9
CHEMBL1200868 21216 66 None -1 4 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 229 2 2 4 2.2 Nc1ccc(C(=O)Oc2ccccc2)c(O)c1 10.1038/s41467-023-40064-9
25102847 84996 93 None -8 10 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 501 8 2 6 5.5 COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC 10.1038/s41467-023-40064-9
CHEMBL2105717 84996 93 None -8 10 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 501 8 2 6 5.5 COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC 10.1038/s41467-023-40064-9
16222096 87258 67 None -66 7 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 531 4 3 4 3.8 O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1 10.1038/s41467-023-40064-9
CHEMBL2146883 87258 67 None -66 7 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 531 4 3 4 3.8 O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1 10.1038/s41467-023-40064-9
5591 164310 90 None -10 17 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 441 5 2 6 4.4 Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2 10.1038/s41467-023-40064-9
CHEMBL408 164310 90 None -10 17 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 441 5 2 6 4.4 Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2 10.1038/s41467-023-40064-9
CHEMBL508338 195745 0 None -194 15 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL None None None None 10.1038/s41467-023-40064-9
3598 194600 76 None -25 17 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 404 2 2 2 6.6 Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl 10.1038/s41467-023-40064-9
CHEMBL496 194600 76 None -25 17 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 404 2 2 2 6.6 Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl 10.1038/s41467-023-40064-9
6719 39442 39 None -4 4 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 4 0 3 4.1 O=C1c2ccccc2C(=O)C1C(=O)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1413199 39442 39 None -4 4 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 4 0 3 4.1 O=C1c2ccccc2C(=O)C1C(=O)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
3397 212267 112 None -1 8 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 3 1 3 3.2 CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1 10.1038/s41467-023-40064-9
CHEMBL806 212267 112 None -1 8 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 3 1 3 3.2 CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1 10.1038/s41467-023-40064-9
1613 9127 53 None -2290 34 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
205 9127 53 None -2290 34 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
3964 9127 53 None -2290 34 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
CHEMBL831 9127 53 None -2290 34 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
DB00408 9127 53 None -2290 34 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
3476 47060 99 None - 1 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 490 7 3 5 3.1 CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O 10.1038/s41467-023-40064-9
CHEMBL1481 47060 99 None - 1 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 490 7 3 5 3.1 CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O 10.1038/s41467-023-40064-9
9846332 58833 37 None -1 3 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 444 2 3 5 2.4 C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C(Cl)=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO 10.1038/s41467-023-40064-9
CHEMBL1587228 58833 37 None -1 3 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 444 2 3 5 2.4 C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C(Cl)=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO 10.1038/s41467-023-40064-9
31101 7516 40 None -6606 29 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
35 7516 40 None -6606 29 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
403 7516 40 None -6606 29 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
CHEMBL493 7516 40 None -6606 29 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
DB01200 7516 40 None -6606 29 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
242 7258 124 None -758 32 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
34 7258 124 None -758 32 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
60795 7258 124 None -758 32 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
CHEMBL1112 7258 124 None -758 32 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
DB01238 7258 124 None -758 32 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
16362 9899 71 None -2089 35 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
2172 9899 71 None -2089 35 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
90 9899 71 None -2089 35 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL1423 9899 71 None -2089 35 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
DB01100 9899 71 None -2089 35 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
135398737 7745 93 None -9332 43 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
38 7745 93 None -9332 43 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
722 7745 93 None -9332 43 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL42 7745 93 None -9332 43 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
DB00363 7745 93 None -9332 43 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
16564 211774 32 None -134 6 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 207 2 3 3 0.3 N=C(N)NCC1COc2ccccc2O1 10.1038/s41467-023-40064-9
CHEMBL76725 211774 32 None -134 6 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 207 2 3 3 0.3 N=C(N)NCC1COc2ccccc2O1 10.1038/s41467-023-40064-9
4037 195795 60 None -1 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 3 2 2 4.7 Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl 10.1038/s41467-023-40064-9
CHEMBL509 195795 60 None -1 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 3 2 2 4.7 Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl 10.1038/s41467-023-40064-9
CHEMBL876 195795 60 None -1 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 3 2 2 4.7 Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl 10.1038/s41467-023-40064-9
441383 27105 57 None -208 20 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 10.1038/s41467-023-40064-9
CHEMBL1306 27105 57 None -208 20 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 10.1038/s41467-023-40064-9
446156 46599 29 None 1 3 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 459 11 3 5 4.9 COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1 10.1038/s41467-023-40064-9
CHEMBL1477 46599 29 None 1 3 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 459 11 3 5 4.9 COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1 10.1038/s41467-023-40064-9
11057 182928 23 None -3 25 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 10.1038/s41467-023-40064-9
3468 182928 23 None -3 25 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 10.1038/s41467-023-40064-9
CHEMBL459265 182928 23 None -3 25 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 10.1038/s41467-023-40064-9
CHEMBL64894 182928 23 None -3 25 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 10.1038/s41467-023-40064-9
3336 101776 30 None -4265 14 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 315 7 1 1 5.6 CC(NCCC(c1ccccc1)c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1405922 101776 30 None -4265 14 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 315 7 1 1 5.6 CC(NCCC(c1ccccc1)c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL254832 101776 30 None -4265 14 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 315 7 1 1 5.6 CC(NCCC(c1ccccc1)c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
3606 210267 60 None -2 8 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 270 5 2 2 4.8 CCC(c1ccc(O)cc1)C(CC)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL6615 210267 60 None -2 8 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 270 5 2 2 4.8 CCC(c1ccc(O)cc1)C(CC)c1ccc(O)cc1 10.1038/s41467-023-40064-9
667492 50679 43 None -1 4 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 234 1 2 3 0.2 CN1C(=O)/C(=N\NC(N)=S)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1512080 50679 43 None -1 4 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 234 1 2 3 0.2 CN1C(=O)/C(=N\NC(N)=S)c2ccccc21 10.1038/s41467-023-40064-9
60663 182448 42 None -29 12 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 495 11 1 5 5.3 COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C 10.1038/s41467-023-40064-9
CHEMBL1421212 182448 42 None -29 12 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 495 11 1 5 5.3 COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C 10.1038/s41467-023-40064-9
CHEMBL1534525 182448 42 None -29 12 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 495 11 1 5 5.3 COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C 10.1038/s41467-023-40064-9
CHEMBL45816 182448 42 None -29 12 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 495 11 1 5 5.3 COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C 10.1038/s41467-023-40064-9
CHEMBL4743867 220812 14 None -4466 15 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL None None None OCCN1CCN(CCC=C2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1 10.1038/s41467-023-40064-9
3952 8669 38 None -2570 21 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 10.1038/s41467-023-40064-9
5353646 8669 38 None -2570 21 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 10.1038/s41467-023-40064-9
5443 8669 38 None -2570 21 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 10.1038/s41467-023-40064-9
5702063 8669 38 None -2570 21 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 10.1038/s41467-023-40064-9
CHEMBL1331786 8669 38 None -2570 21 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 10.1038/s41467-023-40064-9
CHEMBL420 8669 38 None -2570 21 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 10.1038/s41467-023-40064-9
DB00629 8669 38 None -2570 21 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 10.1038/s41467-023-40064-9
5280795 11601 69 None -1 3 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 384 6 1 1 7.6 C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12 10.1038/s41467-023-40064-9
CHEMBL1042 11601 69 None -1 3 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 384 6 1 1 7.6 C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12 10.1038/s41467-023-40064-9
213046 9164 59 None -1445 17 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
4168 9164 59 None -1445 17 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
7461 9164 59 None -1445 17 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
CHEMBL1237021 9164 59 None -1445 17 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
DB08815 9164 59 None -1445 17 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
13791 50565 67 None -3 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 356 4 1 3 5.4 CCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@]12C 10.1038/s41467-023-40064-9
CHEMBL1511 50565 67 None -3 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 356 4 1 3 5.4 CCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@]12C 10.1038/s41467-023-40064-9
3634 90883 51 None -16 9 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 356 7 2 5 3.7 CCN(CC)CCNc1ccc(CO)c2sc3ccccc3c(=O)c12 10.1038/s41467-023-40064-9
CHEMBL22077 90883 51 None -16 9 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 356 7 2 5 3.7 CCN(CC)CCNc1ccc(CO)c2sc3ccccc3c(=O)c12 10.1038/s41467-023-40064-9
5625 206447 72 None -1 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 456 6 3 6 2.7 CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1 10.1038/s41467-023-40064-9
CHEMBL593 206447 72 None -1 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 456 6 3 6 2.7 CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1 10.1038/s41467-023-40064-9
6231 36543 33 None -8 4 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 0 1 2 3.6 C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
CHEMBL1387 36543 33 None -8 4 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 0 1 2 3.6 C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
277 8083 62 None -25118 29 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 10.1038/s41467-023-40064-9
2913 8083 62 None -25118 29 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 10.1038/s41467-023-40064-9
765 8083 62 None -25118 29 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 10.1038/s41467-023-40064-9
CHEMBL516 8083 62 None -25118 29 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 10.1038/s41467-023-40064-9
DB00434 8083 62 None -25118 29 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 10.1038/s41467-023-40064-9
2580 85170 18 None -1174 10 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 446 6 1 4 4.1 NC(=O)C1(N2CCCCC2)CCN(CCCN2c3ccccc3CCc3ccccc32)CC1 10.1038/s41467-023-40064-9
CHEMBL2110775 85170 18 None -1174 10 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 446 6 1 4 4.1 NC(=O)C1(N2CCCCC2)CCN(CCCN2c3ccccc3CCc3ccccc32)CC1 10.1038/s41467-023-40064-9
31703 201496 63 None -38 9 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 543 5 6 12 0.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
CHEMBL359744 201496 63 None -38 9 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 543 5 6 12 0.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
CHEMBL53463 201496 63 None -38 9 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 543 5 6 12 0.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
222528 8150 81 None -144 2 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 4 3 3 4.5 O[C@@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2C[C@H](O)[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)C 10.1038/s41467-023-40064-9
4988 8150 81 None -144 2 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 4 3 3 4.5 O[C@@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2C[C@H](O)[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)C 10.1038/s41467-023-40064-9
610 8150 81 None -144 2 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 4 3 3 4.5 O[C@@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2C[C@H](O)[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)C 10.1038/s41467-023-40064-9
CHEMBL406393 8150 81 None -144 2 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 4 3 3 4.5 O[C@@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2C[C@H](O)[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)C 10.1038/s41467-023-40064-9
DB03619 8150 81 None -144 2 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 4 3 3 4.5 O[C@@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2C[C@H](O)[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)C 10.1038/s41467-023-40064-9
21700 7380 53 None -4897 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 520 6 1 7 4.1 CCC(=O)O[C@@]1([C@@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2CCC2=CC(=O)C=C[C@]12C)Cl)C(=O)COC(=O)CC 10.1038/s41467-023-40064-9
294 7380 53 None -4897 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 520 6 1 7 4.1 CCC(=O)O[C@@]1([C@@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2CCC2=CC(=O)C=C[C@]12C)Cl)C(=O)COC(=O)CC 10.1038/s41467-023-40064-9
5894 7380 53 None -4897 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 520 6 1 7 4.1 CCC(=O)O[C@@]1([C@@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2CCC2=CC(=O)C=C[C@]12C)Cl)C(=O)COC(=O)CC 10.1038/s41467-023-40064-9
CHEMBL1200500 7380 53 None -4897 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 520 6 1 7 4.1 CCC(=O)O[C@@]1([C@@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2CCC2=CC(=O)C=C[C@]12C)Cl)C(=O)COC(=O)CC 10.1038/s41467-023-40064-9
DB00394 7380 53 None -4897 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 520 6 1 7 4.1 CCC(=O)O[C@@]1([C@@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2CCC2=CC(=O)C=C[C@]12C)Cl)C(=O)COC(=O)CC 10.1038/s41467-023-40064-9
65646 128079 26 None -2 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 6 2 9 0.8 Cc1oc(=O)oc1COC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1(C)C 10.1038/s41467-023-40064-9
CHEMBL3580454 128079 26 None -2 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 6 2 9 0.8 Cc1oc(=O)oc1COC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1(C)C 10.1038/s41467-023-40064-9
4167 21272 43 None -4677 10 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 309 2 0 2 5.0 CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1 10.1038/s41467-023-40064-9
CHEMBL1201342 21272 43 None -4677 10 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 309 2 0 2 5.0 CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1 10.1038/s41467-023-40064-9
DB00340 21272 43 None -4677 10 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 309 2 0 2 5.0 CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1 10.1038/s41467-023-40064-9
9051 21214 67 None -5 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 1 0 2 4.5 CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C 10.1038/s41467-023-40064-9
CHEMBL1200853 21214 67 None -5 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 1 0 2 4.5 CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C 10.1038/s41467-023-40064-9
1054 9691 85 None -83 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 282 15 1 1 6.1 CCCCCCCC/C=C\CCCCCCCC(=O)O 10.1038/s41467-023-40064-9
3400 9691 85 None -83 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 282 15 1 1 6.1 CCCCCCCC/C=C\CCCCCCCC(=O)O 10.1038/s41467-023-40064-9
445639 9691 85 None -83 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 282 15 1 1 6.1 CCCCCCCC/C=C\CCCCCCCC(=O)O 10.1038/s41467-023-40064-9
CHEMBL8659 9691 85 None -83 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 282 15 1 1 6.1 CCCCCCCC/C=C\CCCCCCCC(=O)O 10.1038/s41467-023-40064-9
2749 39417 101 None -1 3 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 207 1 1 3 2.4 Cc1cc(C2CCCCC2)n(O)c(=O)c1 10.1038/s41467-023-40064-9
CHEMBL1413 39417 101 None -1 3 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 207 1 1 3 2.4 Cc1cc(C2CCCCC2)n(O)c(=O)c1 10.1038/s41467-023-40064-9
72287 67835 38 None -1862 9 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 328 5 0 4 4.5 COc1ccc2c(c1)N(C[C@H](C)CN(C)C)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL1764 67835 38 None -1862 9 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 328 5 0 4 4.5 COc1ccc2c(c1)N(C[C@H](C)CN(C)C)c1ccccc1S2 10.1038/s41467-023-40064-9
DB01403 67835 38 None -1862 9 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 328 5 0 4 4.5 COc1ccc2c(c1)N(C[C@H](C)CN(C)C)c1ccccc1S2 10.1038/s41467-023-40064-9
180 7189 56 None -56234 38 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
200 7189 56 None -56234 38 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
2160 7189 56 None -56234 38 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL629 7189 56 None -56234 38 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00321 7189 56 None -56234 38 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
134780 175147 131 None - 1 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 273 1 2 5 -0.3 Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O 10.1038/s41467-023-40064-9
CHEMBL43452 175147 131 None - 1 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 273 1 2 5 -0.3 Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O 10.1038/s41467-023-40064-9
2406 107180 89 None -162 17 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 354 2 2 3 5.9 Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O 10.1038/s41467-023-40064-9
CHEMBL290106 107180 89 None -162 17 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 354 2 2 3 5.9 Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O 10.1038/s41467-023-40064-9
1884 9857 52 None -331 9 Human 5.6 pAC50 = 5.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O 10.1038/s41467-023-40064-9
5280363 9857 52 None -331 9 Human 5.6 pAC50 = 5.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O 10.1038/s41467-023-40064-9
912 9857 52 None -331 9 Human 5.6 pAC50 = 5.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O 10.1038/s41467-023-40064-9
CHEMBL815 9857 52 None -331 9 Human 5.6 pAC50 = 5.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O 10.1038/s41467-023-40064-9
DB12789 9857 52 None -331 9 Human 5.6 pAC50 = 5.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O 10.1038/s41467-023-40064-9
1440 8808 119 None -72 7 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 357 4 1 4 3.9 COc1ccc2c(c1)c(CC(=O)O)c(n2C(=O)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
1909 8808 119 None -72 7 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 357 4 1 4 3.9 COc1ccc2c(c1)c(CC(=O)O)c(n2C(=O)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
3715 8808 119 None -72 7 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 357 4 1 4 3.9 COc1ccc2c(c1)c(CC(=O)O)c(n2C(=O)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
CHEMBL6 8808 119 None -72 7 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 357 4 1 4 3.9 COc1ccc2c(c1)c(CC(=O)O)c(n2C(=O)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
DB00328 8808 119 None -72 7 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 357 4 1 4 3.9 COc1ccc2c(c1)c(CC(=O)O)c(n2C(=O)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
2723 160825 108 None -15 4 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 156 0 1 1 2.7 Cc1cc(O)cc(C)c1Cl 10.1038/s41467-023-40064-9
CHEMBL398440 160825 108 None -15 4 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 156 0 1 1 2.7 Cc1cc(O)cc(C)c1Cl 10.1038/s41467-023-40064-9
4756 23421 50 None -14 16 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 213 2 2 5 2.7 Nc1ccc(/N=N/c2ccccc2)c(N)n1 10.1038/s41467-023-40064-9
CHEMBL1201022 23421 50 None -14 16 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 213 2 2 5 2.7 Nc1ccc(/N=N/c2ccccc2)c(N)n1 10.1038/s41467-023-40064-9
CHEMBL1242 23421 50 None -14 16 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 213 2 2 5 2.7 Nc1ccc(/N=N/c2ccccc2)c(N)n1 10.1038/s41467-023-40064-9
9324 16010 60 None -5 6 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 2 0 4 4.8 CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
CHEMBL110691 16010 60 None -5 6 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 2 0 4 4.8 CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
108143 101356 107 None 1 2 Human 4.5 pAC50 = 4.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 351 3 2 2 5.0 CC1(C)CCC(C)(C)c2cc(NC(=O)c3ccc(C(=O)O)cc3)ccc21 10.1038/s41467-023-40064-9
CHEMBL25202 101356 107 None 1 2 Human 4.5 pAC50 = 4.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 351 3 2 2 5.0 CC1(C)CCC(C)(C)c2cc(NC(=O)c3ccc(C(=O)O)cc3)ccc21 10.1038/s41467-023-40064-9
1599 9120 50 None -15488 21 Human 4.5 pAC50 = 4.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
3955 9120 50 None -15488 21 Human 4.5 pAC50 = 4.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
7215 9120 50 None -15488 21 Human 4.5 pAC50 = 4.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL841 9120 50 None -15488 21 Human 4.5 pAC50 = 4.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
DB00836 9120 50 None -15488 21 Human 4.5 pAC50 = 4.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
6237 93579 46 None -3 8 Human 4.5 pAC50 = 4.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 518 3 1 3 5.1 CCc1oc2ccccc2c1C(=O)c1cc(I)c(O)c(I)c1 10.1038/s41467-023-40064-9
CHEMBL232201 93579 46 None -3 8 Human 4.5 pAC50 = 4.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 518 3 1 3 5.1 CCc1oc2ccccc2c1C(=O)c1cc(I)c(O)c(I)c1 10.1038/s41467-023-40064-9
24765256 180076 23 None -2 4 Human 4.5 pAC50 = 4.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 757 6 3 9 3.9 CC[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@H](C(C)(C)C)NC(=O)OCC(C)(C)CCCCc1cccc3c1CN(C3)C(=O)O2)C(=O)NS(=O)(=O)C1CC1 10.1038/s41467-023-40064-9
CHEMBL4525964 180076 23 None -2 4 Human 4.5 pAC50 = 4.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 757 6 3 9 3.9 CC[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@H](C(C)(C)C)NC(=O)OCC(C)(C)CCCCc1cccc3c1CN(C3)C(=O)O2)C(=O)NS(=O)(=O)C1CC1 10.1038/s41467-023-40064-9
4229 10507 57 None - 1 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 452 12 2 5 4.7 CC(OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/C(COc1ccccc1)(F)F)O)C 10.1038/s41467-023-40064-9
7451 10507 57 None - 1 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 452 12 2 5 4.7 CC(OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/C(COc1ccccc1)(F)F)O)C 10.1038/s41467-023-40064-9
9868491 10507 57 None - 1 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 452 12 2 5 4.7 CC(OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/C(COc1ccccc1)(F)F)O)C 10.1038/s41467-023-40064-9
CHEMBL1963683 10507 57 None - 1 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 452 12 2 5 4.7 CC(OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/C(COc1ccccc1)(F)F)O)C 10.1038/s41467-023-40064-9
DB08819 10507 57 None - 1 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 452 12 2 5 4.7 CC(OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/C(COc1ccccc1)(F)F)O)C 10.1038/s41467-023-40064-9
2028 9753 80 None -15135 14 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 4 3.3 CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC 10.1038/s41467-023-40064-9
359 9753 80 None -15135 14 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 4 3.3 CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC 10.1038/s41467-023-40064-9
4634 9753 80 None -15135 14 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 4 3.3 CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC 10.1038/s41467-023-40064-9
CHEMBL1231 9753 80 None -15135 14 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 4 3.3 CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC 10.1038/s41467-023-40064-9
DB01062 9753 80 None -15135 14 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 4 3.3 CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC 10.1038/s41467-023-40064-9
24821094 73868 93 None 1 8 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 440 5 1 7 4.2 C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1 10.1038/s41467-023-40064-9
CHEMBL1873475 73868 93 None 1 8 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 440 5 1 7 4.2 C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1 10.1038/s41467-023-40064-9
2683 109665 25 None -338 24 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 10.1038/s41467-023-40064-9
CHEMBL305906 109665 25 None -338 24 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 10.1038/s41467-023-40064-9
CHEMBL334255 109665 25 None -338 24 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 10.1038/s41467-023-40064-9
242 7258 124 None -758 32 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
34 7258 124 None -758 32 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
60795 7258 124 None -758 32 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
CHEMBL1112 7258 124 None -758 32 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
DB01238 7258 124 None -758 32 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
187 7043 39 None -7 8 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 146 3 0 2 0.3 CC(=O)OCC[N+](C)(C)C 10.1038/s41467-023-40064-9
294 7043 39 None -7 8 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 146 3 0 2 0.3 CC(=O)OCC[N+](C)(C)C 10.1038/s41467-023-40064-9
65 7043 39 None -7 8 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 146 3 0 2 0.3 CC(=O)OCC[N+](C)(C)C 10.1038/s41467-023-40064-9
8593 7043 39 None -7 8 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 146 3 0 2 0.3 CC(=O)OCC[N+](C)(C)C 10.1038/s41467-023-40064-9
CHEMBL667 7043 39 None -7 8 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 146 3 0 2 0.3 CC(=O)OCC[N+](C)(C)C 10.1038/s41467-023-40064-9
DB03128 7043 39 None -7 8 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 146 3 0 2 0.3 CC(=O)OCC[N+](C)(C)C 10.1038/s41467-023-40064-9
1570 64073 97 None -2 3 Human 5.4 pAC50 = 5.4 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 127 0 1 3 1.5 On1ccccc1=S 10.1038/s41467-023-40064-9
CHEMBL1650619 64073 97 None -2 3 Human 5.4 pAC50 = 5.4 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 127 0 1 3 1.5 On1ccccc1=S 10.1038/s41467-023-40064-9
5440 35497 37 None -1288 16 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 399 6 0 5 5.0 CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL1378 35497 37 None -1288 16 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 399 6 0 5 5.0 CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
DB00372 35497 37 None -1288 16 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 399 6 0 5 5.0 CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
123879 10060 82 None 1 6 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1038/s41467-023-40064-9
1910 10060 82 None 1 6 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1038/s41467-023-40064-9
1911 10060 82 None 1 6 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1038/s41467-023-40064-9
2354 10060 82 None 1 6 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1038/s41467-023-40064-9
CHEMBL361812 10060 82 None 1 6 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1038/s41467-023-40064-9
DB13036 10060 82 None 1 6 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1038/s41467-023-40064-9
54758501 145845 58 None -1445 11 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 486 7 2 8 5.1 C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccsc23)c1 10.1038/s41467-023-40064-9
CHEMBL3786343 145845 58 None -1445 11 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 486 7 2 8 5.1 C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccsc23)c1 10.1038/s41467-023-40064-9
443869 84916 45 None -3 10 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 491 7 1 8 3.8 COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@H]2CCN(Cc3ccccc3)C2)[C@H]1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
CHEMBL2103761 84916 45 None -3 10 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 491 7 1 8 3.8 COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@H]2CCN(Cc3ccccc3)C2)[C@H]1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
392622 63086 95 None -7 20 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 720 17 4 9 5.9 CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1 10.1038/s41467-023-40064-9
CHEMBL163 63086 95 None -7 20 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 720 17 4 9 5.9 CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1 10.1038/s41467-023-40064-9
1909 9598 64 None -11 11 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 479 9 1 8 3.7 COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C 10.1038/s41467-023-40064-9
2559 9598 64 None -11 11 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 479 9 1 8 3.7 COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C 10.1038/s41467-023-40064-9
4474 9598 64 None -11 11 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 479 9 1 8 3.7 COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C 10.1038/s41467-023-40064-9
CHEMBL1484 9598 64 None -11 11 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 479 9 1 8 3.7 COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C 10.1038/s41467-023-40064-9
CHEMBL3302409 9598 64 None -11 11 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 479 9 1 8 3.7 COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C 10.1038/s41467-023-40064-9
DB00622 9598 64 None -11 11 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 479 9 1 8 3.7 COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C 10.1038/s41467-023-40064-9
3356 9060 73 None -165 2 Human 8.2 pAC50 = 8.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1038/s41467-023-40064-9
4326 9060 73 None -165 2 Human 8.2 pAC50 = 8.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1038/s41467-023-40064-9
9867642 9060 73 None -165 2 Human 8.2 pAC50 = 8.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1038/s41467-023-40064-9
CHEMBL426559 9060 73 None -165 2 Human 8.2 pAC50 = 8.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1038/s41467-023-40064-9
DB11629 9060 73 None -165 2 Human 8.2 pAC50 = 8.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1038/s41467-023-40064-9
54454 12030 88 None -3 14 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 418 6 1 5 4.6 CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21 10.1038/s41467-023-40064-9
CHEMBL1064 12030 88 None -3 14 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 418 6 1 5 4.6 CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21 10.1038/s41467-023-40064-9
25102847 84996 93 None -8 10 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 501 8 2 6 5.5 COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC 10.1038/s41467-023-40064-9
CHEMBL2105717 84996 93 None -8 10 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 501 8 2 6 5.5 COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC 10.1038/s41467-023-40064-9
2162 48288 100 None -5 22 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1038/s41467-023-40064-9
CHEMBL1491 48288 100 None -5 22 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1038/s41467-023-40064-9
448537 167029 89 None -35 31 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL411 167029 89 None -35 31 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 10.1038/s41467-023-40064-9
82146 11302 113 None -2 8 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 348 3 1 1 6.1 C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C 10.1038/s41467-023-40064-9
CHEMBL1023 11302 113 None -2 8 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 348 3 1 1 6.1 C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C 10.1038/s41467-023-40064-9
3397 212267 112 None -1 8 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 3 1 3 3.2 CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1 10.1038/s41467-023-40064-9
CHEMBL806 212267 112 None -1 8 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 3 1 3 3.2 CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1 10.1038/s41467-023-40064-9
24826799 17570 104 None -19 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 532 4 1 6 4.5 Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12 10.1038/s41467-023-40064-9
CHEMBL1171837 17570 104 None -19 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 532 4 1 6 4.5 Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12 10.1038/s41467-023-40064-9
92727 211331 77 None -1 6 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 628 15 4 5 4.3 Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O 10.1038/s41467-023-40064-9
CHEMBL729 211331 77 None -1 6 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 628 15 4 5 4.3 Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O 10.1038/s41467-023-40064-9
11167602 77235 116 None -4 6 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 482 5 3 4 5.7 CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1 10.1038/s41467-023-40064-9
CHEMBL1946170 77235 116 None -4 6 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 482 5 3 4 5.7 CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1 10.1038/s41467-023-40064-9
1765 10589 98 None -100 8 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1038/s41467-023-40064-9
4184 10589 98 None -100 8 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1038/s41467-023-40064-9
9871419 10589 98 None -100 8 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1038/s41467-023-40064-9
CHEMBL398435 10589 98 None -100 8 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1038/s41467-023-40064-9
DB08816 10589 98 None -100 8 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1038/s41467-023-40064-9
2600 10551 74 None -190 32 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
2608 10551 74 None -190 32 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
5405 10551 74 None -190 32 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
CHEMBL17157 10551 74 None -190 32 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
DB00342 10551 74 None -190 32 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
9822750 85184 65 None -1 8 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)[C@@H]1c1ccccc1Cl 10.1038/s41467-023-40064-9
CHEMBL2111097 85184 65 None -1 8 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)[C@@H]1c1ccccc1Cl 10.1038/s41467-023-40064-9
5353853 24758 47 None -38 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
9556529 24758 47 None -38 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1262 24758 47 None -38 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
6719 39442 39 None -4 4 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 340 4 0 3 4.1 O=C1c2ccccc2C(=O)C1C(=O)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1413199 39442 39 None -4 4 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 340 4 0 3 4.1 O=C1c2ccccc2C(=O)C1C(=O)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
89683805 161212 67 None -2344 6 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 473 6 3 8 4.3 CC(C)(O)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1 10.1038/s41467-023-40064-9
CHEMBL3989908 161212 67 None -2344 6 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 473 6 3 8 4.3 CC(C)(O)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1 10.1038/s41467-023-40064-9
477468 182177 36 None 1 4 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 1269 18 16 23 -3.9 CCCCCOc1ccc(-c2cc(-c3ccc(C(=O)N[C@H]4C[C@@H](O)[C@@H](O)NC(=O)[C@@H]5[C@@H](O)[C@@H](C)CN5C(=O)[C@H]([C@H](O)CC(N)=O)NC(=O)[C@H]([C@H](O)[C@@H](O)c5ccc(O)c(OS(=O)(=O)O)c5)NC(=O)[C@@H]5C[C@@H](O)CN5C(=O)[C@H]([C@@H](C)O)NC4=O)cc3)no2)cc1 10.1038/s41467-023-40064-9
CHEMBL457547 182177 36 None 1 4 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 1269 18 16 23 -3.9 CCCCCOc1ccc(-c2cc(-c3ccc(C(=O)N[C@H]4C[C@@H](O)[C@@H](O)NC(=O)[C@@H]5[C@@H](O)[C@@H](C)CN5C(=O)[C@H]([C@H](O)CC(N)=O)NC(=O)[C@H]([C@H](O)[C@@H](O)c5ccc(O)c(OS(=O)(=O)O)c5)NC(=O)[C@@H]5C[C@@H](O)CN5C(=O)[C@H]([C@@H](C)O)NC4=O)cc3)no2)cc1 10.1038/s41467-023-40064-9
216237 10615 89 None -660 7 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 10.1038/s41467-023-40064-9
2226 10615 89 None -660 7 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 10.1038/s41467-023-40064-9
4110 10615 89 None -660 7 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 10.1038/s41467-023-40064-9
443894 10615 89 None -660 7 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 10.1038/s41467-023-40064-9
CHEMBL344159 10615 89 None -660 7 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 10.1038/s41467-023-40064-9
DB06212 10615 89 None -660 7 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 10.1038/s41467-023-40064-9
115368 9830 47 None -2454 9 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 6 0 6 3.4 O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1CCCC2 10.1038/s41467-023-40064-9
2112 9830 47 None -2454 9 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 6 0 6 3.4 O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1CCCC2 10.1038/s41467-023-40064-9
7556 9830 47 None -2454 9 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 6 0 6 3.4 O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1CCCC2 10.1038/s41467-023-40064-9
CHEMBL1472975 9830 47 None -2454 9 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 6 0 6 3.4 O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1CCCC2 10.1038/s41467-023-40064-9
DB08922 9830 47 None -2454 9 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 6 0 6 3.4 O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1CCCC2 10.1038/s41467-023-40064-9
34040 34858 72 None -2511 11 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 483 4 0 6 3.9 CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13 10.1038/s41467-023-40064-9
CHEMBL1372950 34858 72 None -2511 11 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 483 4 0 6 3.9 CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13 10.1038/s41467-023-40064-9
DB00699 34858 72 None -2511 11 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 483 4 0 6 3.9 CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13 10.1038/s41467-023-40064-9
150311 16584 102 None -1 7 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 409 6 2 3 4.9 O=C1[C@H](CC[C@H](O)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1 10.1038/s41467-023-40064-9
CHEMBL1138 16584 102 None -1 7 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 409 6 2 3 4.9 O=C1[C@H](CC[C@H](O)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1 10.1038/s41467-023-40064-9
3839 10529 84 None -794 2 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 411 4 1 6 3.4 Cc1nc(C)c2c(n1)N(Cc1ccc(cc1)c1ccccc1c1nn[nH]n1)C(=O)CC2 10.1038/s41467-023-40064-9
60919 10529 84 None -794 2 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 411 4 1 6 3.4 Cc1nc(C)c2c(n1)N(Cc1ccc(cc1)c1ccccc1c1nn[nH]n1)C(=O)CC2 10.1038/s41467-023-40064-9
6898 10529 84 None -794 2 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 411 4 1 6 3.4 Cc1nc(C)c2c(n1)N(Cc1ccc(cc1)c1ccccc1c1nn[nH]n1)C(=O)CC2 10.1038/s41467-023-40064-9
CHEMBL432162 10529 84 None -794 2 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 411 4 1 6 3.4 Cc1nc(C)c2c(n1)N(Cc1ccc(cc1)c1ccccc1c1nn[nH]n1)C(=O)CC2 10.1038/s41467-023-40064-9
DB01349 10529 84 None -794 2 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 411 4 1 6 3.4 Cc1nc(C)c2c(n1)N(Cc1ccc(cc1)c1ccccc1c1nn[nH]n1)C(=O)CC2 10.1038/s41467-023-40064-9
151537 169443 49 None -1 5 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 543 5 6 12 0.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
41867 169443 49 None -1 5 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 543 5 6 12 0.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
CHEMBL417 169443 49 None -1 5 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 543 5 6 12 0.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
1726 9275 13 None -104 8 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 160 3 0 2 0.6 CC(C[N+](C)(C)C)OC(=O)C 10.1038/s41467-023-40064-9
1993 9275 13 None -104 8 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 160 3 0 2 0.6 CC(C[N+](C)(C)C)OC(=O)C 10.1038/s41467-023-40064-9
7438 9275 13 None -104 8 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 160 3 0 2 0.6 CC(C[N+](C)(C)C)OC(=O)C 10.1038/s41467-023-40064-9
CHEMBL978 9275 13 None -104 8 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 160 3 0 2 0.6 CC(C[N+](C)(C)C)OC(=O)C 10.1038/s41467-023-40064-9
DB06709 9275 13 None -104 8 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 160 3 0 2 0.6 CC(C[N+](C)(C)C)OC(=O)C 10.1038/s41467-023-40064-9
9853053 127297 74 None -5 9 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 693 10 2 3 8.4 O=C(NC1CCN(CCCCC2(C(=O)NCC(F)(F)F)c3ccccc3-c3ccccc32)CC1)c1ccccc1-c1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
CHEMBL354541 127297 74 None -5 9 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 693 10 2 3 8.4 O=C(NC1CCN(CCCCC2(C(=O)NCC(F)(F)F)c3ccccc3-c3ccccc32)CC1)c1ccccc1-c1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
CHEMBL4743867 220812 14 None -4466 15 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL None None None OCCN1CCN(CCC=C2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1 10.1038/s41467-023-40064-9
25151352 147384 67 None -24 11 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 417 5 2 4 5.2 FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1 10.1038/s41467-023-40064-9
CHEMBL3813873 147384 67 None -24 11 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 417 5 2 4 5.2 FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1 10.1038/s41467-023-40064-9
11976 7707 59 None -2884 16 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 315 3 0 2 5.2 CN(C)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)Cl 10.1038/s41467-023-40064-9
667467 7707 59 None -2884 16 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 315 3 0 2 5.2 CN(C)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)Cl 10.1038/s41467-023-40064-9
CHEMBL908 7707 59 None -2884 16 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 315 3 0 2 5.2 CN(C)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)Cl 10.1038/s41467-023-40064-9
DB01239 7707 59 None -2884 16 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 315 3 0 2 5.2 CN(C)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)Cl 10.1038/s41467-023-40064-9
6324616 175603 25 None -1 3 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 697 2 6 12 4.8 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(cc(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
CHEMBL437765 175603 25 None -1 3 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 697 2 6 12 4.8 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(cc(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
43082 67057 37 None -22 10 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 6 0 2 5.5 CC(OCCN1CCCCCC1)(c1ccccc1)c1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL1742452 67057 37 None -22 10 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 6 0 2 5.5 CC(OCCN1CCCCCC1)(c1ccccc1)c1ccc(Cl)cc1 10.1038/s41467-023-40064-9
9429 208912 58 None -977 18 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 446 6 0 6 3.2 CN1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1 10.1038/s41467-023-40064-9
CHEMBL609109 208912 58 None -977 18 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 446 6 0 6 3.2 CN1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1 10.1038/s41467-023-40064-9
DB01622 208912 58 None -977 18 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 446 6 0 6 3.2 CN1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1 10.1038/s41467-023-40064-9
5584 209990 44 None -537 9 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 294 4 0 2 4.1 CC(CN(C)C)CN1c2ccccc2CCc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL644 209990 44 None -537 9 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 294 4 0 2 4.1 CC(CN(C)C)CN1c2ccccc2CCc2ccccc21 10.1038/s41467-023-40064-9
DB00726 209990 44 None -537 9 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 294 4 0 2 4.1 CC(CN(C)C)CN1c2ccccc2CCc2ccccc21 10.1038/s41467-023-40064-9
4829 206735 108 None -1 3 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 356 7 1 5 3.2 CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1 10.1038/s41467-023-40064-9
CHEMBL595 206735 108 None -1 3 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 356 7 1 5 3.2 CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1 10.1038/s41467-023-40064-9
5832 21232 54 None -11 5 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 1 0 3 4.1 C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
CHEMBL1201146 21232 54 None -11 5 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 1 0 3 4.1 C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
3474 44875 57 None -3 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 372 6 3 6 3.1 O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12 10.1038/s41467-023-40064-9
CHEMBL146095 44875 57 None -3 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 372 6 3 6 3.1 O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12 10.1038/s41467-023-40064-9
108143 101356 107 None 1 2 Human 5.0 pAC50 = 5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 351 3 2 2 5.0 CC1(C)CCC(C)(C)c2cc(NC(=O)c3ccc(C(=O)O)cc3)ccc21 10.1038/s41467-023-40064-9
CHEMBL25202 101356 107 None 1 2 Human 5.0 pAC50 = 5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 351 3 2 2 5.0 CC1(C)CCC(C)(C)c2cc(NC(=O)c3ccc(C(=O)O)cc3)ccc21 10.1038/s41467-023-40064-9
56839344 158830 0 None 10 8 Human 9.5 pEC50 = 9.5 Functional
Cell Based Assay: Ca2+ signaling studies were performed using a FLIPR TETRA system (Molecular Devices, Sunnyvale, Calif., USA) in the 384-format. This is a high-throughput instrument for cell-based assays to monitor Ca2+ signaling associated with GPCRs and ion channels. Cells were seeded at a density of 5×104 cells/well in BioCoat poly-D-lysine coated, black wall, clear bottom 384-well plates (BD Biosciences, Franklin lakes, NJ, USA) and allowed to attach overnight in an incubator at 37° C. The cells were then washed twice with HBSS-HEPES buffer (Hanks' balanced salt solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using an ELx405 Select CW Microplate Washer (BioTek, Winooski, Vt., USA). After 60 min of dye-loading in the dark using the Ca2+-sensitive dye Fluo-4AM (Invitrogen, Carlsbad, Calif., USA), at a final concentration of 2×10^−6M, the plates were washed 4 times with HBSS-HEPES buffer to remove excess dye and leaving 50 μl of buffer in each well. The plates were then placed in the FLIPR TETRA instrument and allowed to equilibrate at 37° C. AGN-211377 was added in a 25 μl volume to each well to give final concentrations of 0.1 μM, 0.3 μM, 1 μM, 3 μM, 10 μM, and 30 μM; or 0.067 μM, 0.1 μM, 0.2 μM, 0.3 μM, 0.67 μM, and 1 μM for cells over-expressing TP receptors. After 4.5 minutes, a 7-point serial dilution of the standard agonist for the corresponding receptor, in a 25 μl volume was injected at the final concentrations from 10^−11M to 10^−5M in 10-fold serial dilution increments for cells expressing human recombinant DP1, EP1, EP2, EP3, EP4, FP, and IP receptors. The dose range for the standard agonist for human recombinant TP receptors was from 10^−12M to 10^−6M. HBSS-HEPES buffer was used as the negative control for the standard agonists. Cells were excited with LED (light emitting diode) excitation at 470-495 nm and emission was measured through an emission filter at 515-575 nm. Assay plates were read for 3.5 minutes using the FLIPRTETRA.Cell Based Assay: Ca2+ signaling studies were performed using a FLIPR TETRA system (Molecular Devices, Sunnyvale, Calif., USA) in the 384-format. This is a high-throughput instrument for cell-based assays to monitor Ca2+ signaling associated with GPCRs and ion channels. Cells were seeded at a density of 5×104 cells/well in BioCoat poly-D-lysine coated, black wall, clear bottom 384-well plates (BD Biosciences, Franklin lakes, NJ, USA) and allowed to attach overnight in an incubator at 37° C. The cells were then washed twice with HBSS-HEPES buffer (Hanks' balanced salt solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using an ELx405 Select CW Microplate Washer (BioTek, Winooski, Vt., USA). After 60 min of dye-loading in the dark using the Ca2+-sensitive dye Fluo-4AM (Invitrogen, Carlsbad, Calif., USA), at a final concentration of 2×10^−6M, the plates were washed 4 times with HBSS-HEPES buffer to remove excess dye and leaving 50 μl of buffer in each well. The plates were then placed in the FLIPR TETRA instrument and allowed to equilibrate at 37° C. AGN-211377 was added in a 25 μl volume to each well to give final concentrations of 0.1 μM, 0.3 μM, 1 μM, 3 μM, 10 μM, and 30 μM; or 0.067 μM, 0.1 μM, 0.2 μM, 0.3 μM, 0.67 μM, and 1 μM for cells over-expressing TP receptors. After 4.5 minutes, a 7-point serial dilution of the standard agonist for the corresponding receptor, in a 25 μl volume was injected at the final concentrations from 10^−11M to 10^−5M in 10-fold serial dilution increments for cells expressing human recombinant DP1, EP1, EP2, EP3, EP4, FP, and IP receptors. The dose range for the standard agonist for human recombinant TP receptors was from 10^−12M to 10^−6M. HBSS-HEPES buffer was used as the negative control for the standard agonists. Cells were excited with LED (light emitting diode) excitation at 470-495 nm and emission was measured through an emission filter at 515-575 nm. Assay plates were read for 3.5 minutes using the FLIPRTETRA.
ChEMBL 656 13 2 9 5.1 O=C(CCc1cc2c(cc1CN1CCC[C@H]1c1nc(C(=O)NCCCCC3CCCCC3)co1)OCO2)NS(=O)(=O)C(F)(F)F nan
CHEMBL3967284 158830 0 None 10 8 Human 9.5 pEC50 = 9.5 Functional
Cell Based Assay: Ca2+ signaling studies were performed using a FLIPR TETRA system (Molecular Devices, Sunnyvale, Calif., USA) in the 384-format. This is a high-throughput instrument for cell-based assays to monitor Ca2+ signaling associated with GPCRs and ion channels. Cells were seeded at a density of 5×104 cells/well in BioCoat poly-D-lysine coated, black wall, clear bottom 384-well plates (BD Biosciences, Franklin lakes, NJ, USA) and allowed to attach overnight in an incubator at 37° C. The cells were then washed twice with HBSS-HEPES buffer (Hanks' balanced salt solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using an ELx405 Select CW Microplate Washer (BioTek, Winooski, Vt., USA). After 60 min of dye-loading in the dark using the Ca2+-sensitive dye Fluo-4AM (Invitrogen, Carlsbad, Calif., USA), at a final concentration of 2×10^−6M, the plates were washed 4 times with HBSS-HEPES buffer to remove excess dye and leaving 50 μl of buffer in each well. The plates were then placed in the FLIPR TETRA instrument and allowed to equilibrate at 37° C. AGN-211377 was added in a 25 μl volume to each well to give final concentrations of 0.1 μM, 0.3 μM, 1 μM, 3 μM, 10 μM, and 30 μM; or 0.067 μM, 0.1 μM, 0.2 μM, 0.3 μM, 0.67 μM, and 1 μM for cells over-expressing TP receptors. After 4.5 minutes, a 7-point serial dilution of the standard agonist for the corresponding receptor, in a 25 μl volume was injected at the final concentrations from 10^−11M to 10^−5M in 10-fold serial dilution increments for cells expressing human recombinant DP1, EP1, EP2, EP3, EP4, FP, and IP receptors. The dose range for the standard agonist for human recombinant TP receptors was from 10^−12M to 10^−6M. HBSS-HEPES buffer was used as the negative control for the standard agonists. Cells were excited with LED (light emitting diode) excitation at 470-495 nm and emission was measured through an emission filter at 515-575 nm. Assay plates were read for 3.5 minutes using the FLIPRTETRA.Cell Based Assay: Ca2+ signaling studies were performed using a FLIPR TETRA system (Molecular Devices, Sunnyvale, Calif., USA) in the 384-format. This is a high-throughput instrument for cell-based assays to monitor Ca2+ signaling associated with GPCRs and ion channels. Cells were seeded at a density of 5×104 cells/well in BioCoat poly-D-lysine coated, black wall, clear bottom 384-well plates (BD Biosciences, Franklin lakes, NJ, USA) and allowed to attach overnight in an incubator at 37° C. The cells were then washed twice with HBSS-HEPES buffer (Hanks' balanced salt solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using an ELx405 Select CW Microplate Washer (BioTek, Winooski, Vt., USA). After 60 min of dye-loading in the dark using the Ca2+-sensitive dye Fluo-4AM (Invitrogen, Carlsbad, Calif., USA), at a final concentration of 2×10^−6M, the plates were washed 4 times with HBSS-HEPES buffer to remove excess dye and leaving 50 μl of buffer in each well. The plates were then placed in the FLIPR TETRA instrument and allowed to equilibrate at 37° C. AGN-211377 was added in a 25 μl volume to each well to give final concentrations of 0.1 μM, 0.3 μM, 1 μM, 3 μM, 10 μM, and 30 μM; or 0.067 μM, 0.1 μM, 0.2 μM, 0.3 μM, 0.67 μM, and 1 μM for cells over-expressing TP receptors. After 4.5 minutes, a 7-point serial dilution of the standard agonist for the corresponding receptor, in a 25 μl volume was injected at the final concentrations from 10^−11M to 10^−5M in 10-fold serial dilution increments for cells expressing human recombinant DP1, EP1, EP2, EP3, EP4, FP, and IP receptors. The dose range for the standard agonist for human recombinant TP receptors was from 10^−12M to 10^−6M. HBSS-HEPES buffer was used as the negative control for the standard agonists. Cells were excited with LED (light emitting diode) excitation at 470-495 nm and emission was measured through an emission filter at 515-575 nm. Assay plates were read for 3.5 minutes using the FLIPRTETRA.
ChEMBL 656 13 2 9 5.1 O=C(CCc1cc2c(cc1CN1CCC[C@H]1c1nc(C(=O)NCCCCC3CCCCC3)co1)OCO2)NS(=O)(=O)C(F)(F)F nan
118517359 151174 0 None -213 4 Human 7.0 pEC50 = 7 Functional
FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.
ChEMBL 456 8 2 3 4.8 O=C(O)c1ccc(CC[C@H]2C(=O)CC[C@@H]2/C=C/C(O)Cc2cccc(Br)c2)cc1 nan
CHEMBL3906016 151174 0 None -213 4 Human 7.0 pEC50 = 7 Functional
FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.
ChEMBL 456 8 2 3 4.8 O=C(O)c1ccc(CC[C@H]2C(=O)CC[C@@H]2/C=C/C(O)Cc2cccc(Br)c2)cc1 nan
118517359 151174 0 None -213 4 Human 7.0 pEC50 = 7.0 Functional
FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.
ChEMBL 456 8 2 3 4.8 O=C(O)c1ccc(CC[C@H]2C(=O)CC[C@@H]2/C=C/C(O)Cc2cccc(Br)c2)cc1 nan
CHEMBL3906016 151174 0 None -213 4 Human 7.0 pEC50 = 7.0 Functional
FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.
ChEMBL 456 8 2 3 4.8 O=C(O)c1ccc(CC[C@H]2C(=O)CC[C@@H]2/C=C/C(O)Cc2cccc(Br)c2)cc1 nan
11955193 150362 0 None -10 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assayAgonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay
ChEMBL 378 7 2 2 5.3 CC(C)(C)c1ccc([C@H]2[C@H](O)C[C@@H](Cl)[C@@H]2C/C=C\CCCC(=O)O)cc1 nan
CHEMBL3899346 150362 0 None -10 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assayAgonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay
ChEMBL 378 7 2 2 5.3 CC(C)(C)c1ccc([C@H]2[C@H](O)C[C@@H](Cl)[C@@H]2C/C=C\CCCC(=O)O)cc1 nan
1884 9857 52 None -331 9 Human 5.9 pEC50 = 5.9 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=95%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=95%)
ChEMBL 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O 10.1016/s0960-894x(00)00273-0
5280363 9857 52 None -331 9 Human 5.9 pEC50 = 5.9 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=95%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=95%)
ChEMBL 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O 10.1016/s0960-894x(00)00273-0
912 9857 52 None -331 9 Human 5.9 pEC50 = 5.9 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=95%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=95%)
ChEMBL 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O 10.1016/s0960-894x(00)00273-0
CHEMBL815 9857 52 None -331 9 Human 5.9 pEC50 = 5.9 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=95%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=95%)
ChEMBL 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O 10.1016/s0960-894x(00)00273-0
DB12789 9857 52 None -331 9 Human 5.9 pEC50 = 5.9 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=95%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=95%)
ChEMBL 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O 10.1016/s0960-894x(00)00273-0
11955293 156620 0 None 1 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assayAgonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay
ChEMBL 394 8 2 4 4.3 COC(=O)CCCCCC[C@@H]1[C@@H](c2ccc3c(c2)CCC3O)[C@H](O)C[C@H]1Cl nan
CHEMBL3948932 156620 0 None 1 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assayAgonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay
ChEMBL 394 8 2 4 4.3 COC(=O)CCCCCC[C@@H]1[C@@H](c2ccc3c(c2)CCC3O)[C@H](O)C[C@H]1Cl nan
11955358 159861 0 None 1 3 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assayAgonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay
ChEMBL 364 8 2 2 4.7 O=C(O)CCCCCC[C@@H]1[C@@H](c2ccc3c(c2)CCC3)[C@H](O)C[C@H]1Cl nan
CHEMBL3976116 159861 0 None 1 3 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assayAgonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay
ChEMBL 364 8 2 2 4.7 O=C(O)CCCCCC[C@@H]1[C@@H](c2ccc3c(c2)CCC3)[C@H](O)C[C@H]1Cl nan
9825293 106831 9 None -83 2 Human 5.7 pEC50 = 5.7 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=50%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=50%)
ChEMBL 456 11 4 4 4.1 O=C(O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)CCc1cccc(C(F)(F)F)c1 10.1016/s0960-894x(00)00273-0
CHEMBL287080 106831 9 None -83 2 Human 5.7 pEC50 = 5.7 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=50%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=50%)
ChEMBL 456 11 4 4 4.1 O=C(O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)CCc1cccc(C(F)(F)F)c1 10.1016/s0960-894x(00)00273-0
118517361 160149 0 None -123 3 Human 6.7 pEC50 = 6.7 Functional
FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.
ChEMBL 446 8 2 3 5.1 O=C(O)c1ccc(CC[C@H]2C(=O)CC[C@@H]2/C=C/C(O)Cc2cccc(C(F)(F)F)c2)cc1 nan
CHEMBL3978590 160149 0 None -123 3 Human 6.7 pEC50 = 6.7 Functional
FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.
ChEMBL 446 8 2 3 5.1 O=C(O)c1ccc(CC[C@H]2C(=O)CC[C@@H]2/C=C/C(O)Cc2cccc(C(F)(F)F)c2)cc1 nan
6441607 161858 28 None 1 4 Human 7.6 pEC50 = 7.6 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=95%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=95%)
ChEMBL 382 12 4 4 3.7 CCCCC(C)(C)[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O 10.1016/s0960-894x(00)00273-0
CHEMBL40183 161858 28 None 1 4 Human 7.6 pEC50 = 7.6 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=95%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=95%)
ChEMBL 382 12 4 4 3.7 CCCCC(C)(C)[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O 10.1016/s0960-894x(00)00273-0
1894 7744 41 None -891 5 Human 5.6 pEC50 = 5.6 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=100%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=100%)
ChEMBL 424 11 4 5 3.2 OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)Cl)O)O 10.1016/s0960-894x(00)00273-0
5311053 7744 41 None -891 5 Human 5.6 pEC50 = 5.6 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=100%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=100%)
ChEMBL 424 11 4 5 3.2 OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)Cl)O)O 10.1016/s0960-894x(00)00273-0
CHEMBL37853 7744 41 None -891 5 Human 5.6 pEC50 = 5.6 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=100%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=100%)
ChEMBL 424 11 4 5 3.2 OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)Cl)O)O 10.1016/s0960-894x(00)00273-0
DB11507 7744 41 None -891 5 Human 5.6 pEC50 = 5.6 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=100%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=100%)
ChEMBL 424 11 4 5 3.2 OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)Cl)O)O 10.1016/s0960-894x(00)00273-0
118517490 159934 0 None -977 4 Human 5.6 pEC50 = 5.6 Functional
FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.
ChEMBL 414 8 2 3 4.4 O=C(O)c1ccc(CC[C@H]2C(=O)CC[C@@H]2/C=C/C(O)Cc2ccc(F)c(F)c2)cc1 nan
CHEMBL3976710 159934 0 None -977 4 Human 5.6 pEC50 = 5.6 Functional
FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.
ChEMBL 414 8 2 3 4.4 O=C(O)c1ccc(CC[C@H]2C(=O)CC[C@@H]2/C=C/C(O)Cc2ccc(F)c(F)c2)cc1 nan
11955294 151546 0 None -1 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assayAgonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay
ChEMBL 380 8 3 3 4.2 O=C(O)CCCCCC[C@@H]1[C@@H](c2ccc3c(c2)CCC3O)[C@H](O)C[C@H]1Cl nan
CHEMBL3909111 151546 0 None -1 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assayAgonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay
ChEMBL 380 8 3 3 4.2 O=C(O)CCCCCC[C@@H]1[C@@H](c2ccc3c(c2)CCC3O)[C@H](O)C[C@H]1Cl nan
5311239 137396 31 None -30 3 Human 4.5 pEC50 = 4.5 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=100%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=100%)
ChEMBL 358 14 4 4 3.5 CCCCC[C@H](O)CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1CCCCCCC(=O)O 10.1016/s0960-894x(00)00273-0
CHEMBL36817 137396 31 None -30 3 Human 4.5 pEC50 = 4.5 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=100%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=100%)
ChEMBL 358 14 4 4 3.5 CCCCC[C@H](O)CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1CCCCCCC(=O)O 10.1016/s0960-894x(00)00273-0
11955384 154316 0 None -41 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assayAgonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay
ChEMBL 360 8 2 3 4.4 CC(C)(C)c1ccc([C@H]2[C@H](O)CC(=O)[C@@H]2CCCCCCC(=O)O)cc1 nan
CHEMBL3930718 154316 0 None -41 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assayAgonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay
ChEMBL 360 8 2 3 4.4 CC(C)(C)c1ccc([C@H]2[C@H](O)CC(=O)[C@@H]2CCCCCCC(=O)O)cc1 nan
118517360 150753 0 None -2398 3 Human 5.3 pEC50 = 5.3 Functional
FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.
ChEMBL 412 8 2 3 4.7 O=C(O)c1ccc(CC[C@H]2C(=O)CC[C@@H]2/C=C/C(O)Cc2cccc(Cl)c2)cc1 nan
CHEMBL3902700 150753 0 None -2398 3 Human 5.3 pEC50 = 5.3 Functional
FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.
ChEMBL 412 8 2 3 4.7 O=C(O)c1ccc(CC[C@H]2C(=O)CC[C@@H]2/C=C/C(O)Cc2cccc(Cl)c2)cc1 nan
11955357 155407 0 None 26 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assayAgonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay
ChEMBL 378 8 1 3 4.8 COC(=O)CCCCCC[C@@H]1[C@@H](c2ccc3c(c2)CCC3)[C@H](O)C[C@H]1Cl nan
CHEMBL3939358 155407 0 None 26 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assayAgonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay
ChEMBL 378 8 1 3 4.8 COC(=O)CCCCCC[C@@H]1[C@@H](c2ccc3c(c2)CCC3)[C@H](O)C[C@H]1Cl nan
118517485 149528 0 None -2041 4 Human 5.3 pEC50 = 5.3 Functional
FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.
ChEMBL 396 8 2 3 4.2 O=C(O)c1ccc(CC[C@H]2C(=O)CC[C@@H]2/C=C/C(O)Cc2ccc(F)cc2)cc1 nan
CHEMBL3892492 149528 0 None -2041 4 Human 5.3 pEC50 = 5.3 Functional
FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.
ChEMBL 396 8 2 3 4.2 O=C(O)c1ccc(CC[C@H]2C(=O)CC[C@@H]2/C=C/C(O)Cc2ccc(F)cc2)cc1 nan
92135977 159675 0 None -36307 4 Human 5.1 pEC50 = 5.1 Functional
FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.
ChEMBL 396 8 2 3 4.2 O=C(O)c1ccc(CC[C@H]2C(=O)CC[C@@H]2/C=C/C(O)Cc2cccc(F)c2)cc1 nan
CHEMBL3974652 159675 0 None -36307 4 Human 5.1 pEC50 = 5.1 Functional
FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.
ChEMBL 396 8 2 3 4.2 O=C(O)c1ccc(CC[C@H]2C(=O)CC[C@@H]2/C=C/C(O)Cc2cccc(F)c2)cc1 nan
1955 6805 1 None -3235 5 Human 5.1 pEC50 = 5.1 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=90%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=90%)
ChEMBL 428 13 4 5 3.6 O[C@@H](COc1cccc(c1)Cl)CC[C@H]1[C@H](O)C[C@@H]([C@@H]1CCCCCCC(=O)O)O 10.1016/s0960-894x(00)00273-0
5311240 6805 1 None -3235 5 Human 5.1 pEC50 = 5.1 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=90%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=90%)
ChEMBL 428 13 4 5 3.6 O[C@@H](COc1cccc(c1)Cl)CC[C@H]1[C@H](O)C[C@@H]([C@@H]1CCCCCCC(=O)O)O 10.1016/s0960-894x(00)00273-0
CHEMBL36041 6805 1 None -3235 5 Human 5.1 pEC50 = 5.1 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=90%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=90%)
ChEMBL 428 13 4 5 3.6 O[C@@H](COc1cccc(c1)Cl)CC[C@H]1[C@H](O)C[C@@H]([C@@H]1CCCCCCC(=O)O)O 10.1016/s0960-894x(00)00273-0
58681361 151459 0 None 19 3 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assayAgonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay
ChEMBL 318 8 2 3 3.5 Cc1ccc([C@H]2[C@H](O)CC(=O)[C@@H]2CCCCCCC(=O)O)cc1 nan
CHEMBL3908432 151459 0 None 19 3 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assayAgonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay
ChEMBL 318 8 2 3 3.5 Cc1ccc([C@H]2[C@H](O)CC(=O)[C@@H]2CCCCCCC(=O)O)cc1 nan
117630978 122648 0 None - 1 Human 10.8 pIC50 = 10.8 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 535 6 2 4 5.9 Cc1cccc(C)c1C1=C(O)CC(Cc2cccc3c2CCC(NS(=O)(=O)c2ccc(Cl)cc2)C3)C1=O 10.1021/ml5002085
CHEMBL3354618 122648 0 None - 1 Human 10.8 pIC50 = 10.8 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 535 6 2 4 5.9 Cc1cccc(C)c1C1=C(O)CC(Cc2cccc3c2CCC(NS(=O)(=O)c2ccc(Cl)cc2)C3)C1=O 10.1021/ml5002085
117631354 122646 0 None - 1 Human 10.3 pIC50 = 10.3 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 537 7 2 5 5.3 COc1ccc(C2=C(O)CC(Cc3cccc4c3CCC(NS(=O)(=O)c3ccc(Cl)cc3)C4)C2=O)cc1 10.1021/ml5002085
CHEMBL3354616 122646 0 None - 1 Human 10.3 pIC50 = 10.3 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 537 7 2 5 5.3 COc1ccc(C2=C(O)CC(Cc3cccc4c3CCC(NS(=O)(=O)c3ccc(Cl)cc3)C4)C2=O)cc1 10.1021/ml5002085
131116 21515 3 None - 1 Rat 9.1 pIC50 = 9.1 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 495 9 2 4 5.1 CC(C)c1ccc2c(CCCCNS(=O)(=O)c3ccc(Cl)cc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL1206329 21515 3 None - 1 Rat 9.1 pIC50 = 9.1 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 495 9 2 4 5.1 CC(C)c1ccc2c(CCCCNS(=O)(=O)c3ccc(Cl)cc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL262655 21515 3 None - 1 Rat 9.1 pIC50 = 9.1 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 495 9 2 4 5.1 CC(C)c1ccc2c(CCCCNS(=O)(=O)c3ccc(Cl)cc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
118714499 121284 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 379 5 2 3 2.8 O=C(O)Cc1cccc2c1CCC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1021/ml5002085
CHEMBL3335473 121284 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 379 5 2 3 2.8 O=C(O)Cc1cccc2c1CCC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1021/ml5002085
15745527 209726 0 None - 1 Human 7.0 pIC50 = 7 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 385 7 4 4 3.4 O=C(O)CCC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccccc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL62937 209726 0 None - 1 Human 7.0 pIC50 = 7 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 385 7 4 4 3.4 O=C(O)CCC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccccc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
10764618 90027 0 None - 1 Human 6.0 pIC50 = 6 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 420 10 3 5 3.2 CN(C)CC/N=C(/NC#N)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL21874 90027 0 None - 1 Human 6.0 pIC50 = 6 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 420 10 3 5 3.2 CN(C)CC/N=C(/NC#N)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
44387221 136868 0 None - 1 Human 6.0 pIC50 = 6 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 326 11 1 3 4.5 CCCCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL367721 136868 0 None - 1 Human 6.0 pIC50 = 6 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 326 11 1 3 4.5 CCCCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
44385988 135797 0 None - 1 Human 5.0 pIC50 = 5 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 370 13 2 4 4.3 CCCCC(O)CSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL366990 135797 0 None - 1 Human 5.0 pIC50 = 5 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 370 13 2 4 4.3 CCCCC(O)CSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
44353269 26821 0 None - 1 Human 5.0 pIC50 = 5 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(\c1cccc(C(F)(F)F)c1)c1cccnn1 10.1021/jm960341g
CHEMBL130365 26821 0 None - 1 Human 5.0 pIC50 = 5 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(\c1cccc(C(F)(F)F)c1)c1cccnn1 10.1021/jm960341g
18921506 21434 0 None - 1 Human 4.0 pIC50 = 4 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 407 8 2 3 3.9 O=C(O)c1ccc2c(c1)CC(CCCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205657 21434 0 None - 1 Human 4.0 pIC50 = 4 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 407 8 2 3 3.9 O=C(O)c1ccc2c(c1)CC(CCCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL130045 21434 0 None - 1 Human 4.0 pIC50 = 4 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 407 8 2 3 3.9 O=C(O)c1ccc2c(c1)CC(CCCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
16757078 99387 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 485 9 2 6 4.3 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Br)cc1 10.1021/jm070427h
CHEMBL243553 99387 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 485 9 2 6 4.3 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Br)cc1 10.1021/jm070427h
71740443 98123 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 372 5 3 5 3.0 Cc1ccccc1Nc1ccc(C#N)cc1S(=O)(=O)NC(=O)NC(C)C 10.1016/j.ejmech.2013.04.033
CHEMBL2402428 98123 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 372 5 3 5 3.0 Cc1ccccc1Nc1ccc(C#N)cc1S(=O)(=O)NC(=O)NC(C)C 10.1016/j.ejmech.2013.04.033
15290037 21580 0 None -79 2 Human 6.0 pIC50 = 6.0 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 345 6 2 3 2.0 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccccc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1207044 21580 0 None -79 2 Human 6.0 pIC50 = 6.0 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 345 6 2 3 2.0 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccccc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL341221 21580 0 None -79 2 Human 6.0 pIC50 = 6.0 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 345 6 2 3 2.0 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccccc1)C2 10.1016/s0960-894x(99)00014-1
71740563 98131 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 400 8 3 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccc(C)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402436 98131 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 400 8 3 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccc(C)cc1 10.1016/j.ejmech.2013.04.033
71740562 98130 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 386 4 3 5 3.4 Cc1ccc(Nc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402435 98130 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 386 4 3 5 3.4 Cc1ccc(Nc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1016/j.ejmech.2013.04.033
71456310 86486 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 489 11 1 4 6.0 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)C[S@+]([O-])[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80103-7
CHEMBL2115518 86486 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 489 11 1 4 6.0 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)C[S@+]([O-])[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80103-7
71740181 98118 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 387 4 2 5 3.4 Cc1cccc(Oc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1 10.1016/j.ejmech.2013.04.033
CHEMBL2402423 98118 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 387 4 2 5 3.4 Cc1cccc(Oc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1 10.1016/j.ejmech.2013.04.033
16757178 100094 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 441 5 2 6 4.1 Cc1cc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)ccc1Cl 10.1021/jm070427h
CHEMBL245262 100094 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 441 5 2 6 4.1 Cc1cc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)ccc1Cl 10.1021/jm070427h
16757487 100022 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 451 8 2 7 4.0 CCCOc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm070427h
CHEMBL244819 100022 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 451 8 2 7 4.0 CCCOc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm070427h
6449876 105969 22 None - 1 Human 8.0 pIC50 = 8.0 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 405 7 3 4 4.4 CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL281398 105969 22 None - 1 Human 8.0 pIC50 = 8.0 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 405 7 3 4 4.4 CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
117631017 122643 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 445 5 2 4 4.1 CC1=C(O)CC(Cc2cccc3c2CCC(NS(=O)(=O)c2ccc(Cl)cc2)C3)C1=O 10.1021/ml5002085
CHEMBL3354613 122643 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 445 5 2 4 4.1 CC1=C(O)CC(Cc2cccc3c2CCC(NS(=O)(=O)c2ccc(Cl)cc2)C3)C1=O 10.1021/ml5002085
10601327 86844 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 496 9 3 4 5.9 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(N/C(=N\C2CCCC2)NC(=O)c2ccccc2)c1 10.1021/jm9707941
CHEMBL21303 86844 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 496 9 3 4 5.9 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(N/C(=N\C2CCCC2)NC(=O)c2ccccc2)c1 10.1021/jm9707941
16757488 100060 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 437 7 2 7 3.6 CCOc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm070427h
CHEMBL245037 100060 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 437 7 2 7 3.6 CCOc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm070427h
15018454 106215 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 369 9 2 3 3.3 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccccc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL282931 106215 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 369 9 2 3 3.3 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccccc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
44386321 67225 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 366 12 1 3 5.5 CCC/C=C(\C)CSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL175285 67225 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 366 12 1 3 5.5 CCC/C=C(\C)CSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
10762387 26650 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 381 9 1 5 3.9 O=C(O)CCCCCO/N=C(\c1cccc(C(F)(F)F)c1)c1ccncn1 10.1021/jm960341g
CHEMBL130236 26650 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 381 9 1 5 3.9 O=C(O)CCCCCO/N=C(\c1cccc(C(F)(F)F)c1)c1ccncn1 10.1021/jm960341g
10067523 26252 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(\c1cccc(C(F)(F)F)c1)c1cnccn1 10.1021/jm960341g
CHEMBL129867 26252 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(\c1cccc(C(F)(F)F)c1)c1cnccn1 10.1021/jm960341g
16757178 100094 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 441 5 2 6 4.1 Cc1cc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)ccc1Cl 10.1021/jm070427h
CHEMBL245262 100094 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 441 5 2 6 4.1 Cc1cc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)ccc1Cl 10.1021/jm070427h
118711723 120791 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Inhibition of human TP receptor expressed in QBI-HEK 293A cells assessed as IP3 metabolite level after 1 hr by HTRF assayInhibition of human TP receptor expressed in QBI-HEK 293A cells assessed as IP3 metabolite level after 1 hr by HTRF assay
ChEMBL 391 6 2 4 3.4 O=C1CC(c2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C=C1O 10.1016/j.bmcl.2014.07.047
CHEMBL3326603 120791 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Inhibition of human TP receptor expressed in QBI-HEK 293A cells assessed as IP3 metabolite level after 1 hr by HTRF assayInhibition of human TP receptor expressed in QBI-HEK 293A cells assessed as IP3 metabolite level after 1 hr by HTRF assay
ChEMBL 391 6 2 4 3.4 O=C1CC(c2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C=C1O 10.1016/j.bmcl.2014.07.047
1976 10745 18 None - 1 Human 7.9 pIC50 = 7.9 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 477 11 2 4 5.7 OC(=O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)C[C@@H]([C@@H]1N1CCCCC1)O 10.1016/S0960-894X(01)80103-7
6918030 10745 18 None - 1 Human 7.9 pIC50 = 7.9 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 477 11 2 4 5.7 OC(=O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)C[C@@H]([C@@H]1N1CCCCC1)O 10.1016/S0960-894X(01)80103-7
CHEMBL65030 10745 18 None - 1 Human 7.9 pIC50 = 7.9 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 477 11 2 4 5.7 OC(=O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)C[C@@H]([C@@H]1N1CCCCC1)O 10.1016/S0960-894X(01)80103-7
15290037 21580 0 None 79 2 Rat 7.9 pIC50 = 7.9 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 345 6 2 3 2.0 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccccc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1207044 21580 0 None 79 2 Rat 7.9 pIC50 = 7.9 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 345 6 2 3 2.0 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccccc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL341221 21580 0 None 79 2 Rat 7.9 pIC50 = 7.9 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 345 6 2 3 2.0 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccccc1)C2 10.1016/s0960-894x(99)00014-1
16757078 99387 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 485 9 2 6 4.3 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Br)cc1 10.1021/jm070427h
CHEMBL243553 99387 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 485 9 2 6 4.3 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Br)cc1 10.1021/jm070427h
10619606 105829 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 377 7 2 4 3.4 CN(C)/C(=N/c1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1)NC#N 10.1021/jm9707941
CHEMBL280380 105829 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 377 7 2 4 3.4 CN(C)/C(=N/c1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1)NC#N 10.1021/jm9707941
44353310 21437 0 None 14 2 Rat 5.9 pIC50 = 5.9 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 351 6 2 3 2.3 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)C1CCCCC1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205662 21437 0 None 14 2 Rat 5.9 pIC50 = 5.9 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 351 6 2 3 2.3 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)C1CCCCC1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL130460 21437 0 None 14 2 Rat 5.9 pIC50 = 5.9 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 351 6 2 3 2.3 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)C1CCCCC1)C2 10.1016/s0960-894x(99)00014-1
44304350 209645 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 369 7 3 3 4.4 O=C(O)CCC/C=C1/C[C@@H]2[C@@H](/C=N/NC(=O)Nc3ccccc3)CC[C@@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL62590 209645 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 369 7 3 3 4.4 O=C(O)CCC/C=C1/C[C@@H]2[C@@H](/C=N/NC(=O)Nc3ccccc3)CC[C@@H]2C1 10.1016/S0960-894X(01)80876-3
44291639 190679 0 None - 1 Rat 4.9 pIC50 = 4.9 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 411 8 2 3 5.0 CC(C)c1ccc2c(CCCS(=O)(=O)Nc3ccccc3)cc(C(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL48117 190679 0 None - 1 Rat 4.9 pIC50 = 4.9 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 411 8 2 3 5.0 CC(C)c1ccc2c(CCCS(=O)(=O)Nc3ccccc3)cc(C(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
54757964 72226 0 None - 1 Mouse 5.9 pIC50 = 5.9 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 419 8 2 4 4.0 O=C1CCC(O)=C1CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm200980u
CHEMBL1829804 72226 0 None - 1 Mouse 5.9 pIC50 = 5.9 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 419 8 2 4 4.0 O=C1CCC(O)=C1CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm200980u
11656254 84552 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 498 9 3 6 4.6 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(Br)c(C)c1 10.1021/jm060108a
CHEMBL209134 84552 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 498 9 3 6 4.6 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(Br)c(C)c1 10.1021/jm060108a
5362391 105872 25 None - 1 Human 5.9 pIC50 = 5.9 Functional
In vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human platelets
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1016/S0960-894X(01)80104-9
CHEMBL280728 105872 25 None - 1 Human 5.9 pIC50 = 5.9 Functional
In vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human platelets
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1016/S0960-894X(01)80104-9
11676121 85097 4 None - 1 Human 7.9 pIC50 = 7.9 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(C)cc1 10.1021/jm060108a
CHEMBL210964 85097 4 None - 1 Human 7.9 pIC50 = 7.9 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(C)cc1 10.1021/jm060108a
44304384 109405 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 419 7 4 4 4.0 O=C(O)CCC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3cccc(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL304254 109405 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 419 7 4 4 4.0 O=C(O)CCC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3cccc(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
10503252 169971 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 440 9 3 5 4.2 N#CN/C(=N/Cc1cccnc1)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL418188 169971 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 440 9 3 5 4.2 N#CN/C(=N/Cc1cccnc1)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
44273591 83501 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 353 8 2 3 3.0 O=C(O)CC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00199-4
CHEMBL20659 83501 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 353 8 2 3 3.0 O=C(O)CC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00199-4
10762411 88661 1 None - 1 Human 5.9 pIC50 = 5.9 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 381 7 3 3 4.7 CC(C)(C)NC(=O)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL21647 88661 1 None - 1 Human 5.9 pIC50 = 5.9 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 381 7 3 3 4.7 CC(C)(C)NC(=O)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
10717572 105473 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 431 8 3 4 4.9 N#CN/C(=N/C1CCCCC1)Nc1ccc(/C(=C\CCCC(=O)O)c2cccnc2)cc1 10.1021/jm9707941
CHEMBL277619 105473 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 431 8 3 4 4.9 N#CN/C(=N/C1CCCCC1)Nc1ccc(/C(=C\CCCC(=O)O)c2cccnc2)cc1 10.1021/jm9707941
44385934 138232 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 352 12 1 3 5.1 CCC/C=C/CSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL369153 138232 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 352 12 1 3 5.1 CCC/C=C/CSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
44387118 67588 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 346 9 1 3 4.8 O=C(O)CCC/C=C\CC1C2CCC(O2)C1CSc1ccccc1 10.1021/jm00125a009
CHEMBL176190 67588 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 346 9 1 3 4.8 O=C(O)CCC/C=C\CC1C2CCC(O2)C1CSc1ccccc1 10.1021/jm00125a009
10542153 27383 1 None - 1 Human 4.9 pIC50 = 4.9 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(/c1ccccc1)c1ccnnc1 10.1021/jm960341g
CHEMBL130823 27383 1 None - 1 Human 4.9 pIC50 = 4.9 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(/c1ccccc1)c1ccnnc1 10.1021/jm960341g
54669848 72228 0 None -42 2 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 419 7 2 4 3.8 CC1=C(O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)CC1=O 10.1021/jm200980u
CHEMBL1829806 72228 0 None -42 2 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 419 7 2 4 3.8 CC1=C(O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)CC1=O 10.1021/jm200980u
9907162 21517 0 None -50 2 Human 5.9 pIC50 = 5.9 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 365 5 2 3 2.7 O=C(O)c1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1206352 21517 0 None -50 2 Human 5.9 pIC50 = 5.9 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 365 5 2 3 2.7 O=C(O)c1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL264516 21517 0 None -50 2 Human 5.9 pIC50 = 5.9 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 365 5 2 3 2.7 O=C(O)c1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
71740182 98119 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 401 8 2 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1cccc(C)c1 10.1016/j.ejmech.2013.04.033
CHEMBL2402424 98119 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 401 8 2 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1cccc(C)c1 10.1016/j.ejmech.2013.04.033
10320462 21573 0 None -34 2 Human 5.9 pIC50 = 5.9 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 407 8 2 3 3.4 O=C(O)CCCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1207010 21573 0 None -34 2 Human 5.9 pIC50 = 5.9 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 407 8 2 3 3.4 O=C(O)CCCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL334501 21573 0 None -34 2 Human 5.9 pIC50 = 5.9 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 407 8 2 3 3.4 O=C(O)CCCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
71740183 98120 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 373 5 2 5 3.1 Cc1ccc(Oc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)C)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402425 98120 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 373 5 2 5 3.1 Cc1ccc(Oc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)C)cc1 10.1016/j.ejmech.2013.04.033
16757177 151523 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 451 11 2 7 4.0 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(OCC)cc1 10.1021/jm070427h
CHEMBL390897 151523 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 451 11 2 7 4.0 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(OCC)cc1 10.1021/jm070427h
11502680 105016 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
CHEMBL274415 105016 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
18921488 21442 0 None 10 2 Rat 7.8 pIC50 = 7.8 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 393 7 2 3 3.1 O=C(O)CCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205669 21442 0 None 10 2 Rat 7.8 pIC50 = 7.8 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 393 7 2 3 3.1 O=C(O)CCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL131894 21442 0 None 10 2 Rat 7.8 pIC50 = 7.8 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 393 7 2 3 3.1 O=C(O)CCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
44304262 108879 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 387 7 4 5 2.2 O=C(O)COC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccccc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL302235 108879 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 387 7 4 5 2.2 O=C(O)COC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccccc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
11269563 148388 0 None -676 2 Human 5.9 pIC50 = 5.9 Functional
Activity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregationActivity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregation
ChEMBL 399 5 1 3 5.2 CC(=O)c1cc(F)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1021/jm0603668
CHEMBL385126 148388 0 None -676 2 Human 5.9 pIC50 = 5.9 Functional
Activity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregationActivity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregation
ChEMBL 399 5 1 3 5.2 CC(=O)c1cc(F)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1021/jm0603668
44353308 21579 0 None 54 2 Rat 5.9 pIC50 = 5.9 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 339 9 2 3 2.1 CCCCCS(=O)(=O)NCC1Cc2ccc(CC(=O)O)cc2C1 10.1016/s0960-894x(99)00014-1
CHEMBL1207038 21579 0 None 54 2 Rat 5.9 pIC50 = 5.9 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 339 9 2 3 2.1 CCCCCS(=O)(=O)NCC1Cc2ccc(CC(=O)O)cc2C1 10.1016/s0960-894x(99)00014-1
CHEMBL340073 21579 0 None 54 2 Rat 5.9 pIC50 = 5.9 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 339 9 2 3 2.1 CCCCCS(=O)(=O)NCC1Cc2ccc(CC(=O)O)cc2C1 10.1016/s0960-894x(99)00014-1
71450832 85276 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(\c1cccc(C(F)(F)F)c1)c1ccncn1 10.1021/jm960341g
CHEMBL2111862 85276 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(\c1cccc(C(F)(F)F)c1)c1ccncn1 10.1021/jm960341g
44291597 21393 0 None - 1 Rat 5.9 pIC50 = 5.9 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 475 10 2 4 5.3 CC(C)c1ccc2c(CCCCCS(=O)(=O)Nc3ccccc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL1205051 21393 0 None - 1 Rat 5.9 pIC50 = 5.9 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 475 10 2 4 5.3 CC(C)c1ccc2c(CCCCCS(=O)(=O)Nc3ccccc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL47605 21393 0 None - 1 Rat 5.9 pIC50 = 5.9 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 475 10 2 4 5.3 CC(C)c1ccc2c(CCCCCS(=O)(=O)Nc3ccccc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
44353303 21438 0 None 2 2 Rat 6.9 pIC50 = 6.9 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 381 6 2 4 2.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)O2 10.1016/s0960-894x(99)00014-1
CHEMBL1205664 21438 0 None 2 2 Rat 6.9 pIC50 = 6.9 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 381 6 2 4 2.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)O2 10.1016/s0960-894x(99)00014-1
CHEMBL131036 21438 0 None 2 2 Rat 6.9 pIC50 = 6.9 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 381 6 2 4 2.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)O2 10.1016/s0960-894x(99)00014-1
71740057 98115 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 387 4 2 5 3.4 Cc1ccccc1Oc1ccc(C#N)cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1016/j.ejmech.2013.04.033
CHEMBL2402420 98115 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 387 4 2 5 3.4 Cc1ccccc1Oc1ccc(C#N)cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1016/j.ejmech.2013.04.033
18921526 21446 0 None -46 2 Human 5.8 pIC50 = 5.8 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 393 7 2 3 3.1 O=C(O)Cc1ccc2c(c1)CC(CCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205680 21446 0 None -46 2 Human 5.8 pIC50 = 5.8 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 393 7 2 3 3.1 O=C(O)Cc1ccc2c(c1)CC(CCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL132659 21446 0 None -46 2 Human 5.8 pIC50 = 5.8 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 393 7 2 3 3.1 O=C(O)Cc1ccc2c(c1)CC(CCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
44353169 26248 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(/c1cncnc1)c1cccc(C(F)(F)F)c1 10.1021/jm960341g
CHEMBL129843 26248 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(/c1cncnc1)c1cccc(C(F)(F)F)c1 10.1021/jm960341g
23276771 28125 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(/c1cccc(C(F)(F)F)c1)c1cnccn1 10.1021/jm960341g
CHEMBL131415 28125 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(/c1cccc(C(F)(F)F)c1)c1cnccn1 10.1021/jm960341g
44292126 21397 0 None - 1 Rat 5.8 pIC50 = 5.8 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 461 9 2 4 4.9 CC(C)c1ccc2c(CCCCS(=O)(=O)Nc3ccccc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL1205057 21397 0 None - 1 Rat 5.8 pIC50 = 5.8 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 461 9 2 4 4.9 CC(C)c1ccc2c(CCCCS(=O)(=O)Nc3ccccc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL48013 21397 0 None - 1 Rat 5.8 pIC50 = 5.8 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 461 9 2 4 4.9 CC(C)c1ccc2c(CCCCS(=O)(=O)Nc3ccccc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
44291705 108180 0 None - 1 Rat 5.8 pIC50 = 5.8 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 439 10 2 3 5.8 CC(C)c1ccc2c(CCCCCS(=O)(=O)Nc3ccccc3)cc(C(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL297275 108180 0 None - 1 Rat 5.8 pIC50 = 5.8 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 439 10 2 3 5.8 CC(C)c1ccc2c(CCCCCS(=O)(=O)Nc3ccccc3)cc(C(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
51550 212529 14 None - 1 Rat 5.8 pIC50 = 5.8 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 335 8 2 4 1.7 O=C(O)COc1ccc(CCNS(=O)(=O)c2ccccc2)cc1 10.1016/S0960-894X(00)80043-8
CHEMBL8273 212529 14 None - 1 Rat 5.8 pIC50 = 5.8 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 335 8 2 4 1.7 O=C(O)COc1ccc(CCNS(=O)(=O)c2ccccc2)cc1 10.1016/S0960-894X(00)80043-8
10780482 27689 1 None - 1 Human 4.8 pIC50 = 4.8 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(/c1ccccc1)c1ncccn1 10.1021/jm960341g
CHEMBL131078 27689 1 None - 1 Human 4.8 pIC50 = 4.8 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(/c1ccccc1)c1ncccn1 10.1021/jm960341g
16756980 100056 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 471 5 2 6 3.9 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1Br 10.1021/jm070427h
CHEMBL245032 100056 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 471 5 2 6 3.9 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1Br 10.1021/jm070427h
54757965 72054 0 None -9 2 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 353 8 2 3 2.8 O=S(=O)(NCCc1cccc(CCCO)c1)c1ccc(Cl)cc1 10.1021/jm200980u
CHEMBL1828642 72054 0 None -9 2 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 353 8 2 3 2.8 O=S(=O)(NCCc1cccc(CCCO)c1)c1ccc(Cl)cc1 10.1021/jm200980u
16757174 100020 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 423 6 2 7 3.2 COc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm070427h
CHEMBL244817 100020 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 423 6 2 7 3.2 COc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm070427h
16756978 99067 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 407 8 2 6 3.5 CCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(C)c1 10.1021/jm070427h
CHEMBL242694 99067 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 407 8 2 6 3.5 CCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(C)c1 10.1021/jm070427h
71740559 98127 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 386 4 3 5 3.4 Cc1cccc(Nc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1 10.1016/j.ejmech.2013.04.033
CHEMBL2402432 98127 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 386 4 3 5 3.4 Cc1cccc(Nc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1 10.1016/j.ejmech.2013.04.033
10761205 90193 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 363 7 3 4 3.2 C/N=C(/NC#N)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL21960 90193 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 363 7 3 4 3.2 C/N=C(/NC#N)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
6073 10557 49 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 407 6 2 3 3.5 OC(=O)CCc1c(C)ccc2c1CC[C@H](C2)NS(=O)(=O)c1ccc(cc1)Cl 10.1021/ml5002085
9938840 10557 49 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 407 6 2 3 3.5 OC(=O)CCc1c(C)ccc2c1CC[C@H](C2)NS(=O)(=O)c1ccc(cc1)Cl 10.1021/ml5002085
CHEMBL2107786 10557 49 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 407 6 2 3 3.5 OC(=O)CCc1c(C)ccc2c1CC[C@H](C2)NS(=O)(=O)c1ccc(cc1)Cl 10.1021/ml5002085
18921488 21442 0 None -10 2 Human 6.8 pIC50 = 6.8 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 393 7 2 3 3.1 O=C(O)CCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205669 21442 0 None -10 2 Human 6.8 pIC50 = 6.8 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 393 7 2 3 3.1 O=C(O)CCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL131894 21442 0 None -10 2 Human 6.8 pIC50 = 6.8 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 393 7 2 3 3.1 O=C(O)CCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
44304642 109018 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 421 7 4 5 2.9 O=C(O)COC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3cccc(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL303114 109018 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 421 7 4 5 2.9 O=C(O)COC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3cccc(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
44273499 105511 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 391 8 2 3 3.2 O=C(O)CC/C=C/C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(F)cc2F)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL277940 105511 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 391 8 2 3 3.2 O=C(O)CC/C=C/C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(F)cc2F)CC[C@H]1F 10.1016/0960-894X(95)00199-4
54757965 72054 0 None 9 2 Mouse 5.8 pIC50 = 5.8 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 353 8 2 3 2.8 O=S(=O)(NCCc1cccc(CCCO)c1)c1ccc(Cl)cc1 10.1021/jm200980u
CHEMBL1828642 72054 0 None 9 2 Mouse 5.8 pIC50 = 5.8 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 353 8 2 3 2.8 O=S(=O)(NCCc1cccc(CCCO)c1)c1ccc(Cl)cc1 10.1021/jm200980u
11676145 84941 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1C 10.1021/jm070427h
CHEMBL210415 84941 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1C 10.1021/jm070427h
16757380 99386 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 471 5 2 6 3.9 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Br)cc1 10.1021/jm070427h
CHEMBL243552 99386 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 471 5 2 6 3.9 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Br)cc1 10.1021/jm070427h
71740180 98117 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 373 5 2 5 3.1 Cc1cccc(Oc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)C)c1 10.1016/j.ejmech.2013.04.033
CHEMBL2402422 98117 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 373 5 2 5 3.1 Cc1cccc(Oc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)C)c1 10.1016/j.ejmech.2013.04.033
16757377 156852 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 407 5 2 6 3.5 Cc1cccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1 10.1021/jm070427h
CHEMBL395079 156852 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 407 5 2 6 3.5 Cc1cccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1 10.1021/jm070427h
9930263 106004 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 389 8 3 4 3.8 N#CN/C(=N/C1CC1)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL281621 106004 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 389 8 3 4 3.8 N#CN/C(=N/C1CC1)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
15745526 85196 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 385 7 4 4 3.4 O=C(O)CCC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccccc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL2111524 85196 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 385 7 4 4 3.4 O=C(O)CCC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccccc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
44304279 109053 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 414 8 3 5 4.3 O=C(O)CCC/C=C1/C[C@@H]2[C@@H](/C=N/NC(=O)Nc3ccc([N+](=O)[O-])cc3)CC[C@@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL303284 109053 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 414 8 3 5 4.3 O=C(O)CCC/C=C1/C[C@@H]2[C@@H](/C=N/NC(=O)Nc3ccc([N+](=O)[O-])cc3)CC[C@@H]2C1 10.1016/S0960-894X(01)80876-3
44304265 210071 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 439 6 4 4 4.3 O=C(O)CC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc(Cl)c(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL64723 210071 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 439 6 4 4 4.3 O=C(O)CC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc(Cl)c(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
44273542 105445 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 381 10 2 3 3.6 O=C(O)CCC/C=C\CC1=CCC[C@@H]1CNS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00199-4
CHEMBL277405 105445 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 381 10 2 3 3.6 O=C(O)CCC/C=C\CC1=CCC[C@@H]1CNS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00199-4
44273435 106240 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 423 8 2 3 4.2 O=C(O)CC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(Cl)c(Cl)c2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL283101 106240 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 423 8 2 3 4.2 O=C(O)CC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(Cl)c(Cl)c2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
44273742 175985 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 373 10 2 4 2.4 O=C(O)COCCCC[C@@H]1[C@@H](NS(=O)(=O)c2ccccc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL440772 175985 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 373 10 2 4 2.4 O=C(O)COCCCC[C@@H]1[C@@H](NS(=O)(=O)c2ccccc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
10786712 89979 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 392 8 3 3 4.4 N/C(=N/C1CCCC1)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL21851 89979 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 392 8 3 3 4.4 N/C(=N/C1CCCC1)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
5362391 105872 25 None - 1 Human 5.8 pIC50 = 5.8 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1021/jm9707941
CHEMBL280728 105872 25 None - 1 Human 5.8 pIC50 = 5.8 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1021/jm9707941
11545850 77011 0 None -446 2 Human 5.8 pIC50 = 5.8 Functional
Inhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptorInhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptor
ChEMBL 402 5 2 4 2.7 O=C(O)Cn1c2c(c3ccccc31)C[C@H](NS(=O)(=O)c1ccc(F)cc1)CC2 10.1021/jm049036i
CHEMBL194085 77011 0 None -446 2 Human 5.8 pIC50 = 5.8 Functional
Inhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptorInhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptor
ChEMBL 402 5 2 4 2.7 O=C(O)Cn1c2c(c3ccccc31)C[C@H](NS(=O)(=O)c1ccc(F)cc1)CC2 10.1021/jm049036i
5362391 105872 25 None - 1 Human 5.8 pIC50 = 5.8 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1021/jm960341g
CHEMBL280728 105872 25 None - 1 Human 5.8 pIC50 = 5.8 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1021/jm960341g
44291864 188411 0 None - 1 Rat 5.8 pIC50 = 5.8 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 473 10 2 3 6.4 CC(C)c1ccc2c(CCCCCS(=O)(=O)Nc3ccc(Cl)cc3)cc(C(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL47743 188411 0 None - 1 Rat 5.8 pIC50 = 5.8 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 473 10 2 3 6.4 CC(C)c1ccc2c(CCCCCS(=O)(=O)Nc3ccc(Cl)cc3)cc(C(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL1829808 72230 0 None -18 2 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 433 8 2 4 4.2 CCC1=C(O)CC(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1=O 10.1021/jm200980u
71740179 98116 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 401 8 2 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccccc1C 10.1016/j.ejmech.2013.04.033
CHEMBL2402421 98116 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 401 8 2 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccccc1C 10.1016/j.ejmech.2013.04.033
44353310 21437 0 None -14 2 Human 4.8 pIC50 = 4.8 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 351 6 2 3 2.3 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)C1CCCCC1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205662 21437 0 None -14 2 Human 4.8 pIC50 = 4.8 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 351 6 2 3 2.3 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)C1CCCCC1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL130460 21437 0 None -14 2 Human 4.8 pIC50 = 4.8 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 351 6 2 3 2.3 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)C1CCCCC1)C2 10.1016/s0960-894x(99)00014-1
54757768 72229 0 None - 1 Mouse 5.8 pIC50 = 5.8 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 475 10 1 4 4.9 CC1=C(OCC(C)C)CC(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1=O 10.1021/jm200980u
CHEMBL1829807 72229 0 None - 1 Mouse 5.8 pIC50 = 5.8 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 475 10 1 4 4.9 CC1=C(OCC(C)C)CC(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1=O 10.1021/jm200980u
CHEMBL1829810 72232 0 None 11 2 Mouse 7.8 pIC50 = 7.8 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 447 8 2 4 4.5 CC(C)C1=C(O)CC(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1=O 10.1021/jm200980u
10524500 92280 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 391 8 3 4 4.0 CC(C)/N=C(/NC#N)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL22721 92280 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 391 8 3 4 4.0 CC(C)/N=C(/NC#N)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
44305675 209753 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 505 11 1 5 5.6 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)CS(=O)(=O)[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80103-7
CHEMBL63056 209753 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 505 11 1 5 5.6 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)CS(=O)(=O)[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80103-7
131717 210168 6 None - 1 Human 7.8 pIC50 = 7.8 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 452 14 2 4 4.7 O=C(O)CCC(CCCCNS(=O)(=O)c1ccc(Cl)cc1)CCCc1cccnc1 10.1016/S0960-894X(01)80103-7
CHEMBL65414 210168 6 None - 1 Human 7.8 pIC50 = 7.8 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 452 14 2 4 4.7 O=C(O)CCC(CCCCNS(=O)(=O)c1ccc(Cl)cc1)CCCc1cccnc1 10.1016/S0960-894X(01)80103-7
131717 210168 6 None - 1 Human 7.8 pIC50 = 7.8 Functional
In vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human platelets
ChEMBL 452 14 2 4 4.7 O=C(O)CCC(CCCCNS(=O)(=O)c1ccc(Cl)cc1)CCCc1cccnc1 10.1016/S0960-894X(01)80104-9
CHEMBL65414 210168 6 None - 1 Human 7.8 pIC50 = 7.8 Functional
In vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human platelets
ChEMBL 452 14 2 4 4.7 O=C(O)CCC(CCCCNS(=O)(=O)c1ccc(Cl)cc1)CCCc1cccnc1 10.1016/S0960-894X(01)80104-9
44304271 107497 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 421 7 4 5 2.9 O=C(O)COC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3cccc(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL292601 107497 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 421 7 4 5 2.9 O=C(O)COC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3cccc(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
44304264 108992 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 455 7 4 5 3.5 O=C(O)COC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc(Cl)c(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL302917 108992 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 455 7 4 5 3.5 O=C(O)COC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc(Cl)c(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
44304297 209946 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 437 7 3 3 5.7 O=C(O)CCC/C=C1\C[C@@H]2[C@@H](/C=N/NC(=O)Nc3ccc(Cl)c(Cl)c3)CC[C@@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL64229 209946 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 437 7 3 3 5.7 O=C(O)CCC/C=C1\C[C@@H]2[C@@H](/C=N/NC(=O)Nc3ccc(Cl)c(Cl)c3)CC[C@@H]2C1 10.1016/S0960-894X(01)80876-3
44273351 80136 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 391 10 2 4 2.5 O=C(O)COCCCC[C@@H]1[C@@H](NS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL20133 80136 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 391 10 2 4 2.5 O=C(O)COCCCC[C@@H]1[C@@H](NS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
44273521 80720 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 414 10 2 5 3.2 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccccc2[N+](=O)[O-])CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL20212 80720 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 414 10 2 5 3.2 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccccc2[N+](=O)[O-])CC[C@H]1F 10.1016/0960-894X(95)00199-4
44273448 81529 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 349 8 2 3 3.2 Cc1ccc(S(=O)(=O)N[C@H]2CCC=C2C/C=C\CCC(=O)O)cc1 10.1016/0960-894X(95)00199-4
CHEMBL20308 81529 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 349 8 2 3 3.2 Cc1ccc(S(=O)(=O)N[C@H]2CCC=C2C/C=C\CCC(=O)O)cc1 10.1016/0960-894X(95)00199-4
44273415 82136 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 387 10 2 4 2.7 Cc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](F)[C@@H]2CCCCOCC(=O)O)cc1 10.1016/0960-894X(95)00199-4
CHEMBL20376 82136 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 387 10 2 4 2.7 Cc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](F)[C@@H]2CCCCOCC(=O)O)cc1 10.1016/0960-894X(95)00199-4
44273414 105505 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 389 10 2 4 2.6 O=C(O)COCCCCC1=CCC[C@@H]1NS(=O)(=O)c1ccc(F)cc1F 10.1016/0960-894X(95)00199-4
CHEMBL277879 105505 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 389 10 2 4 2.6 O=C(O)COCCCCC1=CCC[C@@H]1NS(=O)(=O)c1ccc(F)cc1F 10.1016/0960-894X(95)00199-4
44273570 105896 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 403 9 2 3 3.8 O=C(O)CC/C=C\C[C@@H]1[C@@H](CNS(=O)(=O)c2ccc(Cl)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL280934 105896 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 403 9 2 3 3.8 O=C(O)CC/C=C\C[C@@H]1[C@@H](CNS(=O)(=O)c2ccc(Cl)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
44273449 105964 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 409 10 2 4 2.6 O=C(O)COCCCC[C@@H]1[C@@H](NS(=O)(=O)c2ccc(F)cc2F)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL281383 105964 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 409 10 2 4 2.6 O=C(O)COCCCC[C@@H]1[C@@H](NS(=O)(=O)c2ccc(F)cc2F)CC[C@H]1F 10.1016/0960-894X(95)00199-4
23276768 123538 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(\c1ccnnc1)c1cccc(C(F)(F)F)c1 10.1021/jm960341g
CHEMBL337607 123538 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(\c1ccnnc1)c1cccc(C(F)(F)F)c1 10.1021/jm960341g
11676145 84941 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1C 10.1021/jm070427h
CHEMBL210415 84941 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1C 10.1021/jm070427h
6436053 105487 13 None - 1 Human 7.7 pIC50 = 7.7 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 484 11 2 4 4.9 O=C(O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm9707941
CHEMBL277689 105487 13 None - 1 Human 7.7 pIC50 = 7.7 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 484 11 2 4 4.9 O=C(O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm9707941
44304290 109465 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 432 8 4 7 2.1 O=C(O)COC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc([N+](=O)[O-])cc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL304652 109465 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 432 8 4 7 2.1 O=C(O)COC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc([N+](=O)[O-])cc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
22882094 109534 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 439 6 4 4 4.3 O=C(O)CC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc(Cl)c(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL305114 109534 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 439 6 4 4 4.3 O=C(O)CC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc(Cl)c(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
10546960 210134 0 None -6 2 Human 6.7 pIC50 = 6.7 Functional
Inhibition of human TP receptor expressed in QBI-HEK 293A cells assessed as IP3 metabolite level after 1 hr by HTRF assayInhibition of human TP receptor expressed in QBI-HEK 293A cells assessed as IP3 metabolite level after 1 hr by HTRF assay
ChEMBL 367 8 2 3 2.9 O=C(O)CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1016/j.bmcl.2014.07.047
CHEMBL65121 210134 0 None -6 2 Human 6.7 pIC50 = 6.7 Functional
Inhibition of human TP receptor expressed in QBI-HEK 293A cells assessed as IP3 metabolite level after 1 hr by HTRF assayInhibition of human TP receptor expressed in QBI-HEK 293A cells assessed as IP3 metabolite level after 1 hr by HTRF assay
ChEMBL 367 8 2 3 2.9 O=C(O)CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1016/j.bmcl.2014.07.047
44273404 80964 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 398 11 2 6 2.2 O=C(O)COCCCCC1=CCC[C@@H]1NS(=O)(=O)c1ccccc1[N+](=O)[O-] 10.1016/0960-894X(95)00199-4
CHEMBL20231 80964 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 398 11 2 6 2.2 O=C(O)COCCCCC1=CCC[C@@H]1NS(=O)(=O)c1ccccc1[N+](=O)[O-] 10.1016/0960-894X(95)00199-4
44273523 81220 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 369 8 2 3 3.5 O=C(O)CC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccc(Cl)cc1 10.1016/0960-894X(95)00199-4
CHEMBL20274 81220 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 369 8 2 3 3.5 O=C(O)CC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccc(Cl)cc1 10.1016/0960-894X(95)00199-4
44273474 82732 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 399 9 2 3 4.4 O=C(O)CCC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccc2ccccc2c1 10.1016/0960-894X(95)00199-4
CHEMBL20524 82732 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 399 9 2 3 4.4 O=C(O)CCC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccc2ccccc2c1 10.1016/0960-894X(95)00199-4
44273402 82734 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 387 9 2 3 3.3 O=C(O)CC/C=C\C[C@@H]1[C@@H](CNS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL20525 82734 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 387 9 2 3 3.3 O=C(O)CC/C=C\C[C@@H]1[C@@H](CNS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
44273387 83119 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 421 10 2 4 3.6 O=C(O)COCCCCC1=CCC[C@@H]1NS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/0960-894X(95)00199-4
CHEMBL20590 83119 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 421 10 2 4 3.6 O=C(O)COCCCCC1=CCC[C@@H]1NS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/0960-894X(95)00199-4
44273502 86713 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 369 8 2 3 3.2 Cc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](F)[C@@H]2C/C=C\CCC(=O)O)cc1 10.1016/0960-894X(95)00199-4
CHEMBL21255 86713 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 369 8 2 3 3.2 Cc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](F)[C@@H]2C/C=C\CCC(=O)O)cc1 10.1016/0960-894X(95)00199-4
44273588 105831 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 383 9 2 3 3.4 Cc1ccc(S(=O)(=O)NC[C@H]2CC[C@@H](F)[C@@H]2C/C=C\CCC(=O)O)cc1 10.1016/0960-894X(95)00199-4
CHEMBL280403 105831 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 383 9 2 3 3.4 Cc1ccc(S(=O)(=O)NC[C@H]2CC[C@@H](F)[C@@H]2C/C=C\CCC(=O)O)cc1 10.1016/0960-894X(95)00199-4
44273780 105965 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 367 10 2 4 2.6 Cc1ccc(S(=O)(=O)N[C@H]2CCC=C2CCCCOCC(=O)O)cc1 10.1016/0960-894X(95)00199-4
CHEMBL281385 105965 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 367 10 2 4 2.6 Cc1ccc(S(=O)(=O)N[C@H]2CCC=C2CCCCOCC(=O)O)cc1 10.1016/0960-894X(95)00199-4
44273522 173725 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 403 8 2 3 4.2 O=C(O)CC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/0960-894X(95)00199-4
CHEMBL428707 173725 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 403 8 2 3 4.2 O=C(O)CC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/0960-894X(95)00199-4
44353290 21450 0 None - 1 Rat 5.7 pIC50 = 5.7 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 346 6 2 4 1.4 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1cccnc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205689 21450 0 None - 1 Rat 5.7 pIC50 = 5.7 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 346 6 2 4 1.4 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1cccnc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL134128 21450 0 None - 1 Rat 5.7 pIC50 = 5.7 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 346 6 2 4 1.4 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1cccnc1)C2 10.1016/s0960-894x(99)00014-1
44385988 135797 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 370 13 2 4 4.3 CCCCC(O)CSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL366990 135797 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 370 13 2 4 4.3 CCCCC(O)CSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
44292084 180948 0 None - 1 Rat 4.7 pIC50 = 4.7 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 473 8 2 4 5.1 CC(C)c1ccc2c(CCCC(=O)NS(=O)(=O)c3ccc(Cl)cc3)cc(C(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL45471 180948 0 None - 1 Rat 4.7 pIC50 = 4.7 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 473 8 2 4 5.1 CC(C)c1ccc2c(CCCC(=O)NS(=O)(=O)c3ccc(Cl)cc3)cc(C(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
16756978 99067 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 407 8 2 6 3.5 CCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(C)c1 10.1021/jm070427h
CHEMBL242694 99067 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 407 8 2 6 3.5 CCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(C)c1 10.1021/jm070427h
16757488 100060 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 437 7 2 7 3.6 CCOc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm070427h
CHEMBL245037 100060 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 437 7 2 7 3.6 CCOc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm070427h
16757174 100020 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 423 6 2 7 3.2 COc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm070427h
CHEMBL244817 100020 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 423 6 2 7 3.2 COc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm070427h
11488860 26063 0 None -7762 2 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at TP receptor in human platelet assessed as thromboxane A2- induced platelet aggregationAntagonist activity at TP receptor in human platelet assessed as thromboxane A2- induced platelet aggregation
ChEMBL 497 5 1 4 5.7 C[C@@H](c1ccc(C(F)(F)F)cc1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
CHEMBL1290413 26063 0 None -7762 2 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at TP receptor in human platelet assessed as thromboxane A2- induced platelet aggregationAntagonist activity at TP receptor in human platelet assessed as thromboxane A2- induced platelet aggregation
ChEMBL 497 5 1 4 5.7 C[C@@H](c1ccc(C(F)(F)F)cc1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
16755884 100093 22 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 423 6 2 7 3.2 COc1cccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1 10.1021/jm070427h
CHEMBL245261 100093 22 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 423 6 2 7 3.2 COc1cccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1 10.1021/jm070427h
CHEMBL1829810 72232 0 None -11 2 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 447 8 2 4 4.5 CC(C)C1=C(O)CC(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1=O 10.1021/jm200980u
44293931 108713 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonistic activity against Thromboxane A2 receptor in guinea pig trachea in the presence of 9,11-azo-PGH2Antagonistic activity against Thromboxane A2 receptor in guinea pig trachea in the presence of 9,11-azo-PGH2
ChEMBL 384 10 2 3 4.7 C[C@@H](c1ccccc1)[C@H](O)/C=C/C1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00168a032
CHEMBL301098 108713 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonistic activity against Thromboxane A2 receptor in guinea pig trachea in the presence of 9,11-azo-PGH2Antagonistic activity against Thromboxane A2 receptor in guinea pig trachea in the presence of 9,11-azo-PGH2
ChEMBL 384 10 2 3 4.7 C[C@@H](c1ccccc1)[C@H](O)/C=C/C1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00168a032
163920 21447 12 None 165 2 Rat 8.7 pIC50 = 8.7 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 365 5 2 3 2.4 O=C(O)Cc1ccc2c(c1)CC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205685 21447 12 None 165 2 Rat 8.7 pIC50 = 8.7 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 365 5 2 3 2.4 O=C(O)Cc1ccc2c(c1)CC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL133420 21447 12 None 165 2 Rat 8.7 pIC50 = 8.7 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 365 5 2 3 2.4 O=C(O)Cc1ccc2c(c1)CC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
15291968 107667 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Inhibition of human TP receptor expressed in QBI-HEK 293A cells assessed as IP3 metabolite level after 1 hr by HTRF assayInhibition of human TP receptor expressed in QBI-HEK 293A cells assessed as IP3 metabolite level after 1 hr by HTRF assay
ChEMBL 393 6 2 3 3.2 O=C(O)CCc1cccc2c1CCC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/j.bmcl.2014.07.047
CHEMBL29374 107667 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Inhibition of human TP receptor expressed in QBI-HEK 293A cells assessed as IP3 metabolite level after 1 hr by HTRF assayInhibition of human TP receptor expressed in QBI-HEK 293A cells assessed as IP3 metabolite level after 1 hr by HTRF assay
ChEMBL 393 6 2 3 3.2 O=C(O)CCc1cccc2c1CCC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/j.bmcl.2014.07.047
22882109 107510 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 453 7 4 4 4.7 O=C(O)CCC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc(Cl)c(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL292712 107510 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 453 7 4 4 4.7 O=C(O)CCC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc(Cl)c(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
22882097 174771 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 416 7 4 6 2.9 O=C(O)CC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc([N+](=O)[O-])cc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL431956 174771 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 416 7 4 6 2.9 O=C(O)CC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc([N+](=O)[O-])cc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
44304362 207646 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 432 8 4 7 2.1 O=C(O)COC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc([N+](=O)[O-])cc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL60128 207646 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 432 8 4 7 2.1 O=C(O)COC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc([N+](=O)[O-])cc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
44304641 209669 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 453 7 4 4 4.7 O=C(O)CCC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc(Cl)c(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL62702 209669 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 453 7 4 4 4.7 O=C(O)CCC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc(Cl)c(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
44273434 81219 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 419 9 2 3 4.4 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL20273 81219 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 419 9 2 3 4.4 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
44273540 86588 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 385 11 2 4 2.7 O=C(O)COCCCCC1=CCC[C@@H]1CNS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00199-4
CHEMBL21204 86588 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 385 11 2 4 2.7 O=C(O)COCCCCC1=CCC[C@@H]1CNS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00199-4
44273792 106135 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 405 9 2 3 3.6 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(F)cc2F)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL282458 106135 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 405 9 2 3 3.6 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(F)cc2F)CC[C@H]1F 10.1016/0960-894X(95)00199-4
44273574 83780 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 355 8 2 3 2.9 O=C(O)CC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccccc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL20711 83780 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 355 8 2 3 2.9 O=C(O)CC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccccc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
44273796 84647 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 353 10 2 4 2.3 O=C(O)COCCCCC1=CCC[C@@H]1NS(=O)(=O)c1ccccc1 10.1016/0960-894X(95)00199-4
CHEMBL20933 84647 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 353 10 2 4 2.3 O=C(O)COCCCCC1=CCC[C@@H]1NS(=O)(=O)c1ccccc1 10.1016/0960-894X(95)00199-4
44273805 85099 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 401 10 2 3 3.7 O=C(O)CCC/C=C\C[C@@H]1[C@@H](CNS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL21097 85099 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 401 10 2 3 3.7 O=C(O)CCC/C=C\C[C@@H]1[C@@H](CNS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
44273778 106165 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 371 10 2 4 2.5 O=C(O)COCCCCC1=CCC[C@@H]1NS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00199-4
CHEMBL282652 106165 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 371 10 2 4 2.5 O=C(O)COCCCCC1=CCC[C@@H]1NS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00199-4
44273464 106384 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 400 9 2 4 3.8 O=C(O)CCC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1cccc2cccnc12 10.1016/0960-894X(95)00199-4
CHEMBL284019 106384 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 400 9 2 4 3.8 O=C(O)CCC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1cccc2cccnc12 10.1016/0960-894X(95)00199-4
122197353 140243 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 420 9 2 4 3.8 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2cccc3cccnc23)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL3706741 140243 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 420 9 2 4 3.8 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2cccc3cccnc23)CC[C@H]1F 10.1016/0960-894X(95)00199-4
44273541 106037 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 371 8 2 3 3.1 O=C(O)CC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccc(F)cc1F 10.1016/0960-894X(95)00199-4
CHEMBL281825 106037 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 371 8 2 3 3.1 O=C(O)CC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccc(F)cc1F 10.1016/0960-894X(95)00199-4
44386190 67193 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 390 12 1 4 4.8 O=C(O)CCC/C=C\CC1C2CCC(O2)C1CSCCOc1ccccc1 10.1021/jm00125a009
CHEMBL175076 67193 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 390 12 1 4 4.8 O=C(O)CCC/C=C\CC1C2CCC(O2)C1CSCCOc1ccccc1 10.1021/jm00125a009
44386035 135449 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 366 10 1 3 5.3 O=C(O)CCC/C=C\CC1C2CCC(O2)C1CSCC1CCCCC1 10.1021/jm00125a009
CHEMBL366812 135449 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 366 10 1 3 5.3 O=C(O)CCC/C=C\CC1C2CCC(O2)C1CSCC1CCCCC1 10.1021/jm00125a009
10637871 28590 1 None - 1 Human 4.7 pIC50 = 4.7 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(\c1ccccc1)c1cncnc1 10.1021/jm960341g
CHEMBL131949 28590 1 None - 1 Human 4.7 pIC50 = 4.7 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(\c1ccccc1)c1cncnc1 10.1021/jm960341g
16757080 150958 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 441 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(Cl)c1 10.1021/jm070427h
CHEMBL390414 150958 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 441 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(Cl)c1 10.1021/jm070427h
16757381 150701 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 427 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1Cl 10.1021/jm070427h
CHEMBL390216 150701 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 427 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1Cl 10.1021/jm070427h
16757376 160266 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 393 6 2 6 3.1 Cc1cccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)C)c1 10.1021/jm070427h
CHEMBL397964 160266 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 393 6 2 6 3.1 Cc1cccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)C)c1 10.1021/jm070427h
71740563 98131 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 400 8 3 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccc(C)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402436 98131 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 400 8 3 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccc(C)cc1 10.1016/j.ejmech.2013.04.033
16757268 99062 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 431 5 2 7 3.2 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)N/C(=N\C#N)NC(C)(C)C)cc1 10.1021/jm070427h
CHEMBL242687 99062 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 431 5 2 7 3.2 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)N/C(=N\C#N)NC(C)(C)C)cc1 10.1021/jm070427h
44273497 105539 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 389 8 2 3 3.5 O=C(O)CC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(Cl)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL278100 105539 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 389 8 2 3 3.5 O=C(O)CC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(Cl)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
10500543 89975 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 389 8 3 4 3.8 N#CN/C(=N/C1CC1)Nc1ccc(/C(=C\CCCC(=O)O)c2cccnc2)cc1 10.1021/jm9707941
CHEMBL21849 89975 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 389 8 3 4 3.8 N#CN/C(=N/C1CC1)Nc1ccc(/C(=C\CCCC(=O)O)c2cccnc2)cc1 10.1021/jm9707941
10833696 175302 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 381 9 1 5 3.9 O=C(O)CCCCCO/N=C(\c1ccnnc1)c1cccc(C(F)(F)F)c1 10.1021/jm960341g
CHEMBL435412 175302 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 381 9 1 5 3.9 O=C(O)CCCCCO/N=C(\c1ccnnc1)c1cccc(C(F)(F)F)c1 10.1021/jm960341g
16757083 149376 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 519 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(I)cc1 10.1021/jm070427h
CHEMBL389135 149376 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 519 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(I)cc1 10.1021/jm070427h
54757771 72235 0 None -8 2 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 515 12 1 4 5.7 CC(C)COC1=C(CC2CC2)C(=O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1 10.1021/jm200980u
CHEMBL1829813 72235 0 None -8 2 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 515 12 1 4 5.7 CC(C)COC1=C(CC2CC2)C(=O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1 10.1021/jm200980u
16757486 99986 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 533 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(I)cc1 10.1021/jm070427h
CHEMBL244608 99986 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 533 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(I)cc1 10.1021/jm070427h
44305343 107458 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 473 11 1 4 6.9 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)CS[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80103-7
CHEMBL292331 107458 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 473 11 1 4 6.9 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)CS[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80103-7
10409713 21441 0 None 42 2 Rat 7.7 pIC50 = 7.7 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 395 6 2 3 3.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc3ccccc3c1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205668 21441 0 None 42 2 Rat 7.7 pIC50 = 7.7 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 395 6 2 3 3.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc3ccccc3c1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL131497 21441 0 None 42 2 Rat 7.7 pIC50 = 7.7 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 395 6 2 3 3.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc3ccccc3c1)C2 10.1016/s0960-894x(99)00014-1
44291635 21557 0 None - 1 Rat 6.7 pIC50 = 6.7 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 495 9 2 4 5.6 CC(C)c1ccc2c(CCCCS(=O)(=O)Nc3ccc(Cl)cc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL1206702 21557 0 None - 1 Rat 6.7 pIC50 = 6.7 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 495 9 2 4 5.6 CC(C)c1ccc2c(CCCCS(=O)(=O)Nc3ccc(Cl)cc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL298462 21557 0 None - 1 Rat 6.7 pIC50 = 6.7 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 495 9 2 4 5.6 CC(C)c1ccc2c(CCCCS(=O)(=O)Nc3ccc(Cl)cc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
71740559 98127 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 386 4 3 5 3.4 Cc1cccc(Nc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1 10.1016/j.ejmech.2013.04.033
CHEMBL2402432 98127 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 386 4 3 5 3.4 Cc1cccc(Nc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1 10.1016/j.ejmech.2013.04.033
44273462 81183 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 335 8 2 3 2.9 O=C(O)CC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccccc1 10.1016/0960-894X(95)00199-4
CHEMBL20257 81183 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 335 8 2 3 2.9 O=C(O)CC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccccc1 10.1016/0960-894X(95)00199-4
11633163 145614 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(C)c1 10.1021/jm070427h
CHEMBL378137 145614 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(C)c1 10.1021/jm070427h
71740179 98116 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 401 8 2 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccccc1C 10.1016/j.ejmech.2013.04.033
CHEMBL2402421 98116 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 401 8 2 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccccc1C 10.1016/j.ejmech.2013.04.033
44305452 210140 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 473 11 1 4 6.9 O=C(O)CCC/C=C\C[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)CS[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80103-7
CHEMBL65161 210140 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 473 11 1 4 6.9 O=C(O)CCC/C=C\C[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)CS[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80103-7
44304473 209679 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 369 7 3 3 4.4 O=C(O)CCC/C=C1\C[C@@H]2[C@@H](/C=N/NC(=O)Nc3ccccc3)CC[C@@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL62739 209679 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 369 7 3 3 4.4 O=C(O)CCC/C=C1\C[C@@H]2[C@@H](/C=N/NC(=O)Nc3ccccc3)CC[C@@H]2C1 10.1016/S0960-894X(01)80876-3
44273506 84995 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 349 9 2 3 3.3 O=C(O)CCC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccccc1 10.1016/0960-894X(95)00199-4
CHEMBL21057 84995 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 349 9 2 3 3.3 O=C(O)CCC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccccc1 10.1016/0960-894X(95)00199-4
16756977 99065 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 407 5 2 6 3.5 Cc1ccccc1Oc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm070427h
CHEMBL242692 99065 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 407 5 2 6 3.5 Cc1ccccc1Oc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm070427h
71740560 98128 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 400 8 3 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1cccc(C)c1 10.1016/j.ejmech.2013.04.033
CHEMBL2402433 98128 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 400 8 3 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1cccc(C)c1 10.1016/j.ejmech.2013.04.033
71740180 98117 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 373 5 2 5 3.1 Cc1cccc(Oc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)C)c1 10.1016/j.ejmech.2013.04.033
CHEMBL2402422 98117 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 373 5 2 5 3.1 Cc1cccc(Oc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)C)c1 10.1016/j.ejmech.2013.04.033
16757080 150958 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 441 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(Cl)c1 10.1021/jm070427h
CHEMBL390414 150958 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 441 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(Cl)c1 10.1021/jm070427h
44305478 107520 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 505 11 1 5 5.6 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)S(=O)(=O)C[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80103-7
CHEMBL292740 107520 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 505 11 1 5 5.6 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)S(=O)(=O)C[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80103-7
5312142 85008 11 None - 1 Human 6.6 pIC50 = 6.6 Functional
Inhibition of U46619-induced platelet aggregationInhibition of U46619-induced platelet aggregation
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
CHEMBL210602 85008 11 None - 1 Human 6.6 pIC50 = 6.6 Functional
Inhibition of U46619-induced platelet aggregationInhibition of U46619-induced platelet aggregation
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
15018463 176159 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 389 10 2 3 3.6 O=C(O)CCCCCC[C@@H]1[C@@H](NS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL442143 176159 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 389 10 2 3 3.6 O=C(O)CCCCCC[C@@H]1[C@@H](NS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
10661867 27349 1 None - 1 Human 4.6 pIC50 = 4.6 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(/c1ccccc1)c1cnccn1 10.1021/jm960341g
CHEMBL130790 27349 1 None - 1 Human 4.6 pIC50 = 4.6 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(/c1ccccc1)c1cnccn1 10.1021/jm960341g
16757381 150701 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 427 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1Cl 10.1021/jm070427h
CHEMBL390216 150701 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 427 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1Cl 10.1021/jm070427h
13720717 84626 0 None 1 3 Human 5.6 pIC50 = 5.6 Functional
Inhibitory activity against U-46,619-induced responses in human platelet aggregation (Thromboxane A2 alpha receptor)Inhibitory activity against U-46,619-induced responses in human platelet aggregation (Thromboxane A2 alpha receptor)
ChEMBL 363 5 3 6 2.7 COc1cc(C[C@H]2NCCc3cc(O)c(O)c(F)c32)cc(OC)c1OC 10.1021/jm00081a007
CHEMBL2092996 84626 0 None 1 3 Human 5.6 pIC50 = 5.6 Functional
Inhibitory activity against U-46,619-induced responses in human platelet aggregation (Thromboxane A2 alpha receptor)Inhibitory activity against U-46,619-induced responses in human platelet aggregation (Thromboxane A2 alpha receptor)
ChEMBL 363 5 3 6 2.7 COc1cc(C[C@H]2NCCc3cc(O)c(O)c(F)c32)cc(OC)c1OC 10.1021/jm00081a007
54669847 72227 0 None -4 2 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 405 7 2 4 3.4 O=C1C=C(O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1 10.1021/jm200980u
CHEMBL1829805 72227 0 None -4 2 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 405 7 2 4 3.4 O=C1C=C(O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1 10.1021/jm200980u
44273489 80920 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 363 9 2 3 3.6 Cc1ccc(S(=O)(=O)N[C@H]2CCC=C2C/C=C\CCCC(=O)O)cc1 10.1016/0960-894X(95)00199-4
CHEMBL20228 80920 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 363 9 2 3 3.6 Cc1ccc(S(=O)(=O)N[C@H]2CCC=C2C/C=C\CCCC(=O)O)cc1 10.1016/0960-894X(95)00199-4
23276770 125267 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(/c1cccc(C(F)(F)F)c1)c1ccncn1 10.1021/jm960341g
CHEMBL341426 125267 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(/c1cccc(C(F)(F)F)c1)c1ccncn1 10.1021/jm960341g
44386678 175126 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 386 13 1 4 4.0 CCCCCCS(=O)(=O)CC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL434362 175126 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 386 13 1 4 4.0 CCCCCCS(=O)(=O)CC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
10852668 26342 1 None - 1 Human 4.6 pIC50 = 4.6 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 313 9 1 5 2.9 O=C(O)CCCCCO/N=C(/c1ccccc1)c1ccncn1 10.1021/jm960341g
CHEMBL129995 26342 1 None - 1 Human 4.6 pIC50 = 4.6 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 313 9 1 5 2.9 O=C(O)CCCCCO/N=C(/c1ccccc1)c1ccncn1 10.1021/jm960341g
10827996 122963 1 None - 1 Human 4.6 pIC50 = 4.6 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(/c1ccccc1)c1ccncn1 10.1021/jm960341g
CHEMBL335841 122963 1 None - 1 Human 4.6 pIC50 = 4.6 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(/c1ccccc1)c1ccncn1 10.1021/jm960341g
54757771 72235 0 None 8 2 Mouse 5.6 pIC50 = 5.6 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 515 12 1 4 5.7 CC(C)COC1=C(CC2CC2)C(=O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1 10.1021/jm200980u
CHEMBL1829813 72235 0 None 8 2 Mouse 5.6 pIC50 = 5.6 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 515 12 1 4 5.7 CC(C)COC1=C(CC2CC2)C(=O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1 10.1021/jm200980u
11633163 145614 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(C)c1 10.1021/jm070427h
CHEMBL378137 145614 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(C)c1 10.1021/jm070427h
16756980 100056 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 471 5 2 6 3.9 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1Br 10.1021/jm070427h
CHEMBL245032 100056 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 471 5 2 6 3.9 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1Br 10.1021/jm070427h
54757770 72233 0 None 20 2 Mouse 6.6 pIC50 = 6.6 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 503 11 1 4 5.6 CC(C)COC1=C(C(C)C)C(=O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1 10.1021/jm200980u
CHEMBL1829811 72233 0 None 20 2 Mouse 6.6 pIC50 = 6.6 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 503 11 1 4 5.6 CC(C)COC1=C(C(C)C)C(=O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1 10.1021/jm200980u
9907162 21517 0 None 50 2 Rat 7.6 pIC50 = 7.6 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 365 5 2 3 2.7 O=C(O)c1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1206352 21517 0 None 50 2 Rat 7.6 pIC50 = 7.6 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 365 5 2 3 2.7 O=C(O)c1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL264516 21517 0 None 50 2 Rat 7.6 pIC50 = 7.6 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 365 5 2 3 2.7 O=C(O)c1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
44305522 209750 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
In vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human platelets
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)OC[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80104-9
CHEMBL63040 209750 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
In vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human platelets
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)OC[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80104-9
15018450 79738 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 383 9 2 3 3.6 Cc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](F)[C@@H]2C/C=C\CCCC(=O)O)cc1 10.1016/0960-894X(95)00199-4
CHEMBL20065 79738 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 383 9 2 3 3.6 Cc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](F)[C@@H]2C/C=C\CCCC(=O)O)cc1 10.1016/0960-894X(95)00199-4
10669025 211835 1 None - 1 Human 5.6 pIC50 = 5.6 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 405 7 3 4 4.4 CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=C/CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL7718 211835 1 None - 1 Human 5.6 pIC50 = 5.6 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 405 7 3 4 4.4 CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=C/CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
44291875 108256 0 None - 1 Rat 5.6 pIC50 = 5.6 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 459 9 2 3 6.0 CC(C)c1ccc2c(CCCCS(=O)(=O)Nc3ccc(Cl)cc3)cc(C(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL297808 108256 0 None - 1 Rat 5.6 pIC50 = 5.6 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 459 9 2 3 6.0 CC(C)c1ccc2c(CCCCS(=O)(=O)Nc3ccc(Cl)cc3)cc(C(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
44304706 210067 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 371 6 4 4 3.0 O=C(O)CC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccccc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL64707 210067 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 371 6 4 4 3.0 O=C(O)CC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccccc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
16757376 160266 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 393 6 2 6 3.1 Cc1cccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)C)c1 10.1021/jm070427h
CHEMBL397964 160266 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 393 6 2 6 3.1 Cc1cccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)C)c1 10.1021/jm070427h
16757175 100021 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 437 10 2 7 3.6 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(OC)cc1 10.1021/jm070427h
CHEMBL244818 100021 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 437 10 2 7 3.6 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(OC)cc1 10.1021/jm070427h
10546960 210134 0 None 6 2 Mouse 7.6 pIC50 = 7.6 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 367 8 2 3 2.9 O=C(O)CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm200980u
CHEMBL65121 210134 0 None 6 2 Mouse 7.6 pIC50 = 7.6 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 367 8 2 3 2.9 O=C(O)CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm200980u
10550018 169039 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 419 10 3 4 4.7 CC(C)CC/N=C(/NC#N)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL416374 169039 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 419 10 3 4 4.7 CC(C)CC/N=C(/NC#N)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
16757176 100059 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 465 12 2 7 4.4 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(OCCC)cc1 10.1021/jm070427h
CHEMBL245036 100059 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 465 12 2 7 4.4 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(OCCC)cc1 10.1021/jm070427h
71740444 98124 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 386 4 3 5 3.4 Cc1ccccc1Nc1ccc(C#N)cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1016/j.ejmech.2013.04.033
CHEMBL2402429 98124 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 386 4 3 5 3.4 Cc1ccccc1Nc1ccc(C#N)cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1016/j.ejmech.2013.04.033
117630015 122647 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 591 9 1 4 7.0 Cc1cccc(C)c1C1=C(OCC(C)C)CC(Cc2cccc3c2CCC(NS(=O)(=O)c2ccc(Cl)cc2)C3)C1=O 10.1021/ml5002085
CHEMBL3354617 122647 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 591 9 1 4 7.0 Cc1cccc(C)c1C1=C(OCC(C)C)CC(Cc2cccc3c2CCC(NS(=O)(=O)c2ccc(Cl)cc2)C3)C1=O 10.1021/ml5002085
11676121 85097 4 None - 1 Human 6.6 pIC50 = 6.6 Functional
Inhibition of U46619-induced platelet aggregationInhibition of U46619-induced platelet aggregation
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(C)cc1 10.1021/jm060108a
CHEMBL210964 85097 4 None - 1 Human 6.6 pIC50 = 6.6 Functional
Inhibition of U46619-induced platelet aggregationInhibition of U46619-induced platelet aggregation
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(C)cc1 10.1021/jm060108a
44305522 209750 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
In vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human platelets
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)OC[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80104-9
CHEMBL63040 209750 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
In vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human platelets
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)OC[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80104-9
65772 67177 8 None -54 11 Human 6.6 pIC50 = 6.6 Functional
Inhibitory activity against U-46,619-induced responses in human platelet aggregation (Thromboxane A2 alpha receptor)Inhibitory activity against U-46,619-induced responses in human platelet aggregation (Thromboxane A2 alpha receptor)
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm00081a007
CHEMBL174984 67177 8 None -54 11 Human 6.6 pIC50 = 6.6 Functional
Inhibitory activity against U-46,619-induced responses in human platelet aggregation (Thromboxane A2 alpha receptor)Inhibitory activity against U-46,619-induced responses in human platelet aggregation (Thromboxane A2 alpha receptor)
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm00081a007
15290043 21574 0 None -33 2 Human 5.6 pIC50 = 5.6 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 351 6 2 4 2.1 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1cccs1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1207012 21574 0 None -33 2 Human 5.6 pIC50 = 5.6 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 351 6 2 4 2.1 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1cccs1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL335043 21574 0 None -33 2 Human 5.6 pIC50 = 5.6 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 351 6 2 4 2.1 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1cccs1)C2 10.1016/s0960-894x(99)00014-1
18921481 21436 0 None -81 2 Human 5.5 pIC50 = 5.5 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 421 9 2 3 3.8 O=C(O)CCCCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205661 21436 0 None -81 2 Human 5.5 pIC50 = 5.5 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 421 9 2 3 3.8 O=C(O)CCCCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL130377 21436 0 None -81 2 Human 5.5 pIC50 = 5.5 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 421 9 2 3 3.8 O=C(O)CCCCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
117630458 122649 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 521 7 2 4 5.4 O=C1C(Cc2ccccc2)=C(O)CC1Cc1cccc2c1CCC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1021/ml5002085
CHEMBL3354619 122649 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 521 7 2 4 5.4 O=C1C(Cc2ccccc2)=C(O)CC1Cc1cccc2c1CCC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1021/ml5002085
10385168 123358 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 381 9 1 5 3.9 O=C(O)CCCCCO/N=C(/c1ccnnc1)c1cccc(C(F)(F)F)c1 10.1021/jm960341g
CHEMBL336548 123358 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 381 9 1 5 3.9 O=C(O)CCCCCO/N=C(/c1ccnnc1)c1cccc(C(F)(F)F)c1 10.1021/jm960341g
11633215 146933 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 423 5 2 6 3.8 Cc1ccc(Sc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
CHEMBL380274 146933 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 423 5 2 6 3.8 Cc1ccc(Sc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
15290042 21645 0 None 162 2 Rat 6.5 pIC50 = 6.5 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 395 6 2 3 3.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1cccc3ccccc13)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1207638 21645 0 None 162 2 Rat 6.5 pIC50 = 6.5 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 395 6 2 3 3.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1cccc3ccccc13)C2 10.1016/s0960-894x(99)00014-1
CHEMBL422441 21645 0 None 162 2 Rat 6.5 pIC50 = 6.5 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 395 6 2 3 3.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1cccc3ccccc13)C2 10.1016/s0960-894x(99)00014-1
71740560 98128 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 400 8 3 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1cccc(C)c1 10.1016/j.ejmech.2013.04.033
CHEMBL2402433 98128 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 400 8 3 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1cccc(C)c1 10.1016/j.ejmech.2013.04.033
10646254 87914 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 429 9 3 6 4.8 CC(C)(C)NC(Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1)=C(C#N)C#N 10.1021/jm9707941
CHEMBL21570 87914 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 429 9 3 6 4.8 CC(C)(C)NC(Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1)=C(C#N)C#N 10.1021/jm9707941
219052 21576 2 None 120 2 Rat 8.5 pIC50 = 8.5 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 379 6 2 3 2.7 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1207021 21576 2 None 120 2 Rat 8.5 pIC50 = 8.5 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 379 6 2 3 2.7 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL336846 21576 2 None 120 2 Rat 8.5 pIC50 = 8.5 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 379 6 2 3 2.7 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
54669848 72228 0 None 42 2 Mouse 8.5 pIC50 = 8.5 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 419 7 2 4 3.8 CC1=C(O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)CC1=O 10.1021/jm200980u
CHEMBL1829806 72228 0 None 42 2 Mouse 8.5 pIC50 = 8.5 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 419 7 2 4 3.8 CC1=C(O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)CC1=O 10.1021/jm200980u
117630548 122644 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 507 6 2 4 5.3 O=C1C(c2ccccc2)=C(O)CC1Cc1cccc2c1CCC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1021/ml5002085
CHEMBL3354614 122644 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 507 6 2 4 5.3 O=C1C(c2ccccc2)=C(O)CC1Cc1cccc2c1CCC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1021/ml5002085
10669649 88480 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 417 8 3 4 4.5 N#CN/C(=N/C1CCCC1)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL21639 88480 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 417 8 3 4 4.5 N#CN/C(=N/C1CCCC1)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
11661725 84634 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 420 5 3 6 3.7 Cc1cccc(C)c1Nc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm060108a
CHEMBL209306 84634 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 420 5 3 6 3.7 Cc1cccc(C)c1Nc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm060108a
10503638 171588 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 448 10 4 6 3.8 CC(C)C/N=C(\Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1)Nc1nn[nH]n1 10.1021/jm9707941
CHEMBL421854 171588 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 448 10 4 6 3.8 CC(C)C/N=C(\Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1)Nc1nn[nH]n1 10.1021/jm9707941
11567679 84523 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Inhibition of U46619-induced platelet aggregationInhibition of U46619-induced platelet aggregation
ChEMBL 407 5 2 6 3.5 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
CHEMBL209035 84523 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Inhibition of U46619-induced platelet aggregationInhibition of U46619-induced platelet aggregation
ChEMBL 407 5 2 6 3.5 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
10494367 26277 1 None - 1 Human 5.5 pIC50 = 5.5 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(\c1ccccc1)c1ncccn1 10.1021/jm960341g
CHEMBL129935 26277 1 None - 1 Human 5.5 pIC50 = 5.5 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(\c1ccccc1)c1ncccn1 10.1021/jm960341g
10518244 28700 1 None - 1 Human 4.5 pIC50 = 4.5 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(\c1ccccc1)c1ccncn1 10.1021/jm960341g
CHEMBL132043 28700 1 None - 1 Human 4.5 pIC50 = 4.5 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(\c1ccccc1)c1ccncn1 10.1021/jm960341g
16757486 99986 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 533 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(I)cc1 10.1021/jm070427h
CHEMBL244608 99986 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 533 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(I)cc1 10.1021/jm070427h
71740183 98120 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 373 5 2 5 3.1 Cc1ccc(Oc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)C)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402425 98120 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 373 5 2 5 3.1 Cc1ccc(Oc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)C)cc1 10.1016/j.ejmech.2013.04.033
16757081 99640 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 427 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Cl)cc1 10.1021/jm070427h
CHEMBL243983 99640 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 427 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Cl)cc1 10.1021/jm070427h
16757079 99620 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 441 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1Cl 10.1021/jm070427h
CHEMBL243773 99620 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 441 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1Cl 10.1021/jm070427h
18921526 21446 0 None 46 2 Rat 7.5 pIC50 = 7.5 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 393 7 2 3 3.1 O=C(O)Cc1ccc2c(c1)CC(CCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205680 21446 0 None 46 2 Rat 7.5 pIC50 = 7.5 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 393 7 2 3 3.1 O=C(O)Cc1ccc2c(c1)CC(CCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL132659 21446 0 None 46 2 Rat 7.5 pIC50 = 7.5 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 393 7 2 3 3.1 O=C(O)Cc1ccc2c(c1)CC(CCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
44457587 90270 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 436 9 3 6 3.7 CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=N\OCCCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL22023 90270 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 436 9 3 6 3.7 CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=N\OCCCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
16756981 159381 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 485 9 2 6 4.3 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1Br 10.1021/jm070427h
CHEMBL397198 159381 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 485 9 2 6 4.3 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1Br 10.1021/jm070427h
5312142 85008 11 None - 1 Human 6.5 pIC50 = 6.5 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
CHEMBL210602 85008 11 None - 1 Human 6.5 pIC50 = 6.5 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
5312142 85008 11 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm070427h
CHEMBL210602 85008 11 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm070427h
71740557 98125 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 400 8 3 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccccc1C 10.1016/j.ejmech.2013.04.033
CHEMBL2402430 98125 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 400 8 3 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccccc1C 10.1016/j.ejmech.2013.04.033
10717914 175887 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 439 9 3 4 4.8 N#CN/C(=N/Cc1ccccc1)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL440096 175887 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 439 9 3 4 4.8 N#CN/C(=N/Cc1ccccc1)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
44353303 21438 0 None -2 2 Human 6.5 pIC50 = 6.5 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 381 6 2 4 2.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)O2 10.1016/s0960-894x(99)00014-1
CHEMBL1205664 21438 0 None -2 2 Human 6.5 pIC50 = 6.5 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 381 6 2 4 2.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)O2 10.1016/s0960-894x(99)00014-1
CHEMBL131036 21438 0 None -2 2 Human 6.5 pIC50 = 6.5 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 381 6 2 4 2.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)O2 10.1016/s0960-894x(99)00014-1
10526115 87290 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 419 8 3 4 4.8 CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=C\CCCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL21478 87290 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 419 8 3 4 4.8 CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=C\CCCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
10766313 105475 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 458 8 3 5 3.9 CC(C)(C)/N=C(\Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1)NS(C)(=O)=O 10.1021/jm9707941
CHEMBL277620 105475 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 458 8 3 5 3.9 CC(C)(C)/N=C(\Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1)NS(C)(=O)=O 10.1021/jm9707941
10637870 27296 1 None - 1 Human 4.5 pIC50 = 4.5 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(\c1ccccc1)c1ccnnc1 10.1021/jm960341g
CHEMBL130755 27296 1 None - 1 Human 4.5 pIC50 = 4.5 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(\c1ccccc1)c1ccnnc1 10.1021/jm960341g
10545734 173726 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 349 7 3 4 2.8 N#CN/C(N)=N\c1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL428709 173726 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 349 7 3 4 2.8 N#CN/C(N)=N\c1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
18921481 21436 0 None 81 2 Rat 7.5 pIC50 = 7.5 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 421 9 2 3 3.8 O=C(O)CCCCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205661 21436 0 None 81 2 Rat 7.5 pIC50 = 7.5 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 421 9 2 3 3.8 O=C(O)CCCCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL130377 21436 0 None 81 2 Rat 7.5 pIC50 = 7.5 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 421 9 2 3 3.8 O=C(O)CCCCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
44385759 67232 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 354 13 1 3 5.4 CCCCCCCSC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL175325 67232 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 354 13 1 3 5.4 CCCCCCCSC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
163920 21447 12 None -165 2 Human 6.4 pIC50 = 6.4 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 365 5 2 3 2.4 O=C(O)Cc1ccc2c(c1)CC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205685 21447 12 None -165 2 Human 6.4 pIC50 = 6.4 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 365 5 2 3 2.4 O=C(O)Cc1ccc2c(c1)CC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL133420 21447 12 None -165 2 Human 6.4 pIC50 = 6.4 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 365 5 2 3 2.4 O=C(O)Cc1ccc2c(c1)CC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
219052 21576 2 None -120 2 Human 6.4 pIC50 = 6.4 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 379 6 2 3 2.7 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1207021 21576 2 None -120 2 Human 6.4 pIC50 = 6.4 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 379 6 2 3 2.7 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL336846 21576 2 None -120 2 Human 6.4 pIC50 = 6.4 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 379 6 2 3 2.7 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
10384315 171925 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(\c1cncnc1)c1cccc(C(F)(F)F)c1 10.1021/jm960341g
CHEMBL422793 171925 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(\c1cncnc1)c1cccc(C(F)(F)F)c1 10.1021/jm960341g
71740057 98115 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 387 4 2 5 3.4 Cc1ccccc1Oc1ccc(C#N)cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1016/j.ejmech.2013.04.033
CHEMBL2402420 98115 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 387 4 2 5 3.4 Cc1ccccc1Oc1ccc(C#N)cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1016/j.ejmech.2013.04.033
1986 8094 50 None 7 2 Rat 7.4 pIC50 = 7.4 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 353 7 2 3 2.5 OC(=O)Cc1ccc(cc1)CCNS(=O)(=O)c1ccc(cc1)Cl 10.1016/s0960-894x(99)00014-1
54343 8094 50 None 7 2 Rat 7.4 pIC50 = 7.4 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 353 7 2 3 2.5 OC(=O)Cc1ccc(cc1)CCNS(=O)(=O)c1ccc(cc1)Cl 10.1016/s0960-894x(99)00014-1
CHEMBL71685 8094 50 None 7 2 Rat 7.4 pIC50 = 7.4 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 353 7 2 3 2.5 OC(=O)Cc1ccc(cc1)CCNS(=O)(=O)c1ccc(cc1)Cl 10.1016/s0960-894x(99)00014-1
44387046 68909 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 354 13 1 3 5.3 CCCCCSCCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL177760 68909 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 354 13 1 3 5.3 CCCCCSCCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
16757179 100095 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 455 9 2 6 4.5 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Cl)c(C)c1 10.1021/jm070427h
CHEMBL245263 100095 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 455 9 2 6 4.5 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Cl)c(C)c1 10.1021/jm070427h
16756977 99065 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 407 5 2 6 3.5 Cc1ccccc1Oc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm070427h
CHEMBL242692 99065 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 407 5 2 6 3.5 Cc1ccccc1Oc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm070427h
54758054 72224 0 None -4 2 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 420 8 3 6 1.8 O=c1c(O)c(NCc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)c1=O 10.1021/jm200980u
CHEMBL1829802 72224 0 None -4 2 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 420 8 3 6 1.8 O=c1c(O)c(NCc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)c1=O 10.1021/jm200980u
10620837 105957 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 397 7 3 3 5.3 CC(C)(C)/N=C(/S)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL281338 105957 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 397 7 3 3 5.3 CC(C)(C)/N=C(/S)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
11647396 84557 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 418 5 2 6 3.5 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)N2CCCCC2)cc1 10.1021/jm060108a
CHEMBL209168 84557 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 418 5 2 6 3.5 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)N2CCCCC2)cc1 10.1021/jm060108a
10320462 21573 0 None 34 2 Rat 7.4 pIC50 = 7.4 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 407 8 2 3 3.4 O=C(O)CCCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1207010 21573 0 None 34 2 Rat 7.4 pIC50 = 7.4 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 407 8 2 3 3.4 O=C(O)CCCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL334501 21573 0 None 34 2 Rat 7.4 pIC50 = 7.4 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 407 8 2 3 3.4 O=C(O)CCCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
44386034 67162 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 368 13 1 3 5.7 CCCCCC(C)SCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL174856 67162 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 368 13 1 3 5.7 CCCCCC(C)SCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
118719206 122242 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 354 13 1 3 5.3 CCCCCCSC[C@H]1C2CCC(O2)[C@H]1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL3350918 122242 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 354 13 1 3 5.3 CCCCCCSC[C@H]1C2CCC(O2)[C@H]1C/C=C\CCCC(=O)O 10.1021/jm00125a009
56659855 72092 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at thromboxane receptor in human blood assessed as inhibition of U-46619-induced effectAntagonist activity at thromboxane receptor in human blood assessed as inhibition of U-46619-induced effect
ChEMBL 353 7 2 8 -0.1 NC(=O)c1c(CSCC(=O)Oc2ccccc2C(=O)O)no[n+]1[O-] 10.1016/j.bmc.2011.08.018
CHEMBL1829095 72092 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at thromboxane receptor in human blood assessed as inhibition of U-46619-induced effectAntagonist activity at thromboxane receptor in human blood assessed as inhibition of U-46619-induced effect
ChEMBL 353 7 2 8 -0.1 NC(=O)c1c(CSCC(=O)Oc2ccccc2C(=O)O)no[n+]1[O-] 10.1016/j.bmc.2011.08.018
44386134 69128 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 284 8 1 3 3.3 CSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL177907 69128 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 284 8 1 3 3.3 CSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
54757769 72231 0 None -8 2 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 489 11 1 4 5.3 CCC1=C(OCC(C)C)CC(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1=O 10.1021/jm200980u
CHEMBL1829809 72231 0 None -8 2 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 489 11 1 4 5.3 CCC1=C(OCC(C)C)CC(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1=O 10.1021/jm200980u
16757079 99620 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 441 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1Cl 10.1021/jm070427h
CHEMBL243773 99620 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 441 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1Cl 10.1021/jm070427h
71740308 98133 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 391 4 2 5 3.3 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402438 98133 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 391 4 2 5 3.3 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
10095268 92931 0 None -7 3 Human 7.4 pIC50 = 7.4 Functional
Inhibition of human recombinant TP receptor expressed in CHO cells by calcium mobilisation assayInhibition of human recombinant TP receptor expressed in CHO cells by calcium mobilisation assay
ChEMBL 449 6 1 3 6.8 Cc1ccc(-n2c(C)ccc2-c2cc(Cl)ccc2OCc2ccc(F)cc2)cc1C(=O)O 10.1016/j.bmcl.2006.11.059
CHEMBL231184 92931 0 None -7 3 Human 7.4 pIC50 = 7.4 Functional
Inhibition of human recombinant TP receptor expressed in CHO cells by calcium mobilisation assayInhibition of human recombinant TP receptor expressed in CHO cells by calcium mobilisation assay
ChEMBL 449 6 1 3 6.8 Cc1ccc(-n2c(C)ccc2-c2cc(Cl)ccc2OCc2ccc(F)cc2)cc1C(=O)O 10.1016/j.bmcl.2006.11.059
56680341 72093 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at thromboxane receptor in human blood assessed as inhibition of U-46619-induced effectAntagonist activity at thromboxane receptor in human blood assessed as inhibition of U-46619-induced effect
ChEMBL 337 7 2 8 0.7 NC(=O)c1nonc1CSCC(=O)Oc1ccccc1C(=O)O 10.1016/j.bmc.2011.08.018
CHEMBL1829096 72093 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at thromboxane receptor in human blood assessed as inhibition of U-46619-induced effectAntagonist activity at thromboxane receptor in human blood assessed as inhibition of U-46619-induced effect
ChEMBL 337 7 2 8 0.7 NC(=O)c1nonc1CSCC(=O)Oc1ccccc1C(=O)O 10.1016/j.bmc.2011.08.018
16757377 156852 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 407 5 2 6 3.5 Cc1cccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1 10.1021/jm070427h
CHEMBL395079 156852 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 407 5 2 6 3.5 Cc1cccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1 10.1021/jm070427h
13720716 69827 0 None -165 3 Human 4.4 pIC50 = 4.4 Functional
Inhibitory activity against U-46,619-induced responses in human platelet aggregation (Thromboxane A2 alpha receptor)Inhibitory activity against U-46,619-induced responses in human platelet aggregation (Thromboxane A2 alpha receptor)
ChEMBL 363 5 3 6 2.7 COc1cc(C[C@@H]2NCCc3cc(O)c(O)c(F)c32)cc(OC)c1OC 10.1021/jm00081a007
CHEMBL1788251 69827 0 None -165 3 Human 4.4 pIC50 = 4.4 Functional
Inhibitory activity against U-46,619-induced responses in human platelet aggregation (Thromboxane A2 alpha receptor)Inhibitory activity against U-46,619-induced responses in human platelet aggregation (Thromboxane A2 alpha receptor)
ChEMBL 363 5 3 6 2.7 COc1cc(C[C@@H]2NCCc3cc(O)c(O)c(F)c32)cc(OC)c1OC 10.1021/jm00081a007
16757081 99640 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 427 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Cl)cc1 10.1021/jm070427h
CHEMBL243983 99640 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 427 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Cl)cc1 10.1021/jm070427h
16757083 149376 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 519 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(I)cc1 10.1021/jm070427h
CHEMBL389135 149376 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 519 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(I)cc1 10.1021/jm070427h
44138108 191064 0 None -7413 2 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at TP1 in human platelet-rich plasma assessed as inhibition of U44619-induced platelet aggregationAntagonist activity at TP1 in human platelet-rich plasma assessed as inhibition of U44619-induced platelet aggregation
ChEMBL 434 5 1 4 6.6 CC(C)c1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CC[C@@H]1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL483991 191064 0 None -7413 2 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at TP1 in human platelet-rich plasma assessed as inhibition of U44619-induced platelet aggregationAntagonist activity at TP1 in human platelet-rich plasma assessed as inhibition of U44619-induced platelet aggregation
ChEMBL 434 5 1 4 6.6 CC(C)c1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CC[C@@H]1CC(=O)O 10.1016/j.bmcl.2009.03.010
56680464 72234 0 None -7 2 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 461 9 2 4 3.8 O=C1C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)CC(O)C1CC1CC1 10.1021/jm200980u
CHEMBL1829812 72234 0 None -7 2 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 461 9 2 4 3.8 O=C1C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)CC(O)C1CC1CC1 10.1021/jm200980u
71740561 98129 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 372 5 3 5 3.0 Cc1ccc(Nc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)C)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402434 98129 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 372 5 3 5 3.0 Cc1ccc(Nc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)C)cc1 10.1016/j.ejmech.2013.04.033
16756982 100091 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 485 9 2 6 4.3 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(Br)c1 10.1021/jm070427h
CHEMBL245254 100091 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 485 9 2 6 4.3 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(Br)c1 10.1021/jm070427h
16757375 98962 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 407 8 2 6 3.5 CCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1C 10.1021/jm070427h
CHEMBL242479 98962 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 407 8 2 6 3.5 CCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1C 10.1021/jm070427h
44387050 68079 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 368 14 1 3 5.7 CCCCCCCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL176714 68079 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 368 14 1 3 5.7 CCCCCCCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
71740561 98129 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 372 5 3 5 3.0 Cc1ccc(Nc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)C)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402434 98129 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 372 5 3 5 3.0 Cc1ccc(Nc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)C)cc1 10.1016/j.ejmech.2013.04.033
16757378 100055 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 393 7 2 6 3.1 CCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm070427h
CHEMBL245031 100055 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 393 7 2 6 3.1 CCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm070427h
16756981 159381 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 485 9 2 6 4.3 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1Br 10.1021/jm070427h
CHEMBL397198 159381 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 485 9 2 6 4.3 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1Br 10.1021/jm070427h
11656254 84552 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 498 9 3 6 4.6 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(Br)c(C)c1 10.1021/jm060108a
CHEMBL209134 84552 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 498 9 3 6 4.6 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(Br)c(C)c1 10.1021/jm060108a
11294166 83820 0 None -10232 2 Human 4.4 pIC50 = 4.4 Functional
Activity at TP receptor assessed as inhibition of U46619-induced platelet aggregation in platelet rich plasmaActivity at TP receptor assessed as inhibition of U46619-induced platelet aggregation in platelet rich plasma
ChEMBL 461 6 2 5 4.3 CC(O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1016/j.bmcl.2006.02.062
CHEMBL207203 83820 0 None -10232 2 Human 4.4 pIC50 = 4.4 Functional
Activity at TP receptor assessed as inhibition of U46619-induced platelet aggregation in platelet rich plasmaActivity at TP receptor assessed as inhibition of U46619-induced platelet aggregation in platelet rich plasma
ChEMBL 461 6 2 5 4.3 CC(O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1016/j.bmcl.2006.02.062
11294166 83820 0 None -10232 2 Human 4.4 pIC50 = 4.4 Functional
Activity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregationActivity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregation
ChEMBL 461 6 2 5 4.3 CC(O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1021/jm0603668
CHEMBL207203 83820 0 None -10232 2 Human 4.4 pIC50 = 4.4 Functional
Activity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregationActivity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregation
ChEMBL 461 6 2 5 4.3 CC(O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1021/jm0603668
71740308 98133 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 391 4 2 5 3.3 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402438 98133 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 391 4 2 5 3.3 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
44457567 87043 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 450 11 3 6 5.2 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(N/C(=C/[N+](=O)[O-])NC2CCCCC2)c1 10.1021/jm9707941
CHEMBL21392 87043 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 450 11 3 6 5.2 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(N/C(=C/[N+](=O)[O-])NC2CCCCC2)c1 10.1021/jm9707941
44273488 106247 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 367 9 2 3 3.4 O=C(O)CCC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00199-4
CHEMBL283128 106247 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 367 9 2 3 3.4 O=C(O)CCC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00199-4
16757175 100021 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 437 10 2 7 3.6 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(OC)cc1 10.1021/jm070427h
CHEMBL244818 100021 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 437 10 2 7 3.6 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(OC)cc1 10.1021/jm070427h
16757378 100055 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 393 7 2 6 3.1 CCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm070427h
CHEMBL245031 100055 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 393 7 2 6 3.1 CCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm070427h
11568384 84571 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 440 7 3 6 3.8 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NCc2ccccc2)cc1 10.1021/jm060108a
CHEMBL209245 84571 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 440 7 3 6 3.8 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NCc2ccccc2)cc1 10.1021/jm060108a
11510008 84057 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1cccc(C)c1 10.1021/jm060108a
CHEMBL208115 84057 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1cccc(C)c1 10.1021/jm060108a
16757485 99956 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 533 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(I)c1 10.1021/jm070427h
CHEMBL244401 99956 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 533 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(I)c1 10.1021/jm070427h
44305343 107458 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 473 11 1 4 6.9 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)CS[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80103-7
CHEMBL292331 107458 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 473 11 1 4 6.9 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)CS[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80103-7
44305326 209705 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 473 11 1 4 6.9 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)SC[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80103-7
CHEMBL62834 209705 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 473 11 1 4 6.9 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)SC[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80103-7
11604299 146360 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 426 10 3 6 3.9 CCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1021/jm060108a
CHEMBL379736 146360 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 426 10 3 6 3.9 CCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1021/jm060108a
1986 8094 50 None -7 2 Human 6.3 pIC50 = 6.3 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 353 7 2 3 2.5 OC(=O)Cc1ccc(cc1)CCNS(=O)(=O)c1ccc(cc1)Cl 10.1016/s0960-894x(99)00014-1
54343 8094 50 None -7 2 Human 6.3 pIC50 = 6.3 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 353 7 2 3 2.5 OC(=O)Cc1ccc(cc1)CCNS(=O)(=O)c1ccc(cc1)Cl 10.1016/s0960-894x(99)00014-1
CHEMBL71685 8094 50 None -7 2 Human 6.3 pIC50 = 6.3 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 353 7 2 3 2.5 OC(=O)Cc1ccc(cc1)CCNS(=O)(=O)c1ccc(cc1)Cl 10.1016/s0960-894x(99)00014-1
9802748 142701 0 None -229 2 Human 5.3 pIC50 = 5.3 Functional
Inhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptorInhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptor
ChEMBL 430 6 1 4 3.4 CN([C@@H]1CCc2c(c3ccccc3n2CCC(=O)O)C1)S(=O)(=O)c1ccc(F)cc1 10.1021/jm049036i
CHEMBL373118 142701 0 None -229 2 Human 5.3 pIC50 = 5.3 Functional
Inhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptorInhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptor
ChEMBL 430 6 1 4 3.4 CN([C@@H]1CCc2c(c3ccccc3n2CCC(=O)O)C1)S(=O)(=O)c1ccc(F)cc1 10.1021/jm049036i
54757769 72231 0 None 8 2 Mouse 6.3 pIC50 = 6.3 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 489 11 1 4 5.3 CCC1=C(OCC(C)C)CC(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1=O 10.1021/jm200980u
CHEMBL1829809 72231 0 None 8 2 Mouse 6.3 pIC50 = 6.3 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 489 11 1 4 5.3 CCC1=C(OCC(C)C)CC(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1=O 10.1021/jm200980u
71740668 98112 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 390 4 3 5 3.2 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402417 98112 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 390 4 3 5 3.2 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
10526677 106205 1 None - 1 Human 7.3 pIC50 = 7.3 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 431 8 3 4 4.9 N#CN/C(=N/C1CCCCC1)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL282884 106205 1 None - 1 Human 7.3 pIC50 = 7.3 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 431 8 3 4 4.9 N#CN/C(=N/C1CCCCC1)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
11568248 145433 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 434 9 3 6 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1c(C)cccc1C 10.1021/jm060108a
CHEMBL377679 145433 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 434 9 3 6 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1c(C)cccc1C 10.1021/jm060108a
16757082 99826 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 519 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(I)c1 10.1021/jm070427h
CHEMBL244190 99826 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 519 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(I)c1 10.1021/jm070427h
44273463 168616 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 389 10 2 3 3.5 O=C(O)CCCCC[C@@H]1[C@@H](CNS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL414609 168616 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 389 10 2 3 3.5 O=C(O)CCCCC[C@@H]1[C@@H](CNS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
10756561 27047 1 None - 1 Human 4.3 pIC50 = 4.3 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(\c1ccccc1)c1cnccn1 10.1021/jm960341g
CHEMBL130564 27047 1 None - 1 Human 4.3 pIC50 = 4.3 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(\c1ccccc1)c1cnccn1 10.1021/jm960341g
71740444 98124 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 386 4 3 5 3.4 Cc1ccccc1Nc1ccc(C#N)cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1016/j.ejmech.2013.04.033
CHEMBL2402429 98124 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 386 4 3 5 3.4 Cc1ccccc1Nc1ccc(C#N)cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1016/j.ejmech.2013.04.033
15290042 21645 0 None -162 2 Human 4.3 pIC50 = 4.3 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 395 6 2 3 3.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1cccc3ccccc13)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1207638 21645 0 None -162 2 Human 4.3 pIC50 = 4.3 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 395 6 2 3 3.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1cccc3ccccc13)C2 10.1016/s0960-894x(99)00014-1
CHEMBL422441 21645 0 None -162 2 Human 4.3 pIC50 = 4.3 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 395 6 2 3 3.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1cccc3ccccc13)C2 10.1016/s0960-894x(99)00014-1
16757176 100059 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 465 12 2 7 4.4 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(OCCC)cc1 10.1021/jm070427h
CHEMBL245036 100059 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 465 12 2 7 4.4 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(OCCC)cc1 10.1021/jm070427h
71740668 98112 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 390 4 3 5 3.2 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402417 98112 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 390 4 3 5 3.2 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
56680464 72234 0 None 7 2 Mouse 8.2 pIC50 = 8.2 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 461 9 2 4 3.8 O=C1C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)CC(O)C1CC1CC1 10.1021/jm200980u
CHEMBL1829812 72234 0 None 7 2 Mouse 8.2 pIC50 = 8.2 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 461 9 2 4 3.8 O=C1C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)CC(O)C1CC1CC1 10.1021/jm200980u
22882112 210120 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 430 8 4 6 3.3 O=C(O)CCC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc([N+](=O)[O-])cc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL64977 210120 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 430 8 4 6 3.3 O=C(O)CCC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc([N+](=O)[O-])cc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
11676121 85097 4 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(C)cc1 10.1021/jm060108a
CHEMBL210964 85097 4 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(C)cc1 10.1021/jm060108a
44385825 66462 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 388 12 1 3 5.3 O=C(O)CCC/C=C\CC1C2CCC(O2)C1CSCCCc1ccccc1 10.1021/jm00125a009
CHEMBL172265 66462 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 388 12 1 3 5.3 O=C(O)CCC/C=C\CC1C2CCC(O2)C1CSCCCc1ccccc1 10.1021/jm00125a009
10686658 25635 1 None - 1 Human 5.3 pIC50 = 5.3 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 313 9 1 5 2.9 O=C(O)CCCCCO/N=C(\c1ccccc1)c1ccncn1 10.1021/jm960341g
CHEMBL128188 25635 1 None - 1 Human 5.3 pIC50 = 5.3 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 313 9 1 5 2.9 O=C(O)CCCCCO/N=C(\c1ccccc1)c1ccncn1 10.1021/jm960341g
16756877 98961 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 393 6 2 6 3.1 Cc1ccccc1Oc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)C 10.1021/jm070427h
CHEMBL242478 98961 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 393 6 2 6 3.1 Cc1ccccc1Oc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)C 10.1021/jm070427h
5311234 121917 25 None -257 4 Human 6.3 pIC50 = 6.3 Functional
Functional activity in RAT-1 cells, transiently transfected with human prostaglandin TP receptorFunctional activity in RAT-1 cells, transiently transfected with human prostaglandin TP receptor
ChEMBL 390 11 4 5 2.5 O=C(O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)COc1ccccc1 10.1021/jm010264b
CHEMBL334398 121917 25 None -257 4 Human 6.3 pIC50 = 6.3 Functional
Functional activity in RAT-1 cells, transiently transfected with human prostaglandin TP receptorFunctional activity in RAT-1 cells, transiently transfected with human prostaglandin TP receptor
ChEMBL 390 11 4 5 2.5 O=C(O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)COc1ccccc1 10.1021/jm010264b
70684971 84629 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 436 9 3 6 3.7 CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=N/OCCCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL2093006 84629 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 436 9 3 6 3.7 CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=N/OCCCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
44305522 209750 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
In vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human platelets
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)OC[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80104-9
CHEMBL63040 209750 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
In vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human platelets
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)OC[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80104-9
18921515 21435 0 None 141 2 Rat 6.3 pIC50 = 6.3 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 407 8 2 3 3.4 O=C(O)Cc1ccc2c(c1)CC(CCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205659 21435 0 None 141 2 Rat 6.3 pIC50 = 6.3 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 407 8 2 3 3.4 O=C(O)Cc1ccc2c(c1)CC(CCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL130170 21435 0 None 141 2 Rat 6.3 pIC50 = 6.3 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 407 8 2 3 3.4 O=C(O)Cc1ccc2c(c1)CC(CCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
16755885 151530 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 437 6 2 7 3.5 COc1cc(C)ccc1Oc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm070427h
CHEMBL390899 151530 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 437 6 2 7 3.5 COc1cc(C)ccc1Oc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm070427h
54669847 72227 0 None 4 2 Mouse 7.3 pIC50 = 7.3 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 405 7 2 4 3.4 O=C1C=C(O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1 10.1021/jm200980u
CHEMBL1829805 72227 0 None 4 2 Mouse 7.3 pIC50 = 7.3 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 405 7 2 4 3.4 O=C1C=C(O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1 10.1021/jm200980u
11531590 84668 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 407 8 2 6 3.5 CCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
CHEMBL209406 84668 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 407 8 2 6 3.5 CCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
44304533 107387 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 416 7 4 6 2.9 O=C(O)CC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc([N+](=O)[O-])cc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL291865 107387 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 416 7 4 6 2.9 O=C(O)CC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc([N+](=O)[O-])cc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
44304296 209809 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 405 6 4 4 3.6 O=C(O)CC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3cccc(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL63382 209809 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 405 6 4 4 3.6 O=C(O)CC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3cccc(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
23276769 27136 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(/c1cccc(C(F)(F)F)c1)c1ncccn1 10.1021/jm960341g
CHEMBL130623 27136 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(/c1cccc(C(F)(F)F)c1)c1ncccn1 10.1021/jm960341g
10546960 210134 0 None -6 2 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 367 8 2 3 2.9 O=C(O)CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/ml5002085
CHEMBL65121 210134 0 None -6 2 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 367 8 2 3 2.9 O=C(O)CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/ml5002085
16757380 99386 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 471 5 2 6 3.9 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Br)cc1 10.1021/jm070427h
CHEMBL243552 99386 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 471 5 2 6 3.9 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Br)cc1 10.1021/jm070427h
11704760 84386 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 435 10 2 6 4.3 CCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
CHEMBL208818 84386 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 435 10 2 6 4.3 CCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
71740311 98142 2 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 407 4 2 5 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Cl)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402576 98142 2 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 407 4 2 5 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Cl)cc1 10.1016/j.ejmech.2013.04.033
16755885 151530 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 437 6 2 7 3.5 COc1cc(C)ccc1Oc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm070427h
CHEMBL390899 151530 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 437 6 2 7 3.5 COc1cc(C)ccc1Oc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm070427h
5312142 85008 11 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm070427h
CHEMBL210602 85008 11 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm070427h
5312142 85008 11 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
CHEMBL210602 85008 11 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
54757770 72233 0 None -20 2 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 503 11 1 4 5.6 CC(C)COC1=C(C(C)C)C(=O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1 10.1021/jm200980u
CHEMBL1829811 72233 0 None -20 2 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 503 11 1 4 5.6 CC(C)COC1=C(C(C)C)C(=O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1 10.1021/jm200980u
71740438 98106 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 451 4 2 5 3.9 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Br)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402411 98106 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 451 4 2 5 3.9 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Br)cc1 10.1016/j.ejmech.2013.04.033
11662021 146331 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 434 9 3 6 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1cc(C)cc(C)c1 10.1021/jm060108a
CHEMBL379659 146331 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 434 9 3 6 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1cc(C)cc(C)c1 10.1021/jm060108a
71138349 120790 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of human TP receptor expressed in QBI-HEK 293A cells assessed as IP3 metabolite level after 1 hr by HTRF assayInhibition of human TP receptor expressed in QBI-HEK 293A cells assessed as IP3 metabolite level after 1 hr by HTRF assay
ChEMBL 405 7 2 4 3.6 O=C1CCC(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)=C1O 10.1016/j.bmcl.2014.07.047
CHEMBL3326602 120790 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of human TP receptor expressed in QBI-HEK 293A cells assessed as IP3 metabolite level after 1 hr by HTRF assayInhibition of human TP receptor expressed in QBI-HEK 293A cells assessed as IP3 metabolite level after 1 hr by HTRF assay
ChEMBL 405 7 2 4 3.6 O=C1CCC(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)=C1O 10.1016/j.bmcl.2014.07.047
15018459 106040 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 387 9 2 3 3.4 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL281849 106040 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 387 9 2 3 3.4 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
44386125 67145 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 298 9 1 3 3.7 CCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL174662 67145 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 298 9 1 3 3.7 CCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
44292032 21556 0 None - 1 Rat 4.3 pIC50 = 4.3 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 509 8 2 5 4.6 CC(C)c1ccc2c(CCCC(=O)NS(=O)(=O)c3ccc(Cl)cc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL1206700 21556 0 None - 1 Rat 4.3 pIC50 = 4.3 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 509 8 2 5 4.6 CC(C)c1ccc2c(CCCC(=O)NS(=O)(=O)c3ccc(Cl)cc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL297989 21556 0 None - 1 Rat 4.3 pIC50 = 4.3 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 509 8 2 5 4.6 CC(C)c1ccc2c(CCCC(=O)NS(=O)(=O)c3ccc(Cl)cc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
10697301 90177 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 520 9 3 5 5.3 CC(C)(C)/N=C(\Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1)NS(=O)(=O)c1ccccc1 10.1021/jm9707941
CHEMBL21954 90177 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 520 9 3 5 5.3 CC(C)(C)/N=C(\Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1)NS(=O)(=O)c1ccccc1 10.1021/jm9707941
11633215 146933 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 423 5 2 6 3.8 Cc1ccc(Sc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
CHEMBL380274 146933 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 423 5 2 6 3.8 Cc1ccc(Sc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
11502680 105016 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
CHEMBL274415 105016 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
11697902 85126 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 440 11 3 6 4.3 CCCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1021/jm060108a
CHEMBL211008 85126 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 440 11 3 6 4.3 CCCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1021/jm060108a
44273436 105420 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 418 11 2 6 2.3 O=C(O)COCCCC[C@@H]1[C@@H](NS(=O)(=O)c2ccccc2[N+](=O)[O-])CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL277241 105420 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 418 11 2 6 2.3 O=C(O)COCCCC[C@@H]1[C@@H](NS(=O)(=O)c2ccccc2[N+](=O)[O-])CC[C@H]1F 10.1016/0960-894X(95)00199-4
44386325 138624 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 374 11 1 3 5.0 O=C(O)CCC/C=C\CC1C2CCC(O2)C1CSCCc1ccccc1 10.1021/jm00125a009
CHEMBL369458 138624 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 374 11 1 3 5.0 O=C(O)CCC/C=C\CC1C2CCC(O2)C1CSCCc1ccccc1 10.1021/jm00125a009
71740441 98109 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 499 4 2 5 3.7 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(I)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402414 98109 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 499 4 2 5 3.7 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(I)cc1 10.1016/j.ejmech.2013.04.033
71740441 98109 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 499 4 2 5 3.7 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(I)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402414 98109 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 499 4 2 5 3.7 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(I)cc1 10.1016/j.ejmech.2013.04.033
11531590 84668 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 407 8 2 6 3.5 CCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
CHEMBL209406 84668 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 407 8 2 6 3.5 CCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
11661725 84634 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 420 5 3 6 3.7 Cc1cccc(C)c1Nc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm060108a
CHEMBL209306 84634 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 420 5 3 6 3.7 Cc1cccc(C)c1Nc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm060108a
44273498 169163 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 400 9 2 5 2.8 O=C(O)CC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccccc2[N+](=O)[O-])CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL416551 169163 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 400 9 2 5 2.8 O=C(O)CC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccccc2[N+](=O)[O-])CC[C@H]1F 10.1016/0960-894X(95)00199-4
71740311 98142 2 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 407 4 2 5 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Cl)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402576 98142 2 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 407 4 2 5 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Cl)cc1 10.1016/j.ejmech.2013.04.033
16757179 100095 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 455 9 2 6 4.5 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Cl)c(C)c1 10.1021/jm070427h
CHEMBL245263 100095 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 455 9 2 6 4.5 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Cl)c(C)c1 10.1021/jm070427h
44305481 209708 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 489 11 1 4 6.0 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)[S+]([O-])C[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80103-7
CHEMBL62852 209708 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 489 11 1 4 6.0 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)[S+]([O-])C[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80103-7
11567679 84523 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 407 5 2 6 3.5 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
CHEMBL209035 84523 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 407 5 2 6 3.5 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
70685025 84743 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 352 12 1 3 5.1 CCC/C=C\CSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL2096755 84743 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 352 12 1 3 5.1 CCC/C=C\CSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
16757268 99062 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 431 5 2 7 3.2 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)N/C(=N\C#N)NC(C)(C)C)cc1 10.1021/jm070427h
CHEMBL242687 99062 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 431 5 2 7 3.2 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)N/C(=N\C#N)NC(C)(C)C)cc1 10.1021/jm070427h
11567679 84523 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 407 5 2 6 3.5 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
CHEMBL209035 84523 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 407 5 2 6 3.5 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
11704760 84386 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 435 10 2 6 4.3 CCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
CHEMBL208818 84386 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 435 10 2 6 4.3 CCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
44304557 209665 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 414 8 3 5 4.3 O=C(O)CCC/C=C1\C[C@@H]2[C@@H](/C=N/NC(=O)Nc3ccc([N+](=O)[O-])cc3)CC[C@@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL62671 209665 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 414 8 3 5 4.3 O=C(O)CCC/C=C1\C[C@@H]2[C@@H](/C=N/NC(=O)Nc3ccc([N+](=O)[O-])cc3)CC[C@@H]2C1 10.1016/S0960-894X(01)80876-3
16756982 100091 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 485 9 2 6 4.3 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(Br)c1 10.1021/jm070427h
CHEMBL245254 100091 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 485 9 2 6 4.3 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(Br)c1 10.1021/jm070427h
71740438 98106 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 451 4 2 5 3.9 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Br)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402411 98106 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 451 4 2 5 3.9 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Br)cc1 10.1016/j.ejmech.2013.04.033
71138563 121286 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 481 8 2 4 5.0 O=C1C(c2ccccc2)=C(O)CC1Cc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/ml5002085
CHEMBL3335482 121286 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 481 8 2 4 5.0 O=C1C(c2ccccc2)=C(O)CC1Cc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/ml5002085
16757379 100090 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 471 5 2 6 3.9 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(Br)c1 10.1021/jm070427h
CHEMBL245253 100090 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 471 5 2 6 3.9 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(Br)c1 10.1021/jm070427h
15290041 21443 0 None - 1 Rat 5.2 pIC50 = 5.2 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 359 7 2 3 2.1 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)Cc1ccccc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205676 21443 0 None - 1 Rat 5.2 pIC50 = 5.2 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 359 7 2 3 2.1 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)Cc1ccccc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL132573 21443 0 None - 1 Rat 5.2 pIC50 = 5.2 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 359 7 2 3 2.1 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)Cc1ccccc1)C2 10.1016/s0960-894x(99)00014-1
117631097 122645 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 525 6 2 4 5.4 O=C1C(c2ccc(F)cc2)=C(O)CC1Cc1cccc2c1CCC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1021/ml5002085
CHEMBL3354615 122645 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 525 6 2 4 5.4 O=C1C(c2ccc(F)cc2)=C(O)CC1Cc1cccc2c1CCC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1021/ml5002085
44304559 107361 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 455 7 4 5 3.5 O=C(O)COC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc(Cl)c(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL291651 107361 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 455 7 4 5 3.5 O=C(O)COC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc(Cl)c(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
44304263 209838 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 430 8 4 6 3.3 O=C(O)CCC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc([N+](=O)[O-])cc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL63602 209838 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 430 8 4 6 3.3 O=C(O)CCC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc([N+](=O)[O-])cc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
22882110 209983 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 419 7 4 4 4.0 O=C(O)CCC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3cccc(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL64349 209983 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 419 7 4 4 4.0 O=C(O)CCC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3cccc(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
11510008 84057 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1cccc(C)c1 10.1021/jm060108a
CHEMBL208115 84057 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1cccc(C)c1 10.1021/jm060108a
22882095 107799 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 405 6 4 4 3.6 O=C(O)CC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3cccc(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL294516 107799 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 405 6 4 4 3.6 O=C(O)CC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3cccc(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
22882098 210029 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 371 6 4 4 3.0 O=C(O)CC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccccc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL64561 210029 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 371 6 4 4 3.0 O=C(O)CC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccccc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
44273539 86585 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 367 9 2 3 3.3 O=C(O)CC/C=C\CC1=CCC[C@@H]1CNS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00199-4
CHEMBL21203 86585 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 367 9 2 3 3.3 O=C(O)CC/C=C\CC1=CCC[C@@H]1CNS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00199-4
44273524 106107 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 380 9 2 5 2.8 O=C(O)CC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccccc1[N+](=O)[O-] 10.1016/0960-894X(95)00199-4
CHEMBL282225 106107 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 380 9 2 5 2.8 O=C(O)CC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccccc1[N+](=O)[O-] 10.1016/0960-894X(95)00199-4
11683470 84138 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 433 6 2 6 4.0 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC2CCCCC2)cc1 10.1021/jm060108a
CHEMBL208543 84138 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 433 6 2 6 4.0 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC2CCCCC2)cc1 10.1021/jm060108a
44304222 207097 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 387 7 4 5 2.2 O=C(O)COC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccccc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL59745 207097 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 387 7 4 5 2.2 O=C(O)COC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccccc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
44273260 105454 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 403 11 2 3 3.9 O=C(O)CCCCCC[C@@H]1[C@@H](CNS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL277460 105454 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 403 11 2 3 3.9 O=C(O)CCCCCC[C@@H]1[C@@H](CNS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
10451585 29085 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(/c1ccnnc1)c1cccc(C(F)(F)F)c1 10.1021/jm960341g
CHEMBL132385 29085 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(/c1ccnnc1)c1cccc(C(F)(F)F)c1 10.1021/jm960341g
10546960 210134 0 None -6 2 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 367 8 2 3 2.9 O=C(O)CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm200980u
CHEMBL65121 210134 0 None -6 2 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 367 8 2 3 2.9 O=C(O)CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm200980u
10764758 91670 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 423 9 4 4 3.9 CC(C)C/N=C(/NC(N)=O)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL22363 91670 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 423 9 4 4 3.9 CC(C)C/N=C(/NC(N)=O)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
71740056 98114 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 373 5 2 5 3.1 Cc1ccccc1Oc1ccc(C#N)cc1S(=O)(=O)NC(=O)NC(C)C 10.1016/j.ejmech.2013.04.033
CHEMBL2402419 98114 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 373 5 2 5 3.1 Cc1ccccc1Oc1ccc(C#N)cc1S(=O)(=O)NC(=O)NC(C)C 10.1016/j.ejmech.2013.04.033
5312142 85008 11 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL210602 85008 11 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1016/j.ejmech.2013.04.033
44273538 105477 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 369 10 2 3 3.6 O=C(O)CCCCCCC1=CCC[C@@H]1NS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00199-4
CHEMBL277629 105477 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 369 10 2 3 3.6 O=C(O)CCCCCCC1=CCC[C@@H]1NS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00199-4
71740185 98122 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 401 8 2 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(C)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402427 98122 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 401 8 2 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(C)cc1 10.1016/j.ejmech.2013.04.033
44273447 82970 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 437 9 2 3 4.6 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(Cl)c(Cl)c2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL20583 82970 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 437 9 2 3 4.6 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(Cl)c(Cl)c2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
44385450 137076 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 370 13 1 3 4.3 CCCCCC[S+]([O-])CC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL368006 137076 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 370 13 1 3 4.3 CCCCCC[S+]([O-])CC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
54758053 72223 0 None -8 2 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 391 8 2 5 2.2 O=S(=O)(NCCc1cccc(CCc2nn[nH]n2)c1)c1ccc(Cl)cc1 10.1021/jm200980u
CHEMBL1829801 72223 0 None -8 2 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 391 8 2 5 2.2 O=S(=O)(NCCc1cccc(CCc2nn[nH]n2)c1)c1ccc(Cl)cc1 10.1021/jm200980u
11568384 84571 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 440 7 3 6 3.8 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NCc2ccccc2)cc1 10.1021/jm060108a
CHEMBL209245 84571 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 440 7 3 6 3.8 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NCc2ccccc2)cc1 10.1021/jm060108a
11647396 84557 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 418 5 2 6 3.5 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)N2CCCCC2)cc1 10.1021/jm060108a
CHEMBL209168 84557 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 418 5 2 6 3.5 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)N2CCCCC2)cc1 10.1021/jm060108a
71740669 98113 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 404 8 3 5 3.6 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402418 98113 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 404 8 3 5 3.6 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
44273475 81368 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 405 11 2 4 2.7 O=C(O)COCCCC[C@@H]1[C@@H](CNS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL20298 81368 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 405 11 2 4 2.7 O=C(O)COCCCC[C@@H]1[C@@H](CNS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
44273402 82734 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 387 9 2 3 3.3 O=C(O)CC/C=C\C[C@@H]1[C@@H](CNS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL20525 82734 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 387 9 2 3 3.3 O=C(O)CC/C=C\C[C@@H]1[C@@H](CNS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
44273412 84035 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 387 9 2 3 3.3 O=C(O)CC/C=C\C[C@H]1[C@@H](F)CC[C@@H]1CNS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00199-4
CHEMBL20797 84035 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 387 9 2 3 3.3 O=C(O)CC/C=C\C[C@H]1[C@@H](F)CC[C@@H]1CNS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00199-4
44304226 207286 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 403 7 3 3 5.1 O=C(O)CCC/C=C1/C[C@@H]2[C@@H](/C=N/NC(=O)Nc3cccc(Cl)c3)CC[C@@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL59875 207286 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 403 7 3 3 5.1 O=C(O)CCC/C=C1/C[C@@H]2[C@@H](/C=N/NC(=O)Nc3cccc(Cl)c3)CC[C@@H]2C1 10.1016/S0960-894X(01)80876-3
44292083 21389 0 None - 1 Rat 4.2 pIC50 = 4.2 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 475 8 2 5 4.0 CC(C)c1ccc2c(CCCC(=O)NS(=O)(=O)c3ccccc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL1205041 21389 0 None - 1 Rat 4.2 pIC50 = 4.2 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 475 8 2 5 4.0 CC(C)c1ccc2c(CCCC(=O)NS(=O)(=O)c3ccccc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL45623 21389 0 None - 1 Rat 4.2 pIC50 = 4.2 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 475 8 2 5 4.0 CC(C)c1ccc2c(CCCC(=O)NS(=O)(=O)c3ccccc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
18921514 21575 0 None 117 2 Rat 7.2 pIC50 = 7.2 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 379 6 2 3 3.1 O=C(O)c1ccc2c(c1)CC(CCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1207018 21575 0 None 117 2 Rat 7.2 pIC50 = 7.2 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 379 6 2 3 3.1 O=C(O)c1ccc2c(c1)CC(CCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL336352 21575 0 None 117 2 Rat 7.2 pIC50 = 7.2 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 379 6 2 3 3.1 O=C(O)c1ccc2c(c1)CC(CCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
18921516 21578 0 None -77 2 Human 5.2 pIC50 = 5.2 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 393 7 2 3 3.5 O=C(O)c1ccc2c(c1)CC(CCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1207036 21578 0 None -77 2 Human 5.2 pIC50 = 5.2 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 393 7 2 3 3.5 O=C(O)c1ccc2c(c1)CC(CCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL339994 21578 0 None -77 2 Human 5.2 pIC50 = 5.2 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 393 7 2 3 3.5 O=C(O)c1ccc2c(c1)CC(CCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
11502680 105016 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Inhibition of U46619-induced platelet aggregationInhibition of U46619-induced platelet aggregation
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
CHEMBL274415 105016 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Inhibition of U46619-induced platelet aggregationInhibition of U46619-induced platelet aggregation
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
16757375 98962 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 407 8 2 6 3.5 CCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1C 10.1021/jm070427h
CHEMBL242479 98962 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 407 8 2 6 3.5 CCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1C 10.1021/jm070427h
71740669 98113 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 404 8 3 5 3.6 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402418 98113 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 404 8 3 5 3.6 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
71740182 98119 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 401 8 2 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1cccc(C)c1 10.1016/j.ejmech.2013.04.033
CHEMBL2402424 98119 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 401 8 2 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1cccc(C)c1 10.1016/j.ejmech.2013.04.033
71740184 98121 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 387 4 2 5 3.4 Cc1ccc(Oc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402426 98121 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 387 4 2 5 3.4 Cc1ccc(Oc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1016/j.ejmech.2013.04.033
44273483 81625 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 394 10 2 5 3.2 O=C(O)CCC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccccc1[N+](=O)[O-] 10.1016/0960-894X(95)00199-4
CHEMBL20316 81625 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 394 10 2 5 3.2 O=C(O)CCC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccccc1[N+](=O)[O-] 10.1016/0960-894X(95)00199-4
16757379 100090 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 471 5 2 6 3.9 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(Br)c1 10.1021/jm070427h
CHEMBL245253 100090 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 471 5 2 6 3.9 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(Br)c1 10.1021/jm070427h
71740181 98118 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 387 4 2 5 3.4 Cc1cccc(Oc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1 10.1016/j.ejmech.2013.04.033
CHEMBL2402423 98118 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 387 4 2 5 3.4 Cc1cccc(Oc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1 10.1016/j.ejmech.2013.04.033
16757483 150705 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 427 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(Cl)c1 10.1021/jm070427h
CHEMBL390217 150705 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 427 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(Cl)c1 10.1021/jm070427h
10669026 87447 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 405 9 3 4 4.3 CC(C)C/N=C(/NC#N)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL21513 87447 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 405 9 3 4 4.3 CC(C)C/N=C(/NC#N)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
10024143 81414 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 403 9 2 3 3.9 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(Cl)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL20300 81414 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 403 9 2 3 3.9 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(Cl)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
11683470 84138 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 433 6 2 6 4.0 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC2CCCCC2)cc1 10.1021/jm060108a
CHEMBL208543 84138 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 433 6 2 6 4.0 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC2CCCCC2)cc1 10.1021/jm060108a
5312142 85008 11 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL210602 85008 11 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1016/j.ejmech.2013.04.033
44385826 67159 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 352 12 1 3 5.1 CC/C=C/CCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL174835 67159 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 352 12 1 3 5.1 CC/C=C/CCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
44386126 105399 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 372 13 1 4 5.2 CCCCSCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL277056 105399 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 372 13 1 4 5.2 CCCCSCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
44387119 136259 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 330 10 1 4 4.0 CSCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL367261 136259 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 330 10 1 4 4.0 CSCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
10543197 28029 1 None - 1 Human 5.2 pIC50 = 5.2 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 313 9 1 5 2.9 O=C(O)CCCCCO/N=C(\c1ccccc1)c1ccnnc1 10.1021/jm960341g
CHEMBL131334 28029 1 None - 1 Human 5.2 pIC50 = 5.2 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 313 9 1 5 2.9 O=C(O)CCCCCO/N=C(\c1ccccc1)c1ccnnc1 10.1021/jm960341g
10518243 27699 1 None - 1 Human 4.2 pIC50 = 4.2 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(/c1ccccc1)c1cccnn1 10.1021/jm960341g
CHEMBL131088 27699 1 None - 1 Human 4.2 pIC50 = 4.2 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(/c1ccccc1)c1cccnn1 10.1021/jm960341g
10756559 123436 1 None - 1 Human 5.1 pIC50 = 5.1 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(/c1ccccc1)c1cncnc1 10.1021/jm960341g
CHEMBL337048 123436 1 None - 1 Human 5.1 pIC50 = 5.1 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(/c1ccccc1)c1cncnc1 10.1021/jm960341g
44387045 172989 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 369 12 2 4 3.2 CCCNC(=O)CSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL426586 172989 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 369 12 2 4 3.2 CCCNC(=O)CSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
18921515 21435 0 None -141 2 Human 4.1 pIC50 = 4.1 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 407 8 2 3 3.4 O=C(O)Cc1ccc2c(c1)CC(CCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205659 21435 0 None -141 2 Human 4.1 pIC50 = 4.1 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 407 8 2 3 3.4 O=C(O)Cc1ccc2c(c1)CC(CCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL130170 21435 0 None -141 2 Human 4.1 pIC50 = 4.1 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 407 8 2 3 3.4 O=C(O)Cc1ccc2c(c1)CC(CCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
71740443 98123 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 372 5 3 5 3.0 Cc1ccccc1Nc1ccc(C#N)cc1S(=O)(=O)NC(=O)NC(C)C 10.1016/j.ejmech.2013.04.033
CHEMBL2402428 98123 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 372 5 3 5 3.0 Cc1ccccc1Nc1ccc(C#N)cc1S(=O)(=O)NC(=O)NC(C)C 10.1016/j.ejmech.2013.04.033
16757483 150705 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 427 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(Cl)c1 10.1021/jm070427h
CHEMBL390217 150705 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 427 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(Cl)c1 10.1021/jm070427h
16757177 151523 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 451 11 2 7 4.0 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(OCC)cc1 10.1021/jm070427h
CHEMBL390897 151523 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 451 11 2 7 4.0 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(OCC)cc1 10.1021/jm070427h
71740184 98121 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 387 4 2 5 3.4 Cc1ccc(Oc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402426 98121 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 387 4 2 5 3.4 Cc1ccc(Oc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1016/j.ejmech.2013.04.033
44273500 83397 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 373 8 2 3 3.0 O=C(O)CC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL20635 83397 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 373 8 2 3 3.0 O=C(O)CC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
11662021 146331 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 434 9 3 6 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1cc(C)cc(C)c1 10.1021/jm060108a
CHEMBL379659 146331 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 434 9 3 6 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1cc(C)cc(C)c1 10.1021/jm060108a
10670440 87281 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 433 9 3 4 5.2 CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=C\CCCCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL21476 87281 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 433 9 3 4 5.2 CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=C\CCCCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
71451008 86492 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 489 11 1 4 6.0 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)C[S@@+]([O-])[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80103-7
CHEMBL2115559 86492 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 489 11 1 4 6.0 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)C[S@@+]([O-])[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80103-7
3356 9060 73 None -165 2 Human 6.1 pIC50 = 6.1 Functional
Activity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregationActivity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregation
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1021/jm0603668
4326 9060 73 None -165 2 Human 6.1 pIC50 = 6.1 Functional
Activity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregationActivity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregation
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1021/jm0603668
9867642 9060 73 None -165 2 Human 6.1 pIC50 = 6.1 Functional
Activity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregationActivity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregation
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1021/jm0603668
CHEMBL426559 9060 73 None -165 2 Human 6.1 pIC50 = 6.1 Functional
Activity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregationActivity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregation
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1021/jm0603668
DB11629 9060 73 None -165 2 Human 6.1 pIC50 = 6.1 Functional
Activity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregationActivity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregation
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1021/jm0603668
10591274 122876 1 None - 1 Human 5.1 pIC50 = 5.1 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 313 9 1 5 2.9 O=C(O)CCCCCO/N=C(/c1ccccc1)c1ccnnc1 10.1021/jm960341g
CHEMBL335717 122876 1 None - 1 Human 5.1 pIC50 = 5.1 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 313 9 1 5 2.9 O=C(O)CCCCCO/N=C(/c1ccccc1)c1ccnnc1 10.1021/jm960341g
18921514 21575 0 None -117 2 Human 5.1 pIC50 = 5.1 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 379 6 2 3 3.1 O=C(O)c1ccc2c(c1)CC(CCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1207018 21575 0 None -117 2 Human 5.1 pIC50 = 5.1 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 379 6 2 3 3.1 O=C(O)c1ccc2c(c1)CC(CCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL336352 21575 0 None -117 2 Human 5.1 pIC50 = 5.1 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 379 6 2 3 3.1 O=C(O)c1ccc2c(c1)CC(CCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
44353308 21579 0 None -54 2 Human 4.1 pIC50 = 4.1 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 339 9 2 3 2.1 CCCCCS(=O)(=O)NCC1Cc2ccc(CC(=O)O)cc2C1 10.1016/s0960-894x(99)00014-1
CHEMBL1207038 21579 0 None -54 2 Human 4.1 pIC50 = 4.1 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 339 9 2 3 2.1 CCCCCS(=O)(=O)NCC1Cc2ccc(CC(=O)O)cc2C1 10.1016/s0960-894x(99)00014-1
CHEMBL340073 21579 0 None -54 2 Human 4.1 pIC50 = 4.1 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 339 9 2 3 2.1 CCCCCS(=O)(=O)NCC1Cc2ccc(CC(=O)O)cc2C1 10.1016/s0960-894x(99)00014-1
71740667 98111 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 376 5 3 5 2.8 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402416 98111 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 376 5 3 5 2.8 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
71740557 98125 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 400 8 3 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccccc1C 10.1016/j.ejmech.2013.04.033
CHEMBL2402430 98125 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 400 8 3 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccccc1C 10.1016/j.ejmech.2013.04.033
44305550 210196 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
In vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human platelets
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CO[C@H]1c1cccnc1 10.1016/S0960-894X(01)80104-9
CHEMBL65622 210196 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
In vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human platelets
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CO[C@H]1c1cccnc1 10.1016/S0960-894X(01)80104-9
54758053 72223 0 None 8 2 Mouse 8.1 pIC50 = 8.1 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 391 8 2 5 2.2 O=S(=O)(NCCc1cccc(CCc2nn[nH]n2)c1)c1ccc(Cl)cc1 10.1021/jm200980u
CHEMBL1829801 72223 0 None 8 2 Mouse 8.1 pIC50 = 8.1 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 391 8 2 5 2.2 O=S(=O)(NCCc1cccc(CCc2nn[nH]n2)c1)c1ccc(Cl)cc1 10.1021/jm200980u
123879 10060 82 None 1 6 Human 8.1 pIC50 = 8.1 Functional
Inhibition of beta-arrestin translocation at human Thromboxane A2 receptor in BRET assayInhibition of beta-arrestin translocation at human Thromboxane A2 receptor in BRET assay
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
1910 10060 82 None 1 6 Human 8.1 pIC50 = 8.1 Functional
Inhibition of beta-arrestin translocation at human Thromboxane A2 receptor in BRET assayInhibition of beta-arrestin translocation at human Thromboxane A2 receptor in BRET assay
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
1911 10060 82 None 1 6 Human 8.1 pIC50 = 8.1 Functional
Inhibition of beta-arrestin translocation at human Thromboxane A2 receptor in BRET assayInhibition of beta-arrestin translocation at human Thromboxane A2 receptor in BRET assay
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
2354 10060 82 None 1 6 Human 8.1 pIC50 = 8.1 Functional
Inhibition of beta-arrestin translocation at human Thromboxane A2 receptor in BRET assayInhibition of beta-arrestin translocation at human Thromboxane A2 receptor in BRET assay
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
CHEMBL361812 10060 82 None 1 6 Human 8.1 pIC50 = 8.1 Functional
Inhibition of beta-arrestin translocation at human Thromboxane A2 receptor in BRET assayInhibition of beta-arrestin translocation at human Thromboxane A2 receptor in BRET assay
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
DB13036 10060 82 None 1 6 Human 8.1 pIC50 = 8.1 Functional
Inhibition of beta-arrestin translocation at human Thromboxane A2 receptor in BRET assayInhibition of beta-arrestin translocation at human Thromboxane A2 receptor in BRET assay
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
11597294 172955 4 None -33 2 Human 7.1 pIC50 = 7.1 Functional
Activity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregationActivity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregation
ChEMBL 435 4 1 2 5.7 O=C(O)C[C@H]1CCc2c1n(Cc1ccc(Cl)cc1)c1c(Br)cc(F)cc21 10.1021/jm0603668
CHEMBL426387 172955 4 None -33 2 Human 7.1 pIC50 = 7.1 Functional
Activity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregationActivity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregation
ChEMBL 435 4 1 2 5.7 O=C(O)C[C@H]1CCc2c1n(Cc1ccc(Cl)cc1)c1c(Br)cc(F)cc21 10.1021/jm0603668
11568248 145433 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 434 9 3 6 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1c(C)cccc1C 10.1021/jm060108a
CHEMBL377679 145433 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 434 9 3 6 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1c(C)cccc1C 10.1021/jm060108a
11633215 146933 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Inhibition of U46619-induced platelet aggregationInhibition of U46619-induced platelet aggregation
ChEMBL 423 5 2 6 3.8 Cc1ccc(Sc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
CHEMBL380274 146933 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Inhibition of U46619-induced platelet aggregationInhibition of U46619-induced platelet aggregation
ChEMBL 423 5 2 6 3.8 Cc1ccc(Sc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
44305343 107458 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 473 11 1 4 6.9 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)CS[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80103-7
CHEMBL292331 107458 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 473 11 1 4 6.9 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)CS[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80103-7
10548488 85053 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 391 6 3 4 4.0 CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=C\CCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL21072 85053 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 391 6 3 4 4.0 CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=C\CCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
11604299 146360 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 426 10 3 6 3.9 CCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1021/jm060108a
CHEMBL379736 146360 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 426 10 3 6 3.9 CCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1021/jm060108a
71740667 98111 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 376 5 3 5 2.8 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402416 98111 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 376 5 3 5 2.8 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
44305824 107775 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
In vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human platelets
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)CO[C@H]1c1cccnc1 10.1016/S0960-894X(01)80104-9
CHEMBL294353 107775 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
In vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human platelets
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)CO[C@H]1c1cccnc1 10.1016/S0960-894X(01)80104-9
10552843 89980 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 483 8 3 4 5.6 N#CN/C(=N/C12CC3CC(CC(C3)C1)C2)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL21852 89980 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 483 8 3 4 5.6 N#CN/C(=N/C12CC3CC(CC(C3)C1)C2)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
10741449 85677 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 433 9 3 6 4.3 CC(C)(C)Nc1c(Nc2cccc(/C(=C\CCCC(=O)O)c3cccnc3)c2)c(=O)c1=O 10.1021/jm9707941
CHEMBL2112933 85677 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 433 9 3 6 4.3 CC(C)(C)Nc1c(Nc2cccc(/C(=C\CCCC(=O)O)c3cccnc3)c2)c(=O)c1=O 10.1021/jm9707941
118718127 122054 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 354 13 1 3 5.3 CCCCCCSC[C@H]1C2CC[C@@H](O2)[C@H]1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL3349042 122054 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 354 13 1 3 5.3 CCCCCCSC[C@H]1C2CC[C@@H](O2)[C@H]1C/C=C\CCCC(=O)O 10.1021/jm00125a009
11408533 148105 0 None -2089 2 Human 5.1 pIC50 = 5.1 Functional
Activity at TP receptor assessed as inhibition of U46619-induced platelet aggregation in platelet rich plasmaActivity at TP receptor assessed as inhibition of U46619-induced platelet aggregation in platelet rich plasma
ChEMBL 459 6 1 5 4.5 CC(=O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1016/j.bmcl.2006.02.062
CHEMBL383484 148105 0 None -2089 2 Human 5.1 pIC50 = 5.1 Functional
Activity at TP receptor assessed as inhibition of U46619-induced platelet aggregation in platelet rich plasmaActivity at TP receptor assessed as inhibition of U46619-induced platelet aggregation in platelet rich plasma
ChEMBL 459 6 1 5 4.5 CC(=O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1016/j.bmcl.2006.02.062
11408533 148105 0 None -2089 2 Human 5.1 pIC50 = 5.1 Functional
Activity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregationActivity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregation
ChEMBL 459 6 1 5 4.5 CC(=O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1021/jm0603668
CHEMBL383484 148105 0 None -2089 2 Human 5.1 pIC50 = 5.1 Functional
Activity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregationActivity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregation
ChEMBL 459 6 1 5 4.5 CC(=O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1021/jm0603668
16756979 99091 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 393 6 2 6 3.1 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)C)cc1 10.1021/jm070427h
CHEMBL242904 99091 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 393 6 2 6 3.1 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)C)cc1 10.1021/jm070427h
71740310 98141 2 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 393 5 2 5 3.4 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Cl)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402575 98141 2 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 393 5 2 5 3.4 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Cl)cc1 10.1016/j.ejmech.2013.04.033
15290043 21574 0 None 33 2 Rat 7.1 pIC50 = 7.1 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 351 6 2 4 2.1 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1cccs1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1207012 21574 0 None 33 2 Rat 7.1 pIC50 = 7.1 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 351 6 2 4 2.1 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1cccs1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL335043 21574 0 None 33 2 Rat 7.1 pIC50 = 7.1 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 351 6 2 4 2.1 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1cccs1)C2 10.1016/s0960-894x(99)00014-1
18921516 21578 0 None 77 2 Rat 7.1 pIC50 = 7.1 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 393 7 2 3 3.5 O=C(O)c1ccc2c(c1)CC(CCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1207036 21578 0 None 77 2 Rat 7.1 pIC50 = 7.1 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 393 7 2 3 3.5 O=C(O)c1ccc2c(c1)CC(CCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL339994 21578 0 None 77 2 Rat 7.1 pIC50 = 7.1 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 393 7 2 3 3.5 O=C(O)c1ccc2c(c1)CC(CCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
71740562 98130 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 386 4 3 5 3.4 Cc1ccc(Nc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402435 98130 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 386 4 3 5 3.4 Cc1ccc(Nc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1016/j.ejmech.2013.04.033
71740439 98107 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 465 8 2 5 4.3 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Br)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402412 98107 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 465 8 2 5 4.3 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Br)cc1 10.1016/j.ejmech.2013.04.033
44291594 21390 0 None - 1 Rat 6.1 pIC50 = 6.1 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 509 10 2 4 6.0 CC(C)c1ccc2c(CCCCCS(=O)(=O)Nc3ccc(Cl)cc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL1205044 21390 0 None - 1 Rat 6.1 pIC50 = 6.1 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 509 10 2 4 6.0 CC(C)c1ccc2c(CCCCCS(=O)(=O)Nc3ccc(Cl)cc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL46338 21390 0 None - 1 Rat 6.1 pIC50 = 6.1 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 509 10 2 4 6.0 CC(C)c1ccc2c(CCCCCS(=O)(=O)Nc3ccc(Cl)cc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
44291637 21650 0 None - 1 Rat 6.1 pIC50 = 6.1 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 481 8 2 4 5.2 CC(C)c1ccc2c(CCCS(=O)(=O)Nc3ccc(Cl)cc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL1207689 21650 0 None - 1 Rat 6.1 pIC50 = 6.1 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 481 8 2 4 5.2 CC(C)c1ccc2c(CCCS(=O)(=O)Nc3ccc(Cl)cc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL430569 21650 0 None - 1 Rat 6.1 pIC50 = 6.1 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 481 8 2 4 5.2 CC(C)c1ccc2c(CCCS(=O)(=O)Nc3ccc(Cl)cc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
44386253 67204 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 386 11 1 3 5.4 O=C(O)CCC/C=C\CC1C2CCC(O2)C1CSC/C=C/c1ccccc1 10.1021/jm00125a009
CHEMBL175178 67204 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 386 11 1 3 5.4 O=C(O)CCC/C=C\CC1C2CCC(O2)C1CSC/C=C/c1ccccc1 10.1021/jm00125a009
71740312 98143 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 421 8 2 5 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Cl)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402577 98143 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 421 8 2 5 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Cl)cc1 10.1016/j.ejmech.2013.04.033
71740056 98114 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 373 5 2 5 3.1 Cc1ccccc1Oc1ccc(C#N)cc1S(=O)(=O)NC(=O)NC(C)C 10.1016/j.ejmech.2013.04.033
CHEMBL2402419 98114 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 373 5 2 5 3.1 Cc1ccccc1Oc1ccc(C#N)cc1S(=O)(=O)NC(=O)NC(C)C 10.1016/j.ejmech.2013.04.033
44291863 21392 0 None - 1 Rat 5.1 pIC50 = 5.1 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 447 8 2 4 4.5 CC(C)c1ccc2c(CCCS(=O)(=O)Nc3ccccc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL1205050 21392 0 None - 1 Rat 5.1 pIC50 = 5.1 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 447 8 2 4 4.5 CC(C)c1ccc2c(CCCS(=O)(=O)Nc3ccccc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL47510 21392 0 None - 1 Rat 5.1 pIC50 = 5.1 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 447 8 2 4 4.5 CC(C)c1ccc2c(CCCS(=O)(=O)Nc3ccccc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
44291496 175535 0 None - 1 Rat 5.1 pIC50 = 5.1 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 425 9 2 3 5.4 CC(C)c1ccc2c(CCCCS(=O)(=O)Nc3ccccc3)cc(C(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL43726 175535 0 None - 1 Rat 5.1 pIC50 = 5.1 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 425 9 2 3 5.4 CC(C)c1ccc2c(CCCCS(=O)(=O)Nc3ccccc3)cc(C(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
16757484 99824 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 441 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Cl)cc1 10.1021/jm070427h
CHEMBL244188 99824 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 441 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Cl)cc1 10.1021/jm070427h
71740312 98143 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 421 8 2 5 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Cl)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402577 98143 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 421 8 2 5 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Cl)cc1 10.1016/j.ejmech.2013.04.033
16757487 100022 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 451 8 2 7 4.0 CCCOc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm070427h
CHEMBL244819 100022 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 451 8 2 7 4.0 CCCOc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm070427h
16756877 98961 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 393 6 2 6 3.1 Cc1ccccc1Oc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)C 10.1021/jm070427h
CHEMBL242478 98961 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 393 6 2 6 3.1 Cc1ccccc1Oc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)C 10.1021/jm070427h
16756979 99091 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 393 6 2 6 3.1 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)C)cc1 10.1021/jm070427h
CHEMBL242904 99091 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 393 6 2 6 3.1 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)C)cc1 10.1021/jm070427h
44305538 108913 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
In vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human platelets
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)CO[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80104-9
CHEMBL302457 108913 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
In vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human platelets
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)CO[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80104-9
10686657 26788 1 None - 1 Human 5.1 pIC50 = 5.1 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 313 9 1 5 2.9 O=C(O)CCCCCO/N=C(/c1ccccc1)c1cncnc1 10.1021/jm960341g
CHEMBL130341 26788 1 None - 1 Human 5.1 pIC50 = 5.1 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 313 9 1 5 2.9 O=C(O)CCCCCO/N=C(/c1ccccc1)c1cncnc1 10.1021/jm960341g
16757485 99956 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 533 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(I)c1 10.1021/jm070427h
CHEMBL244401 99956 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 533 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(I)c1 10.1021/jm070427h
118714500 121285 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 346 3 1 2 5.3 Cc1cccc(C)c1C1=C(O)CC(Cc2cccc3c2CCCC3)C1=O 10.1021/ml5002085
CHEMBL3335481 121285 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 346 3 1 2 5.3 Cc1cccc(C)c1C1=C(O)CC(Cc2cccc3c2CCCC3)C1=O 10.1021/ml5002085
71138378 121287 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 487 8 2 4 5.4 O=C1C(C2CCCCC2)=C(O)CC1Cc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/ml5002085
CHEMBL3335483 121287 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 487 8 2 4 5.4 O=C1C(C2CCCCC2)=C(O)CC1Cc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/ml5002085
CHEMBL1829808 72230 0 None 18 2 Mouse 8.0 pIC50 = 8.0 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 433 8 2 4 4.2 CCC1=C(O)CC(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1=O 10.1021/jm200980u
123879 10060 82 None 1 6 Human 8.0 pIC50 = 8.0 Functional
Inhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptorInhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
1910 10060 82 None 1 6 Human 8.0 pIC50 = 8.0 Functional
Inhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptorInhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
1911 10060 82 None 1 6 Human 8.0 pIC50 = 8.0 Functional
Inhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptorInhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
2354 10060 82 None 1 6 Human 8.0 pIC50 = 8.0 Functional
Inhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptorInhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
CHEMBL361812 10060 82 None 1 6 Human 8.0 pIC50 = 8.0 Functional
Inhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptorInhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
DB13036 10060 82 None 1 6 Human 8.0 pIC50 = 8.0 Functional
Inhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptorInhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
11661725 84634 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Inhibition of U46619-induced platelet aggregationInhibition of U46619-induced platelet aggregation
ChEMBL 420 5 3 6 3.7 Cc1cccc(C)c1Nc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm060108a
CHEMBL209306 84634 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Inhibition of U46619-induced platelet aggregationInhibition of U46619-induced platelet aggregation
ChEMBL 420 5 3 6 3.7 Cc1cccc(C)c1Nc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm060108a
71740185 98122 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 401 8 2 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(C)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402427 98122 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 401 8 2 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(C)cc1 10.1016/j.ejmech.2013.04.033
11647396 84557 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Inhibition of U46619-induced platelet aggregationInhibition of U46619-induced platelet aggregation
ChEMBL 418 5 2 6 3.5 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)N2CCCCC2)cc1 10.1021/jm060108a
CHEMBL209168 84557 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Inhibition of U46619-induced platelet aggregationInhibition of U46619-induced platelet aggregation
ChEMBL 418 5 2 6 3.5 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)N2CCCCC2)cc1 10.1021/jm060108a
44304640 209608 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 437 7 3 3 5.7 O=C(O)CCC/C=C1/C[C@@H]2[C@@H](/C=N/NC(=O)Nc3ccc(Cl)c(Cl)c3)CC[C@@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL62410 209608 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 437 7 3 3 5.7 O=C(O)CCC/C=C1/C[C@@H]2[C@@H](/C=N/NC(=O)Nc3ccc(Cl)c(Cl)c3)CC[C@@H]2C1 10.1016/S0960-894X(01)80876-3
54758054 72224 0 None 4 2 Mouse 7.0 pIC50 = 7.0 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 420 8 3 6 1.8 O=c1c(O)c(NCc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)c1=O 10.1021/jm200980u
CHEMBL1829802 72224 0 None 4 2 Mouse 7.0 pIC50 = 7.0 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 420 8 3 6 1.8 O=c1c(O)c(NCc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)c1=O 10.1021/jm200980u
44291693 188326 0 None - 1 Rat 5.0 pIC50 = 5.0 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 445 8 2 3 5.6 CC(C)c1ccc2c(CCCS(=O)(=O)Nc3ccc(Cl)cc3)cc(C(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL47658 188326 0 None - 1 Rat 5.0 pIC50 = 5.0 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 445 8 2 3 5.6 CC(C)c1ccc2c(CCCS(=O)(=O)Nc3ccc(Cl)cc3)cc(C(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
71740558 98126 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 372 5 3 5 3.0 Cc1cccc(Nc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)C)c1 10.1016/j.ejmech.2013.04.033
CHEMBL2402431 98126 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 372 5 3 5 3.0 Cc1cccc(Nc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)C)c1 10.1016/j.ejmech.2013.04.033
71740313 98105 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 437 5 2 5 3.5 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Br)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402410 98105 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 437 5 2 5 3.5 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Br)cc1 10.1016/j.ejmech.2013.04.033
11697902 85126 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 440 11 3 6 4.3 CCCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1021/jm060108a
CHEMBL211008 85126 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 440 11 3 6 4.3 CCCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1021/jm060108a
71740307 98132 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 377 5 2 5 2.9 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402437 98132 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 377 5 2 5 2.9 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
71740309 98134 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 405 8 2 5 3.7 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402439 98134 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 405 8 2 5 3.7 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
71740310 98141 2 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 393 5 2 5 3.4 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Cl)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402575 98141 2 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 393 5 2 5 3.4 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Cl)cc1 10.1016/j.ejmech.2013.04.033
71740313 98105 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 437 5 2 5 3.5 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Br)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402410 98105 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 437 5 2 5 3.5 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Br)cc1 10.1016/j.ejmech.2013.04.033
71740440 98108 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 485 5 2 5 3.4 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(I)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402413 98108 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 485 5 2 5 3.4 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(I)cc1 10.1016/j.ejmech.2013.04.033
71740442 98110 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 513 8 2 5 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(I)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402415 98110 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 513 8 2 5 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(I)cc1 10.1016/j.ejmech.2013.04.033
16757082 99826 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 519 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(I)c1 10.1021/jm070427h
CHEMBL244190 99826 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 519 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(I)c1 10.1021/jm070427h
10409713 21441 0 None -42 2 Human 6.0 pIC50 = 6.0 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 395 6 2 3 3.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc3ccccc3c1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205668 21441 0 None -42 2 Human 6.0 pIC50 = 6.0 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 395 6 2 3 3.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc3ccccc3c1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL131497 21441 0 None -42 2 Human 6.0 pIC50 = 6.0 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 395 6 2 3 3.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc3ccccc3c1)C2 10.1016/s0960-894x(99)00014-1
71740558 98126 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 372 5 3 5 3.0 Cc1cccc(Nc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)C)c1 10.1016/j.ejmech.2013.04.033
CHEMBL2402431 98126 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 372 5 3 5 3.0 Cc1cccc(Nc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)C)c1 10.1016/j.ejmech.2013.04.033
71740440 98108 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 485 5 2 5 3.4 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(I)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402413 98108 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 485 5 2 5 3.4 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(I)cc1 10.1016/j.ejmech.2013.04.033
71740442 98110 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 513 8 2 5 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(I)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402415 98110 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 513 8 2 5 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(I)cc1 10.1016/j.ejmech.2013.04.033
71740309 98134 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 405 8 2 5 3.7 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402439 98134 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 405 8 2 5 3.7 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
71740439 98107 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 465 8 2 5 4.3 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Br)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402412 98107 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 465 8 2 5 4.3 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Br)cc1 10.1016/j.ejmech.2013.04.033
71740307 98132 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 377 5 2 5 2.9 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402437 98132 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 377 5 2 5 2.9 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
18921519 21440 0 None - 1 Rat 6.0 pIC50 = 6.0 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 421 9 2 3 3.8 O=C(O)Cc1ccc2c(c1)CC(CCCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205667 21440 0 None - 1 Rat 6.0 pIC50 = 6.0 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 421 9 2 3 3.8 O=C(O)Cc1ccc2c(c1)CC(CCCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL131336 21440 0 None - 1 Rat 6.0 pIC50 = 6.0 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 421 9 2 3 3.8 O=C(O)Cc1ccc2c(c1)CC(CCCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
16757484 99824 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 441 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Cl)cc1 10.1021/jm070427h
CHEMBL244188 99824 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 441 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Cl)cc1 10.1021/jm070427h
16755884 100093 22 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 423 6 2 7 3.2 COc1cccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1 10.1021/jm070427h
CHEMBL245261 100093 22 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 423 6 2 7 3.2 COc1cccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1 10.1021/jm070427h
44353162 27336 0 None - 1 Human 4.0 pIC50 = 4 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(\c1cccc(C(F)(F)F)c1)c1ncccn1 10.1021/jm960341g
CHEMBL130785 27336 0 None - 1 Human 4.0 pIC50 = 4 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(\c1cccc(C(F)(F)F)c1)c1ncccn1 10.1021/jm960341g
44305299 210175 0 None - 0 Rat 10.8 pKd = 10.8 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 457 10 2 3 4.5 O=C(O)CCc1cc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc(Cc2ccccc2)c1 10.1016/s0960-894x(98)00242-x
CHEMBL65478 210175 0 None - 0 Rat 10.8 pKd = 10.8 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 457 10 2 3 4.5 O=C(O)CCc1cc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc(Cc2ccccc2)c1 10.1016/s0960-894x(98)00242-x
9891134 209663 3 None - 0 Rat 10.6 pKd = 10.6 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 475 10 2 3 4.6 O=C(O)CCc1cc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc(Cc2ccc(F)cc2)c1 10.1016/s0960-894x(98)00242-x
CHEMBL62666 209663 3 None - 0 Rat 10.6 pKd = 10.6 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 475 10 2 3 4.6 O=C(O)CCc1cc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc(Cc2ccc(F)cc2)c1 10.1016/s0960-894x(98)00242-x
19962365 210277 0 None - 0 Rat 10.6 pKd = 10.6 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 501 11 2 5 4.1 COc1ccc(C(=O)c2cc(CCNS(=O)(=O)c3ccc(Cl)cc3)cc(CCC(=O)O)c2)cc1 10.1016/s0960-894x(98)00242-x
CHEMBL66194 210277 0 None - 0 Rat 10.6 pKd = 10.6 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 501 11 2 5 4.1 COc1ccc(C(=O)c2cc(CCNS(=O)(=O)c3ccc(Cl)cc3)cc(CCC(=O)O)c2)cc1 10.1016/s0960-894x(98)00242-x
19962395 210222 0 None - 0 Rat 10.4 pKd = 10.4 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 496 10 2 5 4.0 N#Cc1ccc(C(=O)c2cc(CCNS(=O)(=O)c3ccc(Cl)cc3)cc(CCC(=O)O)c2)cc1 10.1016/s0960-894x(98)00242-x
CHEMBL65780 210222 0 None - 0 Rat 10.4 pKd = 10.4 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 496 10 2 5 4.0 N#Cc1ccc(C(=O)c2cc(CCNS(=O)(=O)c3ccc(Cl)cc3)cc(CCC(=O)O)c2)cc1 10.1016/s0960-894x(98)00242-x
44305435 210141 0 None - 0 Rat 10.2 pKd = 10.2 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 487 11 2 4 4.5 COc1ccccc1Cc1cc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc(CCC(=O)O)c1 10.1016/s0960-894x(98)00242-x
CHEMBL65167 210141 0 None - 0 Rat 10.2 pKd = 10.2 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 487 11 2 4 4.5 COc1ccccc1Cc1cc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc(CCC(=O)O)c1 10.1016/s0960-894x(98)00242-x
44305171 210189 0 None - 0 Rat 10.2 pKd = 10.2 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 535 11 2 5 3.9 CS(=O)(=O)c1ccc(Cc2cc(CCNS(=O)(=O)c3ccc(Cl)cc3)cc(CCC(=O)O)c2)cc1 10.1016/s0960-894x(98)00242-x
CHEMBL65571 210189 0 None - 0 Rat 10.2 pKd = 10.2 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 535 11 2 5 3.9 CS(=O)(=O)c1ccc(Cc2cc(CCNS(=O)(=O)c3ccc(Cl)cc3)cc(CCC(=O)O)c2)cc1 10.1016/s0960-894x(98)00242-x
44332831 11342 0 None - 0 Rat 10.1 pKd = 10.1 Functional
Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 495 10 2 5 4.1 Cc1c(Cc2ccncc2)c2cc(CCC(=O)O)ccc2n1CCNS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00529-4
CHEMBL102533 11342 0 None - 0 Rat 10.1 pKd = 10.1 Functional
Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 495 10 2 5 4.1 Cc1c(Cc2ccncc2)c2cc(CCC(=O)O)ccc2n1CCNS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00529-4
44305385 109016 0 None - 0 Rat 10.1 pKd = 10.1 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 475 10 2 3 4.6 O=C(O)CCc1cc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc(Cc2cccc(F)c2)c1 10.1016/s0960-894x(98)00242-x
CHEMBL303097 109016 0 None - 0 Rat 10.1 pKd = 10.1 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 475 10 2 3 4.6 O=C(O)CCc1cc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc(Cc2cccc(F)c2)c1 10.1016/s0960-894x(98)00242-x
19962368 210142 0 None - 0 Rat 10.0 pKd = 10 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 489 10 2 4 4.2 O=C(O)CCc1cc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc(C(=O)c2ccc(F)cc2)c1 10.1016/s0960-894x(98)00242-x
CHEMBL65175 210142 0 None - 0 Rat 10.0 pKd = 10 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 489 10 2 4 4.2 O=C(O)CCc1cc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc(C(=O)c2ccc(F)cc2)c1 10.1016/s0960-894x(98)00242-x
18926588 175596 0 None - 0 Rat 9.8 pKd = 9.8 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 482 9 2 5 4.7 COc1ccc(S(=O)(=O)Nc2ccc3c(c2)c(Cc2ccc(F)cc2)cn3CCC(=O)O)cc1 10.1016/0960-894X(96)00299-5
CHEMBL43770 175596 0 None - 0 Rat 9.8 pKd = 9.8 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 482 9 2 5 4.7 COc1ccc(S(=O)(=O)Nc2ccc3c(c2)c(Cc2ccc(F)cc2)cn3CCC(=O)O)cc1 10.1016/0960-894X(96)00299-5
19962351 210221 0 None - 0 Rat 9.7 pKd = 9.7 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 491 10 3 4 4.1 O=C(O)CCc1cc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc(C(O)c2ccc(F)cc2)c1 10.1016/s0960-894x(98)00242-x
CHEMBL65779 210221 0 None - 0 Rat 9.7 pKd = 9.7 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 491 10 3 4 4.1 O=C(O)CCc1cc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc(C(O)c2ccc(F)cc2)c1 10.1016/s0960-894x(98)00242-x
18926534 175599 0 None - 0 Rat 9.6 pKd = 9.6 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 486 8 2 4 5.3 O=C(O)CCn1cc(Cc2ccc(F)cc2)c2cc(NS(=O)(=O)c3ccc(Cl)cc3)ccc21 10.1016/0960-894X(96)00299-5
CHEMBL43772 175599 0 None - 0 Rat 9.6 pKd = 9.6 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 486 8 2 4 5.3 O=C(O)CCn1cc(Cc2ccc(F)cc2)c2cc(NS(=O)(=O)c3ccc(Cl)cc3)ccc21 10.1016/0960-894X(96)00299-5
18926517 186140 0 None - 0 Rat 9.6 pKd = 9.6 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 466 8 2 4 5.0 Cc1ccc(S(=O)(=O)Nc2ccc3c(c2)c(Cc2ccc(F)cc2)cn3CCC(=O)O)cc1 10.1016/0960-894X(96)00299-5
CHEMBL47372 186140 0 None - 0 Rat 9.6 pKd = 9.6 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 466 8 2 4 5.0 Cc1ccc(S(=O)(=O)Nc2ccc3c(c2)c(Cc2ccc(F)cc2)cn3CCC(=O)O)cc1 10.1016/0960-894X(96)00299-5
10367276 103398 0 None - 0 Human 9.5 pKd = 9.5 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 466 8 2 5 4.2 O=C(O)CC/C=C\C[C@@H]1CN(S(=O)(=O)c2cccc3cnccc23)C[C@@H]1c1ccccc1O 10.1016/0960-894X(96)00021-2
CHEMBL263442 103398 0 None - 0 Human 9.5 pKd = 9.5 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 466 8 2 5 4.2 O=C(O)CC/C=C\C[C@@H]1CN(S(=O)(=O)c2cccc3cnccc23)C[C@@H]1c1ccccc1O 10.1016/0960-894X(96)00021-2
19962400 210119 0 None - 0 Rat 9.5 pKd = 9.5 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 549 11 2 6 3.5 CS(=O)(=O)c1ccc(C(=O)c2cc(CCNS(=O)(=O)c3ccc(Cl)cc3)cc(CCC(=O)O)c2)cc1 10.1016/s0960-894x(98)00242-x
CHEMBL64971 210119 0 None - 0 Rat 9.5 pKd = 9.5 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 549 11 2 6 3.5 CS(=O)(=O)c1ccc(C(=O)c2cc(CCNS(=O)(=O)c3ccc(Cl)cc3)cc(CCC(=O)O)c2)cc1 10.1016/s0960-894x(98)00242-x
6604763 108593 15 None - 0 Human 9.4 pKd = 9.4 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 402 7 2 4 5.3 O=C(O)CC/C=C\C[C@@H]1CO[C@H](c2ccccc2Cl)O[C@@H]1c1ccccc1O 10.1016/0960-894X(96)00021-2
CHEMBL30024 108593 15 None - 0 Human 9.4 pKd = 9.4 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 402 7 2 4 5.3 O=C(O)CC/C=C\C[C@@H]1CO[C@H](c2ccccc2Cl)O[C@@H]1c1ccccc1O 10.1016/0960-894X(96)00021-2
44294109 194495 0 None - 0 Rat 9.4 pKd = 9.4 Functional
Antagonistic activity against Thromboxane A2 receptor in rat aorta in the presence of 11,9-epoxymethano-PGH2Antagonistic activity against Thromboxane A2 receptor in rat aorta in the presence of 11,9-epoxymethano-PGH2
ChEMBL 387 10 4 4 3.3 O=C(O)CCC/C=C\C[C@H]1C2CCC(O2)[C@H]1CNNC(=O)Nc1ccccc1 10.1021/jm00168a032
CHEMBL49535 194495 0 None - 0 Rat 9.4 pKd = 9.4 Functional
Antagonistic activity against Thromboxane A2 receptor in rat aorta in the presence of 11,9-epoxymethano-PGH2Antagonistic activity against Thromboxane A2 receptor in rat aorta in the presence of 11,9-epoxymethano-PGH2
ChEMBL 387 10 4 4 3.3 O=C(O)CCC/C=C\C[C@H]1C2CCC(O2)[C@H]1CNNC(=O)Nc1ccccc1 10.1021/jm00168a032
10321942 209760 0 None - 0 Rat 9.4 pKd = 9.4 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 458 10 2 4 3.9 O=C(O)CCc1cc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc(Cc2cccnc2)c1 10.1016/s0960-894x(98)00242-x
CHEMBL63090 209760 0 None - 0 Rat 9.4 pKd = 9.4 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 458 10 2 4 3.9 O=C(O)CCc1cc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc(Cc2cccnc2)c1 10.1016/s0960-894x(98)00242-x
18926553 190691 0 None - 0 Rat 9.3 pKd = 9.3 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 470 8 2 4 4.8 O=C(O)CCn1cc(Cc2ccc(F)cc2)c2cc(NS(=O)(=O)c3ccc(F)cc3)ccc21 10.1016/0960-894X(96)00299-5
CHEMBL48128 190691 0 None - 0 Rat 9.3 pKd = 9.3 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 470 8 2 4 4.8 O=C(O)CCn1cc(Cc2ccc(F)cc2)c2cc(NS(=O)(=O)c3ccc(F)cc3)ccc21 10.1016/0960-894X(96)00299-5
44294109 194495 0 None - 0 Human 9.2 pKd = 9.2 Functional
Antagonistic activity against Thromboxane A2 receptor in guinea pig trachea in the presence of 11,9-epoxymethano-PGH2Antagonistic activity against Thromboxane A2 receptor in guinea pig trachea in the presence of 11,9-epoxymethano-PGH2
ChEMBL 387 10 4 4 3.3 O=C(O)CCC/C=C\C[C@H]1C2CCC(O2)[C@H]1CNNC(=O)Nc1ccccc1 10.1021/jm00168a032
CHEMBL49535 194495 0 None - 0 Human 9.2 pKd = 9.2 Functional
Antagonistic activity against Thromboxane A2 receptor in guinea pig trachea in the presence of 11,9-epoxymethano-PGH2Antagonistic activity against Thromboxane A2 receptor in guinea pig trachea in the presence of 11,9-epoxymethano-PGH2
ChEMBL 387 10 4 4 3.3 O=C(O)CCC/C=C\C[C@H]1C2CCC(O2)[C@H]1CNNC(=O)Nc1ccccc1 10.1021/jm00168a032
44374902 61583 0 None - 0 Rat 9.2 pKd = 9.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 579 11 2 6 3.5 O=C(O)CCO/N=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL161253 61583 0 None - 0 Rat 9.2 pKd = 9.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 579 11 2 6 3.5 O=C(O)CCO/N=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
9830229 62981 0 None - 0 Rat 9.2 pKd = 9.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 604 11 2 4 5.6 CC(C)(CNS(=O)(=O)c1ccc(I)cc1)c1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL162641 62981 0 None - 0 Rat 9.2 pKd = 9.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 604 11 2 4 5.6 CC(C)(CNS(=O)(=O)c1ccc(I)cc1)c1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1016/S0960-894X(01)81051-9
18926545 178426 0 None - 0 Rat 9.2 pKd = 9.2 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 452 8 2 4 4.6 O=C(O)CCn1cc(Cc2ccc(F)cc2)c2cc(NS(=O)(=O)c3ccccc3)ccc21 10.1016/0960-894X(96)00299-5
CHEMBL44660 178426 0 None - 0 Rat 9.2 pKd = 9.2 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 452 8 2 4 4.6 O=C(O)CCn1cc(Cc2ccc(F)cc2)c2cc(NS(=O)(=O)c3ccccc3)ccc21 10.1016/0960-894X(96)00299-5
10323516 115338 1 None - 0 Rat 9.2 pKd = 9.2 Functional
Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 495 10 2 5 4.1 Cc1c(Cc2cccnc2)c2cc(CCC(=O)O)ccc2n1CCNS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00529-4
CHEMBL320235 115338 1 None - 0 Rat 9.2 pKd = 9.2 Functional
Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 495 10 2 5 4.1 Cc1c(Cc2cccnc2)c2cc(CCC(=O)O)ccc2n1CCNS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00529-4
44344654 17293 0 None - 0 Human 9.0 pKd = 9 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 449 8 2 4 4.3 O=C(O)CC/C=C\C[C@@H]1CN(S(=O)(=O)c2ccc(Cl)cc2)C[C@@H]1c1ccccc1O 10.1016/0960-894X(96)00021-2
CHEMBL116852 17293 0 None - 0 Human 9.0 pKd = 9 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 449 8 2 4 4.3 O=C(O)CC/C=C\C[C@@H]1CN(S(=O)(=O)c2ccc(Cl)cc2)C[C@@H]1c1ccccc1O 10.1016/0960-894X(96)00021-2
15684002 126640 0 None - 0 Rat 9.0 pKd = 9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 576 11 2 4 4.9 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL348790 126640 0 None - 0 Rat 9.0 pKd = 9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 576 11 2 4 4.9 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
15024087 126988 0 None - 0 Human 9.0 pKd = 9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 506 12 1 5 6.0 CCc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL352040 126988 0 None - 0 Human 9.0 pKd = 9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 506 12 1 5 6.0 CCc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
131717 210168 6 None - 1 Human 8.9 pKd = 8.9 Functional
In vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous veinIn vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous vein
ChEMBL 452 14 2 4 4.7 O=C(O)CCC(CCCCNS(=O)(=O)c1ccc(Cl)cc1)CCCc1cccnc1 10.1016/S0960-894X(01)80104-9
CHEMBL65414 210168 6 None - 1 Human 8.9 pKd = 8.9 Functional
In vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous veinIn vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous vein
ChEMBL 452 14 2 4 4.7 O=C(O)CCC(CCCCNS(=O)(=O)c1ccc(Cl)cc1)CCCc1cccnc1 10.1016/S0960-894X(01)80104-9
10321666 187984 0 None - 0 Rat 8.9 pKd = 8.9 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 453 8 2 5 4.0 O=C(O)CCn1cc(Cc2cccnc2)c2cc(NS(=O)(=O)c3ccc(F)cc3)ccc21 10.1016/0960-894X(96)00299-5
CHEMBL47612 187984 0 None - 0 Rat 8.9 pKd = 8.9 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 453 8 2 5 4.0 O=C(O)CCn1cc(Cc2cccnc2)c2cc(NS(=O)(=O)c3ccc(F)cc3)ccc21 10.1016/0960-894X(96)00299-5
44344840 17014 0 None - 0 Human 8.8 pKd = 8.8 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 465 8 2 4 4.8 O=C(O)CC/C=C\C[C@@H]1CN(S(=O)(=O)c2cccc3ccccc23)C[C@@H]1c1ccccc1O 10.1016/0960-894X(96)00021-2
CHEMBL116088 17014 0 None - 0 Human 8.8 pKd = 8.8 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 465 8 2 4 4.8 O=C(O)CC/C=C\C[C@@H]1CN(S(=O)(=O)c2cccc3ccccc23)C[C@@H]1c1ccccc1O 10.1016/0960-894X(96)00021-2
10005561 174907 1 None - 0 Rat 8.8 pKd = 8.8 Functional
Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 484 10 2 6 3.3 Cc1c(Cn2ccnc2)c2cc(CCC(=O)O)ccc2n1CCNS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00529-4
CHEMBL432958 174907 1 None - 0 Rat 8.8 pKd = 8.8 Functional
Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 484 10 2 6 3.3 Cc1c(Cn2ccnc2)c2cc(CCC(=O)O)ccc2n1CCNS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00529-4
44374886 59873 0 None - 0 Rat 8.8 pKd = 8.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 565 10 2 6 3.1 O=C(O)CO/N=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL159775 59873 0 None - 0 Rat 8.8 pKd = 8.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 565 10 2 6 3.1 O=C(O)CO/N=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
44374517 61417 0 None - 0 Human 8.8 pKd = 8.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3CO)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL161108 61417 0 None - 0 Human 8.8 pKd = 8.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3CO)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
10546960 210134 0 None - 2 Rat 8.7 pKd = 8.7 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 367 8 2 3 2.9 O=C(O)CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1016/s0960-894x(98)00242-x
CHEMBL65121 210134 0 None - 2 Rat 8.7 pKd = 8.7 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 367 8 2 3 2.9 O=C(O)CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1016/s0960-894x(98)00242-x
44374837 60104 0 None - 0 Rat 8.7 pKd = 8.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 607 11 2 6 4.2 CC(C)(CNS(=O)(=O)c1ccc(I)cc1)c1cccc(/C(=N\OCCC(=O)O)c2cccnc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL159979 60104 0 None - 0 Rat 8.7 pKd = 8.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 607 11 2 6 4.2 CC(C)(CNS(=O)(=O)c1ccc(I)cc1)c1cccc(/C(=N\OCCC(=O)O)c2cccnc2)c1 10.1016/S0960-894X(01)81051-9
44374461 61579 0 None - 0 Human 8.7 pKd = 8.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 521 13 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3CCO)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL161252 61579 0 None - 0 Human 8.7 pKd = 8.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 521 13 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3CCO)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
44293931 108713 0 None - 1 Human 8.0 pKd = 8 Functional
Antagonistic activity against Thromboxane A2 receptor in guinea pig trachea in the presence of 11,9-epoxymethano-PGH2Antagonistic activity against Thromboxane A2 receptor in guinea pig trachea in the presence of 11,9-epoxymethano-PGH2
ChEMBL 384 10 2 3 4.7 C[C@@H](c1ccccc1)[C@H](O)/C=C/C1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00168a032
CHEMBL301098 108713 0 None - 1 Human 8.0 pKd = 8 Functional
Antagonistic activity against Thromboxane A2 receptor in guinea pig trachea in the presence of 11,9-epoxymethano-PGH2Antagonistic activity against Thromboxane A2 receptor in guinea pig trachea in the presence of 11,9-epoxymethano-PGH2
ChEMBL 384 10 2 3 4.7 C[C@@H](c1ccccc1)[C@H](O)/C=C/C1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00168a032
44293931 108713 0 None - 1 Rat 8.0 pKd = 8 Functional
Antagonistic activity against Thromboxane A2 receptor in rat aorta in the presence of 11,9-epoxymethano-PGH2Antagonistic activity against Thromboxane A2 receptor in rat aorta in the presence of 11,9-epoxymethano-PGH2
ChEMBL 384 10 2 3 4.7 C[C@@H](c1ccccc1)[C@H](O)/C=C/C1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00168a032
CHEMBL301098 108713 0 None - 1 Rat 8.0 pKd = 8 Functional
Antagonistic activity against Thromboxane A2 receptor in rat aorta in the presence of 11,9-epoxymethano-PGH2Antagonistic activity against Thromboxane A2 receptor in rat aorta in the presence of 11,9-epoxymethano-PGH2
ChEMBL 384 10 2 3 4.7 C[C@@H](c1ccccc1)[C@H](O)/C=C/C1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00168a032
44374917 61710 0 None - 0 Rat 8.0 pKd = 8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 590 12 2 4 5.3 O=C(O)CCCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL161422 61710 0 None - 0 Rat 8.0 pKd = 8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 590 12 2 4 5.3 O=C(O)CCCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
15024089 58666 0 None - 0 Rat 8.0 pKd = 8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 534 14 1 5 6.8 CCCCc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL158576 58666 0 None - 0 Rat 8.0 pKd = 8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 534 14 1 5 6.8 CCCCc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
15024087 126988 0 None - 0 Rat 8.0 pKd = 8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 506 12 1 5 6.0 CCc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL352040 126988 0 None - 0 Rat 8.0 pKd = 8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 506 12 1 5 6.0 CCc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
13560651 61714 0 None - 0 Human 8.0 pKd = 8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL161427 61714 0 None - 0 Human 8.0 pKd = 8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
44374532 126848 0 None - 0 Human 8.0 pKd = 8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 570 13 2 6 5.5 CS(=O)(=O)Nc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL350642 126848 0 None - 0 Human 8.0 pKd = 8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 570 13 2 6 5.5 CS(=O)(=O)Nc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
15024095 63000 0 None - 0 Human 8.0 pKd = 8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 478 11 1 5 5.5 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2ccncc2)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL162691 63000 0 None - 0 Human 8.0 pKd = 8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 478 11 1 5 5.5 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2ccncc2)cc1 10.1016/S0960-894X(01)81050-7
44305522 209750 0 None - 1 Human 8.0 pKd = 8.0 Functional
In vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous veinIn vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous vein
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)OC[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80104-9
CHEMBL63040 209750 0 None - 1 Human 8.0 pKd = 8.0 Functional
In vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous veinIn vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous vein
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)OC[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80104-9
19104271 179454 0 None - 0 Rat 7.0 pKd = 7 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 353 7 2 3 3.5 O=C(O)CCCc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)cc1 10.1016/0960-894X(96)00299-5
CHEMBL44998 179454 0 None - 0 Rat 7.0 pKd = 7 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 353 7 2 3 3.5 O=C(O)CCCc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)cc1 10.1016/0960-894X(96)00299-5
44374902 61583 0 None - 0 Human 7.0 pKd = 7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 579 11 2 6 3.5 O=C(O)CCO/N=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL161253 61583 0 None - 0 Human 7.0 pKd = 7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 579 11 2 6 3.5 O=C(O)CCO/N=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
44374454 126686 0 None - 0 Human 7.0 pKd = 7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL349223 126686 0 None - 0 Human 7.0 pKd = 7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
15684009 63342 0 None - 0 Human 6.0 pKd = 6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 495 12 2 6 4.2 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccccc2[N+](=O)[O-])c1 10.1016/S0960-894X(01)81051-9
CHEMBL164109 63342 0 None - 0 Human 6.0 pKd = 6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 495 12 2 6 4.2 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccccc2[N+](=O)[O-])c1 10.1016/S0960-894X(01)81051-9
44375168 171648 0 None - 0 Human 6.0 pKd = 6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 464 12 2 4 4.7 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCCNS(=O)(=O)c2ccccc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL422017 171648 0 None - 0 Human 6.0 pKd = 6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 464 12 2 4 4.7 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCCNS(=O)(=O)c2ccccc2)c1 10.1016/S0960-894X(01)81051-9
44374454 126686 0 None - 0 Rat 6.0 pKd = 6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL349223 126686 0 None - 0 Rat 6.0 pKd = 6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
44387031 67266 0 None - 0 Human 6.0 pKd = 6 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 496 8 1 4 6.3 O=C(O)CC1CCCc2c1n(Cc1cccc(OCCCC#Cc3cccnc3)c1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
CHEMBL175538 67266 0 None - 0 Human 6.0 pKd = 6 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 496 8 1 4 6.3 O=C(O)CC1CCCc2c1n(Cc1cccc(OCCCC#Cc3cccnc3)c1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
44326663 115375 0 None - 0 Human 5.0 pKd = 5 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 851 21 3 10 9.3 N#Cc1ccc([C@H]2OC[C@@H](C/C=C\CCC(=O)NCCCCCCNC(=O)CC/C=C\C[C@@H]3CO[C@H](c4ccc(C#N)cc4)O[C@@H]3c3ccccc3O)[C@@H](c3cccnc3)O2)cc1 10.1016/0960-894X(96)00004-2
CHEMBL320461 115375 0 None - 0 Human 5.0 pKd = 5 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 851 21 3 10 9.3 N#Cc1ccc([C@H]2OC[C@@H](C/C=C\CCC(=O)NCCCCCCNC(=O)CC/C=C\C[C@@H]3CO[C@H](c4ccc(C#N)cc4)O[C@@H]3c3ccccc3O)[C@@H](c3cccnc3)O2)cc1 10.1016/0960-894X(96)00004-2
10010816 115410 0 None - 0 Human 5.0 pKd = 5 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 854 16 1 11 10.8 N#Cc1ccc([C@H]2OC[C@@H](C/C=C\CCC(=O)Oc3ccccc3OC(=O)CC/C=C\C[C@@H]3CO[C@H](c4ccccc4Cl)O[C@@H]3c3ccccc3O)[C@@H](c3cccnc3)O2)cc1 10.1016/0960-894X(96)00004-2
CHEMBL320682 115410 0 None - 0 Human 5.0 pKd = 5 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 854 16 1 11 10.8 N#Cc1ccc([C@H]2OC[C@@H](C/C=C\CCC(=O)Oc3ccccc3OC(=O)CC/C=C\C[C@@H]3CO[C@H](c4ccccc4Cl)O[C@@H]3c3ccccc3O)[C@@H](c3cccnc3)O2)cc1 10.1016/0960-894X(96)00004-2
44326662 118321 0 None - 0 Human 5.0 pKd = 5 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 853 21 1 12 10.1 N#Cc1ccc([C@H]2OC[C@@H](C/C=C\CCC(=O)OCCCCCCOC(=O)CC/C=C\C[C@@H]3CO[C@H](c4ccc(C#N)cc4)O[C@@H]3c3ccccc3O)[C@@H](c3cccnc3)O2)cc1 10.1016/0960-894X(96)00004-2
CHEMBL327992 118321 0 None - 0 Human 5.0 pKd = 5 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 853 21 1 12 10.1 N#Cc1ccc([C@H]2OC[C@@H](C/C=C\CCC(=O)OCCCCCCOC(=O)CC/C=C\C[C@@H]3CO[C@H](c4ccc(C#N)cc4)O[C@@H]3c3ccccc3O)[C@@H](c3cccnc3)O2)cc1 10.1016/0960-894X(96)00004-2
44326473 214265 0 None - 0 Human 5.0 pKd = 5 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 795 17 3 10 7.7 N#Cc1ccc([C@H]2OC[C@@H](C/C=C\CCC(=O)NCCNC(=O)CC/C=C\C[C@@H]3CO[C@H](c4ccc(C#N)cc4)O[C@@H]3c3ccccc3O)[C@@H](c3cccnc3)O2)cc1 10.1016/0960-894X(96)00004-2
CHEMBL94375 214265 0 None - 0 Human 5.0 pKd = 5 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 795 17 3 10 7.7 N#Cc1ccc([C@H]2OC[C@@H](C/C=C\CCC(=O)NCCNC(=O)CC/C=C\C[C@@H]3CO[C@H](c4ccc(C#N)cc4)O[C@@H]3c3ccccc3O)[C@@H](c3cccnc3)O2)cc1 10.1016/0960-894X(96)00004-2
10259965 214266 0 None - 0 Human 5.0 pKd = 5 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 845 16 1 12 10.0 N#Cc1ccc([C@H]2OC[C@@H](C/C=C\CCC(=O)Oc3ccccc3OC(=O)CC/C=C\C[C@@H]3CO[C@H](c4ccc(C#N)cc4)O[C@@H]3c3ccccc3O)[C@@H](c3cccnc3)O2)cc1 10.1016/0960-894X(96)00004-2
CHEMBL94381 214266 0 None - 0 Human 5.0 pKd = 5 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 845 16 1 12 10.0 N#Cc1ccc([C@H]2OC[C@@H](C/C=C\CCC(=O)Oc3ccccc3OC(=O)CC/C=C\C[C@@H]3CO[C@H](c4ccc(C#N)cc4)O[C@@H]3c3ccccc3O)[C@@H](c3cccnc3)O2)cc1 10.1016/0960-894X(96)00004-2
44326472 214318 0 None - 0 Human 5.0 pKd = 5 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 845 16 1 12 10.0 N#Cc1ccc([C@H]2OC[C@@H](C/C=C\CCC(=O)Oc3ccc(OC(=O)CC/C=C\C[C@@H]4CO[C@H](c5ccc(C#N)cc5)O[C@@H]4c4ccccc4O)cc3)[C@@H](c3cccnc3)O2)cc1 10.1016/0960-894X(96)00004-2
CHEMBL94692 214318 0 None - 0 Human 5.0 pKd = 5 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 845 16 1 12 10.0 N#Cc1ccc([C@H]2OC[C@@H](C/C=C\CCC(=O)Oc3ccc(OC(=O)CC/C=C\C[C@@H]4CO[C@H](c5ccc(C#N)cc5)O[C@@H]4c4ccccc4O)cc3)[C@@H](c3cccnc3)O2)cc1 10.1016/0960-894X(96)00004-2
10601707 50883 0 None - 0 Human 7.0 pKd = 7.0 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 507 11 2 5 6.1 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)N[C@@H]3C[C@H]3c3ccccc3)co2)cc1)c1cccnc1 10.1021/jm980173n
CHEMBL151519 50883 0 None - 0 Human 7.0 pKd = 7.0 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 507 11 2 5 6.1 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)N[C@@H]3C[C@H]3c3ccccc3)co2)cc1)c1cccnc1 10.1021/jm980173n
10768214 49636 0 None - 0 Human 7.0 pKd = 7.0 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 517 13 2 6 5.9 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCOC3CCCCC3)co2)cc1)c1cccnc1 10.1021/jm980173n
CHEMBL150289 49636 0 None - 0 Human 7.0 pKd = 7.0 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 517 13 2 6 5.9 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCOC3CCCCC3)co2)cc1)c1cccnc1 10.1021/jm980173n
10840154 50558 0 None - 0 Human 6.9 pKd = 6.9 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 539 14 2 6 6.2 COc1ccc(CCCNC(=O)c2coc(-c3ccc(/C(=C\CCCCC(=O)O)c4cccnc4)cc3)n2)cc1 10.1021/jm980173n
CHEMBL151091 50558 0 None - 0 Human 6.9 pKd = 6.9 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 539 14 2 6 6.2 COc1ccc(CCCNC(=O)c2coc(-c3ccc(/C(=C\CCCCC(=O)O)c4cccnc4)cc3)n2)cc1 10.1021/jm980173n
44344874 170138 0 None - 0 Human 7.9 pKd = 7.9 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 449 8 2 4 4.3 O=C(O)CC/C=C\C[C@@H]1CN(S(=O)(=O)c2ccc(Cl)cc2)C[C@H]1c1ccccc1O 10.1016/0960-894X(96)00021-2
CHEMBL419224 170138 0 None - 0 Human 7.9 pKd = 7.9 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 449 8 2 4 4.3 O=C(O)CC/C=C\C[C@@H]1CN(S(=O)(=O)c2ccc(Cl)cc2)C[C@H]1c1ccccc1O 10.1016/0960-894X(96)00021-2
44374860 63263 0 None - 0 Rat 7.9 pKd = 7.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 593 12 2 6 3.8 O=C(O)CCCO/N=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL163276 63263 0 None - 0 Rat 7.9 pKd = 7.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 593 12 2 6 3.8 O=C(O)CCCO/N=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
44374518 59366 0 None - 0 Rat 7.9 pKd = 7.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3cccc(CO)c3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL159275 59366 0 None - 0 Rat 7.9 pKd = 7.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3cccc(CO)c3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
15024091 59886 0 None - 0 Rat 7.9 pKd = 7.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 508 12 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cnccc2CO)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL159787 59886 0 None - 0 Rat 7.9 pKd = 7.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 508 12 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cnccc2CO)cc1 10.1016/S0960-894X(01)81050-7
44374517 61417 0 None - 0 Rat 7.9 pKd = 7.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3CO)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL161108 61417 0 None - 0 Rat 7.9 pKd = 7.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3CO)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
44374723 61952 0 None - 0 Rat 7.9 pKd = 7.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 584 14 2 6 5.1 CNS(=O)(=O)Cc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL161746 61952 0 None - 0 Rat 7.9 pKd = 7.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 584 14 2 6 5.1 CNS(=O)(=O)Cc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
44374699 59365 0 None - 0 Human 7.9 pKd = 7.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 477 11 1 4 6.1 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL159272 59365 0 None - 0 Human 7.9 pKd = 7.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 477 11 1 4 6.1 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
44374525 126915 0 None - 0 Human 7.9 pKd = 7.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 570 13 2 6 5.5 CS(=O)(=O)Nc1cccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)c1 10.1016/S0960-894X(01)81049-0
CHEMBL351252 126915 0 None - 0 Human 7.9 pKd = 7.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 570 13 2 6 5.5 CS(=O)(=O)Nc1cccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)c1 10.1016/S0960-894X(01)81049-0
15024085 175045 0 None - 0 Human 7.9 pKd = 7.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 478 11 1 5 5.5 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cccnc2)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL433884 175045 0 None - 0 Human 7.9 pKd = 7.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 478 11 1 5 5.5 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cccnc2)cc1 10.1016/S0960-894X(01)81050-7
10626384 127969 1 None - 0 Human 6.9 pKd = 6.9 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 545 14 2 6 6.5 COC1CCC(CCCNC(=O)c2coc(-c3ccc(/C(=C\CCCCC(=O)O)c4cccnc4)cc3)n2)CC1 10.1021/jm980173n
CHEMBL357723 127969 1 None - 0 Human 6.9 pKd = 6.9 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 545 14 2 6 6.5 COC1CCC(CCCNC(=O)c2coc(-c3ccc(/C(=C\CCCCC(=O)O)c4cccnc4)cc3)n2)CC1 10.1021/jm980173n
44375168 171648 0 None - 0 Rat 6.9 pKd = 6.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 464 12 2 4 4.7 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCCNS(=O)(=O)c2ccccc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL422017 171648 0 None - 0 Rat 6.9 pKd = 6.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 464 12 2 4 4.7 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCCNS(=O)(=O)c2ccccc2)c1 10.1016/S0960-894X(01)81051-9
44374600 60216 0 None - 0 Rat 6.9 pKd = 6.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 548 13 2 5 5.7 CC(=O)NCc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL160091 60216 0 None - 0 Rat 6.9 pKd = 6.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 548 13 2 5 5.7 CC(=O)NCc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
5362391 105872 25 None - 1 Rat 5.9 pKd = 5.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1016/S0960-894X(01)81051-9
CHEMBL280728 105872 25 None - 1 Rat 5.9 pKd = 5.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1016/S0960-894X(01)81051-9
5362391 105872 25 None - 1 Rat 5.9 pKd = 5.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1016/S0960-894X(01)81050-7
CHEMBL280728 105872 25 None - 1 Rat 5.9 pKd = 5.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1016/S0960-894X(01)81050-7
10091054 214685 0 None - 0 Human 5.9 pKd = 5.9 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 378 7 1 5 4.2 N#Cc1ccc([C@H]2OC[C@@H](C/C=C\CCC(=O)O)[C@@H](c3cccnc3)O2)cc1 10.1016/0960-894X(96)00004-2
CHEMBL96727 214685 0 None - 0 Human 5.9 pKd = 5.9 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 378 7 1 5 4.2 N#Cc1ccc([C@H]2OC[C@@H](C/C=C\CCC(=O)O)[C@@H](c3cccnc3)O2)cc1 10.1016/0960-894X(96)00004-2
15462462 205041 0 None - 0 Human 6.9 pKd = 6.9 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 481 11 2 5 5.7 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCc3ccccc3)co2)cc1)c1cccnc1 10.1021/jm980173n
CHEMBL57576 205041 0 None - 0 Human 6.9 pKd = 6.9 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 481 11 2 5 5.7 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCc3ccccc3)co2)cc1)c1cccnc1 10.1021/jm980173n
44333075 11365 0 None - 0 Rat 6.9 pKd = 6.9 Functional
Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 484 10 2 6 3.3 Cc1c(Cn2ccnc2)n(CCNS(=O)(=O)c2ccc(F)cc2)c2ccc(CCC(=O)O)cc12 10.1016/0960-894X(95)00529-4
CHEMBL102692 11365 0 None - 0 Rat 6.9 pKd = 6.9 Functional
Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 484 10 2 6 3.3 Cc1c(Cn2ccnc2)n(CCNS(=O)(=O)c2ccc(F)cc2)c2ccc(CCC(=O)O)cc12 10.1016/0960-894X(95)00529-4
10790792 128071 0 None - 0 Human 5.9 pKd = 5.9 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 477 14 2 6 5.0 CCOCCCNC(=O)c1coc(-c2ccc(/C(=C\CCCCC(=O)O)c3cccnc3)cc2)n1 10.1021/jm980173n
CHEMBL358012 128071 0 None - 0 Human 5.9 pKd = 5.9 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 477 14 2 6 5.0 CCOCCCNC(=O)c1coc(-c2ccc(/C(=C\CCCCC(=O)O)c3cccnc3)cc2)n1 10.1021/jm980173n
6439002 126296 5 None - 0 Rat 6.8 pKd = 6.8 Functional
Ability to inhibit U-46,619-induced contraction of isolated strips of rat aorta, which is the measure of thromboxane receptor antagonismAbility to inhibit U-46,619-induced contraction of isolated strips of rat aorta, which is the measure of thromboxane receptor antagonism
ChEMBL 318 7 1 3 4.3 CC1(C)OC[C@@H](C/C=C\CCCC(=O)O)[C@@H](c2ccccc2)O1 10.1021/jm00384a012
CHEMBL345614 126296 5 None - 0 Rat 6.8 pKd = 6.8 Functional
Ability to inhibit U-46,619-induced contraction of isolated strips of rat aorta, which is the measure of thromboxane receptor antagonismAbility to inhibit U-46,619-induced contraction of isolated strips of rat aorta, which is the measure of thromboxane receptor antagonism
ChEMBL 318 7 1 3 4.3 CC1(C)OC[C@@H](C/C=C\CCCC(=O)O)[C@@H](c2ccccc2)O1 10.1021/jm00384a012
44374895 59500 0 None - 0 Rat 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 450 11 2 4 4.3 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccccc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL159447 59500 0 None - 0 Rat 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 450 11 2 4 4.3 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccccc2)c1 10.1016/S0960-894X(01)81051-9
44374564 59663 0 None - 0 Rat 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 520 12 2 5 5.2 NC(=O)c1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL159581 59663 0 None - 0 Rat 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 520 12 2 5 5.2 NC(=O)c1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
44374480 61684 0 None - 0 Rat 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 584 14 2 6 5.1 CNS(=O)(=O)Cc1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL161360 61684 0 None - 0 Rat 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 584 14 2 6 5.1 CNS(=O)(=O)Cc1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1 10.1016/S0960-894X(01)81049-0
15024096 62398 0 None - 0 Rat 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 508 12 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2ccncc2CO)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL162133 62398 0 None - 0 Rat 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 508 12 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2ccncc2CO)cc1 10.1016/S0960-894X(01)81050-7
44374440 62922 0 None - 0 Rat 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL162589 62922 0 None - 0 Rat 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
15024098 126806 0 None - 0 Rat 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 506 12 1 5 6.0 CCc1cnccc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL350292 126806 0 None - 0 Rat 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 506 12 1 5 6.0 CCc1cnccc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
44374564 59663 0 None - 0 Human 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 520 12 2 5 5.2 NC(=O)c1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL159581 59663 0 None - 0 Human 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 520 12 2 5 5.2 NC(=O)c1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
44374693 126805 0 None - 0 Human 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 493 11 2 5 5.8 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3O)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL350286 126805 0 None - 0 Human 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 493 11 2 5 5.8 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3O)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
44374439 126837 0 None - 0 Human 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL350579 126837 0 None - 0 Human 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
44301194 107339 0 None - 0 Human 6.8 pKd = 6.8 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 461 13 2 5 5.7 CCCCCNC(=O)c1coc(-c2ccc(/C(=C\CCCCC(=O)O)c3cccnc3)cc2)n1 10.1021/jm980173n
CHEMBL291539 107339 0 None - 0 Human 6.8 pKd = 6.8 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 461 13 2 5 5.7 CCCCCNC(=O)c1coc(-c2ccc(/C(=C\CCCCC(=O)O)c3cccnc3)cc2)n1 10.1021/jm980173n
11800240 51184 0 None - 0 Human 6.8 pKd = 6.8 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 525 14 2 6 5.8 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCOCc3ccccc3)co2)cc1)c1cccnc1 10.1021/jm980173n
CHEMBL151860 51184 0 None - 0 Human 6.8 pKd = 6.8 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 525 14 2 6 5.8 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCOCc3ccccc3)co2)cc1)c1cccnc1 10.1021/jm980173n
44374482 126658 0 None - 0 Rat 6.8 pKd = 6.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 534 13 2 5 5.1 NC(=O)Cc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL348980 126658 0 None - 0 Rat 6.8 pKd = 6.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 534 13 2 5 5.1 NC(=O)Cc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
44385671 173119 0 None - 0 Human 6.8 pKd = 6.8 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 496 8 1 4 6.3 O=C(O)CC1CCCc2c1n(Cc1ccc(OCCCC#Cc3cccnc3)cc1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
CHEMBL427300 173119 0 None - 0 Human 6.8 pKd = 6.8 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 496 8 1 4 6.3 O=C(O)CC1CCCc2c1n(Cc1ccc(OCCCC#Cc3cccnc3)cc1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
44344856 20972 0 None - 0 Human 5.8 pKd = 5.8 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 366 8 2 4 3.8 O=C(O)CC/C=C\C[C@@H]1CN(Cc2cccnc2)C[C@@H]1c1ccccc1O 10.1016/0960-894X(96)00021-2
CHEMBL119887 20972 0 None - 0 Human 5.8 pKd = 5.8 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 366 8 2 4 3.8 O=C(O)CC/C=C\C[C@@H]1CN(Cc2cccnc2)C[C@@H]1c1ccccc1O 10.1016/0960-894X(96)00021-2
44374860 63263 0 None - 0 Human 5.8 pKd = 5.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 593 12 2 6 3.8 O=C(O)CCCO/N=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL163276 63263 0 None - 0 Human 5.8 pKd = 5.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 593 12 2 6 3.8 O=C(O)CCCO/N=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
5284442 103950 30 None - 0 Human 4.8 pKd = 4.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 281 7 1 2 4.2 O=C(O)CCCC/C=C(\c1ccccc1)c1cccnc1 10.1016/S0960-894X(01)81051-9
CHEMBL26820 103950 30 None - 0 Human 4.8 pKd = 4.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 281 7 1 2 4.2 O=C(O)CCCC/C=C(\c1ccccc1)c1cccnc1 10.1016/S0960-894X(01)81051-9
5284442 103950 30 None - 0 Human 4.8 pKd = 4.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 281 7 1 2 4.2 O=C(O)CCCC/C=C(\c1ccccc1)c1cccnc1 10.1016/S0960-894X(01)81050-7
CHEMBL26820 103950 30 None - 0 Human 4.8 pKd = 4.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 281 7 1 2 4.2 O=C(O)CCCC/C=C(\c1ccccc1)c1cccnc1 10.1016/S0960-894X(01)81050-7
44366545 175140 0 None - 0 Human 6.8 pKd = 6.8 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 565 11 2 7 5.6 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)co2)cc1)c1cccnc1 10.1021/jm980173n
CHEMBL434449 175140 0 None - 0 Human 6.8 pKd = 6.8 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 565 11 2 7 5.6 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)co2)cc1)c1cccnc1 10.1021/jm980173n
10554249 126478 0 None - 0 Human 6.8 pKd = 6.8 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 531 14 2 6 6.3 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCOC3CCCCC3)co2)cc1)c1cccnc1 10.1021/jm980173n
CHEMBL347343 126478 0 None - 0 Human 6.8 pKd = 6.8 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 531 14 2 6 6.3 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCOC3CCCCC3)co2)cc1)c1cccnc1 10.1021/jm980173n
44344859 117403 0 None - 0 Human 7.7 pKd = 7.7 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 387 11 2 3 4.7 CCCCCCC(=O)N1C[C@@H](C/C=C\CCC(=O)O)[C@@H](c2ccccc2O)C1 10.1016/0960-894X(96)00021-2
CHEMBL325703 117403 0 None - 0 Human 7.7 pKd = 7.7 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 387 11 2 3 4.7 CCCCCCC(=O)N1C[C@@H](C/C=C\CCC(=O)O)[C@@H](c2ccccc2O)C1 10.1016/0960-894X(96)00021-2
15024097 59963 0 None - 0 Rat 7.7 pKd = 7.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 492 11 1 5 5.8 Cc1cnccc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL159860 59963 0 None - 0 Rat 7.7 pKd = 7.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 492 11 1 5 5.8 Cc1cnccc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
44374514 60043 0 None - 0 Rat 7.7 pKd = 7.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 520 12 2 5 5.2 NC(=O)c1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL159927 60043 0 None - 0 Rat 7.7 pKd = 7.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 520 12 2 5 5.2 NC(=O)c1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1 10.1016/S0960-894X(01)81049-0
44374473 61563 0 None - 0 Rat 7.7 pKd = 7.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccc(CO)cc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL161240 61563 0 None - 0 Rat 7.7 pKd = 7.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccc(CO)cc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
44374693 126805 0 None - 0 Rat 7.7 pKd = 7.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 493 11 2 5 5.8 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3O)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL350286 126805 0 None - 0 Rat 7.7 pKd = 7.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 493 11 2 5 5.8 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3O)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
44374724 126993 0 None - 0 Rat 7.7 pKd = 7.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 548 13 2 5 5.7 CC(=O)NCc1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL352076 126993 0 None - 0 Rat 7.7 pKd = 7.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 548 13 2 5 5.7 CC(=O)NCc1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1 10.1016/S0960-894X(01)81049-0
44374481 171571 0 None - 0 Rat 7.7 pKd = 7.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 534 13 2 5 5.1 NC(=O)Cc1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL421831 171571 0 None - 0 Rat 7.7 pKd = 7.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 534 13 2 5 5.1 NC(=O)Cc1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1 10.1016/S0960-894X(01)81049-0
44344858 17548 0 None - 0 Human 6.7 pKd = 6.7 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 345 7 2 3 3.4 CC(C)C(=O)N1C[C@@H](C/C=C\CCC(=O)O)[C@@H](c2ccccc2O)C1 10.1016/0960-894X(96)00021-2
CHEMBL117163 17548 0 None - 0 Human 6.7 pKd = 6.7 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 345 7 2 3 3.4 CC(C)C(=O)N1C[C@@H](C/C=C\CCC(=O)O)[C@@H](c2ccccc2O)C1 10.1016/0960-894X(96)00021-2
44272000 105579 0 None - 0 Human 6.7 pKd = 6.7 Functional
Antagonistic potency against Thromboxane A2 receptor expressed as inhibition of U 46619-induced platelet aggregation in human platelet rich plasma.Antagonistic potency against Thromboxane A2 receptor expressed as inhibition of U 46619-induced platelet aggregation in human platelet rich plasma.
ChEMBL 543 15 1 8 6.4 CCCCCCn1cncc1[C@H]1O[C@@H](C(C)(C)Oc2ccc(C)cc2[N+](=O)[O-])OC[C@H]1C/C=C\CCC(=O)O 10.1016/S0960-894X(00)80210-3
CHEMBL278458 105579 0 None - 0 Human 6.7 pKd = 6.7 Functional
Antagonistic potency against Thromboxane A2 receptor expressed as inhibition of U 46619-induced platelet aggregation in human platelet rich plasma.Antagonistic potency against Thromboxane A2 receptor expressed as inhibition of U 46619-induced platelet aggregation in human platelet rich plasma.
ChEMBL 543 15 1 8 6.4 CCCCCCn1cncc1[C@H]1O[C@@H](C(C)(C)Oc2ccc(C)cc2[N+](=O)[O-])OC[C@H]1C/C=C\CCC(=O)O 10.1016/S0960-894X(00)80210-3
44374850 59550 0 None - 0 Rat 6.7 pKd = 6.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 607 13 2 6 4.2 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL159481 59550 0 None - 0 Rat 6.7 pKd = 6.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 607 13 2 6 4.2 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
15684009 63342 0 None - 0 Rat 6.7 pKd = 6.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 495 12 2 6 4.2 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccccc2[N+](=O)[O-])c1 10.1016/S0960-894X(01)81051-9
CHEMBL164109 63342 0 None - 0 Rat 6.7 pKd = 6.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 495 12 2 6 4.2 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccccc2[N+](=O)[O-])c1 10.1016/S0960-894X(01)81051-9
44374886 59873 0 None - 0 Human 6.7 pKd = 6.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 565 10 2 6 3.1 O=C(O)CO/N=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL159775 59873 0 None - 0 Human 6.7 pKd = 6.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 565 10 2 6 3.1 O=C(O)CO/N=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
9830229 62981 0 None - 0 Human 6.7 pKd = 6.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 604 11 2 4 5.6 CC(C)(CNS(=O)(=O)c1ccc(I)cc1)c1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL162641 62981 0 None - 0 Human 6.7 pKd = 6.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 604 11 2 4 5.6 CC(C)(CNS(=O)(=O)c1ccc(I)cc1)c1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1016/S0960-894X(01)81051-9
44385499 66443 0 None - 0 Human 6.7 pKd = 6.7 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 510 9 1 4 6.7 O=C(O)CC1CCCc2c1n(Cc1ccc(OCCCCC#Cc3cccnc3)cc1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
CHEMBL172198 66443 0 None - 0 Human 6.7 pKd = 6.7 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 510 9 1 4 6.7 O=C(O)CC1CCCc2c1n(Cc1ccc(OCCCCC#Cc3cccnc3)cc1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
44374850 59550 0 None - 0 Human 5.7 pKd = 5.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 607 13 2 6 4.2 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL159481 59550 0 None - 0 Human 5.7 pKd = 5.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 607 13 2 6 4.2 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
44333081 179662 0 None - 0 Rat 8.6 pKd = 8.6 Functional
Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 418 8 2 4 3.4 Cc1c(C)n(CCNS(=O)(=O)c2ccc(F)cc2)c2ccc(CCC(=O)O)cc12 10.1016/0960-894X(95)00529-4
CHEMBL451553 179662 0 None - 0 Rat 8.6 pKd = 8.6 Functional
Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 418 8 2 4 3.4 Cc1c(C)n(CCNS(=O)(=O)c2ccc(F)cc2)c2ccc(CCC(=O)O)cc12 10.1016/0960-894X(95)00529-4
44374724 126993 0 None - 0 Human 8.6 pKd = 8.6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 548 13 2 5 5.7 CC(=O)NCc1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL352076 126993 0 None - 0 Human 8.6 pKd = 8.6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 548 13 2 5 5.7 CC(=O)NCc1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1 10.1016/S0960-894X(01)81049-0
15024088 59593 0 None - 0 Human 8.6 pKd = 8.6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 520 13 1 5 6.4 CCCc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL159517 59593 0 None - 0 Human 8.6 pKd = 8.6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 520 13 1 5 6.4 CCCc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
15024086 126724 0 None - 0 Human 8.6 pKd = 8.6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 492 11 1 5 5.8 Cc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL349625 126724 0 None - 0 Human 8.6 pKd = 8.6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 492 11 1 5 5.8 Cc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
18926528 187975 0 None - 0 Rat 8.6 pKd = 8.6 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 378 6 2 4 3.6 O=C(O)CCn1ccc2cc(NS(=O)(=O)c3ccc(Cl)cc3)ccc21 10.1016/0960-894X(96)00299-5
CHEMBL47611 187975 0 None - 0 Rat 8.6 pKd = 8.6 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 378 6 2 4 3.6 O=C(O)CCn1ccc2cc(NS(=O)(=O)c3ccc(Cl)cc3)ccc21 10.1016/0960-894X(96)00299-5
44305522 209750 0 None - 1 Human 7.7 pKd = 7.7 Functional
In vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous veinIn vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous vein
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)OC[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80104-9
CHEMBL63040 209750 0 None - 1 Human 7.7 pKd = 7.7 Functional
In vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous veinIn vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous vein
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)OC[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80104-9
44374845 126956 0 None - 0 Rat 7.6 pKd = 7.6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 468 11 2 4 4.4 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(F)cc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL351657 126956 0 None - 0 Rat 7.6 pKd = 7.6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 468 11 2 4 4.4 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(F)cc2)c1 10.1016/S0960-894X(01)81051-9
15024092 59014 0 None - 0 Rat 7.6 pKd = 7.6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 508 12 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cncc(CO)c2)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL158875 59014 0 None - 0 Rat 7.6 pKd = 7.6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 508 12 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cncc(CO)c2)cc1 10.1016/S0960-894X(01)81050-7
44374699 59365 0 None - 0 Rat 7.6 pKd = 7.6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 477 11 1 4 6.1 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL159272 59365 0 None - 0 Rat 7.6 pKd = 7.6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 477 11 1 4 6.1 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
44374600 60216 0 None - 0 Human 7.6 pKd = 7.6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 548 13 2 5 5.7 CC(=O)NCc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL160091 60216 0 None - 0 Human 7.6 pKd = 7.6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 548 13 2 5 5.7 CC(=O)NCc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
44344788 120746 0 None - 0 Human 6.6 pKd = 6.6 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 365 8 2 3 4.4 O=C(O)CC/C=C\C[C@@H]1CN(Cc2ccccc2)C[C@@H]1c1ccccc1O 10.1016/0960-894X(96)00021-2
CHEMBL332609 120746 0 None - 0 Human 6.6 pKd = 6.6 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 365 8 2 3 4.4 O=C(O)CC/C=C\C[C@@H]1CN(Cc2ccccc2)C[C@@H]1c1ccccc1O 10.1016/0960-894X(96)00021-2
44386636 67307 0 None - 0 Human 5.6 pKd = 5.6 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 510 9 1 4 6.7 O=C(O)CC1CCCc2c1n(Cc1cccc(OCCCCC#Cc3cccnc3)c1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
CHEMBL175801 67307 0 None - 0 Human 5.6 pKd = 5.6 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 510 9 1 4 6.7 O=C(O)CC1CCCc2c1n(Cc1cccc(OCCCCC#Cc3cccnc3)c1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
6439002 126296 5 None - 0 Human 6.6 pKd = 6.6 Functional
Ability to inhibit U-46,619-induced contraction of isolated strips of guinea pig tracheal chain, which is the measure of thromboxane receptor antagonismAbility to inhibit U-46,619-induced contraction of isolated strips of guinea pig tracheal chain, which is the measure of thromboxane receptor antagonism
ChEMBL 318 7 1 3 4.3 CC1(C)OC[C@@H](C/C=C\CCCC(=O)O)[C@@H](c2ccccc2)O1 10.1021/jm00384a012
CHEMBL345614 126296 5 None - 0 Human 6.6 pKd = 6.6 Functional
Ability to inhibit U-46,619-induced contraction of isolated strips of guinea pig tracheal chain, which is the measure of thromboxane receptor antagonismAbility to inhibit U-46,619-induced contraction of isolated strips of guinea pig tracheal chain, which is the measure of thromboxane receptor antagonism
ChEMBL 318 7 1 3 4.3 CC1(C)OC[C@@H](C/C=C\CCCC(=O)O)[C@@H](c2ccccc2)O1 10.1021/jm00384a012
44366527 46409 0 None - 0 Human 7.6 pKd = 7.6 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 531 15 3 4 6.3 C=C(NC(=O)c1ccc(/C(=C\CCCCC(=O)O)c2cccnc2)cc1)C(=O)NCCCCC1CCCCC1 10.1021/jm980173n
CHEMBL147444 46409 0 None - 0 Human 7.6 pKd = 7.6 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 531 15 3 4 6.3 C=C(NC(=O)c1ccc(/C(=C\CCCCC(=O)O)c2cccnc2)cc1)C(=O)NCCCCC1CCCCC1 10.1021/jm980173n
15024094 61733 0 None - 0 Rat 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 522 13 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cnccc2CCO)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL161532 61733 0 None - 0 Rat 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 522 13 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cnccc2CCO)cc1 10.1016/S0960-894X(01)81050-7
15024093 62737 0 None - 0 Rat 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 508 12 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cccnc2CO)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL162409 62737 0 None - 0 Rat 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 508 12 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cccnc2CO)cc1 10.1016/S0960-894X(01)81050-7
15024090 126326 0 None - 0 Rat 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 534 11 1 5 6.8 CC(C)(C)c1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL345876 126326 0 None - 0 Rat 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 534 11 1 5 6.8 CC(C)(C)c1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
44374514 60043 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 520 12 2 5 5.2 NC(=O)c1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL159927 60043 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 520 12 2 5 5.2 NC(=O)c1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1 10.1016/S0960-894X(01)81049-0
44374473 61563 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccc(CO)cc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL161240 61563 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccc(CO)cc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
44374480 61684 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 584 14 2 6 5.1 CNS(=O)(=O)Cc1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL161360 61684 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 584 14 2 6 5.1 CNS(=O)(=O)Cc1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1 10.1016/S0960-894X(01)81049-0
44374487 126858 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3CO)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL350805 126858 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3CO)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
15024091 59886 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 508 12 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cnccc2CO)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL159787 59886 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 508 12 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cnccc2CO)cc1 10.1016/S0960-894X(01)81050-7
15024094 61733 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 522 13 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cnccc2CCO)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL161532 61733 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 522 13 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cnccc2CCO)cc1 10.1016/S0960-894X(01)81050-7
15024096 62398 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 508 12 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2ccncc2CO)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL162133 62398 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 508 12 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2ccncc2CO)cc1 10.1016/S0960-894X(01)81050-7
15024093 62737 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 508 12 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cccnc2CO)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL162409 62737 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 508 12 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cccnc2CO)cc1 10.1016/S0960-894X(01)81050-7
15024090 126326 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 534 11 1 5 6.8 CC(C)(C)c1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL345876 126326 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 534 11 1 5 6.8 CC(C)(C)c1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
6604763 108593 15 None - 0 Human 8.5 pKd = 8.5 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 402 7 2 4 5.3 O=C(O)CC/C=C\C[C@@H]1CO[C@H](c2ccccc2Cl)O[C@@H]1c1ccccc1O 10.1016/0960-894X(96)00004-2
CHEMBL30024 108593 15 None - 0 Human 8.5 pKd = 8.5 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 402 7 2 4 5.3 O=C(O)CC/C=C\C[C@@H]1CO[C@H](c2ccccc2Cl)O[C@@H]1c1ccccc1O 10.1016/0960-894X(96)00004-2
18926578 175592 0 None - 0 Rat 8.4 pKd = 8.4 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 362 6 2 4 3.1 O=C(O)CCn1ccc2cc(NS(=O)(=O)c3ccc(F)cc3)ccc21 10.1016/0960-894X(96)00299-5
CHEMBL43768 175592 0 None - 0 Rat 8.4 pKd = 8.4 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 362 6 2 4 3.1 O=C(O)CCn1ccc2cc(NS(=O)(=O)c3ccc(F)cc3)ccc21 10.1016/0960-894X(96)00299-5
44272014 105604 0 None - 0 Human 8.4 pKd = 8.4 Functional
Antagonistic potency against Thromboxane A2 receptor expressed as inhibition of U 46619-induced platelet aggregation in human platelet rich plasma.Antagonistic potency against Thromboxane A2 receptor expressed as inhibition of U 46619-induced platelet aggregation in human platelet rich plasma.
ChEMBL 473 10 1 8 4.3 Cc1ccc(OC(C)(C)[C@H]2OC[C@@H](C/C=C\CCC(=O)O)[C@@H](c3cncn3C)O2)c([N+](=O)[O-])c1 10.1016/S0960-894X(00)80210-3
CHEMBL278714 105604 0 None - 0 Human 8.4 pKd = 8.4 Functional
Antagonistic potency against Thromboxane A2 receptor expressed as inhibition of U 46619-induced platelet aggregation in human platelet rich plasma.Antagonistic potency against Thromboxane A2 receptor expressed as inhibition of U 46619-induced platelet aggregation in human platelet rich plasma.
ChEMBL 473 10 1 8 4.3 Cc1ccc(OC(C)(C)[C@H]2OC[C@@H](C/C=C\CCC(=O)O)[C@@H](c3cncn3C)O2)c([N+](=O)[O-])c1 10.1016/S0960-894X(00)80210-3
6439492 105753 14 None - 0 Human 8.4 pKd = 8.4 Functional
Antagonistic potency against Thromboxane A2 receptor expressed as inhibition of U 46619-induced platelet aggregation in human platelet rich plasma.Antagonistic potency against Thromboxane A2 receptor expressed as inhibition of U 46619-induced platelet aggregation in human platelet rich plasma.
ChEMBL 470 10 1 7 5.0 Cc1ccc(OC(C)(C)[C@H]2OC[C@@H](C/C=C\CCC(=O)O)[C@@H](c3cccnc3)O2)c([N+](=O)[O-])c1 10.1016/S0960-894X(00)80210-3
CHEMBL279847 105753 14 None - 0 Human 8.4 pKd = 8.4 Functional
Antagonistic potency against Thromboxane A2 receptor expressed as inhibition of U 46619-induced platelet aggregation in human platelet rich plasma.Antagonistic potency against Thromboxane A2 receptor expressed as inhibition of U 46619-induced platelet aggregation in human platelet rich plasma.
ChEMBL 470 10 1 7 5.0 Cc1ccc(OC(C)(C)[C@H]2OC[C@@H](C/C=C\CCC(=O)O)[C@@H](c3cccnc3)O2)c([N+](=O)[O-])c1 10.1016/S0960-894X(00)80210-3
44374857 63050 0 None - 0 Rat 8.4 pKd = 8.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 495 12 2 6 4.2 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc([N+](=O)[O-])cc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL162879 63050 0 None - 0 Rat 8.4 pKd = 8.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 495 12 2 6 4.2 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc([N+](=O)[O-])cc2)c1 10.1016/S0960-894X(01)81051-9
44374532 126848 0 None - 0 Rat 8.4 pKd = 8.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 570 13 2 6 5.5 CS(=O)(=O)Nc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL350642 126848 0 None - 0 Rat 8.4 pKd = 8.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 570 13 2 6 5.5 CS(=O)(=O)Nc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
44374711 126822 0 None - 0 Human 8.4 pKd = 8.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccc(CO)cc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL350418 126822 0 None - 0 Human 8.4 pKd = 8.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccc(CO)cc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
44374481 171571 0 None - 0 Human 8.4 pKd = 8.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 534 13 2 5 5.1 NC(=O)Cc1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL421831 171571 0 None - 0 Human 8.4 pKd = 8.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 534 13 2 5 5.1 NC(=O)Cc1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1 10.1016/S0960-894X(01)81049-0
15024089 58666 0 None - 0 Human 8.4 pKd = 8.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 534 14 1 5 6.8 CCCCc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL158576 58666 0 None - 0 Human 8.4 pKd = 8.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 534 14 1 5 6.8 CCCCc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
44375026 126528 0 None - 0 Rat 7.5 pKd = 7.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 436 10 2 4 3.9 O=C(O)CC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccccc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL347812 126528 0 None - 0 Rat 7.5 pKd = 7.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 436 10 2 4 3.9 O=C(O)CC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccccc2)c1 10.1016/S0960-894X(01)81051-9
15024088 59593 0 None - 0 Rat 7.5 pKd = 7.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 520 13 1 5 6.4 CCCc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL159517 59593 0 None - 0 Rat 7.5 pKd = 7.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 520 13 1 5 6.4 CCCc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
44374461 61579 0 None - 0 Rat 7.5 pKd = 7.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 521 13 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3CCO)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL161252 61579 0 None - 0 Rat 7.5 pKd = 7.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 521 13 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3CCO)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
13560651 61714 0 None - 0 Rat 7.5 pKd = 7.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL161427 61714 0 None - 0 Rat 7.5 pKd = 7.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
15024086 126724 0 None - 0 Rat 7.5 pKd = 7.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 492 11 1 5 5.8 Cc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL349625 126724 0 None - 0 Rat 7.5 pKd = 7.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 492 11 1 5 5.8 Cc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
15684007 60055 0 None - 0 Human 6.5 pKd = 6.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 518 11 2 4 5.6 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(Cl)c(Cl)c2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL159936 60055 0 None - 0 Human 6.5 pKd = 6.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 518 11 2 4 5.6 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(Cl)c(Cl)c2)c1 10.1016/S0960-894X(01)81051-9
44374837 60104 0 None - 0 Human 6.5 pKd = 6.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 607 11 2 6 4.2 CC(C)(CNS(=O)(=O)c1ccc(I)cc1)c1cccc(/C(=N\OCCC(=O)O)c2cccnc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL159979 60104 0 None - 0 Human 6.5 pKd = 6.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 607 11 2 6 4.2 CC(C)(CNS(=O)(=O)c1ccc(I)cc1)c1cccc(/C(=N\OCCC(=O)O)c2cccnc2)c1 10.1016/S0960-894X(01)81051-9
44385778 67080 0 None - 0 Human 5.5 pKd = 5.5 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 500 11 1 4 6.9 O=C(O)CC1CCCc2c1n(Cc1cccc(OCCCCCc3cccnc3)c1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
CHEMBL174388 67080 0 None - 0 Human 5.5 pKd = 5.5 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 500 11 1 4 6.9 O=C(O)CC1CCCc2c1n(Cc1cccc(OCCCCCc3cccnc3)c1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
44386372 136174 0 None - 0 Human 5.5 pKd = 5.5 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 338 4 1 3 4.1 O=C(O)CC1CCCc2c1n(Cc1cccnc1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
CHEMBL367109 136174 0 None - 0 Human 5.5 pKd = 5.5 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 338 4 1 3 4.1 O=C(O)CC1CCCc2c1n(Cc1cccnc1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
18926585 179516 0 None - 0 Rat 5.4 pKd = 5.4 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 456 8 2 6 3.6 Cc1c(Cn2ccnc2)c2cc(NS(=O)(=O)c3ccc(F)cc3)ccc2n1CCC(=O)O 10.1016/0960-894X(96)00299-5
CHEMBL45075 179516 0 None - 0 Rat 5.4 pKd = 5.4 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 456 8 2 6 3.6 Cc1c(Cn2ccnc2)c2cc(NS(=O)(=O)c3ccc(F)cc3)ccc2n1CCC(=O)O 10.1016/0960-894X(96)00299-5
44374561 126783 0 None - 0 Rat 7.4 pKd = 7.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 477 11 1 4 6.1 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL350111 126783 0 None - 0 Rat 7.4 pKd = 7.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 477 11 1 4 6.1 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
15024085 175045 0 None - 0 Rat 7.4 pKd = 7.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 478 11 1 5 5.5 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cccnc2)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL433884 175045 0 None - 0 Rat 7.4 pKd = 7.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 478 11 1 5 5.5 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cccnc2)cc1 10.1016/S0960-894X(01)81050-7
44374440 62922 0 None - 0 Human 7.4 pKd = 7.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL162589 62922 0 None - 0 Human 7.4 pKd = 7.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
5362391 105872 25 None - 1 Human 5.4 pKd = 5.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1016/S0960-894X(01)81051-9
CHEMBL280728 105872 25 None - 1 Human 5.4 pKd = 5.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1016/S0960-894X(01)81051-9
5362391 105872 25 None - 1 Human 5.4 pKd = 5.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1016/S0960-894X(01)81050-7
CHEMBL280728 105872 25 None - 1 Human 5.4 pKd = 5.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1016/S0960-894X(01)81050-7
44385951 68885 0 None - 0 Human 5.4 pKd = 5.4 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 484 10 1 3 7.1 O=C(O)CC1CCCc2c1n(Cc1cccc(CCCCCc3cccnc3)c1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
CHEMBL177596 68885 0 None - 0 Human 5.4 pKd = 5.4 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 484 10 1 3 7.1 O=C(O)CC1CCCc2c1n(Cc1cccc(CCCCCc3cccnc3)c1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
10554248 126406 0 None - 0 Human 7.4 pKd = 7.4 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 531 14 2 6 6.1 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCOCC3CCCCC3)co2)cc1)c1cccnc1 10.1021/jm980173n
CHEMBL346644 126406 0 None - 0 Human 7.4 pKd = 7.4 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 531 14 2 6 6.1 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCOCC3CCCCC3)co2)cc1)c1cccnc1 10.1021/jm980173n
5362391 105872 25 None - 1 Human 6.4 pKd = 6.4 Functional
In vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous veinIn vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous vein
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1016/S0960-894X(01)80104-9
CHEMBL280728 105872 25 None - 1 Human 6.4 pKd = 6.4 Functional
In vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous veinIn vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous vein
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1016/S0960-894X(01)80104-9
10602360 46317 0 None - 0 Human 6.3 pKd = 6.3 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 533 14 2 7 5.1 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCOCC3CCCCO3)co2)cc1)c1cccnc1 10.1021/jm980173n
CHEMBL147308 46317 0 None - 0 Human 6.3 pKd = 6.3 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 533 14 2 7 5.1 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCOCC3CCCCO3)co2)cc1)c1cccnc1 10.1021/jm980173n
9869582 105412 0 None - 0 Human 8.3 pKd = 8.3 Functional
Antagonistic potency against Thromboxane A2 receptor expressed as inhibition of U 46619-induced platelet aggregation in human platelet rich plasma.Antagonistic potency against Thromboxane A2 receptor expressed as inhibition of U 46619-induced platelet aggregation in human platelet rich plasma.
ChEMBL 476 10 1 8 5.1 Cc1ccc(OC(C)(C)[C@H]2OC[C@@H](C/C=C\CCC(=O)O)[C@@H](c3cncs3)O2)c([N+](=O)[O-])c1 10.1016/S0960-894X(00)80210-3
CHEMBL277167 105412 0 None - 0 Human 8.3 pKd = 8.3 Functional
Antagonistic potency against Thromboxane A2 receptor expressed as inhibition of U 46619-induced platelet aggregation in human platelet rich plasma.Antagonistic potency against Thromboxane A2 receptor expressed as inhibition of U 46619-induced platelet aggregation in human platelet rich plasma.
ChEMBL 476 10 1 8 5.1 Cc1ccc(OC(C)(C)[C@H]2OC[C@@H](C/C=C\CCC(=O)O)[C@@H](c3cncs3)O2)c([N+](=O)[O-])c1 10.1016/S0960-894X(00)80210-3
44374516 126683 0 None - 0 Human 8.3 pKd = 8.3 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3cccc(CO)c3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL349187 126683 0 None - 0 Human 8.3 pKd = 8.3 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3cccc(CO)c3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
44374561 126783 0 None - 0 Human 8.3 pKd = 8.3 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 477 11 1 4 6.1 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL350111 126783 0 None - 0 Human 8.3 pKd = 8.3 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 477 11 1 4 6.1 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
44326541 175918 0 None - 0 Human 8.3 pKd = 8.3 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 393 7 2 5 4.5 N#Cc1ccc([C@H]2OC[C@@H](C/C=C\CCC(=O)O)[C@@H](c3ccccc3O)O2)cc1 10.1016/0960-894X(96)00004-2
CHEMBL440321 175918 0 None - 0 Human 8.3 pKd = 8.3 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 393 7 2 5 4.5 N#Cc1ccc([C@H]2OC[C@@H](C/C=C\CCC(=O)O)[C@@H](c3ccccc3O)O2)cc1 10.1016/0960-894X(96)00004-2
13560651 61714 0 None - 0 Rat 7.3 pKd = 7.3 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL161427 61714 0 None - 0 Rat 7.3 pKd = 7.3 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
44374711 126822 0 None - 0 Rat 7.3 pKd = 7.3 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccc(CO)cc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL350418 126822 0 None - 0 Rat 7.3 pKd = 7.3 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccc(CO)cc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
44374525 126915 0 None - 0 Rat 7.3 pKd = 7.3 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 570 13 2 6 5.5 CS(=O)(=O)Nc1cccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)c1 10.1016/S0960-894X(01)81049-0
CHEMBL351252 126915 0 None - 0 Rat 7.3 pKd = 7.3 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 570 13 2 6 5.5 CS(=O)(=O)Nc1cccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)c1 10.1016/S0960-894X(01)81049-0
6439002 126296 5 None - 0 Human 6.3 pKd = 6.3 Functional
Ability to inhibit U-46,619-induced contraction of isolated strips of rabbit thoracic aorta, which is the measure of thromboxane receptor antagonismAbility to inhibit U-46,619-induced contraction of isolated strips of rabbit thoracic aorta, which is the measure of thromboxane receptor antagonism
ChEMBL 318 7 1 3 4.3 CC1(C)OC[C@@H](C/C=C\CCCC(=O)O)[C@@H](c2ccccc2)O1 10.1021/jm00384a012
CHEMBL345614 126296 5 None - 0 Human 6.3 pKd = 6.3 Functional
Ability to inhibit U-46,619-induced contraction of isolated strips of rabbit thoracic aorta, which is the measure of thromboxane receptor antagonismAbility to inhibit U-46,619-induced contraction of isolated strips of rabbit thoracic aorta, which is the measure of thromboxane receptor antagonism
ChEMBL 318 7 1 3 4.3 CC1(C)OC[C@@H](C/C=C\CCCC(=O)O)[C@@H](c2ccccc2)O1 10.1021/jm00384a012
44374666 126735 0 None - 0 Human 6.3 pKd = 6.3 Functional
Ability to inhibit U-46,619-induced contraction of isolated strips of rabbit thoracic aorta, which is the measure of thromboxane receptor antagonismAbility to inhibit U-46,619-induced contraction of isolated strips of rabbit thoracic aorta, which is the measure of thromboxane receptor antagonism
ChEMBL 290 7 1 3 3.5 O=C(O)CCC/C=C\C[C@@H]1COCO[C@@H]1c1ccccc1 10.1021/jm00384a012
CHEMBL349706 126735 0 None - 0 Human 6.3 pKd = 6.3 Functional
Ability to inhibit U-46,619-induced contraction of isolated strips of rabbit thoracic aorta, which is the measure of thromboxane receptor antagonismAbility to inhibit U-46,619-induced contraction of isolated strips of rabbit thoracic aorta, which is the measure of thromboxane receptor antagonism
ChEMBL 290 7 1 3 3.5 O=C(O)CCC/C=C\C[C@@H]1COCO[C@@H]1c1ccccc1 10.1021/jm00384a012
44386373 172764 0 None - 0 Human 6.3 pKd = 6.3 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 486 10 1 4 6.5 O=C(O)CC1CCCc2c1n(Cc1cccc(OCCCCc3cccnc3)c1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
CHEMBL425325 172764 0 None - 0 Human 6.3 pKd = 6.3 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 486 10 1 4 6.5 O=C(O)CC1CCCc2c1n(Cc1cccc(OCCCCc3cccnc3)c1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
10768772 49600 0 None - 0 Human 7.3 pKd = 7.3 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 539 15 2 6 6.4 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCOc3ccccc3)co2)cc1)c1cccnc1 10.1021/jm980173n
CHEMBL150252 49600 0 None - 0 Human 7.3 pKd = 7.3 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 539 15 2 6 6.4 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCOc3ccccc3)co2)cc1)c1cccnc1 10.1021/jm980173n
10530889 49541 0 None - 0 Human 7.2 pKd = 7.2 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 559 15 2 6 6.9 CC(OCCCNC(=O)c1coc(-c2ccc(/C(=C\CCCCC(=O)O)c3cccnc3)cc2)n1)C1CCCCC1 10.1021/jm980173n
CHEMBL150206 49541 0 None - 0 Human 7.2 pKd = 7.2 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 559 15 2 6 6.9 CC(OCCCNC(=O)c1coc(-c2ccc(/C(=C\CCCCC(=O)O)c3cccnc3)cc2)n1)C1CCCCC1 10.1021/jm980173n
44344807 20671 0 None - 0 Human 8.2 pKd = 8.2 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 479 9 2 4 5.2 O=C(O)CCC/C=C\C[C@@H]1CN(S(=O)(=O)c2cccc3ccccc23)C[C@@H]1c1ccccc1O 10.1016/0960-894X(96)00021-2
CHEMBL119624 20671 0 None - 0 Human 8.2 pKd = 8.2 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 479 9 2 4 5.2 O=C(O)CCC/C=C\C[C@@H]1CN(S(=O)(=O)c2cccc3ccccc23)C[C@@H]1c1ccccc1O 10.1016/0960-894X(96)00021-2
18926535 107938 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 442 8 2 6 3.3 O=C(O)CCn1cc(Cn2ccnc2)c2cc(NS(=O)(=O)c3ccc(F)cc3)ccc21 10.1016/0960-894X(96)00299-5
CHEMBL295512 107938 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 442 8 2 6 3.3 O=C(O)CCn1cc(Cn2ccnc2)c2cc(NS(=O)(=O)c3ccc(F)cc3)ccc21 10.1016/0960-894X(96)00299-5
44374487 126858 0 None - 0 Rat 8.2 pKd = 8.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3CO)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL350805 126858 0 None - 0 Rat 8.2 pKd = 8.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3CO)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
44374546 126945 0 None - 0 Rat 8.2 pKd = 8.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 493 11 2 5 5.8 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccc(O)cc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL351563 126945 0 None - 0 Rat 8.2 pKd = 8.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 493 11 2 5 5.8 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccc(O)cc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
14371756 85152 0 None - 0 Human 8.2 pKd = 8.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2ccccc2CO)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL2110359 85152 0 None - 0 Human 8.2 pKd = 8.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2ccccc2CO)cc1 10.1016/S0960-894X(01)81049-0
44374579 126268 0 None - 0 Human 8.2 pKd = 8.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 570 13 2 6 5.5 CS(=O)(=O)Nc1ccccc1-c1ccc(CO[C@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL345396 126268 0 None - 0 Human 8.2 pKd = 8.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 570 13 2 6 5.5 CS(=O)(=O)Nc1ccccc1-c1ccc(CO[C@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
44374546 126945 0 None - 0 Human 8.2 pKd = 8.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 493 11 2 5 5.8 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccc(O)cc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL351563 126945 0 None - 0 Human 8.2 pKd = 8.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 493 11 2 5 5.8 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccc(O)cc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
15024092 59014 0 None - 0 Human 8.2 pKd = 8.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 508 12 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cncc(CO)c2)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL158875 59014 0 None - 0 Human 8.2 pKd = 8.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 508 12 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cncc(CO)c2)cc1 10.1016/S0960-894X(01)81050-7
15024097 59963 0 None - 0 Human 8.2 pKd = 8.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 492 11 1 5 5.8 Cc1cnccc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL159860 59963 0 None - 0 Human 8.2 pKd = 8.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 492 11 1 5 5.8 Cc1cnccc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
15024098 126806 0 None - 0 Human 8.2 pKd = 8.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 506 12 1 5 6.0 CCc1cnccc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL350292 126806 0 None - 0 Human 8.2 pKd = 8.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 506 12 1 5 6.0 CCc1cnccc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
44332843 11496 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Compound was tested in vitro for thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619Compound was tested in vitro for thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 294 5 2 2 3.5 Cc1[nH]c2ccc(CCC(=O)O)cc2c1Cc1ccncc1 10.1016/0960-894X(95)00529-4
CHEMBL103580 11496 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Compound was tested in vitro for thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619Compound was tested in vitro for thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 294 5 2 2 3.5 Cc1[nH]c2ccc(CCC(=O)O)cc2c1Cc1ccncc1 10.1016/0960-894X(95)00529-4
10601707 50883 0 None - 0 Human 7.2 pKd = 7.2 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 507 11 2 5 6.1 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)N[C@@H]3C[C@H]3c3ccccc3)co2)cc1)c1cccnc1 10.1021/jm980173n
CHEMBL151519 50883 0 None - 0 Human 7.2 pKd = 7.2 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 507 11 2 5 6.1 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)N[C@@H]3C[C@H]3c3ccccc3)co2)cc1)c1cccnc1 10.1021/jm980173n
15684007 60055 0 None - 0 Rat 7.2 pKd = 7.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 518 11 2 4 5.6 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(Cl)c(Cl)c2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL159936 60055 0 None - 0 Rat 7.2 pKd = 7.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 518 11 2 4 5.6 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(Cl)c(Cl)c2)c1 10.1016/S0960-894X(01)81051-9
44374550 59914 0 None - 0 Rat 7.2 pKd = 7.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 535 12 3 5 5.6 NC(=O)Nc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL159814 59914 0 None - 0 Rat 7.2 pKd = 7.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 535 12 3 5 5.6 NC(=O)Nc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
44374579 126268 0 None - 0 Rat 7.2 pKd = 7.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 570 13 2 6 5.5 CS(=O)(=O)Nc1ccccc1-c1ccc(CO[C@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL345396 126268 0 None - 0 Rat 7.2 pKd = 7.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 570 13 2 6 5.5 CS(=O)(=O)Nc1ccccc1-c1ccc(CO[C@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
44374439 126837 0 None - 0 Rat 7.2 pKd = 7.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL350579 126837 0 None - 0 Rat 7.2 pKd = 7.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
44374439 126837 0 None - 0 Human 7.2 pKd = 7.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL350579 126837 0 None - 0 Human 7.2 pKd = 7.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
44374857 63050 0 None - 0 Human 6.2 pKd = 6.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 495 12 2 6 4.2 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc([N+](=O)[O-])cc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL162879 63050 0 None - 0 Human 6.2 pKd = 6.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 495 12 2 6 4.2 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc([N+](=O)[O-])cc2)c1 10.1016/S0960-894X(01)81051-9
15684002 126640 0 None - 0 Human 6.2 pKd = 6.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 576 11 2 4 4.9 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL348790 126640 0 None - 0 Human 6.2 pKd = 6.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 576 11 2 4 4.9 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
44386425 130601 0 None - 0 Human 6.2 pKd = 6.2 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 498 10 1 4 7.0 O=C(O)CC1CCCc2c1n(Cc1cccc(OCCC/C=C\c3cccnc3)c1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
CHEMBL362418 130601 0 None - 0 Human 6.2 pKd = 6.2 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 498 10 1 4 7.0 O=C(O)CC1CCCc2c1n(Cc1cccc(OCCC/C=C\c3cccnc3)c1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
5284442 103950 30 None - 0 Rat 5.2 pKd = 5.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 281 7 1 2 4.2 O=C(O)CCCC/C=C(\c1ccccc1)c1cccnc1 10.1016/S0960-894X(01)81051-9
CHEMBL26820 103950 30 None - 0 Rat 5.2 pKd = 5.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 281 7 1 2 4.2 O=C(O)CCCC/C=C(\c1ccccc1)c1cccnc1 10.1016/S0960-894X(01)81051-9
5284442 103950 30 None - 0 Rat 5.2 pKd = 5.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 281 7 1 2 4.2 O=C(O)CCCC/C=C(\c1ccccc1)c1cccnc1 10.1016/S0960-894X(01)81050-7
CHEMBL26820 103950 30 None - 0 Rat 5.2 pKd = 5.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 281 7 1 2 4.2 O=C(O)CCCC/C=C(\c1ccccc1)c1cccnc1 10.1016/S0960-894X(01)81050-7
10769084 49796 0 None - 0 Human 7.2 pKd = 7.2 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 553 16 2 6 6.8 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCCOc3ccccc3)co2)cc1)c1cccnc1 10.1021/jm980173n
CHEMBL150436 49796 0 None - 0 Human 7.2 pKd = 7.2 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 553 16 2 6 6.8 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCCOc3ccccc3)co2)cc1)c1cccnc1 10.1021/jm980173n
10696954 49991 0 None - 0 Human 5.2 pKd = 5.2 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 507 16 2 7 4.6 COCCOCCCNC(=O)c1coc(-c2ccc(/C(=C\CCCCC(=O)O)c3cccnc3)cc2)n1 10.1021/jm980173n
CHEMBL150598 49991 0 None - 0 Human 5.2 pKd = 5.2 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 507 16 2 7 4.6 COCCOCCCNC(=O)c1coc(-c2ccc(/C(=C\CCCCC(=O)O)c3cccnc3)cc2)n1 10.1021/jm980173n
44332844 11542 0 None - 0 Rat 8.1 pKd = 8.1 Functional
Compound was tested in vitro for thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619Compound was tested in vitro for thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 481 10 2 5 3.8 O=C(O)CCc1ccc2c(c1)c(Cc1ccncc1)cn2CCNS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00529-4
CHEMBL103924 11542 0 None - 0 Rat 8.1 pKd = 8.1 Functional
Compound was tested in vitro for thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619Compound was tested in vitro for thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 481 10 2 5 3.8 O=C(O)CCc1ccc2c(c1)c(Cc1ccncc1)cn2CCNS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00529-4
44374518 59366 0 None - 0 Human 8.1 pKd = 8.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3cccc(CO)c3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL159275 59366 0 None - 0 Human 8.1 pKd = 8.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3cccc(CO)c3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
44374550 59914 0 None - 0 Human 8.1 pKd = 8.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 535 12 3 5 5.6 NC(=O)Nc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL159814 59914 0 None - 0 Human 8.1 pKd = 8.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 535 12 3 5 5.6 NC(=O)Nc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
13560651 61714 0 None - 0 Human 8.1 pKd = 8.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL161427 61714 0 None - 0 Human 8.1 pKd = 8.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
44374723 61952 0 None - 0 Human 8.1 pKd = 8.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 584 14 2 6 5.1 CNS(=O)(=O)Cc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL161746 61952 0 None - 0 Human 8.1 pKd = 8.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 584 14 2 6 5.1 CNS(=O)(=O)Cc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
44374482 126658 0 None - 0 Human 8.1 pKd = 8.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 534 13 2 5 5.1 NC(=O)Cc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL348980 126658 0 None - 0 Human 8.1 pKd = 8.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 534 13 2 5 5.1 NC(=O)Cc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
44305522 209750 0 None - 1 Human 7.2 pKd = 7.2 Functional
In vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous veinIn vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous vein
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)OC[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80104-9
CHEMBL63040 209750 0 None - 1 Human 7.2 pKd = 7.2 Functional
In vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous veinIn vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous vein
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)OC[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80104-9
44305538 108913 0 None - 1 Human 7.1 pKd = 7.1 Functional
In vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous veinIn vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous vein
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)CO[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80104-9
CHEMBL302457 108913 0 None - 1 Human 7.1 pKd = 7.1 Functional
In vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous veinIn vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous vein
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)CO[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80104-9
10505899 50547 0 None - 0 Human 7.1 pKd = 7.1 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 511 13 2 6 5.6 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCOc3ccccc3)co2)cc1)c1cccnc1 10.1021/jm980173n
CHEMBL151083 50547 0 None - 0 Human 7.1 pKd = 7.1 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 511 13 2 6 5.6 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCOc3ccccc3)co2)cc1)c1cccnc1 10.1021/jm980173n
15024095 63000 0 None - 0 Rat 7.1 pKd = 7.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 478 11 1 5 5.5 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2ccncc2)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL162691 63000 0 None - 0 Rat 7.1 pKd = 7.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 478 11 1 5 5.5 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2ccncc2)cc1 10.1016/S0960-894X(01)81050-7
44374516 126683 0 None - 0 Rat 7.1 pKd = 7.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3cccc(CO)c3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL349187 126683 0 None - 0 Rat 7.1 pKd = 7.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3cccc(CO)c3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
10406932 105792 1 None - 0 Human 7.1 pKd = 7.1 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 371 4 1 2 5.4 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
CHEMBL280107 105792 1 None - 0 Human 7.1 pKd = 7.1 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 371 4 1 2 5.4 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
15462460 208623 0 None - 0 Human 6.1 pKd = 6.1 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 445 11 2 5 5.0 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCC3CC3)co2)cc1)c1cccnc1 10.1021/jm980173n
CHEMBL60710 208623 0 None - 0 Human 6.1 pKd = 6.1 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 445 11 2 5 5.0 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCC3CC3)co2)cc1)c1cccnc1 10.1021/jm980173n
44374895 59500 0 None - 0 Human 6.1 pKd = 6.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 450 11 2 4 4.3 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccccc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL159447 59500 0 None - 0 Human 6.1 pKd = 6.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 450 11 2 4 4.3 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccccc2)c1 10.1016/S0960-894X(01)81051-9
44374917 61710 0 None - 0 Human 6.1 pKd = 6.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 590 12 2 4 5.3 O=C(O)CCCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL161422 61710 0 None - 0 Human 6.1 pKd = 6.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 590 12 2 4 5.3 O=C(O)CCCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
44374845 126956 0 None - 0 Human 6.1 pKd = 6.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 468 11 2 4 4.4 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(F)cc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL351657 126956 0 None - 0 Human 6.1 pKd = 6.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 468 11 2 4 4.4 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(F)cc2)c1 10.1016/S0960-894X(01)81051-9
44374439 126837 0 None - 0 Rat 6.1 pKd = 6.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL350579 126837 0 None - 0 Rat 6.1 pKd = 6.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
44375026 126528 0 None - 0 Human 5.1 pKd = 5.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 436 10 2 4 3.9 O=C(O)CC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccccc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL347812 126528 0 None - 0 Human 5.1 pKd = 5.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 436 10 2 4 3.9 O=C(O)CC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccccc2)c1 10.1016/S0960-894X(01)81051-9
5362391 105872 25 None - 1 Human 5.1 pKd = 5.1 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1021/jm980173n
CHEMBL280728 105872 25 None - 1 Human 5.1 pKd = 5.1 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1021/jm980173n
51550 212529 14 None - 1 Rat 7.1 pKd = 7.1 Functional
Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 335 8 2 4 1.7 O=C(O)COc1ccc(CCNS(=O)(=O)c2ccccc2)cc1 10.1016/0960-894X(95)00529-4
CHEMBL8273 212529 14 None - 1 Rat 7.1 pKd = 7.1 Functional
Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 335 8 2 4 1.7 O=C(O)COc1ccc(CCNS(=O)(=O)c2ccccc2)cc1 10.1016/0960-894X(95)00529-4
10720045 49946 0 None - 0 Human 7.1 pKd = 7.1 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 495 12 2 5 5.8 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCc3ccccc3)co2)cc1)c1cccnc1 10.1021/jm980173n
CHEMBL150563 49946 0 None - 0 Human 7.1 pKd = 7.1 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 495 12 2 5 5.8 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCc3ccccc3)co2)cc1)c1cccnc1 10.1021/jm980173n
5284442 103950 30 None - 0 Human 5.1 pKd = 5.1 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 281 7 1 2 4.2 O=C(O)CCCC/C=C(\c1ccccc1)c1cccnc1 10.1021/jm980173n
CHEMBL26820 103950 30 None - 0 Human 5.1 pKd = 5.1 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 281 7 1 2 4.2 O=C(O)CCCC/C=C(\c1ccccc1)c1cccnc1 10.1021/jm980173n
10768926 50068 0 None - 0 Human 7.1 pKd = 7.1 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 545 15 2 6 6.7 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCOC3CCCCC3)co2)cc1)c1cccnc1 10.1021/jm980173n
CHEMBL150660 50068 0 None - 0 Human 7.1 pKd = 7.1 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 545 15 2 6 6.7 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCOC3CCCCC3)co2)cc1)c1cccnc1 10.1021/jm980173n
9958626 108480 0 None - 0 Human 8.0 pKd = 8 Functional
Compound was tested in vitro for antagonistic activity against thromboxane receptor. Compound was tested in vitro for antagonistic activity against thromboxane receptor.
ChEMBL 529 14 2 5 7.3 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)cc1)c1cccnc1 10.1021/jm980173n
CHEMBL299467 108480 0 None - 0 Human 8.0 pKd = 8 Functional
Compound was tested in vitro for antagonistic activity against thromboxane receptor. Compound was tested in vitro for antagonistic activity against thromboxane receptor.
ChEMBL 529 14 2 5 7.3 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)cc1)c1cccnc1 10.1021/jm980173n
52944928 26064 0 None - 0 Human 7.0 pKi = 7 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 447 5 1 4 4.8 C[C@@H](c1ccc(F)cc1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
CHEMBL1290414 26064 0 None - 0 Human 7.0 pKi = 7 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 447 5 1 4 4.8 C[C@@H](c1ccc(F)cc1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
9817405 172182 5 None - 0 Human 5.0 pKi = 5 Functional
Antagonistic activity at Thromboxane A2 receptor in human was determinedAntagonistic activity at Thromboxane A2 receptor in human was determined
ChEMBL 288 4 1 1 4.5 O=C(O)/C=C/c1ccccc1Cc1ccc2ccccc2c1 10.1016/s0960-894x(01)00056-7
CHEMBL423815 172182 5 None - 0 Human 5.0 pKi = 5 Functional
Antagonistic activity at Thromboxane A2 receptor in human was determinedAntagonistic activity at Thromboxane A2 receptor in human was determined
ChEMBL 288 4 1 1 4.5 O=C(O)/C=C/c1ccccc1Cc1ccc2ccccc2c1 10.1016/s0960-894x(01)00056-7
52949846 26081 0 None - 0 Human 7.0 pKi = 7.0 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 507 5 1 4 5.5 C[C@@H](c1ccc(Br)cc1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
CHEMBL1290523 26081 0 None - 0 Human 7.0 pKi = 7.0 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 507 5 1 4 5.5 C[C@@H](c1ccc(Br)cc1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
52943623 25752 0 None - 0 Human 7.0 pKi = 7.0 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 497 5 1 4 6.0 C[C@@H](c1ccc(Cl)c(Cl)c1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
CHEMBL1287835 25752 0 None - 0 Human 7.0 pKi = 7.0 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 497 5 1 4 6.0 C[C@@H](c1ccc(Cl)c(Cl)c1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
11386109 26103 0 None - 0 Human 6.9 pKi = 6.9 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 481 6 1 4 5.3 CS(=O)(=O)c1cc(F)cc2c3c(n([C@@H](CF)c4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CCC3 10.1016/j.bmcl.2010.10.018
CHEMBL1290639 26103 0 None - 0 Human 6.9 pKi = 6.9 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 481 6 1 4 5.3 CS(=O)(=O)c1cc(F)cc2c3c(n([C@@H](CF)c4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CCC3 10.1016/j.bmcl.2010.10.018
11294992 26123 0 None - 0 Human 6.9 pKi = 6.9 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 499 6 1 4 5.6 CS(=O)(=O)c1cc(F)cc2c3c(n([C@H](c4ccc(Cl)cc4)C(F)F)c12)[C@@H](CC(=O)O)CCC3 10.1016/j.bmcl.2010.10.018
CHEMBL1290755 26123 0 None - 0 Human 6.9 pKi = 6.9 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 499 6 1 4 5.6 CS(=O)(=O)c1cc(F)cc2c3c(n([C@H](c4ccc(Cl)cc4)C(F)F)c12)[C@@H](CC(=O)O)CCC3 10.1016/j.bmcl.2010.10.018
52945002 26102 0 None - 0 Human 5.8 pKi = 5.8 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 507 6 1 6 4.1 C[C@@H](c1ccc(S(C)(=O)=O)cc1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
CHEMBL1290638 26102 0 None - 0 Human 5.8 pKi = 5.8 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 507 6 1 6 4.1 C[C@@H](c1ccc(S(C)(=O)=O)cc1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
10095268 92931 0 None -7 3 Human 7.8 pKi = 7.8 Functional
Inhibition of human recombinant TP receptor expressed in CHO cells by calcium mobilisation assayInhibition of human recombinant TP receptor expressed in CHO cells by calcium mobilisation assay
ChEMBL 449 6 1 3 6.8 Cc1ccc(-n2c(C)ccc2-c2cc(Cl)ccc2OCc2ccc(F)cc2)cc1C(=O)O 10.1016/j.bmcl.2006.11.059
CHEMBL231184 92931 0 None -7 3 Human 7.8 pKi = 7.8 Functional
Inhibition of human recombinant TP receptor expressed in CHO cells by calcium mobilisation assayInhibition of human recombinant TP receptor expressed in CHO cells by calcium mobilisation assay
ChEMBL 449 6 1 3 6.8 Cc1ccc(-n2c(C)ccc2-c2cc(Cl)ccc2OCc2ccc(F)cc2)cc1C(=O)O 10.1016/j.bmcl.2006.11.059
44390268 71043 0 None - 0 Human 5.8 pKi = 5.8 Functional
Inhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranesInhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranes
ChEMBL 416 6 2 4 3.9 O=C(O)CCn1c2c(c3cc(NS(=O)(=O)c4ccc(F)cc4)ccc31)CCCC2 10.1016/j.bmcl.2004.12.055
CHEMBL180929 71043 0 None - 0 Human 5.8 pKi = 5.8 Functional
Inhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranesInhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranes
ChEMBL 416 6 2 4 3.9 O=C(O)CCn1c2c(c3cc(NS(=O)(=O)c4ccc(F)cc4)ccc31)CCCC2 10.1016/j.bmcl.2004.12.055
123879 10060 82 None 1 6 Human 7.8 pKi = 7.8 Functional
Inhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranesInhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranes
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2004.12.055
1910 10060 82 None 1 6 Human 7.8 pKi = 7.8 Functional
Inhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranesInhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranes
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2004.12.055
1911 10060 82 None 1 6 Human 7.8 pKi = 7.8 Functional
Inhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranesInhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranes
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2004.12.055
2354 10060 82 None 1 6 Human 7.8 pKi = 7.8 Functional
Inhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranesInhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranes
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2004.12.055
CHEMBL361812 10060 82 None 1 6 Human 7.8 pKi = 7.8 Functional
Inhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranesInhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranes
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2004.12.055
DB13036 10060 82 None 1 6 Human 7.8 pKi = 7.8 Functional
Inhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranesInhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranes
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2004.12.055
11259797 26006 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 463 5 1 4 5.3 C[C@@H](c1ccc(Cl)cc1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
CHEMBL1290079 26006 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 463 5 1 4 5.3 C[C@@H](c1ccc(Cl)cc1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
10216985 25992 0 None - 0 Human 8.6 pKi = 8.6 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 449 5 1 4 4.8 CS(=O)(=O)c1cc(F)cc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2010.10.018
CHEMBL1289984 25992 0 None - 0 Human 8.6 pKi = 8.6 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 449 5 1 4 4.8 CS(=O)(=O)c1cc(F)cc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2010.10.018
21019821 26007 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 481 5 1 4 5.5 C[C@@H](c1ccc(Cl)c(F)c1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
CHEMBL1290080 26007 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 481 5 1 4 5.5 C[C@@H](c1ccc(Cl)c(F)c1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
52948543 26022 0 None - 0 Human 6.6 pKi = 6.6 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 481 5 1 4 5.5 C[C@@H](c1ccc(Cl)cc1F)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
CHEMBL1290187 26022 0 None - 0 Human 6.6 pKi = 6.6 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 481 5 1 4 5.5 C[C@@H](c1ccc(Cl)cc1F)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
52948585 26040 0 None - 0 Human 6.5 pKi = 6.5 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 463 5 1 4 5.3 C[C@@H](c1cccc(Cl)c1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
CHEMBL1290299 26040 0 None - 0 Human 6.5 pKi = 6.5 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 463 5 1 4 5.3 C[C@@H](c1cccc(Cl)c1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
24760470 21511 0 None - 1 Human 7.5 pKi = 7.5 Functional
Antagonist activity against TP receptor by FLIPR assayAntagonist activity against TP receptor by FLIPR assay
ChEMBL 334 4 1 4 4.6 CC(C)Cc1cn(-c2nc(C(=O)O)cs2)c2cc(Cl)ccc12 10.1016/j.bmcl.2008.03.018
CHEMBL1206294 21511 0 None - 1 Human 7.5 pKi = 7.5 Functional
Antagonist activity against TP receptor by FLIPR assayAntagonist activity against TP receptor by FLIPR assay
ChEMBL 334 4 1 4 4.6 CC(C)Cc1cn(-c2nc(C(=O)O)cs2)c2cc(Cl)ccc12 10.1016/j.bmcl.2008.03.018
CHEMBL257997 21511 0 None - 1 Human 7.5 pKi = 7.5 Functional
Antagonist activity against TP receptor by FLIPR assayAntagonist activity against TP receptor by FLIPR assay
ChEMBL 334 4 1 4 4.6 CC(C)Cc1cn(-c2nc(C(=O)O)cs2)c2cc(Cl)ccc12 10.1016/j.bmcl.2008.03.018
11488860 26063 0 None -7762 2 Human 6.5 pKi = 6.5 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 497 5 1 4 5.7 C[C@@H](c1ccc(C(F)(F)F)cc1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
CHEMBL1290413 26063 0 None -7762 2 Human 6.5 pKi = 6.5 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 497 5 1 4 5.7 C[C@@H](c1ccc(C(F)(F)F)cc1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
52941281 26039 0 None - 0 Human 6.4 pKi = 6.4 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 429 5 1 4 4.7 C[C@@H](c1ccccc1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
CHEMBL1290298 26039 0 None - 0 Human 6.4 pKi = 6.4 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 429 5 1 4 4.7 C[C@@H](c1ccccc1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
24760471 21616 0 None - 1 Human 6.4 pKi = 6.4 Functional
Antagonist activity against TP receptor by FLIPR assayAntagonist activity against TP receptor by FLIPR assay
ChEMBL 317 4 1 3 4.8 CC(C)Cc1cn(-c2ccc(C(=O)O)o2)c2cc(Cl)ccc12 10.1016/j.bmcl.2008.03.018
CHEMBL1207406 21616 0 None - 1 Human 6.4 pKi = 6.4 Functional
Antagonist activity against TP receptor by FLIPR assayAntagonist activity against TP receptor by FLIPR assay
ChEMBL 317 4 1 3 4.8 CC(C)Cc1cn(-c2ccc(C(=O)O)o2)c2cc(Cl)ccc12 10.1016/j.bmcl.2008.03.018
CHEMBL403407 21616 0 None - 1 Human 6.4 pKi = 6.4 Functional
Antagonist activity against TP receptor by FLIPR assayAntagonist activity against TP receptor by FLIPR assay
ChEMBL 317 4 1 3 4.8 CC(C)Cc1cn(-c2ccc(C(=O)O)o2)c2cc(Cl)ccc12 10.1016/j.bmcl.2008.03.018
9817292 64001 0 None - 0 Human 5.3 pKi = 5.3 Functional
Antagonistic activity at Thromboxane A2 receptor in human was determinedAntagonistic activity at Thromboxane A2 receptor in human was determined
ChEMBL 284 5 1 2 4.1 CSc1ccc(Cc2ccccc2/C=C/C(=O)O)cc1 10.1016/s0960-894x(01)00056-7
CHEMBL165010 64001 0 None - 0 Human 5.3 pKi = 5.3 Functional
Antagonistic activity at Thromboxane A2 receptor in human was determinedAntagonistic activity at Thromboxane A2 receptor in human was determined
ChEMBL 284 5 1 2 4.1 CSc1ccc(Cc2ccccc2/C=C/C(=O)O)cc1 10.1016/s0960-894x(01)00056-7
24760390 21505 0 None - 1 Human 7.3 pKi = 7.3 Functional
Antagonist activity against TP receptor by FLIPR assayAntagonist activity against TP receptor by FLIPR assay
ChEMBL 378 4 1 4 4.7 CC(C)Cc1cn(-c2nc(C(=O)O)cs2)c2cc(Br)ccc12 10.1016/j.bmcl.2008.03.018
CHEMBL1206284 21505 0 None - 1 Human 7.3 pKi = 7.3 Functional
Antagonist activity against TP receptor by FLIPR assayAntagonist activity against TP receptor by FLIPR assay
ChEMBL 378 4 1 4 4.7 CC(C)Cc1cn(-c2nc(C(=O)O)cs2)c2cc(Br)ccc12 10.1016/j.bmcl.2008.03.018
CHEMBL257134 21505 0 None - 1 Human 7.3 pKi = 7.3 Functional
Antagonist activity against TP receptor by FLIPR assayAntagonist activity against TP receptor by FLIPR assay
ChEMBL 378 4 1 4 4.7 CC(C)Cc1cn(-c2nc(C(=O)O)cs2)c2cc(Br)ccc12 10.1016/j.bmcl.2008.03.018
44377464 126863 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonistic activity at Thromboxane A2 receptor in human was determinedAntagonistic activity at Thromboxane A2 receptor in human was determined
ChEMBL 306 4 1 1 4.7 O=C(O)/C=C/c1ccccc1Cc1ccc(Cl)cc1Cl 10.1016/s0960-894x(01)00056-7
CHEMBL350832 126863 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonistic activity at Thromboxane A2 receptor in human was determinedAntagonistic activity at Thromboxane A2 receptor in human was determined
ChEMBL 306 4 1 1 4.7 O=C(O)/C=C/c1ccccc1Cc1ccc(Cl)cc1Cl 10.1016/s0960-894x(01)00056-7
24760322 21494 0 None - 1 Human 7.1 pKi = 7.1 Functional
Antagonist activity against TP receptor by FLIPR assayAntagonist activity against TP receptor by FLIPR assay
ChEMBL 362 4 1 4 5.4 CC(C)(C)CCc1cn(-c2nc(C(=O)O)cs2)c2cc(Cl)ccc12 10.1016/j.bmcl.2008.03.018
CHEMBL1206265 21494 0 None - 1 Human 7.1 pKi = 7.1 Functional
Antagonist activity against TP receptor by FLIPR assayAntagonist activity against TP receptor by FLIPR assay
ChEMBL 362 4 1 4 5.4 CC(C)(C)CCc1cn(-c2nc(C(=O)O)cs2)c2cc(Cl)ccc12 10.1016/j.bmcl.2008.03.018
CHEMBL255675 21494 0 None - 1 Human 7.1 pKi = 7.1 Functional
Antagonist activity against TP receptor by FLIPR assayAntagonist activity against TP receptor by FLIPR assay
ChEMBL 362 4 1 4 5.4 CC(C)(C)CCc1cn(-c2nc(C(=O)O)cs2)c2cc(Cl)ccc12 10.1016/j.bmcl.2008.03.018
10402929 64317 0 None - 0 Human 6.1 pKi = 6.1 Functional
Antagonistic activity at Thromboxane A2 receptor in human was determinedAntagonistic activity at Thromboxane A2 receptor in human was determined
ChEMBL 306 4 1 1 4.7 O=C(O)/C=C/c1ccccc1Cc1ccc(Cl)c(Cl)c1 10.1016/s0960-894x(01)00056-7
CHEMBL166351 64317 0 None - 0 Human 6.1 pKi = 6.1 Functional
Antagonistic activity at Thromboxane A2 receptor in human was determinedAntagonistic activity at Thromboxane A2 receptor in human was determined
ChEMBL 306 4 1 1 4.7 O=C(O)/C=C/c1ccccc1Cc1ccc(Cl)c(Cl)c1 10.1016/s0960-894x(01)00056-7
52944959 26082 0 None - 0 Human 7.0 pKi = 7.0 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 454 5 1 5 4.6 C[C@@H](c1ccc(C#N)cc1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
CHEMBL1290524 26082 0 None - 0 Human 7.0 pKi = 7.0 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 454 5 1 5 4.6 C[C@@H](c1ccc(C#N)cc1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
6071 7099 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 382 13 2 5 4.4 CCCCC[C@@H](CC[C@H]1[C@@H]2OC(=O)O[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 8882612
73755173 7099 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 382 13 2 5 4.4 CCCCC[C@@H](CC[C@H]1[C@@H]2OC(=O)O[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 8882612
11968293 7100 0 None - 1 Rat 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 366 12 2 5 4.1 CCCCC[C@@H](/C=C/[C@H]1[C@H]2OC(=O)O[C@H]([C@@H]1C/C=C\CCCCO)C2)O 8882612
3387 7100 0 None - 1 Rat 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 366 12 2 5 4.1 CCCCC[C@@H](/C=C/[C@H]1[C@H]2OC(=O)O[C@H]([C@@H]1C/C=C\CCCCO)C2)O 8882612
6070 10432 0 None - 1 Rat 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 350 12 2 3 4.5 CCCCC[C@@H](/C=C/[C@H]1C[C@H]2C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O2)O 4067988
73755172 10432 0 None - 1 Rat 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 350 12 2 3 4.5 CCCCC[C@@H](/C=C/[C@H]1C[C@H]2C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O2)O 4067988
10341876 9787 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonism of TPalpha (short) isoform expressed in COS7 cells.Antagonism of TPalpha (short) isoform expressed in COS7 cells.
Guide to Pharmacology 416 17 1 3 6.8 CCCCC/C=C\CC(C(C1CC1)[C@H](/C=C\C/C=C\CCCC(=O)OC)O)C1CC1 14560042
9755 9787 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonism of TPalpha (short) isoform expressed in COS7 cells.Antagonism of TPalpha (short) isoform expressed in COS7 cells.
Guide to Pharmacology 416 17 1 3 6.8 CCCCC/C=C\CC(C(C1CC1)[C@H](/C=C\C/C=C\CCCC(=O)OC)O)C1CC1 14560042
10341876 9787 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonism of TPbeta (long) isoform expressed in COS7 cells.Antagonism of TPbeta (long) isoform expressed in COS7 cells.
Guide to Pharmacology 416 17 1 3 6.8 CCCCC/C=C\CC(C(C1CC1)[C@H](/C=C\C/C=C\CCCC(=O)OC)O)C1CC1 14560042
9755 9787 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonism of TPbeta (long) isoform expressed in COS7 cells.Antagonism of TPbeta (long) isoform expressed in COS7 cells.
Guide to Pharmacology 416 17 1 3 6.8 CCCCC/C=C\CC(C(C1CC1)[C@H](/C=C\C/C=C\CCCC(=O)OC)O)C1CC1 14560042
11537 9672 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonism of U46619-mediated [Ca<sup>2+</sup>]<sup>i</sup> mobilization in HEK293 cells expressing TP&aipha;Antagonism of U46619-mediated [Ca<sup>2+</sup>]<sup>i</sup> mobilization in HEK293 cells expressing TP&aipha;
Guide to Pharmacology 515 7 2 6 5.4 N#Cc1ccc(c(c1)S(=O)(=O)NC(=O)NC(C)(C)C)Oc1cccc(c1)c1ccc(cc1)OC(F)F None
124147085 9672 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonism of U46619-mediated [Ca<sup>2+</sup>]<sup>i</sup> mobilization in HEK293 cells expressing TP&aipha;Antagonism of U46619-mediated [Ca<sup>2+</sup>]<sup>i</sup> mobilization in HEK293 cells expressing TP&aipha;
Guide to Pharmacology 515 7 2 6 5.4 N#Cc1ccc(c(c1)S(=O)(=O)NC(=O)NC(C)(C)C)Oc1cccc(c1)c1ccc(cc1)OC(F)F None
11537 9672 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonism of U46619-mediated [Ca<sup>2+</sup>]<sup>i</sup> mobilization in HEK293 cells expressing TP&beta;Antagonism of U46619-mediated [Ca<sup>2+</sup>]<sup>i</sup> mobilization in HEK293 cells expressing TP&beta;
Guide to Pharmacology 515 7 2 6 5.4 N#Cc1ccc(c(c1)S(=O)(=O)NC(=O)NC(C)(C)C)Oc1cccc(c1)c1ccc(cc1)OC(F)F None
124147085 9672 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonism of U46619-mediated [Ca<sup>2+</sup>]<sup>i</sup> mobilization in HEK293 cells expressing TP&beta;Antagonism of U46619-mediated [Ca<sup>2+</sup>]<sup>i</sup> mobilization in HEK293 cells expressing TP&beta;
Guide to Pharmacology 515 7 2 6 5.4 N#Cc1ccc(c(c1)S(=O)(=O)NC(=O)NC(C)(C)C)Oc1cccc(c1)c1ccc(cc1)OC(F)F None
6073 10557 49 None - 1 Human 6.5 pIC50 = 6.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 407 6 2 3 3.5 OC(=O)CCc1c(C)ccc2c1CC[C@H](C2)NS(=O)(=O)c1ccc(cc1)Cl 9871769
9938840 10557 49 None - 1 Human 6.5 pIC50 = 6.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 407 6 2 3 3.5 OC(=O)CCc1c(C)ccc2c1CC[C@H](C2)NS(=O)(=O)c1ccc(cc1)Cl 9871769
CHEMBL2107786 10557 49 None - 1 Human 6.5 pIC50 = 6.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 407 6 2 3 3.5 OC(=O)CCc1c(C)ccc2c1CC[C@H](C2)NS(=O)(=O)c1ccc(cc1)Cl 9871769
1939 10460 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 366 12 2 3 5.2 CCCCC[C@H](/C=C/[C@H]1C[C@H]2C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)S2)O 8242228
5311453 10460 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 366 12 2 3 5.2 CCCCC[C@H](/C=C/[C@H]1C[C@H]2C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)S2)O 8242228
23654676 8758 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 402 7 2 4 5.3 OC(=O)CC/C=C/C[C@@H]1CO[C@@H](O[C@@H]1c1ccccc1O)c1ccccc1Cl 8859002
6072 8758 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 402 7 2 4 5.3 OC(=O)CC/C=C/C[C@@H]1CO[C@@H](O[C@@H]1c1ccccc1O)c1ccccc1Cl 8859002




Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Affinity)
# tested GPCRs
(Affinity)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
31508 103993 38 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 278 2 0 3 4.0 Cc1ccc2c(-c3ccccc3)nc(=O)n(C(C)C)c2c1 10.1038/s41467-023-40064-9
CHEMBL268501 103993 38 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 278 2 0 3 4.0 Cc1ccc2c(-c3ccccc3)nc(=O)n(C(C)C)c2c1 10.1038/s41467-023-40064-9
91610 148131 96 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 527 7 2 6 3.5 COc1ccc2c(c1)C(=O)N(CCc1ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc1)C(=O)C2(C)C 10.1038/s41467-023-40064-9
CHEMBL383634 148131 96 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 527 7 2 6 3.5 COc1ccc2c(c1)C(=O)N(CCc1ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc1)C(=O)C2(C)C 10.1038/s41467-023-40064-9
5029 22317 92 None - 4 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 359 8 1 5 3.0 COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C 10.1038/s41467-023-40064-9
CHEMBL1219 22317 92 None - 4 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 359 8 1 5 3.0 COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C 10.1038/s41467-023-40064-9
135564886 21265 5 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
135673376 21265 5 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
137157436 21265 5 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
145948239 21265 5 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
71587099 21265 5 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
CHEMBL1201304 21265 5 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
2179 174297 76 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 393 5 2 5 4.5 COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12 10.1038/s41467-023-40064-9
CHEMBL1256655 174297 76 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 393 5 2 5 4.5 COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12 10.1038/s41467-023-40064-9
CHEMBL43 174297 76 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 393 5 2 5 4.5 COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12 10.1038/s41467-023-40064-9
53232 195404 95 None - 2 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 404 6 1 5 4.2 CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21 10.1038/s41467-023-40064-9
CHEMBL503 195404 95 None - 2 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 404 6 1 5 4.2 CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21 10.1038/s41467-023-40064-9
5282219 42643 63 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 450 12 1 5 5.7 CC(C)=CCOc1ccc(/C=C/C(=O)c2ccc(OCC=C(C)C)cc2OCC(=O)O)cc1 10.1038/s41467-023-40064-9
CHEMBL1441961 42643 63 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 450 12 1 5 5.7 CC(C)=CCOc1ccc(/C=C/C(=O)c2ccc(OCC=C(C)C)cc2OCC(=O)O)cc1 10.1038/s41467-023-40064-9
4614 12163 103 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 293 5 1 3 4.0 O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1 10.1038/s41467-023-40064-9
CHEMBL1071 12163 103 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 293 5 1 3 4.0 O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1 10.1038/s41467-023-40064-9
10531 8202 21 None - 24 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
121 8202 21 None - 24 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
888 8202 21 None - 24 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
CHEMBL1732 8202 21 None - 24 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
DB00320 8202 21 None - 24 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
5353627 91316 8 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 411 8 3 4 4.6 CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL2220442 91316 8 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 411 8 3 4 4.6 CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21 10.1038/s41467-023-40064-9
11980903 21264 19 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 382 4 0 2 5.3 Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1 10.1038/s41467-023-40064-9
22526 21264 19 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 382 4 0 2 5.3 Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1 10.1038/s41467-023-40064-9
5281035 21264 19 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 382 4 0 2 5.3 Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1201303 21264 19 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 382 4 0 2 5.3 Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1 10.1038/s41467-023-40064-9
5991 210698 72 None - 5 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 296 0 2 2 3.6 C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
CHEMBL691 210698 72 None - 5 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 296 0 2 2 3.6 C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
445643 104164 69 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 803 7 3 12 4.6 C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC 10.1038/s41467-023-40064-9
CHEMBL269732 104164 69 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 803 7 3 12 4.6 C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC 10.1038/s41467-023-40064-9
2812 11551 101 None - 34 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 10.1038/s41467-023-40064-9
CHEMBL104 11551 101 None - 34 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 10.1038/s41467-023-40064-9
54454 12030 88 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 418 6 1 5 4.6 CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21 10.1038/s41467-023-40064-9
CHEMBL1064 12030 88 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 418 6 1 5 4.6 CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21 10.1038/s41467-023-40064-9
236702 52504 63 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 434 3 2 6 2.5 CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C 10.1038/s41467-023-40064-9
CHEMBL1530428 52504 63 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 434 3 2 6 2.5 CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C 10.1038/s41467-023-40064-9
2194 69857 101 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 240 2 0 4 4.2 COc1ccc(-c2cc(=S)ss2)cc1 10.1038/s41467-023-40064-9
CHEMBL178862 69857 101 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 240 2 0 4 4.2 COc1ccc(-c2cc(=S)ss2)cc1 10.1038/s41467-023-40064-9
2880 104784 49 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 310 5 0 3 4.6 C=C(c1ccccc1OCc1cccc(Cl)c1)n1ccnc1 10.1038/s41467-023-40064-9
CHEMBL27289 104784 49 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 310 5 0 3 4.6 C=C(c1ccccc1OCc1cccc(Cl)c1)n1ccnc1 10.1038/s41467-023-40064-9
216239 30567 118 None - 7 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 464 5 3 4 5.6 CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1 10.1038/s41467-023-40064-9
CHEMBL1200485 30567 118 None - 7 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 464 5 3 4 5.6 CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1 10.1038/s41467-023-40064-9
CHEMBL1336 30567 118 None - 7 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 464 5 3 4 5.6 CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1 10.1038/s41467-023-40064-9
2540 11173 111 None - 4 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 610 10 1 11 6.3 CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1 10.1038/s41467-023-40064-9
CHEMBL1014 11173 111 None - 4 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 610 10 1 11 6.3 CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1 10.1038/s41467-023-40064-9
135398735 143746 32 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
136262914 143746 32 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
CHEMBL374478 143746 32 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
2583 10548 118 None - 1 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
592 10548 118 None - 1 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
65999 10548 118 None - 1 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
CHEMBL1017 10548 118 None - 1 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
DB00966 10548 118 None - 1 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
1605 9121 117 None - 4 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 382 1 0 3 4.9 CCOC(=O)N1CCC(=C2c3ccc(cc3CCc3c2nccc3)Cl)CC1 10.1038/s41467-023-40064-9
3957 9121 117 None - 4 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 382 1 0 3 4.9 CCOC(=O)N1CCC(=C2c3ccc(cc3CCc3c2nccc3)Cl)CC1 10.1038/s41467-023-40064-9
7216 9121 117 None - 4 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 382 1 0 3 4.9 CCOC(=O)N1CCC(=C2c3ccc(cc3CCc3c2nccc3)Cl)CC1 10.1038/s41467-023-40064-9
CHEMBL998 9121 117 None - 4 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 382 1 0 3 4.9 CCOC(=O)N1CCC(=C2c3ccc(cc3CCc3c2nccc3)Cl)CC1 10.1038/s41467-023-40064-9
DB00455 9121 117 None - 4 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 382 1 0 3 4.9 CCOC(=O)N1CCC(=C2c3ccc(cc3CCc3c2nccc3)Cl)CC1 10.1038/s41467-023-40064-9
392622 63086 95 None - 4 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 720 17 4 9 5.9 CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1 10.1038/s41467-023-40064-9
CHEMBL163 63086 95 None - 4 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 720 17 4 9 5.9 CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1 10.1038/s41467-023-40064-9
104850 10103 96 None - 6 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
4150 10103 96 None - 6 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
743 10103 96 None - 6 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
CHEMBL111 10103 96 None - 6 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
DB06155 10103 96 None - 6 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
6436173 61890 45 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 785 2 5 13 6.2 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
CHEMBL1617 61890 45 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 785 2 5 13 6.2 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
448537 167029 89 None - 25 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL411 167029 89 None - 25 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 10.1038/s41467-023-40064-9
3784 63946 101 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 371 4 1 8 2.6 COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc2nonc12 10.1038/s41467-023-40064-9
CHEMBL1648 63946 101 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 371 4 1 8 2.6 COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc2nonc12 10.1038/s41467-023-40064-9
41781 16751 104 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 348 5 3 5 2.5 Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1 10.1038/s41467-023-40064-9
51371498 16751 104 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 348 5 3 5 2.5 Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1 10.1038/s41467-023-40064-9
CHEMBL1148 16751 104 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 348 5 3 5 2.5 Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1 10.1038/s41467-023-40064-9
5282138 179902 95 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 492 10 1 8 4.3 COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
CHEMBL452076 179902 95 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 492 10 1 8 4.3 COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
5564 212785 118 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 288 2 1 2 5.1 Oc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl 10.1038/s41467-023-40064-9
CHEMBL849 212785 118 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 288 2 1 2 5.1 Oc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl 10.1038/s41467-023-40064-9
8730 202670 72 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 777 5 3 4 4.6 N[C@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O 10.1038/s41467-023-40064-9
90657408 202670 72 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 777 5 3 4 4.6 N[C@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O 10.1038/s41467-023-40064-9
CHEMBL559 202670 72 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 777 5 3 4 4.6 N[C@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O 10.1038/s41467-023-40064-9
16220172 79818 95 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 392 2 3 3 5.1 CC(C)(C)c1cc(C(C)(C)C)c(NC(=O)c2c[nH]c3ccccc3c2=O)cc1O 10.1038/s41467-023-40064-9
CHEMBL2010601 79818 95 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 392 2 3 3 5.1 CC(C)(C)c1cc(C(C)(C)C)c(NC(=O)c2c[nH]c3ccccc3c2=O)cc1O 10.1038/s41467-023-40064-9
240 7731 43 None - 25 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
2769 7731 43 None - 25 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
44279790 7731 43 None - 25 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
660 7731 43 None - 25 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
CHEMBL1729 7731 43 None - 25 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
CHEMBL560739 7731 43 None - 25 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
DB00604 7731 43 None - 25 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
72081 216055 55 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL None None None NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1038/s41467-023-40064-9
CHEMBL2135460 216055 55 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL None None None NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1038/s41467-023-40064-9
DB02638 216055 55 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL None None None NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1038/s41467-023-40064-9
1890 9535 49 None - 16 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
4449 9535 49 None - 16 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
7247 9535 49 None - 16 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
CHEMBL623 9535 49 None - 16 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
DB01149 9535 49 None - 16 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
5077 10351 79 None - 4 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 496 12 1 7 3.9 O=C(NS(=O)(=O)C)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C 10.1038/s41467-023-40064-9
7552 10351 79 None - 4 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 496 12 1 7 3.9 O=C(NS(=O)(=O)C)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C 10.1038/s41467-023-40064-9
9913767 10351 79 None - 4 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 496 12 1 7 3.9 O=C(NS(=O)(=O)C)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C 10.1038/s41467-023-40064-9
CHEMBL238804 10351 79 None - 4 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 496 12 1 7 3.9 O=C(NS(=O)(=O)C)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C 10.1038/s41467-023-40064-9
DB11362 10351 79 None - 4 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 496 12 1 7 3.9 O=C(NS(=O)(=O)C)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C 10.1038/s41467-023-40064-9
134 9292 24 None - 67 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO 10.1038/s41467-023-40064-9
1775 9292 24 None - 67 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO 10.1038/s41467-023-40064-9
9681 9292 24 None - 67 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO 10.1038/s41467-023-40064-9
CHEMBL1065 9292 24 None - 67 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO 10.1038/s41467-023-40064-9
DB00247 9292 24 None - 67 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO 10.1038/s41467-023-40064-9
15951529 13200 121 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 464 3 1 4 4.0 CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F 10.1038/s41467-023-40064-9
CHEMBL1082407 13200 121 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 464 3 1 4 4.0 CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F 10.1038/s41467-023-40064-9
30323 69259 57 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 527 4 5 11 1.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
CHEMBL1563 69259 57 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 527 4 5 11 1.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
CHEMBL178 69259 57 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 527 4 5 11 1.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
71771 214132 92 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 353 6 2 4 3.9 O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
CHEMBL93645 214132 92 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 353 6 2 4 3.9 O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
2449 211009 94 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 354 8 1 3 4.6 CC1=C(C)C(=O)C(C(CCCCCC(=O)O)c2ccccc2)=C(C)C1=O 10.1038/s41467-023-40064-9
CHEMBL70972 211009 94 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 354 8 1 3 4.6 CC1=C(C)C(=O)C(C(CCCCCC(=O)O)c2ccccc2)=C(C)C1=O 10.1038/s41467-023-40064-9
DB06739 211009 94 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 354 8 1 3 4.6 CC1=C(C)C(=O)C(C(CCCCCC(=O)O)c2ccccc2)=C(C)C1=O 10.1038/s41467-023-40064-9
1549120 203265 85 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 319 4 1 4 2.9 CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL56337 203265 85 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 319 4 1 4 2.9 CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1 10.1038/s41467-023-40064-9
4495 203314 92 None - 29 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 308 5 1 5 2.8 CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL56367 203314 92 None - 29 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 308 5 1 5 2.8 CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1 10.1038/s41467-023-40064-9
5852 9395 55 None - 4 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 419 11 1 5 4.9 OC(=O)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C 10.1038/s41467-023-40064-9
9931891 9395 55 None - 4 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 419 11 1 5 4.9 OC(=O)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C 10.1038/s41467-023-40064-9
CHEMBL239226 9395 55 None - 4 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 419 11 1 5 4.9 OC(=O)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C 10.1038/s41467-023-40064-9
5482 21192 80 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 386 6 0 4 5.9 Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1200438 21192 80 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 386 6 0 4 5.9 Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
53276 101809 53 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 304 5 3 5 3.0 CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N 10.1038/s41467-023-40064-9
CHEMBL255044 101809 53 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 304 5 3 5 3.0 CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N 10.1038/s41467-023-40064-9
71398 113216 44 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 302 5 4 4 3.6 C[C@@H](Cc1ccc(O)c(O)c1)[C@H](C)Cc1ccc(O)c(O)c1 10.1038/s41467-023-40064-9
CHEMBL313972 113216 44 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 302 5 4 4 3.6 C[C@@H](Cc1ccc(O)c(O)c1)[C@H](C)Cc1ccc(O)c(O)c1 10.1038/s41467-023-40064-9
2333 149113 97 None - 2 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 422 3 1 3 5.5 CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1 10.1038/s41467-023-40064-9
CHEMBL388590 149113 97 None - 2 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 422 3 1 3 5.5 CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1 10.1038/s41467-023-40064-9
135398745 9688 112 None -512 65 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
47 9688 112 None -512 65 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
CHEMBL715 9688 112 None -512 65 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
DB00334 9688 112 None -512 65 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
3760 57074 37 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 414 6 0 3 6.5 Clc1ccc(C(Cn2ccnc2)OCc2c(Cl)cccc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1571863 57074 37 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 414 6 0 3 6.5 Clc1ccc(C(Cn2ccnc2)OCc2c(Cl)cccc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
3401 85058 80 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 346 4 0 2 5.0 Fc1ccc(C(c2ccccc2)(c2ccccc2F)n2ccnc2)cc1 10.1038/s41467-023-40064-9
CHEMBL2107430 85058 80 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 346 4 0 2 5.0 Fc1ccc(C(c2ccccc2)(c2ccccc2F)n2ccnc2)cc1 10.1038/s41467-023-40064-9
123879 10060 82 None 3 4 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1038/s41467-023-40064-9
1910 10060 82 None 3 4 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1038/s41467-023-40064-9
1911 10060 82 None 3 4 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1038/s41467-023-40064-9
2354 10060 82 None 3 4 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1038/s41467-023-40064-9
CHEMBL361812 10060 82 None 3 4 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1038/s41467-023-40064-9
DB13036 10060 82 None 3 4 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1038/s41467-023-40064-9
3686 101442 108 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 338 12 1 5 3.5 COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O 10.1038/s41467-023-40064-9
CHEMBL252556 101442 108 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 338 12 1 5 3.5 COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O 10.1038/s41467-023-40064-9
2132 52998 91 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 376 3 3 3 3.2 Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1 10.1038/s41467-023-40064-9
CHEMBL1514634 52998 91 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 376 3 3 3 3.2 Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1 10.1038/s41467-023-40064-9
CHEMBL153479 52998 91 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 376 3 3 3 3.2 Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1 10.1038/s41467-023-40064-9
5472 212597 75 None - 3 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 10.1038/s41467-023-40064-9
CHEMBL1717 212597 75 None - 3 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 10.1038/s41467-023-40064-9
CHEMBL833 212597 75 None - 3 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 10.1038/s41467-023-40064-9
DB00208 212597 75 None - 3 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 10.1038/s41467-023-40064-9
3883 190314 112 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 369 5 1 4 3.5 Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1 10.1038/s41467-023-40064-9
CHEMBL480 190314 112 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 369 5 1 4 3.5 Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1 10.1038/s41467-023-40064-9
4494 196966 87 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 385 5 1 8 2.5 COC(=O)C1=C(C#N)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
CHEMBL517427 196966 87 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 385 5 1 8 2.5 COC(=O)C1=C(C#N)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
1883 9856 75 None -380 24 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O 10.1038/s41467-023-40064-9
1916 9856 75 None -380 24 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O 10.1038/s41467-023-40064-9
5280360 9856 75 None -380 24 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O 10.1038/s41467-023-40064-9
913 9856 75 None -380 24 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O 10.1038/s41467-023-40064-9
CHEMBL548 9856 75 None -380 24 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O 10.1038/s41467-023-40064-9
DB00917 9856 75 None -380 24 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O 10.1038/s41467-023-40064-9
3356 9060 73 None -38 8 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1038/s41467-023-40064-9
4326 9060 73 None -38 8 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1038/s41467-023-40064-9
9867642 9060 73 None -38 8 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1038/s41467-023-40064-9
CHEMBL426559 9060 73 None -38 8 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1038/s41467-023-40064-9
DB11629 9060 73 None -38 8 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1038/s41467-023-40064-9
41684 37995 105 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 307 4 1 7 2.2 CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1 10.1038/s41467-023-40064-9
CHEMBL1401 37995 105 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 307 4 1 7 2.2 CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1 10.1038/s41467-023-40064-9
28230148 212510 97 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 320 3 2 6 0.7 CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21 10.1038/s41467-023-40064-9
3229 212510 97 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 320 3 2 6 0.7 CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21 10.1038/s41467-023-40064-9
CHEMBL826 212510 97 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 320 3 2 6 0.7 CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21 10.1038/s41467-023-40064-9
135409453 10545 41 None - 2 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
226 10545 41 None - 2 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
CHEMBL76370 10545 41 None - 2 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
24821094 73868 93 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 440 5 1 7 4.2 C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1 10.1038/s41467-023-40064-9
CHEMBL1873475 73868 93 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 440 5 1 7 4.2 C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1 10.1038/s41467-023-40064-9
3333 46942 111 None - 1 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 383 4 1 5 4.0 CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl 10.1038/s41467-023-40064-9
CHEMBL1480 46942 111 None - 1 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 383 4 1 5 4.0 CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl 10.1038/s41467-023-40064-9
6450551 25983 106 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 386 5 2 4 4.6 CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1 10.1038/s41467-023-40064-9
CHEMBL1289926 25983 106 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 386 5 2 4 4.6 CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1 10.1038/s41467-023-40064-9
5329102 201505 86 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 398 7 3 3 3.3 CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C 10.1038/s41467-023-40064-9
CHEMBL535 201505 86 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 398 7 3 3 3.3 CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C 10.1038/s41467-023-40064-9
44306573 169936 0 None - 0 Rat 9.6 pEC50 = 9.6 Binding
Activity against thromboxane A2 receptor evaluated by contraction of isolated rat thoracic aortaActivity against thromboxane A2 receptor evaluated by contraction of isolated rat thoracic aorta
ChEMBL 380 12 2 5 4.2 CCCCCC(O)/C=C/[C@H]1[C@H]2C[C@H](OC(=O)O2)[C@@H]1C/C=C\CCCC(=O)O 10.1016/S0960-894X(01)80110-4
CHEMBL417967 169936 0 None - 0 Rat 9.6 pEC50 = 9.6 Binding
Activity against thromboxane A2 receptor evaluated by contraction of isolated rat thoracic aortaActivity against thromboxane A2 receptor evaluated by contraction of isolated rat thoracic aorta
ChEMBL 380 12 2 5 4.2 CCCCCC(O)/C=C/[C@H]1[C@H]2C[C@H](OC(=O)O2)[C@@H]1C/C=C\CCCC(=O)O 10.1016/S0960-894X(01)80110-4
15289204 209869 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Activity against thromboxane A2 receptor evaluated by contraction of isolated rat thoracic aortaActivity against thromboxane A2 receptor evaluated by contraction of isolated rat thoracic aorta
ChEMBL 366 12 2 5 4.1 CCCCCC(O)/C=C/[C@H]1[C@H]2C[C@H](OC(=O)O2)[C@@H]1C/C=C\CCCCO 10.1016/S0960-894X(01)80110-4
CHEMBL63892 209869 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Activity against thromboxane A2 receptor evaluated by contraction of isolated rat thoracic aortaActivity against thromboxane A2 receptor evaluated by contraction of isolated rat thoracic aorta
ChEMBL 366 12 2 5 4.1 CCCCCC(O)/C=C/[C@H]1[C@H]2C[C@H](OC(=O)O2)[C@@H]1C/C=C\CCCCO 10.1016/S0960-894X(01)80110-4
44306573 169936 0 None - 0 Human 7.6 pEC50 = 7.6 Binding
Activity against thromboxane A2 receptor evaluated by aggregation of human plateletsActivity against thromboxane A2 receptor evaluated by aggregation of human platelets
ChEMBL 380 12 2 5 4.2 CCCCCC(O)/C=C/[C@H]1[C@H]2C[C@H](OC(=O)O2)[C@@H]1C/C=C\CCCC(=O)O 10.1016/S0960-894X(01)80110-4
CHEMBL417967 169936 0 None - 0 Human 7.6 pEC50 = 7.6 Binding
Activity against thromboxane A2 receptor evaluated by aggregation of human plateletsActivity against thromboxane A2 receptor evaluated by aggregation of human platelets
ChEMBL 380 12 2 5 4.2 CCCCCC(O)/C=C/[C@H]1[C@H]2C[C@H](OC(=O)O2)[C@@H]1C/C=C\CCCC(=O)O 10.1016/S0960-894X(01)80110-4
44306604 176093 0 None - 0 Human 5.5 pEC50 = 5.5 Binding
Activity against thromboxane A2 receptor evaluated by aggregation of human plateletsActivity against thromboxane A2 receptor evaluated by aggregation of human platelets
ChEMBL 379 12 2 5 3.6 CCCCCC(O)/C=C/[C@H]1[C@H]2C[C@H](OC(=O)O2)[C@@H]1C/C=C\CCCC(N)=O 10.1016/S0960-894X(01)80110-4
CHEMBL441620 176093 0 None - 0 Human 5.5 pEC50 = 5.5 Binding
Activity against thromboxane A2 receptor evaluated by aggregation of human plateletsActivity against thromboxane A2 receptor evaluated by aggregation of human platelets
ChEMBL 379 12 2 5 3.6 CCCCCC(O)/C=C/[C@H]1[C@H]2C[C@H](OC(=O)O2)[C@@H]1C/C=C\CCCC(N)=O 10.1016/S0960-894X(01)80110-4
44306912 109132 0 None - 0 Rat 6.5 pEC50 = 6.5 Binding
Activity against thromboxane A2 receptor evaluated by contraction of isolated rat thoracic aortaActivity against thromboxane A2 receptor evaluated by contraction of isolated rat thoracic aorta
ChEMBL 421 13 2 5 4.7 CCCCCC(O)/C=C/[C@H]1[C@H]2C[C@H](OC(=O)O2)[C@@H]1C/C=C\CCCC(=O)NC(C)C 10.1016/S0960-894X(01)80110-4
CHEMBL303777 109132 0 None - 0 Rat 6.5 pEC50 = 6.5 Binding
Activity against thromboxane A2 receptor evaluated by contraction of isolated rat thoracic aortaActivity against thromboxane A2 receptor evaluated by contraction of isolated rat thoracic aorta
ChEMBL 421 13 2 5 4.7 CCCCCC(O)/C=C/[C@H]1[C@H]2C[C@H](OC(=O)O2)[C@@H]1C/C=C\CCCC(=O)NC(C)C 10.1016/S0960-894X(01)80110-4
44306604 176093 0 None - 0 Rat 7.2 pEC50 = 7.2 Binding
Activity against thromboxane A2 receptor evaluated by contraction of isolated rat thoracic aortaActivity against thromboxane A2 receptor evaluated by contraction of isolated rat thoracic aorta
ChEMBL 379 12 2 5 3.6 CCCCCC(O)/C=C/[C@H]1[C@H]2C[C@H](OC(=O)O2)[C@@H]1C/C=C\CCCC(N)=O 10.1016/S0960-894X(01)80110-4
CHEMBL441620 176093 0 None - 0 Rat 7.2 pEC50 = 7.2 Binding
Activity against thromboxane A2 receptor evaluated by contraction of isolated rat thoracic aortaActivity against thromboxane A2 receptor evaluated by contraction of isolated rat thoracic aorta
ChEMBL 379 12 2 5 3.6 CCCCCC(O)/C=C/[C@H]1[C@H]2C[C@H](OC(=O)O2)[C@@H]1C/C=C\CCCC(N)=O 10.1016/S0960-894X(01)80110-4
10717385 175291 0 None - 0 Human 9.9 pIC50 = 9.9 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 427 9 2 3 4.7 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)[C@H]2CC[C@@H]1C2 10.1021/jm970343g
CHEMBL435382 175291 0 None - 0 Human 9.9 pIC50 = 9.9 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 427 9 2 3 4.7 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)[C@H]2CC[C@@H]1C2 10.1021/jm970343g
11647396 84557 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 418 5 2 6 3.5 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)N2CCCCC2)cc1 10.1021/jm060108a
CHEMBL209168 84557 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 418 5 2 6 3.5 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)N2CCCCC2)cc1 10.1021/jm060108a
11661725 84634 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 420 5 3 6 3.7 Cc1cccc(C)c1Nc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm060108a
CHEMBL209306 84634 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 420 5 3 6 3.7 Cc1cccc(C)c1Nc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm060108a
11656254 84552 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 498 9 3 6 4.6 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(Br)c(C)c1 10.1021/jm060108a
CHEMBL209134 84552 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 498 9 3 6 4.6 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(Br)c(C)c1 10.1021/jm060108a
11502680 105016 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
CHEMBL274415 105016 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
11647396 84557 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 418 5 2 6 3.5 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)N2CCCCC2)cc1 10.1021/jm060108a
CHEMBL209168 84557 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 418 5 2 6 3.5 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)N2CCCCC2)cc1 10.1021/jm060108a
11531590 84668 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 407 8 2 6 3.5 CCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
CHEMBL209406 84668 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 407 8 2 6 3.5 CCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
11662021 146331 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 434 9 3 6 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1cc(C)cc(C)c1 10.1021/jm060108a
CHEMBL379659 146331 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 434 9 3 6 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1cc(C)cc(C)c1 10.1021/jm060108a
11604299 146360 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 426 10 3 6 3.9 CCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1021/jm060108a
CHEMBL379736 146360 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 426 10 3 6 3.9 CCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1021/jm060108a
11704760 84386 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 435 10 2 6 4.3 CCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
CHEMBL208818 84386 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 435 10 2 6 4.3 CCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
11531590 84668 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 407 8 2 6 3.5 CCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
CHEMBL209406 84668 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 407 8 2 6 3.5 CCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
11633215 146933 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 423 5 2 6 3.8 Cc1ccc(Sc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
CHEMBL380274 146933 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 423 5 2 6 3.8 Cc1ccc(Sc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
5312142 85008 11 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
CHEMBL210602 85008 11 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
11661725 84634 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 420 5 3 6 3.7 Cc1cccc(C)c1Nc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm060108a
CHEMBL209306 84634 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 420 5 3 6 3.7 Cc1cccc(C)c1Nc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm060108a
11683470 84138 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 433 6 2 6 4.0 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC2CCCCC2)cc1 10.1021/jm060108a
CHEMBL208543 84138 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 433 6 2 6 4.0 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC2CCCCC2)cc1 10.1021/jm060108a
11510008 84057 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1cccc(C)c1 10.1021/jm060108a
CHEMBL208115 84057 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1cccc(C)c1 10.1021/jm060108a
5312142 85008 11 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
CHEMBL210602 85008 11 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
11604299 146360 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 426 10 3 6 3.9 CCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1021/jm060108a
CHEMBL379736 146360 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 426 10 3 6 3.9 CCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1021/jm060108a
11662021 146331 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 434 9 3 6 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1cc(C)cc(C)c1 10.1021/jm060108a
CHEMBL379659 146331 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 434 9 3 6 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1cc(C)cc(C)c1 10.1021/jm060108a
9866368 211414 33 None - 0 Human 9.0 pIC50 = 9.0 Binding
In vitro inhibitory concentration of compound against thromboxane A2 receptorIn vitro inhibitory concentration of compound against thromboxane A2 receptor
ChEMBL 412 9 3 6 3.5 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1016/s0960-894x(01)00114-7
CHEMBL7353 211414 33 None - 0 Human 9.0 pIC50 = 9.0 Binding
In vitro inhibitory concentration of compound against thromboxane A2 receptorIn vitro inhibitory concentration of compound against thromboxane A2 receptor
ChEMBL 412 9 3 6 3.5 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1016/s0960-894x(01)00114-7
11568384 84571 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 440 7 3 6 3.8 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NCc2ccccc2)cc1 10.1021/jm060108a
CHEMBL209245 84571 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 440 7 3 6 3.8 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NCc2ccccc2)cc1 10.1021/jm060108a
11567679 84523 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 407 5 2 6 3.5 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
CHEMBL209035 84523 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 407 5 2 6 3.5 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
11568248 145433 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 434 9 3 6 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1c(C)cccc1C 10.1021/jm060108a
CHEMBL377679 145433 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 434 9 3 6 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1c(C)cccc1C 10.1021/jm060108a
11683470 84138 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 433 6 2 6 4.0 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC2CCCCC2)cc1 10.1021/jm060108a
CHEMBL208543 84138 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 433 6 2 6 4.0 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC2CCCCC2)cc1 10.1021/jm060108a
11568248 145433 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 434 9 3 6 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1c(C)cccc1C 10.1021/jm060108a
CHEMBL377679 145433 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 434 9 3 6 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1c(C)cccc1C 10.1021/jm060108a
11704760 84386 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 435 10 2 6 4.3 CCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
CHEMBL208818 84386 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 435 10 2 6 4.3 CCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
11633215 146933 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 423 5 2 6 3.8 Cc1ccc(Sc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
CHEMBL380274 146933 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 423 5 2 6 3.8 Cc1ccc(Sc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
11567679 84523 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 407 5 2 6 3.5 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
CHEMBL209035 84523 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 407 5 2 6 3.5 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
11656254 84552 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 498 9 3 6 4.6 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(Br)c(C)c1 10.1021/jm060108a
CHEMBL209134 84552 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 498 9 3 6 4.6 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(Br)c(C)c1 10.1021/jm060108a
11568384 84571 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 440 7 3 6 3.8 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NCc2ccccc2)cc1 10.1021/jm060108a
CHEMBL209245 84571 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 440 7 3 6 3.8 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NCc2ccccc2)cc1 10.1021/jm060108a
44350662 24783 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 518 9 2 4 5.5 O=C(O)c1cccc(/C=C(\c2ccc(CCNS(=O)(=O)c3ccc(Cl)cc3)cc2)c2cccnc2)c1 10.1021/jm00027a004
CHEMBL126334 24783 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 518 9 2 4 5.5 O=C(O)c1cccc(/C=C(\c2ccc(CCNS(=O)(=O)c3ccc(Cl)cc3)cc2)c2cccnc2)c1 10.1021/jm00027a004
10386455 118051 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 403 11 1 5 4.5 O=C(O)/C=C/CCCO/N=C(\c1ccccc1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
CHEMBL326521 118051 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 403 11 1 5 4.5 O=C(O)/C=C/CCCO/N=C(\c1ccccc1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
10669025 211835 1 None - 0 Human 8.0 pIC50 = 8.0 Binding
In vitro inhibitory concentration of compound against thromboxane A2 receptorIn vitro inhibitory concentration of compound against thromboxane A2 receptor
ChEMBL 405 7 3 4 4.4 CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=C/CCCC(=O)O)c2cccnc2)c1 10.1016/s0960-894x(01)00114-7
CHEMBL7718 211835 1 None - 0 Human 8.0 pIC50 = 8.0 Binding
In vitro inhibitory concentration of compound against thromboxane A2 receptorIn vitro inhibitory concentration of compound against thromboxane A2 receptor
ChEMBL 405 7 3 4 4.4 CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=C/CCCC(=O)O)c2cccnc2)c1 10.1016/s0960-894x(01)00114-7
54592351 84034 5 None - 0 Human 8.0 pIC50 = 8.0 Binding
Binding affinity towards Thromboxane A2/ Prostaglandin H2 receptor in human platelet membranes using [125I]- as the radioligand.Binding affinity towards Thromboxane A2/ Prostaglandin H2 receptor in human platelet membranes using [125I]- as the radioligand.
ChEMBL 371 4 1 2 5.4 O=C(O)C[C@@H]1CCCc2c1n(Cc1ccc(Cl)cc1)c1ccc(F)cc21 10.1021/jm00108a042
CHEMBL2079673 84034 5 None - 0 Human 8.0 pIC50 = 8.0 Binding
Binding affinity towards Thromboxane A2/ Prostaglandin H2 receptor in human platelet membranes using [125I]- as the radioligand.Binding affinity towards Thromboxane A2/ Prostaglandin H2 receptor in human platelet membranes using [125I]- as the radioligand.
ChEMBL 371 4 1 2 5.4 O=C(O)C[C@@H]1CCCc2c1n(Cc1ccc(Cl)cc1)c1ccc(F)cc21 10.1021/jm00108a042
9983481 25727 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 500 11 2 4 4.2 O=C(O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1ccc[n+]([O-])c1 10.1021/jm00027a004
CHEMBL128678 25727 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 500 11 2 4 4.2 O=C(O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1ccc[n+]([O-])c1 10.1021/jm00027a004
10002804 168723 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 430 13 2 4 4.0 CCCCS(=O)(=O)NCCc1ccc(/C(=C\CCCC(=O)O)c2cccnc2)cc1 10.1021/jm00027a004
CHEMBL415519 168723 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 430 13 2 4 4.0 CCCCS(=O)(=O)NCCc1ccc(/C(=C\CCCC(=O)O)c2cccnc2)cc1 10.1021/jm00027a004
10623568 212107 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 453 10 2 3 5.2 O=C(O)CCC/C=C\C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc(-c2ccccc2)cc1 10.1021/jm970343g
CHEMBL79511 212107 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 453 10 2 3 5.2 O=C(O)CCC/C=C\C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc(-c2ccccc2)cc1 10.1021/jm970343g
44159772 75167 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranesDisplacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranes
ChEMBL 535 9 1 4 6.8 CCN(Cc1cc(C(F)(F)F)ccc1-c1cc(CC(=O)O)ccc1OC)C(=O)OCc1ccc(Cl)cc1 10.1016/j.bmcl.2011.01.024
CHEMBL1916708 75167 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranesDisplacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranes
ChEMBL 535 9 1 4 6.8 CCN(Cc1cc(C(F)(F)F)ccc1-c1cc(CC(=O)O)ccc1OC)C(=O)OCc1ccc(Cl)cc1 10.1016/j.bmcl.2011.01.024
9865257 22356 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 391 11 1 5 4.3 O=C(O)CCCCO/N=C(/c1ccccc1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
CHEMBL122123 22356 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 391 11 1 5 4.3 O=C(O)CCCCO/N=C(/c1ccccc1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
10458951 24751 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 508 11 2 6 4.2 O=S(=O)(NCCc1ccc(/C(=C\CCCc2nnn[nH]2)c2cccnc2)cc1)c1ccc(Cl)cc1 10.1021/jm00027a004
CHEMBL126185 24751 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 508 11 2 6 4.2 O=S(=O)(NCCc1ccc(/C(=C\CCCc2nnn[nH]2)c2cccnc2)cc1)c1ccc(Cl)cc1 10.1021/jm00027a004
10028328 25285 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 484 11 2 4 4.9 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm00027a004
CHEMBL127380 25285 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 484 11 2 4 4.9 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm00027a004
11753841 124850 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 456 9 2 4 4.2 O=C(O)C/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL340504 124850 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 456 9 2 4 4.2 O=C(O)C/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10460371 26179 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 556 14 2 5 5.1 O=C(O)CCC/C=C(\c1ccc(CCN(CCC(=O)O)S(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL129365 26179 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 556 14 2 5 5.1 O=C(O)CCC/C=C(\c1ccc(CCN(CCC(=O)O)S(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10340286 21283 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 389 10 1 5 4.1 O=C(O)/C=C/CCO/N=C(\c1ccccc1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
CHEMBL120165 21283 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 389 10 1 5 4.1 O=C(O)/C=C/CCO/N=C(\c1ccccc1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
10047870 24841 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 422 8 2 4 3.4 Cc1ccc(S(=O)(=O)NCCc2ccc(/C(=C\C(=O)O)c3cccnc3)cc2)cc1 10.1021/jm00027a004
CHEMBL126654 24841 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 422 8 2 4 3.4 Cc1ccc(S(=O)(=O)NCCc2ccc(/C(=C\C(=O)O)c3cccnc3)cc2)cc1 10.1021/jm00027a004
10320386 123669 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 428 11 2 3 4.7 O=C(O)CCC/C=C(\c1ccc(CCNC(=O)Cc2ccccc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL338334 123669 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 428 11 2 3 4.7 O=C(O)CCC/C=C(\c1ccc(CCNC(=O)Cc2ccccc2)cc1)c1cccnc1 10.1021/jm00027a004
10767455 112587 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 492 10 3 3 5.7 O=C(O)CCC/C=C\C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc2cc(-c3ccccc3)[nH]c2c1 10.1021/jm970343g
CHEMBL312697 112587 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 492 10 3 3 5.7 O=C(O)CCC/C=C\C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc2cc(-c3ccccc3)[nH]c2c1 10.1021/jm970343g
10448061 21756 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 309 13 1 5 3.5 CCCCCC/C(Cn1ccnc1)=N/OCCCCC(=O)O 10.1021/jm00047a016
CHEMBL120904 21756 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 309 13 1 5 3.5 CCCCCC/C(Cn1ccnc1)=N/OCCCCC(=O)O 10.1021/jm00047a016
10369102 24828 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 510 9 2 4 5.3 O=C(O)CCC/C=C(/c1cccnc1)c1ccc2c(c1)CCC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1021/jm00027a004
CHEMBL126577 24828 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 510 9 2 4 5.3 O=C(O)CCC/C=C(/c1cccnc1)c1ccc2c(c1)CCC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1021/jm00027a004
44350670 24782 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 518 9 2 4 5.5 O=C(O)c1ccc(/C=C(\c2ccc(CCNS(=O)(=O)c3ccc(Cl)cc3)cc2)c2cccnc2)cc1 10.1021/jm00027a004
CHEMBL126333 24782 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 518 9 2 4 5.5 O=C(O)c1ccc(/C=C(\c2ccc(CCNS(=O)(=O)c3ccc(Cl)cc3)cc2)c2cccnc2)cc1 10.1021/jm00027a004
18944131 93970 0 None - 1 Human 6.9 pIC50 = 6.9 Binding
In vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparationIn vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparation
ChEMBL 484 10 2 6 4.0 O=C(O)CCc1ccccc1CC1OCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
CHEMBL23273 93970 0 None - 1 Human 6.9 pIC50 = 6.9 Binding
In vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparationIn vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparation
ChEMBL 484 10 2 6 4.0 O=C(O)CCc1ccccc1CC1OCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
10251833 21972 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 425 12 0 6 5.4 CCOC(=O)CCCCO/N=C(\C1CCCCC1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
CHEMBL121043 21972 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 425 12 0 6 5.4 CCOC(=O)CCCCO/N=C(\C1CCCCC1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
10696132 174903 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 481 11 2 5 6.0 O=C(O)CCC/C=C\C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc(/N=N/c2ccccc2)cc1 10.1021/jm970343g
CHEMBL432935 174903 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 481 11 2 5 6.0 O=C(O)CCC/C=C\C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc(/N=N/c2ccccc2)cc1 10.1021/jm970343g
10648014 212078 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 469 11 2 4 5.4 O=C(O)CCC/C=C\C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc(Oc2ccccc2)cc1 10.1021/jm970343g
CHEMBL79260 212078 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 469 11 2 4 5.4 O=C(O)CCC/C=C\C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc(Oc2ccccc2)cc1 10.1021/jm970343g
44537923 145964 7 None - 0 Human 4.9 pIC50 = 4.9 Binding
Binding affinity to thromboxane A2 receptor (unknown origin)Binding affinity to thromboxane A2 receptor (unknown origin)
ChEMBL 457 6 2 8 1.4 O=C(NCc1cc(Cl)ccc1-n1cnnn1)[C@@H]1CC=NN1C(=O)[C@H](O)c1ccc(F)cc1 10.1039/C5MD00479A
CHEMBL3787587 145964 7 None - 0 Human 4.9 pIC50 = 4.9 Binding
Binding affinity to thromboxane A2 receptor (unknown origin)Binding affinity to thromboxane A2 receptor (unknown origin)
ChEMBL 457 6 2 8 1.4 O=C(NCc1cc(Cl)ccc1-n1cnnn1)[C@@H]1CC=NN1C(=O)[C@H](O)c1ccc(F)cc1 10.1039/C5MD00479A
123879 10060 82 None 3 4 Human 7.9 pIC50 = 7.9 Binding
Displacement of [3H]SQ-29548 from thromboxane receptor in human platelet membraneDisplacement of [3H]SQ-29548 from thromboxane receptor in human platelet membrane
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2009.06.085
1910 10060 82 None 3 4 Human 7.9 pIC50 = 7.9 Binding
Displacement of [3H]SQ-29548 from thromboxane receptor in human platelet membraneDisplacement of [3H]SQ-29548 from thromboxane receptor in human platelet membrane
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2009.06.085
1911 10060 82 None 3 4 Human 7.9 pIC50 = 7.9 Binding
Displacement of [3H]SQ-29548 from thromboxane receptor in human platelet membraneDisplacement of [3H]SQ-29548 from thromboxane receptor in human platelet membrane
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2009.06.085
2354 10060 82 None 3 4 Human 7.9 pIC50 = 7.9 Binding
Displacement of [3H]SQ-29548 from thromboxane receptor in human platelet membraneDisplacement of [3H]SQ-29548 from thromboxane receptor in human platelet membrane
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2009.06.085
CHEMBL361812 10060 82 None 3 4 Human 7.9 pIC50 = 7.9 Binding
Displacement of [3H]SQ-29548 from thromboxane receptor in human platelet membraneDisplacement of [3H]SQ-29548 from thromboxane receptor in human platelet membrane
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2009.06.085
DB13036 10060 82 None 3 4 Human 7.9 pIC50 = 7.9 Binding
Displacement of [3H]SQ-29548 from thromboxane receptor in human platelet membraneDisplacement of [3H]SQ-29548 from thromboxane receptor in human platelet membrane
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2009.06.085
10341794 21299 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 415 11 1 5 5.0 O=C(O)CCCCO/N=C(/C1CCCCC1)C(Cc1cccc(F)c1)n1ccnc1 10.1021/jm00047a016
CHEMBL120207 21299 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 415 11 1 5 5.0 O=C(O)CCCCO/N=C(/C1CCCCC1)C(Cc1cccc(F)c1)n1ccnc1 10.1021/jm00047a016
15616468 211049 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Compound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membraneCompound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membrane
ChEMBL 372 8 1 3 4.7 CC1=C(C)C(=O)C(C(CCCCCC(=O)O)c2ccc(F)cc2)=C(C)C1=O 10.1021/jm00090a009
CHEMBL71222 211049 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Compound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membraneCompound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membrane
ChEMBL 372 8 1 3 4.7 CC1=C(C)C(=O)C(C(CCCCCC(=O)O)c2ccc(F)cc2)=C(C)C1=O 10.1021/jm00090a009
10402603 22216 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 301 9 1 5 2.6 O=C(O)CCCCO/N=C(\Cn1ccnc1)c1ccccc1 10.1021/jm00047a016
CHEMBL121507 22216 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 301 9 1 5 2.6 O=C(O)CCCCO/N=C(\Cn1ccnc1)c1ccccc1 10.1021/jm00047a016
1986 8094 50 None - 1 Human 6.8 pIC50 = 6.8 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 353 7 2 3 2.5 OC(=O)Cc1ccc(cc1)CCNS(=O)(=O)c1ccc(cc1)Cl 10.1021/jm00047a016
54343 8094 50 None - 1 Human 6.8 pIC50 = 6.8 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 353 7 2 3 2.5 OC(=O)Cc1ccc(cc1)CCNS(=O)(=O)c1ccc(cc1)Cl 10.1021/jm00047a016
CHEMBL71685 8094 50 None - 1 Human 6.8 pIC50 = 6.8 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 353 7 2 3 2.5 OC(=O)Cc1ccc(cc1)CCNS(=O)(=O)c1ccc(cc1)Cl 10.1021/jm00047a016
10552450 212090 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 473 10 2 4 7.1 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3ccc(/N=N/c4ccccc4)cc3)[C@@H]1C2 10.1021/jm970343g
CHEMBL79360 212090 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 473 10 2 4 7.1 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3ccc(/N=N/c4ccccc4)cc3)[C@@H]1C2 10.1021/jm970343g
54592351 84034 5 None - 0 Human 5.8 pIC50 = 5.8 Binding
Binding affinity towards Thromboxane A2/ Prostaglandin H2 receptor in human platelet membranes using [125I]- as the radioligand.Binding affinity towards Thromboxane A2/ Prostaglandin H2 receptor in human platelet membranes using [125I]- as the radioligand.
ChEMBL 371 4 1 2 5.4 O=C(O)C[C@@H]1CCCc2c1n(Cc1ccc(Cl)cc1)c1ccc(F)cc21 10.1021/jm00108a042
CHEMBL2079673 84034 5 None - 0 Human 5.8 pIC50 = 5.8 Binding
Binding affinity towards Thromboxane A2/ Prostaglandin H2 receptor in human platelet membranes using [125I]- as the radioligand.Binding affinity towards Thromboxane A2/ Prostaglandin H2 receptor in human platelet membranes using [125I]- as the radioligand.
ChEMBL 371 4 1 2 5.4 O=C(O)C[C@@H]1CCCc2c1n(Cc1ccc(Cl)cc1)c1ccc(F)cc21 10.1021/jm00108a042
11545879 21678 3 None -125 3 Human 5.8 pIC50 = 5.8 Binding
Activity at TP receptor by FLIPR methodActivity at TP receptor by FLIPR method
ChEMBL 381 6 1 3 5.8 CC(C)COc1ccc(Cl)cc1-c1ccccc1-c1cccc(C(=O)O)n1 10.1016/j.bmcl.2008.11.032
CHEMBL1207973 21678 3 None -125 3 Human 5.8 pIC50 = 5.8 Binding
Activity at TP receptor by FLIPR methodActivity at TP receptor by FLIPR method
ChEMBL 381 6 1 3 5.8 CC(C)COc1ccc(Cl)cc1-c1ccccc1-c1cccc(C(=O)O)n1 10.1016/j.bmcl.2008.11.032
CHEMBL467510 21678 3 None -125 3 Human 5.8 pIC50 = 5.8 Binding
Activity at TP receptor by FLIPR methodActivity at TP receptor by FLIPR method
ChEMBL 381 6 1 3 5.8 CC(C)COc1ccc(Cl)cc1-c1ccccc1-c1cccc(C(=O)O)n1 10.1016/j.bmcl.2008.11.032
10431402 21314 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 405 12 1 5 4.7 O=C(O)CCCCCO/N=C(\c1ccccc1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
CHEMBL120284 21314 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 405 12 1 5 4.7 O=C(O)CCCCCO/N=C(\c1ccccc1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
10255332 26041 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 497 11 2 4 4.6 CNC(=O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL129030 26041 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 497 11 2 4 4.6 CNC(=O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10430550 18567 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 391 11 1 5 4.3 O=C(O)CCCCO/N=C(\c1ccccc1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
CHEMBL118184 18567 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 391 11 1 5 4.3 O=C(O)CCCCO/N=C(\c1ccccc1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
10455115 21382 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 425 11 1 5 5.0 O=C(O)CCCCO/N=C(/c1ccccc1)C(Cc1ccc(Cl)cc1)n1ccnc1 10.1021/jm00047a016
CHEMBL120496 21382 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 425 11 1 5 5.0 O=C(O)CCCCO/N=C(/c1ccccc1)C(Cc1ccc(Cl)cc1)n1ccnc1 10.1021/jm00047a016
5362391 105872 25 None -1 2 Human 5.8 pIC50 = 5.8 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1021/jm00027a004
CHEMBL280728 105872 25 None -1 2 Human 5.8 pIC50 = 5.8 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1021/jm00027a004
10671942 110993 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 467 9 2 4 5.5 O=C(O)CCC/C=C\C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc2oc3ccccc3c2c1 10.1021/jm970343g
CHEMBL309835 110993 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 467 9 2 4 5.5 O=C(O)CCC/C=C\C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc2oc3ccccc3c2c1 10.1021/jm970343g
10074652 25002 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 498 12 2 4 5.3 O=C(O)CCCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL127017 25002 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 498 12 2 4 5.3 O=C(O)CCCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
6436053 105487 13 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 484 11 2 4 4.9 O=C(O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL277689 105487 13 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 484 11 2 4 4.9 O=C(O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
6436053 105487 13 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration against thromboxane A2 receptorInhibitory concentration against thromboxane A2 receptor
ChEMBL 484 11 2 4 4.9 O=C(O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm058225d
CHEMBL277689 105487 13 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration against thromboxane A2 receptorInhibitory concentration against thromboxane A2 receptor
ChEMBL 484 11 2 4 4.9 O=C(O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm058225d
9930816 123759 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 399 11 1 7 3.7 O=C(O)CCCCO/N=C(\C1CCCCC1)C(Cc1cnccn1)n1ccnc1 10.1021/jm00047a016
CHEMBL338741 123759 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 399 11 1 7 3.7 O=C(O)CCCCO/N=C(\C1CCCCC1)C(Cc1cnccn1)n1ccnc1 10.1021/jm00047a016
10024132 19167 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 403 11 1 5 5.6 O=C(O)CCCCO/N=C(\C1CCCCC1)C(CC1CCCCC1)n1ccnc1 10.1021/jm00047a016
CHEMBL118568 19167 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 403 11 1 5 5.6 O=C(O)CCCCO/N=C(\C1CCCCC1)C(CC1CCCCC1)n1ccnc1 10.1021/jm00047a016
10018213 22057 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 309 13 1 5 3.5 CCCCCC/C(Cn1ccnc1)=N\OCCCCC(=O)O 10.1021/jm00047a016
CHEMBL121306 22057 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 309 13 1 5 3.5 CCCCCC/C(Cn1ccnc1)=N\OCCCCC(=O)O 10.1021/jm00047a016
11697902 85126 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 440 11 3 6 4.3 CCCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1021/jm060108a
CHEMBL211008 85126 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 440 11 3 6 4.3 CCCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1021/jm060108a
10007859 173268 0 None - 2 Human 8.6 pIC50 = 8.6 Binding
Inhibition of TP receptorInhibition of TP receptor
ChEMBL 554 7 2 4 6.7 CC(=O)Nc1cc(C(=O)O)cc(-n2c(C)ccc2-c2cc(Br)ccc2OCc2ccc(F)cc2F)c1 10.1016/j.bmcl.2006.10.078
CHEMBL427844 173268 0 None - 2 Human 8.6 pIC50 = 8.6 Binding
Inhibition of TP receptorInhibition of TP receptor
ChEMBL 554 7 2 4 6.7 CC(=O)Nc1cc(C(=O)O)cc(-n2c(C)ccc2-c2cc(Br)ccc2OCc2ccc(F)cc2F)c1 10.1016/j.bmcl.2006.10.078
11502680 105016 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
CHEMBL274415 105016 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
11676121 85097 4 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(C)cc1 10.1021/jm060108a
CHEMBL210964 85097 4 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(C)cc1 10.1021/jm060108a
11697902 85126 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 440 11 3 6 4.3 CCCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1021/jm060108a
CHEMBL211008 85126 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 440 11 3 6 4.3 CCCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1021/jm060108a
44310390 108921 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Compound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membraneCompound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membrane
ChEMBL 368 9 2 3 5.3 Cc1c(C)c(C=O)c(C)c(C(CCCCCC(=O)O)c2ccccc2)c1O 10.1021/jm00090a009
CHEMBL302514 108921 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Compound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membraneCompound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membrane
ChEMBL 368 9 2 3 5.3 Cc1c(C)c(C=O)c(C)c(C(CCCCCC(=O)O)c2ccccc2)c1O 10.1021/jm00090a009
6366701 21189 7 None - 0 Human 7.7 pIC50 = 7.7 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 415 11 1 5 5.0 O=C(O)CCCCO/N=C(\C1CCCCC1)C(Cc1ccc(F)cc1)n1ccnc1 10.1021/jm00047a016
CHEMBL120041 21189 7 None - 0 Human 7.7 pIC50 = 7.7 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 415 11 1 5 5.0 O=C(O)CCCCO/N=C(\C1CCCCC1)C(Cc1ccc(F)cc1)n1ccnc1 10.1021/jm00047a016
44310394 210892 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Compound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membraneCompound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membrane
ChEMBL 374 8 3 3 5.3 Cc1c(C)c(O)c(C(CCCCCC(=O)O)c2ccc(F)cc2)c(C)c1O 10.1021/jm00090a009
CHEMBL70314 210892 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Compound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membraneCompound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membrane
ChEMBL 374 8 3 3 5.3 Cc1c(C)c(O)c(C(CCCCCC(=O)O)c2ccc(F)cc2)c(C)c1O 10.1021/jm00090a009
10347272 25411 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 540 11 1 5 6.2 CC(C)(C)OC(=O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL127682 25411 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 540 11 1 5 6.2 CC(C)(C)OC(=O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
59179260 110661 0 None - 1 Human 6.7 pIC50 = 6.7 Binding
Inhibition of TP receptor (unknown origin)Inhibition of TP receptor (unknown origin)
ChEMBL 362 4 2 6 3.9 Nc1c(-c2ccccc2)nn(-c2nc(C(=O)O)cs2)c1-c1ccccc1 10.1016/j.bmcl.2013.10.065
CHEMBL3092130 110661 0 None - 1 Human 6.7 pIC50 = 6.7 Binding
Inhibition of TP receptor (unknown origin)Inhibition of TP receptor (unknown origin)
ChEMBL 362 4 2 6 3.9 Nc1c(-c2ccccc2)nn(-c2nc(C(=O)O)cs2)c1-c1ccccc1 10.1016/j.bmcl.2013.10.065
1610 9126 95 None - 4 Human 4.7 pIC50 = 4.7 Binding
Modulation of TxA2 receptor in human platelets assessed as reduction in U46619-induced platelet aggregation preincubated for 5 min followed by U46619 stimulationModulation of TxA2 receptor in human platelets assessed as reduction in U46619-induced platelet aggregation preincubated for 5 min followed by U46619 stimulation
ChEMBL 422 8 2 6 4.3 CCCCc1nc(c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)CO)Cl 10.1021/acs.jmedchem.0c00262
3941 9126 95 None - 4 Human 4.7 pIC50 = 4.7 Binding
Modulation of TxA2 receptor in human platelets assessed as reduction in U46619-induced platelet aggregation preincubated for 5 min followed by U46619 stimulationModulation of TxA2 receptor in human platelets assessed as reduction in U46619-induced platelet aggregation preincubated for 5 min followed by U46619 stimulation
ChEMBL 422 8 2 6 4.3 CCCCc1nc(c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)CO)Cl 10.1021/acs.jmedchem.0c00262
3961 9126 95 None - 4 Human 4.7 pIC50 = 4.7 Binding
Modulation of TxA2 receptor in human platelets assessed as reduction in U46619-induced platelet aggregation preincubated for 5 min followed by U46619 stimulationModulation of TxA2 receptor in human platelets assessed as reduction in U46619-induced platelet aggregation preincubated for 5 min followed by U46619 stimulation
ChEMBL 422 8 2 6 4.3 CCCCc1nc(c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)CO)Cl 10.1021/acs.jmedchem.0c00262
590 9126 95 None - 4 Human 4.7 pIC50 = 4.7 Binding
Modulation of TxA2 receptor in human platelets assessed as reduction in U46619-induced platelet aggregation preincubated for 5 min followed by U46619 stimulationModulation of TxA2 receptor in human platelets assessed as reduction in U46619-induced platelet aggregation preincubated for 5 min followed by U46619 stimulation
ChEMBL 422 8 2 6 4.3 CCCCc1nc(c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)CO)Cl 10.1021/acs.jmedchem.0c00262
CHEMBL191 9126 95 None - 4 Human 4.7 pIC50 = 4.7 Binding
Modulation of TxA2 receptor in human platelets assessed as reduction in U46619-induced platelet aggregation preincubated for 5 min followed by U46619 stimulationModulation of TxA2 receptor in human platelets assessed as reduction in U46619-induced platelet aggregation preincubated for 5 min followed by U46619 stimulation
ChEMBL 422 8 2 6 4.3 CCCCc1nc(c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)CO)Cl 10.1021/acs.jmedchem.0c00262
DB00678 9126 95 None - 4 Human 4.7 pIC50 = 4.7 Binding
Modulation of TxA2 receptor in human platelets assessed as reduction in U46619-induced platelet aggregation preincubated for 5 min followed by U46619 stimulationModulation of TxA2 receptor in human platelets assessed as reduction in U46619-induced platelet aggregation preincubated for 5 min followed by U46619 stimulation
ChEMBL 422 8 2 6 4.3 CCCCc1nc(c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)CO)Cl 10.1021/acs.jmedchem.0c00262
44190762 183659 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of radioligand from TXA2 receptorDisplacement of radioligand from TXA2 receptor
ChEMBL 531 8 1 5 6.6 Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(O[C@H](C)C(=O)O)c1 10.1016/j.bmcl.2008.07.103
CHEMBL461571 183659 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of radioligand from TXA2 receptorDisplacement of radioligand from TXA2 receptor
ChEMBL 531 8 1 5 6.6 Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(O[C@H](C)C(=O)O)c1 10.1016/j.bmcl.2008.07.103
10479865 25412 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 470 10 2 4 4.9 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm00027a004
CHEMBL127683 25412 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 470 10 2 4 4.9 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm00027a004
10343670 25619 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 448 10 2 3 5.4 O=C(O)CCC/C=C(\c1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL128104 25619 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 448 10 2 3 5.4 O=C(O)CCC/C=C(\c1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10345903 123880 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 500 13 2 4 5.4 O=C(O)CCCCCC(c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL339335 123880 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 500 13 2 4 5.4 O=C(O)CCCCCC(c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10502508 20913 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 425 8 2 3 5.9 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3cccc4ccsc34)[C@@H]1C2 10.1021/jm970343g
CHEMBL119809 20913 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 425 8 2 3 5.9 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3cccc4ccsc34)[C@@H]1C2 10.1021/jm970343g
5362391 105872 25 None -1 2 Human 5.7 pIC50 = 5.7 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1021/jm00047a016
CHEMBL280728 105872 25 None -1 2 Human 5.7 pIC50 = 5.7 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1021/jm00047a016
10547489 170113 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 375 8 2 3 4.7 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3ccsc3)[C@@H]1C2 10.1021/jm970343g
CHEMBL419040 170113 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 375 8 2 3 4.7 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3ccsc3)[C@@H]1C2 10.1021/jm970343g
10050347 22044 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 469 12 1 7 3.7 CS(=O)(=O)c1ccc(/C(=N\OCCCCC(=O)O)C(Cc2ccccc2)n2ccnc2)cc1 10.1021/jm00047a016
CHEMBL121289 22044 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 469 12 1 7 3.7 CS(=O)(=O)c1ccc(/C(=N\OCCCCC(=O)O)C(Cc2ccccc2)n2ccnc2)cc1 10.1021/jm00047a016
11283 7373 10 None - 1 Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at recombinant full-length human TP receptor expressed in HEK293 cells assessed as inhibition of U-44069-induced response measured after 30 mins by TR-FRET assayAntagonist activity at recombinant full-length human TP receptor expressed in HEK293 cells assessed as inhibition of U-44069-induced response measured after 30 mins by TR-FRET assay
ChEMBL 543 8 2 4 5.9 OC(=O)CC[C@H](c1ccccc1Cl)CNC(=O)c1c(C)c(nc2c1cc(Br)cc2)N1CCCC1 10.1021/acs.jmedchem.0c00834
146368333 7373 10 None - 1 Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at recombinant full-length human TP receptor expressed in HEK293 cells assessed as inhibition of U-44069-induced response measured after 30 mins by TR-FRET assayAntagonist activity at recombinant full-length human TP receptor expressed in HEK293 cells assessed as inhibition of U-44069-induced response measured after 30 mins by TR-FRET assay
ChEMBL 543 8 2 4 5.9 OC(=O)CC[C@H](c1ccccc1Cl)CNC(=O)c1c(C)c(nc2c1cc(Br)cc2)N1CCCC1 10.1021/acs.jmedchem.0c00834
CHEMBL4643852 7373 10 None - 1 Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at recombinant full-length human TP receptor expressed in HEK293 cells assessed as inhibition of U-44069-induced response measured after 30 mins by TR-FRET assayAntagonist activity at recombinant full-length human TP receptor expressed in HEK293 cells assessed as inhibition of U-44069-induced response measured after 30 mins by TR-FRET assay
ChEMBL 543 8 2 4 5.9 OC(=O)CC[C@H](c1ccccc1Cl)CNC(=O)c1c(C)c(nc2c1cc(Br)cc2)N1CCCC1 10.1021/acs.jmedchem.0c00834
10457484 124177 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 471 11 2 5 3.8 Cn1c(CCNS(=O)(=O)c2ccc(F)cc2)ccc1/C(=C\CCCC(=O)O)c1cccnc1 10.1021/jm00027a004
CHEMBL339812 124177 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 471 11 2 5 3.8 Cn1c(CCNS(=O)(=O)c2ccc(F)cc2)ccc1/C(=C\CCCC(=O)O)c1cccnc1 10.1021/jm00027a004
10367685 21305 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 475 12 1 7 4.3 CS(=O)(=O)c1ccc(CC(/C(=N/OCCCCC(=O)O)C2CCCCC2)n2ccnc2)cc1 10.1021/jm00047a016
CHEMBL120249 21305 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 475 12 1 7 4.3 CS(=O)(=O)c1ccc(CC(/C(=N/OCCCCC(=O)O)C2CCCCC2)n2ccnc2)cc1 10.1021/jm00047a016
10342027 23220 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 419 11 1 5 5.0 CC(C)(CCO/N=C(\c1ccccc1)C(Cc1ccccc1)n1ccnc1)CC(=O)O 10.1021/jm00047a016
CHEMBL123307 23220 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 419 11 1 5 5.0 CC(C)(CCO/N=C(\c1ccccc1)C(Cc1ccccc1)n1ccnc1)CC(=O)O 10.1021/jm00047a016
44159530 75159 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Displacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranesDisplacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranes
ChEMBL 501 9 1 4 6.2 CCN(Cc1cc(C(F)(F)F)ccc1-c1cc(CC(=O)O)ccc1OC)C(=O)OCc1ccccc1 10.1016/j.bmcl.2011.01.024
CHEMBL1916700 75159 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Displacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranesDisplacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranes
ChEMBL 501 9 1 4 6.2 CCN(Cc1cc(C(F)(F)F)ccc1-c1cc(CC(=O)O)ccc1OC)C(=O)OCc1ccccc1 10.1016/j.bmcl.2011.01.024
10087973 119616 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 329 10 1 5 3.3 C/C(=N\OCCCCC(=O)O)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
CHEMBL330837 119616 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 329 10 1 5 3.3 C/C(=N\OCCCCC(=O)O)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
10344641 22056 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 469 11 1 5 5.1 O=C(O)CCCCO/N=C(\c1ccc(Br)cc1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
CHEMBL121304 22056 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 469 11 1 5 5.1 O=C(O)CCCCO/N=C(\c1ccc(Br)cc1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
11723604 22061 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 321 10 1 5 3.5 O=C(O)CCCCCO/N=C(\Cn1ccnc1)C1CCCCC1 10.1021/jm00047a016
CHEMBL121314 22061 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 321 10 1 5 3.5 O=C(O)CCCCCO/N=C(\Cn1ccnc1)C1CCCCC1 10.1021/jm00047a016
10529261 212551 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 495 9 2 4 6.1 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NS(=O)(=O)c3ccc4oc5ccccc5c4c3)[C@@H]1C2 10.1021/jm970343g
CHEMBL82896 212551 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 495 9 2 4 6.1 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NS(=O)(=O)c3ccc4oc5ccccc5c4c3)[C@@H]1C2 10.1021/jm970343g
11755659 26178 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 498 11 1 4 5.3 CN(CCc1ccc(/C(=C\CCCC(=O)O)c2cccnc2)cc1)S(=O)(=O)c1ccc(Cl)cc1 10.1021/jm00027a004
CHEMBL129355 26178 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 498 11 1 4 5.3 CN(CCc1ccc(/C(=C\CCCC(=O)O)c2cccnc2)cc1)S(=O)(=O)c1ccc(Cl)cc1 10.1021/jm00027a004
44333604 11349 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Compound was evaluated for the competitive binding of [3H]U-46619 to washed human platelets at the Thromboxane A2 receptorCompound was evaluated for the competitive binding of [3H]U-46619 to washed human platelets at the Thromboxane A2 receptor
ChEMBL 337 13 2 3 4.0 CCCCCCNC[C@H]1C2CC(CO2)[C@@H]1C/C=C\CCCC(=O)O 10.1021/jm00094a017
CHEMBL102584 11349 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Compound was evaluated for the competitive binding of [3H]U-46619 to washed human platelets at the Thromboxane A2 receptorCompound was evaluated for the competitive binding of [3H]U-46619 to washed human platelets at the Thromboxane A2 receptor
ChEMBL 337 13 2 3 4.0 CCCCCCNC[C@H]1C2CC(CO2)[C@@H]1C/C=C\CCCC(=O)O 10.1021/jm00094a017
10590325 136454 0 None - 1 Human 4.6 pIC50 = 4.6 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 300 3 3 5 2.4 O=[N+]([O-])c1ccc(CC2NCCc3cc(O)c(O)cc32)cc1 10.1021/jm950896w
CHEMBL367394 136454 0 None - 1 Human 4.6 pIC50 = 4.6 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 300 3 3 5 2.4 O=[N+]([O-])c1ccc(CC2NCCc3cc(O)c(O)cc32)cc1 10.1021/jm950896w
11755215 24814 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 487 11 2 6 3.5 O=C(O)CCO/N=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL126494 24814 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 487 11 2 6 3.5 O=C(O)CCO/N=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10479578 25282 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 464 12 2 4 4.4 O=C(O)CCC/C=C(\c1ccc(CCNS(=O)(=O)Cc2ccccc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL127357 25282 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 464 12 2 4 4.4 O=C(O)CCC/C=C(\c1ccc(CCNS(=O)(=O)Cc2ccccc2)cc1)c1cccnc1 10.1021/jm00027a004
10072780 124067 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 456 9 2 4 5.2 O=C(O)CCC/C=C(\c1ccc(NS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL339568 124067 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 456 9 2 4 5.2 O=C(O)CCC/C=C(\c1ccc(NS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10813802 20561 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 459 8 2 3 6.6 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3ccc4oc5ccccc5c4c3)[C@@H]1C2 10.1021/jm970343g
CHEMBL119550 20561 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 459 8 2 3 6.6 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3ccc4oc5ccccc5c4c3)[C@@H]1C2 10.1021/jm970343g
10244703 22058 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 307 9 1 5 3.1 O=C(O)CCCCO/N=C(/Cn1ccnc1)C1CCCCC1 10.1021/jm00047a016
CHEMBL121307 22058 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 307 9 1 5 3.1 O=C(O)CCCCO/N=C(/Cn1ccnc1)C1CCCCC1 10.1021/jm00047a016
10258317 24989 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 618 14 2 5 6.6 O=C(O)CCC/C=C(\c1ccc(CCN(Cc2ccc(C(=O)O)cc2)S(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL127008 24989 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 618 14 2 5 6.6 O=C(O)CCC/C=C(\c1ccc(CCN(Cc2ccc(C(=O)O)cc2)S(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10075294 123674 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 518 11 2 4 5.3 O=C(O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(C(F)(F)F)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL338360 123674 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 518 11 2 4 5.3 O=C(O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(C(F)(F)F)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10023102 21309 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 387 11 1 6 4.5 O=C(O)CCCCO/N=C(\C1CCCCC1)C(Cc1ccco1)n1ccnc1 10.1021/jm00047a016
CHEMBL120259 21309 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 387 11 1 6 4.5 O=C(O)CCCCO/N=C(\C1CCCCC1)C(Cc1ccco1)n1ccnc1 10.1021/jm00047a016
10552612 212495 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 477 9 2 3 5.0 O=C(O)CCC/C=C\C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc(C#Cc2ccccc2)cc1 10.1021/jm970343g
CHEMBL82489 212495 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 477 9 2 3 5.0 O=C(O)CCC/C=C\C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc(C#Cc2ccccc2)cc1 10.1021/jm970343g
11676121 85097 4 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(C)cc1 10.1021/jm060108a
CHEMBL210964 85097 4 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(C)cc1 10.1021/jm060108a
15125130 210610 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Compound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membraneCompound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membrane
ChEMBL 386 9 2 3 5.4 Cc1c(C)c(C(CCCCCC(=O)O)c2ccc(F)cc2)c(O)c(C)c1C=O 10.1021/jm00090a009
CHEMBL68512 210610 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Compound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membraneCompound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membrane
ChEMBL 386 9 2 3 5.4 Cc1c(C)c(C(CCCCCC(=O)O)c2ccc(F)cc2)c(O)c(C)c1C=O 10.1021/jm00090a009
10251282 121208 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 415 11 1 5 5.0 O=C(O)CCCCO/N=C(\C1CCCCC1)C(Cc1cccc(F)c1)n1ccnc1 10.1021/jm00047a016
CHEMBL333237 121208 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 415 11 1 5 5.0 O=C(O)CCCCO/N=C(\C1CCCCC1)C(Cc1cccc(F)c1)n1ccnc1 10.1021/jm00047a016
10075114 25410 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 511 11 1 4 4.9 CN(C)C(=O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL127681 25410 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 511 11 1 4 4.9 CN(C)C(=O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10454526 121207 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 415 11 1 5 5.0 O=C(O)CCCCO/N=C(\C1CCCCC1)C(Cc1ccccc1F)n1ccnc1 10.1021/jm00047a016
CHEMBL333236 121207 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 415 11 1 5 5.0 O=C(O)CCCCO/N=C(\C1CCCCC1)C(Cc1ccccc1F)n1ccnc1 10.1021/jm00047a016
11754856 25964 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 479 10 3 5 2.5 Cc1ccc(S(=O)(=O)NCCc2ccc(/C(=C\C(=O)NCC(=O)O)c3cccnc3)cc2)cc1 10.1021/jm00027a004
CHEMBL128973 25964 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 479 10 3 5 2.5 Cc1ccc(S(=O)(=O)NCCc2ccc(/C(=C\C(=O)NCC(=O)O)c3cccnc3)cc2)cc1 10.1021/jm00027a004
10250339 21141 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 399 15 1 5 5.3 CCCCCC/C(=N\OCCCCC(=O)O)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
CHEMBL120019 21141 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 399 15 1 5 5.3 CCCCCC/C(=N\OCCCCC(=O)O)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
10483360 206007 28 None - 4 Human 4.5 pIC50 = 4.5 Binding
Displacement of [3H]SQ29548 from human TP receptor transfected in HEK 293 EBNA cellsDisplacement of [3H]SQ29548 from human TP receptor transfected in HEK 293 EBNA cells
ChEMBL 580 12 3 6 5.8 CCCCNC(=O)c1ccc(Oc2ccc(CC(=O)O)cc2OC)c(NS(=O)(=O)c2ccc(Cl)cc2Cl)c1 10.1016/j.bmcl.2009.09.052
CHEMBL589973 206007 28 None - 4 Human 4.5 pIC50 = 4.5 Binding
Displacement of [3H]SQ29548 from human TP receptor transfected in HEK 293 EBNA cellsDisplacement of [3H]SQ29548 from human TP receptor transfected in HEK 293 EBNA cells
ChEMBL 580 12 3 6 5.8 CCCCNC(=O)c1ccc(Oc2ccc(CC(=O)O)cc2OC)c(NS(=O)(=O)c2ccc(Cl)cc2Cl)c1 10.1016/j.bmcl.2009.09.052
16219283 128051 6 None - 0 Human 7.5 pIC50 = 7.5 Binding
In vitro concentration that reduced specific binding of [3H]U-440619 to guinea pig platelet receptor, Thromboxane A2 receptor by 50%In vitro concentration that reduced specific binding of [3H]U-440619 to guinea pig platelet receptor, Thromboxane A2 receptor by 50%
ChEMBL 350 12 2 3 4.3 CCCCC[C@H](O)/C=C/[C@H]1C2CC(CO2)[C@@H]1C/C=C\CCCC(=O)O 10.1021/jm00129a030
CHEMBL357834 128051 6 None - 0 Human 7.5 pIC50 = 7.5 Binding
In vitro concentration that reduced specific binding of [3H]U-440619 to guinea pig platelet receptor, Thromboxane A2 receptor by 50%In vitro concentration that reduced specific binding of [3H]U-440619 to guinea pig platelet receptor, Thromboxane A2 receptor by 50%
ChEMBL 350 12 2 3 4.3 CCCCC[C@H](O)/C=C/[C@H]1C2CC(CO2)[C@@H]1C/C=C\CCCC(=O)O 10.1021/jm00129a030
18944131 93970 0 None - 1 Human 6.5 pIC50 = 6.5 Binding
In vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparationIn vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparation
ChEMBL 484 10 2 6 4.0 O=C(O)CCc1ccccc1CC1OCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
CHEMBL23273 93970 0 None - 1 Human 6.5 pIC50 = 6.5 Binding
In vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparationIn vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparation
ChEMBL 484 10 2 6 4.0 O=C(O)CCc1ccccc1CC1OCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
18944131 93970 0 None - 1 Human 5.5 pIC50 = 5.5 Binding
In vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparationIn vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparation
ChEMBL 484 10 2 6 4.0 O=C(O)CCc1ccccc1CC1OCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
CHEMBL23273 93970 0 None - 1 Human 5.5 pIC50 = 5.5 Binding
In vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparationIn vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparation
ChEMBL 484 10 2 6 4.0 O=C(O)CCc1ccccc1CC1OCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
10594576 17783 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 358 8 3 2 4.0 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3ccc[nH]3)[C@@H]1C2 10.1021/jm970343g
CHEMBL117399 17783 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 358 8 3 2 4.0 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3ccc[nH]3)[C@@H]1C2 10.1021/jm970343g
16222207 14417 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Inhibition of thromboxane A2 receptorInhibition of thromboxane A2 receptor
ChEMBL 434 6 1 3 5.4 O=C(O)Cc1cnc(C(c2ccc(F)cc2)c2ccc(F)cc2)nc1-c1cccc(F)c1 10.1016/j.bmcl.2010.01.092
CHEMBL1088284 14417 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Inhibition of thromboxane A2 receptorInhibition of thromboxane A2 receptor
ChEMBL 434 6 1 3 5.4 O=C(O)Cc1cnc(C(c2ccc(F)cc2)c2ccc(F)cc2)nc1-c1cccc(F)c1 10.1016/j.bmcl.2010.01.092
9978202 21303 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 398 11 1 6 4.3 O=C(O)CCCCO/N=C(\C1CCCCC1)C(Cc1ccccn1)n1ccnc1 10.1021/jm00047a016
CHEMBL120228 21303 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 398 11 1 6 4.3 O=C(O)CCCCO/N=C(\C1CCCCC1)C(Cc1ccccn1)n1ccnc1 10.1021/jm00047a016
10095993 26232 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 464 11 2 4 4.6 Cc1ccc(S(=O)(=O)NCCc2ccc(/C(=C\CCCC(=O)O)c3cccnc3)cc2)cc1 10.1021/jm00027a004
CHEMBL129734 26232 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 464 11 2 4 4.6 Cc1ccc(S(=O)(=O)NCCc2ccc(/C(=C\CCCC(=O)O)c3cccnc3)cc2)cc1 10.1021/jm00027a004
10436457 26946 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 512 12 1 4 5.7 CCN(CCc1ccc(/C(=C\CCCC(=O)O)c2cccnc2)cc1)S(=O)(=O)c1ccc(Cl)cc1 10.1021/jm00027a004
CHEMBL130470 26946 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 512 12 1 4 5.7 CCN(CCc1ccc(/C(=C\CCCC(=O)O)c2cccnc2)cc1)S(=O)(=O)c1ccc(Cl)cc1 10.1021/jm00027a004
9979675 123716 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 422 11 2 4 4.1 O=C(O)CCC/C=C(\CCCNS(=O)(=O)c1ccc(Cl)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL338546 123716 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 422 11 2 4 4.1 O=C(O)CCC/C=C(\CCCNS(=O)(=O)c1ccc(Cl)cc1)c1cccnc1 10.1021/jm00027a004
44210947 105892 0 None - 1 Human 6.5 pIC50 = 6.5 Binding
In vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparationIn vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparation
ChEMBL 498 10 2 6 4.2 O=C(O)CCc1ccccc1CC1COCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
CHEMBL280890 105892 0 None - 1 Human 6.5 pIC50 = 6.5 Binding
In vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparationIn vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparation
ChEMBL 498 10 2 6 4.2 O=C(O)CCc1ccccc1CC1COCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
10052055 26224 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 510 13 2 6 4.3 COc1ccc(S(=O)(=O)NCCc2ccc(/C(=C\CCCC(=O)O)c3cccnc3)cc2)cc1OC 10.1021/jm00027a004
CHEMBL129635 26224 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 510 13 2 6 4.3 COc1ccc(S(=O)(=O)NCCc2ccc(/C(=C\CCCC(=O)O)c3cccnc3)cc2)cc1OC 10.1021/jm00027a004
73354171 100029 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity towards Thromboxane A2 receptor/Prostaglandin receptor in human platelet membranes using [125I]- as the radioligandBinding affinity towards Thromboxane A2 receptor/Prostaglandin receptor in human platelet membranes using [125I]- as the radioligand
ChEMBL 387 10 4 4 3.3 O=C(O)CCC/C=C\C[C@H]1[C@H]2CC[C@@H](O2)[C@H]1CNNC(=O)Nc1ccccc1 10.1021/jm00108a042
CHEMBL2448578 100029 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity towards Thromboxane A2 receptor/Prostaglandin receptor in human platelet membranes using [125I]- as the radioligandBinding affinity towards Thromboxane A2 receptor/Prostaglandin receptor in human platelet membranes using [125I]- as the radioligand
ChEMBL 387 10 4 4 3.3 O=C(O)CCC/C=C\C[C@H]1[C@H]2CC[C@@H](O2)[C@H]1CNNC(=O)Nc1ccccc1 10.1021/jm00108a042
10074653 24784 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 498 11 1 5 5.0 COC(=O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL126337 24784 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 498 11 1 5 5.0 COC(=O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
44364273 49001 8 None - 1 Human 7.4 pIC50 = 7.4 Binding
Displacement of radiolabeled U44069 from human TXA2 receptorDisplacement of radiolabeled U44069 from human TXA2 receptor
ChEMBL 350 12 2 3 4.3 CCCCC[C@H](O)/C=C/[C@H]1C2COC(C2)[C@@H]1C/C=C\CCCC(=O)O 10.1021/jm8007618
CHEMBL149724 49001 8 None - 1 Human 7.4 pIC50 = 7.4 Binding
Displacement of radiolabeled U44069 from human TXA2 receptorDisplacement of radiolabeled U44069 from human TXA2 receptor
ChEMBL 350 12 2 3 4.3 CCCCC[C@H](O)/C=C/[C@H]1C2COC(C2)[C@@H]1C/C=C\CCCC(=O)O 10.1021/jm8007618
6537211 23898 6 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 484 11 2 4 4.9 O=C(O)CCC/C=C(/c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL125519 23898 6 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 484 11 2 4 4.9 O=C(O)CCC/C=C(/c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10025456 120772 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 425 8 2 3 5.9 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3csc4ccccc34)[C@@H]1C2 10.1021/jm970343g
CHEMBL332635 120772 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 425 8 2 3 5.9 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3csc4ccccc34)[C@@H]1C2 10.1021/jm970343g
15125138 170250 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Compound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membraneCompound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membrane
ChEMBL 386 9 2 3 5.4 Cc1c(C)c(C=O)c(C)c(C(CCCCCC(=O)O)c2ccc(F)cc2)c1O 10.1021/jm00090a009
CHEMBL420002 170250 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Compound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membraneCompound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membrane
ChEMBL 386 9 2 3 5.4 Cc1c(C)c(C=O)c(C)c(C(CCCCCC(=O)O)c2ccc(F)cc2)c1O 10.1021/jm00090a009
11510008 84057 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1cccc(C)c1 10.1021/jm060108a
CHEMBL208115 84057 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1cccc(C)c1 10.1021/jm060108a
10092922 18570 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 409 11 1 5 4.5 O=C(O)CCCCO/N=C(\c1ccccc1)C(Cc1ccc(F)cc1)n1ccnc1 10.1021/jm00047a016
CHEMBL118188 18570 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 409 11 1 5 4.5 O=C(O)CCCCO/N=C(\c1ccccc1)C(Cc1ccc(F)cc1)n1ccnc1 10.1021/jm00047a016
10365109 124236 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 425 11 1 5 5.0 O=C(O)CCCCO/N=C(\c1ccccc1)C(Cc1ccc(Cl)cc1)n1ccnc1 10.1021/jm00047a016
CHEMBL339877 124236 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 425 11 1 5 5.0 O=C(O)CCCCO/N=C(\c1ccccc1)C(Cc1ccc(Cl)cc1)n1ccnc1 10.1021/jm00047a016
10599289 20914 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 441 8 3 4 5.6 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3csc4cc(O)ccc34)[C@@H]1C2 10.1021/jm970343g
CHEMBL119810 20914 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 441 8 3 4 5.6 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3csc4cc(O)ccc34)[C@@H]1C2 10.1021/jm970343g
10409839 21693 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 419 11 1 5 5.0 CC(C)(CCCO/N=C(\c1ccccc1)C(Cc1ccccc1)n1ccnc1)C(=O)O 10.1021/jm00047a016
CHEMBL120811 21693 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 419 11 1 5 5.0 CC(C)(CCCO/N=C(\c1ccccc1)C(Cc1ccccc1)n1ccnc1)C(=O)O 10.1021/jm00047a016
10742144 66431 0 None - 1 Human 4.4 pIC50 = 4.4 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 449 8 2 6 4.5 COc1cc(CC2c3cc(O)c(O)cc3CCN2CCc2ccccc2)cc(OC)c1OC 10.1021/jm950896w
CHEMBL172163 66431 0 None - 1 Human 4.4 pIC50 = 4.4 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 449 8 2 6 4.5 COc1cc(CC2c3cc(O)c(O)cc3CCN2CCc2ccccc2)cc(OC)c1OC 10.1021/jm950896w
10051348 123726 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 492 11 2 4 5.2 Cc1cc(C)c(S(=O)(=O)NCCc2ccc(/C(=C\CCCC(=O)O)c3cccnc3)cc2)c(C)c1 10.1021/jm00027a004
CHEMBL338588 123726 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 492 11 2 4 5.2 Cc1cc(C)c(S(=O)(=O)NCCc2ccc(/C(=C\CCCC(=O)O)c3cccnc3)cc2)c(C)c1 10.1021/jm00027a004
10254162 170216 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 470 10 2 4 4.6 O=C(O)CC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL419774 170216 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 470 10 2 4 4.6 O=C(O)CC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10741899 17290 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 443 8 2 3 6.0 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3csc4ccc(F)cc34)[C@@H]1C2 10.1021/jm970343g
CHEMBL116836 17290 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 443 8 2 3 6.0 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3csc4ccc(F)cc34)[C@@H]1C2 10.1021/jm970343g
44344457 117290 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 467 10 1 4 5.3 COC(=O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(-c3ccccc3)cc2)[C@H]2CC[C@@H]1C2 10.1021/jm970343g
CHEMBL325026 117290 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 467 10 1 4 5.3 COC(=O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(-c3ccccc3)cc2)[C@H]2CC[C@@H]1C2 10.1021/jm970343g
65772 67177 8 None -9 6 Human 6.4 pIC50 = 6.4 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm950896w
CHEMBL174984 67177 8 None -9 6 Human 6.4 pIC50 = 6.4 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm950896w
10402602 21848 0 None - 0 Human 4.3 pIC50 = 4.3 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 301 9 1 5 2.6 O=C(O)CCCCO/N=C(/Cn1ccnc1)c1ccccc1 10.1021/jm00047a016
CHEMBL120947 21848 0 None - 0 Human 4.3 pIC50 = 4.3 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 301 9 1 5 2.6 O=C(O)CCCCO/N=C(/Cn1ccnc1)c1ccccc1 10.1021/jm00047a016
10370098 24756 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 541 13 2 5 4.1 NC(=O)CN(CCc1ccc(/C(=C\CCCC(=O)O)c2cccnc2)cc1)S(=O)(=O)c1ccc(Cl)cc1 10.1021/jm00027a004
CHEMBL126196 24756 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 541 13 2 5 4.1 NC(=O)CN(CCc1ccc(/C(=C\CCCC(=O)O)c2cccnc2)cc1)S(=O)(=O)c1ccc(Cl)cc1 10.1021/jm00027a004
10424476 19240 0 None - 0 Human 4.3 pIC50 = 4.3 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 293 8 1 5 2.7 O=C(O)CCCO/N=C(/Cn1ccnc1)C1CCCCC1 10.1021/jm00047a016
CHEMBL118619 19240 0 None - 0 Human 4.3 pIC50 = 4.3 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 293 8 1 5 2.7 O=C(O)CCCO/N=C(/Cn1ccnc1)C1CCCCC1 10.1021/jm00047a016
1938 8750 18 None -1 4 Human 7.3 pIC50 = 7.3 Binding
Binding affinity towards Thromboxane A2 receptor/Prostaglandin receptor in human platelet membranes using [125I]- as the radioligandBinding affinity towards Thromboxane A2 receptor/Prostaglandin receptor in human platelet membranes using [125I]- as the radioligand
ChEMBL 512 11 2 4 4.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1/C=C/[C@H](COc1ccc(cc1)I)O)O2 10.1021/jm00108a042
5311175 8750 18 None -1 4 Human 7.3 pIC50 = 7.3 Binding
Binding affinity towards Thromboxane A2 receptor/Prostaglandin receptor in human platelet membranes using [125I]- as the radioligandBinding affinity towards Thromboxane A2 receptor/Prostaglandin receptor in human platelet membranes using [125I]- as the radioligand
ChEMBL 512 11 2 4 4.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1/C=C/[C@H](COc1ccc(cc1)I)O)O2 10.1021/jm00108a042
CHEMBL2113346 8750 18 None -1 4 Human 7.3 pIC50 = 7.3 Binding
Binding affinity towards Thromboxane A2 receptor/Prostaglandin receptor in human platelet membranes using [125I]- as the radioligandBinding affinity towards Thromboxane A2 receptor/Prostaglandin receptor in human platelet membranes using [125I]- as the radioligand
ChEMBL 512 11 2 4 4.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1/C=C/[C@H](COc1ccc(cc1)I)O)O2 10.1021/jm00108a042
10096033 105141 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 465 11 1 5 5.9 O=C(O)CCCCO/N=C(\C1CCCCC1)C(Cc1ccc(C(F)(F)F)cc1)n1ccnc1 10.1021/jm00047a016
CHEMBL275256 105141 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 465 11 1 5 5.9 O=C(O)CCCCO/N=C(\C1CCCCC1)C(Cc1ccc(C(F)(F)F)cc1)n1ccnc1 10.1021/jm00047a016
10052612 170219 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 526 12 1 4 6.1 CC(C)N(CCc1ccc(/C(=C\CCCC(=O)O)c2cccnc2)cc1)S(=O)(=O)c1ccc(Cl)cc1 10.1021/jm00027a004
CHEMBL419790 170219 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 526 12 1 4 6.1 CC(C)N(CCc1ccc(/C(=C\CCCC(=O)O)c2cccnc2)cc1)S(=O)(=O)c1ccc(Cl)cc1 10.1021/jm00027a004
10096697 123653 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 480 12 2 5 4.3 COc1ccc(S(=O)(=O)NCCc2ccc(/C(=C\CCCC(=O)O)c3cccnc3)cc2)cc1 10.1021/jm00027a004
CHEMBL338241 123653 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 480 12 2 5 4.3 COc1ccc(S(=O)(=O)NCCc2ccc(/C(=C\CCCC(=O)O)c3cccnc3)cc2)cc1 10.1021/jm00027a004
10364364 23063 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 412 11 2 6 4.3 O=C(CCCCO/N=C(\C1CCCCC1)C(Cc1ccccc1)n1ccnc1)NO 10.1021/jm00047a016
CHEMBL122472 23063 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 412 11 2 6 4.3 O=C(CCCCO/N=C(\C1CCCCC1)C(Cc1ccccc1)n1ccnc1)NO 10.1021/jm00047a016
5362391 105872 25 None -1 2 Human 5.3 pIC50 = 5.3 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1021/jm00027a004
CHEMBL280728 105872 25 None -1 2 Human 5.3 pIC50 = 5.3 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1021/jm00027a004
9931330 22334 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 409 11 1 5 4.5 O=C(O)CCCCO/N=C(/c1ccccc1)C(Cc1ccc(F)cc1)n1ccnc1 10.1021/jm00047a016
CHEMBL122008 22334 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 409 11 1 5 4.5 O=C(O)CCCCO/N=C(/c1ccccc1)C(Cc1ccc(F)cc1)n1ccnc1 10.1021/jm00047a016
10244704 175863 0 None - 0 Human 4.3 pIC50 = 4.3 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 307 9 1 5 3.1 O=C(O)CCCCO/N=C(\Cn1ccnc1)C1CCCCC1 10.1021/jm00047a016
CHEMBL439790 175863 0 None - 0 Human 4.3 pIC50 = 4.3 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 307 9 1 5 3.1 O=C(O)CCCCO/N=C(\Cn1ccnc1)C1CCCCC1 10.1021/jm00047a016
10254161 124825 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 470 10 2 4 4.9 O=C(O)CCC/C=C(\c1ccc(CNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL340396 124825 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 470 10 2 4 4.9 O=C(O)CCC/C=C(\c1ccc(CNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10371334 123690 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 597 14 1 6 5.0 O=C(O)CCC/C=C(\c1ccc(CCN(CCN2CCOCC2)S(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL338419 123690 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 597 14 1 6 5.0 O=C(O)CCC/C=C(\c1ccc(CCN(CCN2CCOCC2)S(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
131717 210168 6 None - 1 Human 8.2 pIC50 = 8.2 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 452 14 2 4 4.7 O=C(O)CCC(CCCCNS(=O)(=O)c1ccc(Cl)cc1)CCCc1cccnc1 10.1021/jm00027a004
CHEMBL65414 210168 6 None - 1 Human 8.2 pIC50 = 8.2 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 452 14 2 4 4.7 O=C(O)CCC(CCCCNS(=O)(=O)c1ccc(Cl)cc1)CCCc1cccnc1 10.1021/jm00027a004
10434230 25603 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 456 9 2 4 5.2 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(NS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm00027a004
CHEMBL128022 25603 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 456 9 2 4 5.2 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(NS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm00027a004
10256828 25473 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 542 13 2 5 4.7 O=C(O)CCC/C=C(\c1ccc(CCN(CC(=O)O)S(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL127738 25473 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 542 13 2 5 4.7 O=C(O)CCC/C=C(\c1ccc(CCN(CC(=O)O)S(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10483231 25994 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 574 13 1 4 6.9 O=C(O)CCC/C=C(\c1ccc(CCN(Cc2ccccc2)S(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL129000 25994 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 574 13 1 4 6.9 O=C(O)CCC/C=C(\c1ccc(CCN(Cc2ccccc2)S(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
56924869 75156 0 None - 0 Human 4.2 pIC50 = 4.2 Binding
Displacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranesDisplacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranes
ChEMBL 487 8 1 4 5.8 COC(=O)N(Cc1ccccc1)Cc1cc(C(F)(F)F)ccc1-c1cc(CC(=O)O)ccc1OC 10.1016/j.bmcl.2011.01.024
CHEMBL1916697 75156 0 None - 0 Human 4.2 pIC50 = 4.2 Binding
Displacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranesDisplacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranes
ChEMBL 487 8 1 4 5.8 COC(=O)N(Cc1ccccc1)Cc1cc(C(F)(F)F)ccc1-c1cc(CC(=O)O)ccc1OC 10.1016/j.bmcl.2011.01.024
45270144 202130 33 None - 0 Human 4.2 pIC50 = 4.2 Binding
Displacement of [3H]SQ-29548 from thromboxane receptor in human platelet membraneDisplacement of [3H]SQ-29548 from thromboxane receptor in human platelet membrane
ChEMBL 501 8 2 6 4.1 CN(C)c1nc(Cc2ccc(NC(=O)c3ccc(C(F)(F)F)cc3)cc2)nc(N(C)C)c1CC(=O)O 10.1016/j.bmcl.2009.06.085
CHEMBL551813 202130 33 None - 0 Human 4.2 pIC50 = 4.2 Binding
Displacement of [3H]SQ-29548 from thromboxane receptor in human platelet membraneDisplacement of [3H]SQ-29548 from thromboxane receptor in human platelet membrane
ChEMBL 501 8 2 6 4.1 CN(C)c1nc(Cc2ccc(NC(=O)c3ccc(C(F)(F)F)cc3)cc2)nc(N(C)C)c1CC(=O)O 10.1016/j.bmcl.2009.06.085
44205724 75144 0 None - 0 Human 4.2 pIC50 = 4.2 Binding
Displacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranesDisplacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranes
ChEMBL 499 7 1 4 6.1 COc1ccc(CC(=O)O)cc1-c1ccc(C(F)(F)F)cc1CN1C(=O)O[C@H](c2ccccc2)[C@@H]1C 10.1016/j.bmcl.2011.01.024
CHEMBL1916686 75144 0 None - 0 Human 4.2 pIC50 = 4.2 Binding
Displacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranesDisplacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranes
ChEMBL 499 7 1 4 6.1 COc1ccc(CC(=O)O)cc1-c1ccc(C(F)(F)F)cc1CN1C(=O)O[C@H](c2ccccc2)[C@@H]1C 10.1016/j.bmcl.2011.01.024
10050297 125220 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 468 11 2 4 4.4 O=C(O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(F)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL341094 125220 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 468 11 2 4 4.4 O=C(O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(F)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10502610 170497 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 427 9 2 3 4.7 O=C(O)CCC/C=C\C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc2ccccc2c1 10.1021/jm970343g
CHEMBL420507 170497 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 427 9 2 3 4.7 O=C(O)CCC/C=C\C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc2ccccc2c1 10.1021/jm970343g
44159411 75163 0 None - 0 Human 4.2 pIC50 = 4.2 Binding
Displacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranesDisplacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranes
ChEMBL 425 7 1 4 4.6 CCN(Cc1cc(C(F)(F)F)ccc1-c1cc(CC(=O)O)ccc1OC)C(=O)OC 10.1016/j.bmcl.2011.01.024
CHEMBL1916704 75163 0 None - 0 Human 4.2 pIC50 = 4.2 Binding
Displacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranesDisplacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranes
ChEMBL 425 7 1 4 4.6 CCN(Cc1cc(C(F)(F)F)ccc1-c1cc(CC(=O)O)ccc1OC)C(=O)OC 10.1016/j.bmcl.2011.01.024
15486805 172832 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Affinity for Prostanoid TP receptor expressed in CHO cellsAffinity for Prostanoid TP receptor expressed in CHO cells
ChEMBL 394 13 4 5 3.0 O=C(O)CCCCCC[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)COc1ccccc1 10.1021/jm990542v
CHEMBL425681 172832 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Affinity for Prostanoid TP receptor expressed in CHO cellsAffinity for Prostanoid TP receptor expressed in CHO cells
ChEMBL 394 13 4 5 3.0 O=C(O)CCCCCC[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)COc1ccccc1 10.1021/jm990542v
19097508 105548 0 None - 1 Human 8.2 pIC50 = 8.2 Binding
In vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparationIn vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparation
ChEMBL 508 10 2 5 4.8 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
CHEMBL278159 105548 0 None - 1 Human 8.2 pIC50 = 8.2 Binding
In vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparationIn vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparation
ChEMBL 508 10 2 5 4.8 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
2449 211009 94 None - 0 Human 8.1 pIC50 = 8.1 Binding
In vitro concentration that reduced specific binding of [3H]U-440619 to guinea pig platelet receptor, TXA2 by 50%In vitro concentration that reduced specific binding of [3H]U-440619 to guinea pig platelet receptor, TXA2 by 50%
ChEMBL 354 8 1 3 4.6 CC1=C(C)C(=O)C(C(CCCCCC(=O)O)c2ccccc2)=C(C)C1=O 10.1021/jm00129a030
CHEMBL70972 211009 94 None - 0 Human 8.1 pIC50 = 8.1 Binding
In vitro concentration that reduced specific binding of [3H]U-440619 to guinea pig platelet receptor, TXA2 by 50%In vitro concentration that reduced specific binding of [3H]U-440619 to guinea pig platelet receptor, TXA2 by 50%
ChEMBL 354 8 1 3 4.6 CC1=C(C)C(=O)C(C(CCCCCC(=O)O)c2ccccc2)=C(C)C1=O 10.1021/jm00129a030
DB06739 211009 94 None - 0 Human 8.1 pIC50 = 8.1 Binding
In vitro concentration that reduced specific binding of [3H]U-440619 to guinea pig platelet receptor, TXA2 by 50%In vitro concentration that reduced specific binding of [3H]U-440619 to guinea pig platelet receptor, TXA2 by 50%
ChEMBL 354 8 1 3 4.6 CC1=C(C)C(=O)C(C(CCCCCC(=O)O)c2ccccc2)=C(C)C1=O 10.1021/jm00129a030
9801735 21307 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 411 11 1 5 5.2 Cc1ccc(CC(/C(=N/OCCCCC(=O)O)C2CCCCC2)n2ccnc2)cc1 10.1021/jm00047a016
CHEMBL120250 21307 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 411 11 1 5 5.2 Cc1ccc(CC(/C(=N/OCCCCC(=O)O)C2CCCCC2)n2ccnc2)cc1 10.1021/jm00047a016
10071192 119850 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 427 12 1 6 4.9 COc1ccc(CC(/C(=N/OCCCCC(=O)O)C2CCCCC2)n2ccnc2)cc1 10.1021/jm00047a016
CHEMBL331218 119850 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 427 12 1 6 4.9 COc1ccc(CC(/C(=N/OCCCCC(=O)O)C2CCCCC2)n2ccnc2)cc1 10.1021/jm00047a016
46202376 70528 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibition of thromboxane A2 receptorInhibition of thromboxane A2 receptor
ChEMBL 394 4 0 4 5.1 COc1ccc2c(c1)C(CC1CCOCC1)(c1ccc(Cl)cc1)n1ccnc1-2 10.1016/j.bmcl.2010.04.016
CHEMBL1801358 70528 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibition of thromboxane A2 receptorInhibition of thromboxane A2 receptor
ChEMBL 394 4 0 4 5.1 COc1ccc2c(c1)C(CC1CCOCC1)(c1ccc(Cl)cc1)n1ccnc1-2 10.1016/j.bmcl.2010.04.016
9973005 121518 0 None - 0 Human 4.1 pIC50 = 4.1 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 315 9 1 5 3.1 CC(/C(=N/OCCCCC(=O)O)c1ccccc1)n1ccnc1 10.1021/jm00047a016
CHEMBL333868 121518 0 None - 0 Human 4.1 pIC50 = 4.1 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 315 9 1 5 3.1 CC(/C(=N/OCCCCC(=O)O)c1ccccc1)n1ccnc1 10.1021/jm00047a016
10096378 24792 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 472 11 2 4 4.6 O=C(O)CCCC(c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL126373 24792 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 472 11 2 4 4.6 O=C(O)CCCC(c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10529683 170423 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 509 11 2 5 6.6 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NS(=O)(=O)c3ccc(/N=N/c4ccccc4)cc3)[C@@H]1C2 10.1021/jm970343g
CHEMBL420404 170423 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 509 11 2 5 6.6 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NS(=O)(=O)c3ccc(/N=N/c4ccccc4)cc3)[C@@H]1C2 10.1021/jm970343g
10380987 21327 0 None - 0 Human 4.1 pIC50 = 4.1 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 315 10 1 5 2.9 O=C(O)CCCCCO/N=C(\Cn1ccnc1)c1ccccc1 10.1021/jm00047a016
CHEMBL120370 21327 0 None - 0 Human 4.1 pIC50 = 4.1 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 315 10 1 5 2.9 O=C(O)CCCCCO/N=C(\Cn1ccnc1)c1ccccc1 10.1021/jm00047a016
10320883 20721 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 437 12 1 6 5.1 CSc1ccc(/C(=N\OCCCCC(=O)O)C(Cc2ccccc2)n2ccnc2)cc1 10.1021/jm00047a016
CHEMBL119661 20721 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 437 12 1 6 5.1 CSc1ccc(/C(=N\OCCCCC(=O)O)C(Cc2ccccc2)n2ccnc2)cc1 10.1021/jm00047a016
53358921 71215 0 None - 6 Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]-SQ29548 from human TP receptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]-SQ29548 from human TP receptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 482 7 1 5 5.4 CCN1c2ccccc2C[C@@H]1COc1ccc(C(=O)n2c(C)c(CC(=O)O)c3ccccc32)c(C)c1 10.1016/j.bmc.2011.06.014
CHEMBL1813287 71215 0 None - 6 Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]-SQ29548 from human TP receptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]-SQ29548 from human TP receptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 482 7 1 5 5.4 CCN1c2ccccc2C[C@@H]1COc1ccc(C(=O)n2c(C)c(CC(=O)O)c3ccccc32)c(C)c1 10.1016/j.bmc.2011.06.014
6366700 21292 7 None - 0 Human 7.1 pIC50 = 7.1 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 397 11 1 5 4.9 O=C(O)CCCCO/N=C(\C1CCCCC1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
CHEMBL120181 21292 7 None - 0 Human 7.1 pIC50 = 7.1 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 397 11 1 5 4.9 O=C(O)CCCCO/N=C(\C1CCCCC1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
10411480 24862 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 450 11 2 4 4.3 O=C(O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccccc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL126761 24862 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 450 11 2 4 4.3 O=C(O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccccc2)cc1)c1cccnc1 10.1021/jm00027a004
10595288 212097 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 369 8 2 2 4.7 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3ccccc3)[C@@H]1C2 10.1021/jm970343g
CHEMBL79413 212097 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 369 8 2 2 4.7 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3ccccc3)[C@@H]1C2 10.1021/jm970343g
3077003 123864 3 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 486 12 2 4 5.0 O=C(O)CCCCC(c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL339269 123864 3 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 486 12 2 4 5.0 O=C(O)CCCCC(c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10495597 66057 0 None - 1 Human 6.1 pIC50 = 6.1 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 316 3 4 6 2.1 O=[N+]([O-])c1cc(CC2NCCc3cc(O)c(O)cc32)ccc1O 10.1021/jm950896w
CHEMBL170451 66057 0 None - 1 Human 6.1 pIC50 = 6.1 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 316 3 4 6 2.1 O=[N+]([O-])c1cc(CC2NCCc3cc(O)c(O)cc32)ccc1O 10.1021/jm950896w
10453182 21840 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 393 11 1 6 3.2 O=C(O)COCCO/N=C(\c1ccccc1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
CHEMBL120943 21840 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 393 11 1 6 3.2 O=C(O)COCCO/N=C(\c1ccccc1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
10683471 66671 0 None - 1 Human 4.1 pIC50 = 4.1 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 270 2 4 4 2.1 Nc1ccc(CC2NCCc3cc(O)c(O)cc32)cc1 10.1021/jm950896w
CHEMBL173039 66671 0 None - 1 Human 4.1 pIC50 = 4.1 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 270 2 4 4 2.1 Nc1ccc(CC2NCCc3cc(O)c(O)cc32)cc1 10.1021/jm950896w
22901615 123691 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 480 9 2 4 4.4 O=C(O)CCC/C=C(/c1cccnc1)c1ccc2c(c1)CC(NS(=O)(=O)c1ccc(F)cc1)C2 10.1021/jm00027a004
CHEMBL338420 123691 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 480 9 2 4 4.4 O=C(O)CCC/C=C(/c1cccnc1)c1ccc2c(c1)CC(NS(=O)(=O)c1ccc(F)cc1)C2 10.1021/jm00027a004
10254733 25240 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 483 11 2 4 4.3 NC(=O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL127212 25240 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 483 11 2 4 4.3 NC(=O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
9867949 17291 24 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 441 8 3 4 5.6 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3csc4ccc(O)cc34)[C@@H]1C2 10.1021/jm970343g
CHEMBL116837 17291 24 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 441 8 3 4 5.6 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3csc4ccc(O)cc34)[C@@H]1C2 10.1021/jm970343g
10431401 18476 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 405 12 1 5 4.7 O=C(O)CCCCCO/N=C(/c1ccccc1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
CHEMBL118124 18476 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 405 12 1 5 4.7 O=C(O)CCCCCO/N=C(/c1ccccc1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
5747298 177214 1 None - 0 Human 6.0 pIC50 = 6.0 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 397 11 1 5 4.9 O=C(O)CCCCO/N=C(/C1CCCCC1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
CHEMBL444856 177214 1 None - 0 Human 6.0 pIC50 = 6.0 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 397 11 1 5 4.9 O=C(O)CCCCO/N=C(/C1CCCCC1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
19884707 111980 0 None - 1 Human 10.3 pKd = 10.3 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 507 13 1 5 6.9 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)CCCCCC2CCCCC2)co1 10.1021/jm00062a013
CHEMBL31146 111980 0 None - 1 Human 10.3 pKd = 10.3 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 507 13 1 5 6.9 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)CCCCCC2CCCCC2)co1 10.1021/jm00062a013
14952347 114128 0 None - 1 Human 10.0 pKd = 10 Binding
Compound was evaluated for the receptor binding studies with Thromboxane A2 receptor using [3H]-SQ 29548 as radioligand in human platelet membranes.Compound was evaluated for the receptor binding studies with Thromboxane A2 receptor using [3H]-SQ 29548 as radioligand in human platelet membranes.
ChEMBL 508 12 2 5 5.7 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/S0960-894X(01)81106-9
CHEMBL31765 114128 0 None - 1 Human 10.0 pKd = 10 Binding
Compound was evaluated for the receptor binding studies with Thromboxane A2 receptor using [3H]-SQ 29548 as radioligand in human platelet membranes.Compound was evaluated for the receptor binding studies with Thromboxane A2 receptor using [3H]-SQ 29548 as radioligand in human platelet membranes.
ChEMBL 508 12 2 5 5.7 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/S0960-894X(01)81106-9
14952347 114128 0 None - 1 Human 10.0 pKd = 10 Binding
Dissociation constant was determined from radioligand binding studies in human platelet membranes using Thromboxane A2 receptor radioligand [3H]-SQ 29,548.Dissociation constant was determined from radioligand binding studies in human platelet membranes using Thromboxane A2 receptor radioligand [3H]-SQ 29,548.
ChEMBL 508 12 2 5 5.7 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/S0960-894X(00)80592-2
CHEMBL31765 114128 0 None - 1 Human 10.0 pKd = 10 Binding
Dissociation constant was determined from radioligand binding studies in human platelet membranes using Thromboxane A2 receptor radioligand [3H]-SQ 29,548.Dissociation constant was determined from radioligand binding studies in human platelet membranes using Thromboxane A2 receptor radioligand [3H]-SQ 29,548.
ChEMBL 508 12 2 5 5.7 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/S0960-894X(00)80592-2
14952347 114128 0 None - 1 Human 10.0 pKd = 10 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 508 12 2 5 5.7 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1021/jm00062a013
CHEMBL31765 114128 0 None - 1 Human 10.0 pKd = 10 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 508 12 2 5 5.7 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1021/jm00062a013
14952443 109698 0 None - 1 Human 9.7 pKd = 9.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 536 12 2 5 5.6 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCc2ccc(Cl)cc2)co1 10.1021/jm00062a013
CHEMBL30615 109698 0 None - 1 Human 9.7 pKd = 9.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 536 12 2 5 5.6 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCc2ccc(Cl)cc2)co1 10.1021/jm00062a013
14952423 109854 0 None - 1 Human 9.7 pKd = 9.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 468 13 2 5 4.9 CCCCCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
CHEMBL30743 109854 0 None - 1 Human 9.7 pKd = 9.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 468 13 2 5 4.9 CCCCCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
19875349 106062 0 None - 1 Human 9.5 pKd = 9.5 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 532 13 2 6 5.0 COc1ccc(CCCCNC(=O)c2coc(C3C4CCC(O4)C3Cc3ccccc3CCC(=O)O)n2)cc1 10.1021/jm00062a013
CHEMBL281959 106062 0 None - 1 Human 9.5 pKd = 9.5 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 532 13 2 6 5.0 COc1ccc(CCCCNC(=O)c2coc(C3C4CCC(O4)C3Cc3ccccc3CCC(=O)O)n2)cc1 10.1021/jm00062a013
19875370 106370 0 None - 1 Human 9.5 pKd = 9.5 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 502 12 2 5 4.9 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCc2ccccc2)co1 10.1021/jm00062a013
CHEMBL283923 106370 0 None - 1 Human 9.5 pKd = 9.5 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 502 12 2 5 4.9 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCc2ccccc2)co1 10.1021/jm00062a013
52935553 84744 0 None - 1 Human 9.4 pKd = 9.4 Binding
Compound was evaluated for inhibition of specific binding of HSQ (5,6-di-3H-SQ 29,548) in washed plateletsCompound was evaluated for inhibition of specific binding of HSQ (5,6-di-3H-SQ 29,548) in washed platelets
ChEMBL 352 12 1 3 5.1 CC/C=C\CCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL2096756 84744 0 None - 1 Human 9.4 pKd = 9.4 Binding
Compound was evaluated for inhibition of specific binding of HSQ (5,6-di-3H-SQ 29,548) in washed plateletsCompound was evaluated for inhibition of specific binding of HSQ (5,6-di-3H-SQ 29,548) in washed platelets
ChEMBL 352 12 1 3 5.1 CC/C=C\CCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
44458593 102106 0 None - 1 Human 9.3 pKd = 9.3 Binding
Binding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligandBinding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligand
ChEMBL 466 9 2 4 5.4 O=C(O)CCc1ccccc1C[C@@H]1CCC[C@H]1c1nc(C(=O)NCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80329-7
CHEMBL25657 102106 0 None - 1 Human 9.3 pKd = 9.3 Binding
Binding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligandBinding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligand
ChEMBL 466 9 2 4 5.4 O=C(O)CCc1ccccc1C[C@@H]1CCC[C@H]1c1nc(C(=O)NCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80329-7
19875466 107763 0 None - 1 Human 9.3 pKd = 9.3 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 518 12 3 6 4.7 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCc2ccc(O)cc2)co1 10.1021/jm00062a013
CHEMBL29429 107763 0 None - 1 Human 9.3 pKd = 9.3 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 518 12 3 6 4.7 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCc2ccc(O)cc2)co1 10.1021/jm00062a013
19875479 110956 0 None - 1 Human 9.2 pKd = 9.2 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 482 11 2 5 5.1 CC(C)(C)CCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
CHEMBL30972 110956 0 None - 1 Human 9.2 pKd = 9.2 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 482 11 2 5 5.1 CC(C)(C)CCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
19875360 114600 0 None - 1 Human 9.2 pKd = 9.2 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 480 10 2 5 4.9 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCC2CCCCC2)co1 10.1021/jm00062a013
CHEMBL31922 114600 0 None - 1 Human 9.2 pKd = 9.2 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 480 10 2 5 4.9 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCC2CCCCC2)co1 10.1021/jm00062a013
19875435 166726 0 None - 1 Human 9.2 pKd = 9.2 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 474 10 2 5 4.2 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCc2ccccc2)co1 10.1021/jm00062a013
CHEMBL410732 166726 0 None - 1 Human 9.2 pKd = 9.2 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 474 10 2 5 4.2 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCc2ccccc2)co1 10.1021/jm00062a013
19875423 106020 0 None - 1 Human 9.1 pKd = 9.1 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 440 9 2 5 4.1 CCC(C)(C)NC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
CHEMBL281726 106020 0 None - 1 Human 9.1 pKd = 9.1 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 440 9 2 5 4.1 CCC(C)(C)NC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
44279917 112069 0 None - 1 Human 9.1 pKd = 9.1 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 522 13 2 5 6.1 O=C(O)CCCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1021/jm00062a013
CHEMBL31154 112069 0 None - 1 Human 9.1 pKd = 9.1 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 522 13 2 5 6.1 O=C(O)CCCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1021/jm00062a013
44279871 106816 0 None - 1 Human 9.0 pKd = 9 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 509 12 1 6 6.1 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)OCCCCC2CCCCC2)co1 10.1021/jm00062a013
CHEMBL286978 106816 0 None - 1 Human 9.0 pKd = 9 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 509 12 1 6 6.1 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)OCCCCC2CCCCC2)co1 10.1021/jm00062a013
20844482 214534 0 None - 1 Human 9.0 pKd = 9 Binding
The compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranesThe compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranes
ChEMBL 421 8 3 4 3.8 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1/C=N/NC(=O)Nc1ccccc1 10.1021/jm00113a030
CHEMBL95872 214534 0 None - 1 Human 9.0 pKd = 9 Binding
The compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranesThe compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranes
ChEMBL 421 8 3 4 3.8 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1/C=N/NC(=O)Nc1ccccc1 10.1021/jm00113a030
13799378 111234 0 None - 1 Human 9.0 pKd = 9.0 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 462 14 3 4 4.0 O=C(O)CCC/C=C/CC1C2CCC(O2)C1CNC(=O)CNC(=O)CCCC1CCCCC1 10.1021/jm00171a021
CHEMBL310406 111234 0 None - 1 Human 9.0 pKd = 9.0 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 462 14 3 4 4.0 O=C(O)CCC/C=C/CC1C2CCC(O2)C1CNC(=O)CNC(=O)CCCC1CCCCC1 10.1021/jm00171a021
18675848 106610 0 None - 1 Human 8.9 pKd = 8.9 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 494 11 2 5 5.3 O=C(O)Cc1cccc(CC2C3CCC(O3)C2c2nc(C(=O)NCCCCC3CCCCC3)co2)c1 10.1021/jm00062a013
CHEMBL285596 106610 0 None - 1 Human 8.9 pKd = 8.9 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 494 11 2 5 5.3 O=C(O)Cc1cccc(CC2C3CCC(O3)C2c2nc(C(=O)NCCCCC3CCCCC3)co2)c1 10.1021/jm00062a013
19097508 105548 0 None - 1 Human 8.9 pKd = 8.9 Binding
In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548
ChEMBL 508 10 2 5 4.8 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
CHEMBL278159 105548 0 None - 1 Human 8.9 pKd = 8.9 Binding
In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548
ChEMBL 508 10 2 5 4.8 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
19097508 105548 0 None - 1 Human 8.9 pKd = 8.9 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 508 10 2 5 4.8 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1021/jm00062a013
CHEMBL278159 105548 0 None - 1 Human 8.9 pKd = 8.9 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 508 10 2 5 4.8 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1021/jm00062a013
118718127 122054 0 None - 1 Human 8.8 pKd = 8.8 Binding
Compound was evaluated for inhibition of specific binding of HSQ (5,6-di-3H-SQ 29,548) in washed plateletsCompound was evaluated for inhibition of specific binding of HSQ (5,6-di-3H-SQ 29,548) in washed platelets
ChEMBL 354 13 1 3 5.3 CCCCCCSC[C@H]1C2CC[C@@H](O2)[C@H]1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL3349042 122054 0 None - 1 Human 8.8 pKd = 8.8 Binding
Compound was evaluated for inhibition of specific binding of HSQ (5,6-di-3H-SQ 29,548) in washed plateletsCompound was evaluated for inhibition of specific binding of HSQ (5,6-di-3H-SQ 29,548) in washed platelets
ChEMBL 354 13 1 3 5.3 CCCCCCSC[C@H]1C2CC[C@@H](O2)[C@H]1C/C=C\CCCC(=O)O 10.1021/jm00125a009
19875425 109188 0 None - 1 Human 8.8 pKd = 8.8 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 585 13 2 7 4.7 CS(=O)(=O)NC(=O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1021/jm00062a013
CHEMBL30398 109188 0 None - 1 Human 8.8 pKd = 8.8 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 585 13 2 7 4.7 CS(=O)(=O)NC(=O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1021/jm00062a013
19973038 174983 0 None - 1 Human 8.0 pKd = 8 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 412 9 2 5 3.3 CCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
CHEMBL433435 174983 0 None - 1 Human 8.0 pKd = 8 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 412 9 2 5 3.3 CCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
19097519 169052 0 None - 1 Human 8.0 pKd = 8.0 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 524 12 2 5 6.6 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(/C(S)=N/CCCCC2CCCCC2)co1 10.1021/jm00062a013
CHEMBL416395 169052 0 None - 1 Human 8.0 pKd = 8.0 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 524 12 2 5 6.6 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(/C(S)=N/CCCCC2CCCCC2)co1 10.1021/jm00062a013
3356 9060 73 None -38 8 Human 8.0 pKd = 8.0 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1021/jm0603668
4326 9060 73 None -38 8 Human 8.0 pKd = 8.0 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1021/jm0603668
9867642 9060 73 None -38 8 Human 8.0 pKd = 8.0 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1021/jm0603668
CHEMBL426559 9060 73 None -38 8 Human 8.0 pKd = 8.0 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1021/jm0603668
DB11629 9060 73 None -38 8 Human 8.0 pKd = 8.0 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1021/jm0603668
54757965 72054 0 None - 1 Mouse 5.0 pKd = 5 Binding
Displacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 353 8 2 3 2.8 O=S(=O)(NCCc1cccc(CCCO)c1)c1ccc(Cl)cc1 10.1021/jm200980u
CHEMBL1828642 72054 0 None - 1 Mouse 5.0 pKd = 5 Binding
Displacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 353 8 2 3 2.8 O=S(=O)(NCCc1cccc(CCCO)c1)c1ccc(Cl)cc1 10.1021/jm200980u
19838931 215118 0 None - 1 Human 6.0 pKd = 6.0 Binding
The compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranesThe compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranes
ChEMBL 421 8 3 4 3.8 O=C(O)Cc1cccc(CCC2C3CCC(O3)C2/C=N/NC(=O)Nc2ccccc2)c1 10.1021/jm00113a030
CHEMBL99348 215118 0 None - 1 Human 6.0 pKd = 6.0 Binding
The compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranesThe compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranes
ChEMBL 421 8 3 4 3.8 O=C(O)Cc1cccc(CCC2C3CCC(O3)C2/C=N/NC(=O)Nc2ccccc2)c1 10.1021/jm00113a030
19104215 94735 0 None - 1 Human 8.0 pKd = 8.0 Binding
Binding affinity was determined for Thromboxane A2 receptor in human platelet membrane in presence of [3H]-SQ-29,548 radioligandBinding affinity was determined for Thromboxane A2 receptor in human platelet membrane in presence of [3H]-SQ-29,548 radioligand
ChEMBL 481 12 2 5 5.5 O=C(O)CCc1ccccc1CN1CCCC1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/S0960-894X(00)80328-5
CHEMBL23414 94735 0 None - 1 Human 8.0 pKd = 8.0 Binding
Binding affinity was determined for Thromboxane A2 receptor in human platelet membrane in presence of [3H]-SQ-29,548 radioligandBinding affinity was determined for Thromboxane A2 receptor in human platelet membrane in presence of [3H]-SQ-29,548 radioligand
ChEMBL 481 12 2 5 5.5 O=C(O)CCc1ccccc1CN1CCCC1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/S0960-894X(00)80328-5
54669847 72227 0 None 18 2 Mouse 8.0 pKd = 8.0 Binding
Displacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 405 7 2 4 3.4 O=C1C=C(O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1 10.1021/jm200980u
CHEMBL1829805 72227 0 None 18 2 Mouse 8.0 pKd = 8.0 Binding
Displacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 405 7 2 4 3.4 O=C1C=C(O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1 10.1021/jm200980u
19875443 170039 0 None - 1 Human 8.0 pKd = 8.0 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 454 11 1 5 4.5 CCCCCN(C)C(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
CHEMBL418583 170039 0 None - 1 Human 8.0 pKd = 8.0 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 454 11 1 5 4.5 CCCCCN(C)C(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
23302977 209418 0 None - 1 Human 7.0 pKd = 7.0 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 543 15 2 5 7.7 O=C(O)CCCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
CHEMBL61306 209418 0 None - 1 Human 7.0 pKd = 7.0 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 543 15 2 5 7.7 O=C(O)CCCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
44301139 108824 0 None - 1 Human 6.0 pKd = 6.0 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 531 14 2 5 6.2 O=C(O)CCCC/C=C(\c1cccnc1)c1ccccc1C1=N[C@@H](C(=O)NCCCCC2CCCCC2)CO1 10.1016/s0960-894x(98)00353-9
CHEMBL301904 108824 0 None - 1 Human 6.0 pKd = 6.0 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 531 14 2 5 6.2 O=C(O)CCCC/C=C(\c1cccnc1)c1ccccc1C1=N[C@@H](C(=O)NCCCCC2CCCCC2)CO1 10.1016/s0960-894x(98)00353-9
19813455 106156 0 None - 1 Human 7.0 pKd = 7.0 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 494 12 2 5 5.6 O=C(NCCCCC1CCCCC1)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCCO)n1 10.1021/jm00062a013
CHEMBL282601 106156 0 None - 1 Human 7.0 pKd = 7.0 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 494 12 2 5 5.6 O=C(NCCCCC1CCCCC1)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCCO)n1 10.1021/jm00062a013
15462459 108448 0 None - 1 Human 6.0 pKd = 6.0 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 447 11 2 5 3.8 O=C(O)CCCC/C=C(\c1ccc(C2=N[C@H](C(=O)NCC3CC3)CO2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
CHEMBL299280 108448 0 None - 1 Human 6.0 pKd = 6.0 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 447 11 2 5 3.8 O=C(O)CCCC/C=C(\c1ccc(C2=N[C@H](C(=O)NCC3CC3)CO2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
54757867 72225 0 None -9 2 Human 4.9 pKd = 4.9 Binding
Displacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 405 7 2 4 3.6 O=C1CCC(O)=C1Cc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm200980u
CHEMBL1829803 72225 0 None -9 2 Human 4.9 pKd = 4.9 Binding
Displacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 405 7 2 4 3.6 O=C1CCC(O)=C1Cc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm200980u
54757867 72225 0 None 9 2 Mouse 5.9 pKd = 5.9 Binding
Displacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 405 7 2 4 3.6 O=C1CCC(O)=C1Cc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm200980u
CHEMBL1829803 72225 0 None 9 2 Mouse 5.9 pKd = 5.9 Binding
Displacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 405 7 2 4 3.6 O=C1CCC(O)=C1Cc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm200980u
14673099 114295 0 None - 1 Human 5.9 pKd = 5.9 Binding
The compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranesThe compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranes
ChEMBL 423 8 3 5 3.3 O=C(O)COc1cccc(CC2C3CCC(O3)C2/C=N/NC(=O)Nc2ccccc2)c1 10.1021/jm00113a030
CHEMBL318673 114295 0 None - 1 Human 5.9 pKd = 5.9 Binding
The compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranesThe compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranes
ChEMBL 423 8 3 5 3.3 O=C(O)COc1cccc(CC2C3CCC(O3)C2/C=N/NC(=O)Nc2ccccc2)c1 10.1021/jm00113a030
10369704 107670 0 None - 1 Human 7.9 pKd = 7.9 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 529 14 2 5 7.3 O=C(O)CCCC/C=C(/c1cccnc1)c1cccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)c1 10.1016/s0960-894x(98)00353-9
CHEMBL293764 107670 0 None - 1 Human 7.9 pKd = 7.9 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 529 14 2 5 7.3 O=C(O)CCCC/C=C(/c1cccnc1)c1cccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)c1 10.1016/s0960-894x(98)00353-9
14885216 212084 0 None - 1 Human 7.9 pKd = 7.9 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 438 15 3 4 4.4 CCCCCC/C(S)=N/CC(=O)NCC1C2CCC(O2)C1C/C=C/CCCC(=O)O 10.1021/jm00171a021
CHEMBL79287 212084 0 None - 1 Human 7.9 pKd = 7.9 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 438 15 3 4 4.4 CCCCCC/C(S)=N/CC(=O)NCC1C2CCC(O2)C1C/C=C/CCCC(=O)O 10.1021/jm00171a021
15462462 205041 0 None - 1 Human 6.9 pKd = 6.9 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 481 11 2 5 5.7 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCc3ccccc3)co2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
CHEMBL57576 205041 0 None - 1 Human 6.9 pKd = 6.9 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 481 11 2 5 5.7 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCc3ccccc3)co2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
71452805 86471 0 None - 1 Human 6.9 pKd = 6.9 Binding
Binding affinity of Thromboxane A2 (TXA2) receptor using [3H]-SQ 29,548 radioligand in washed human plateletsBinding affinity of Thromboxane A2 (TXA2) receptor using [3H]-SQ 29,548 radioligand in washed human platelets
ChEMBL 282 2 0 2 4.4 CC1(C)C2CC[C@H](Cc3cccc4ccc(=O)oc34)C1C2 10.1016/0960-894X(95)00284-Z
CHEMBL2115413 86471 0 None - 1 Human 6.9 pKd = 6.9 Binding
Binding affinity of Thromboxane A2 (TXA2) receptor using [3H]-SQ 29,548 radioligand in washed human plateletsBinding affinity of Thromboxane A2 (TXA2) receptor using [3H]-SQ 29,548 radioligand in washed human platelets
ChEMBL 282 2 0 2 4.4 CC1(C)C2CC[C@H](Cc3cccc4ccc(=O)oc34)C1C2 10.1016/0960-894X(95)00284-Z
10546960 210134 0 None -70 3 Human 6.9 pKd = 6.9 Binding
Displacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 367 8 2 3 2.9 O=C(O)CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm200980u
CHEMBL65121 210134 0 None -70 3 Human 6.9 pKd = 6.9 Binding
Displacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 367 8 2 3 2.9 O=C(O)CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm200980u
15852312 208282 0 None - 1 Human 6.8 pKd = 6.8 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 529 14 2 5 7.3 O=C(O)CCCC/C=C(/c1ccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
CHEMBL60516 208282 0 None - 1 Human 6.8 pKd = 6.8 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 529 14 2 5 7.3 O=C(O)CCCC/C=C(/c1ccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
44301318 203906 0 None - 1 Human 7.8 pKd = 7.8 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 531 14 2 5 6.2 O=C(O)CCCC/C=C(\c1ccc(C2=N[C@@H](C(=O)NCCCCC3CCCCC3)CO2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
CHEMBL56778 203906 0 None - 1 Human 7.8 pKd = 7.8 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 531 14 2 5 6.2 O=C(O)CCCC/C=C(\c1ccc(C2=N[C@@H](C(=O)NCCCCC3CCCCC3)CO2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
15852311 205575 0 None - 1 Human 7.8 pKd = 7.8 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 531 14 2 5 6.2 O=C(O)CCCC/C=C(\c1ccc(C2=N[C@H](C(=O)NCCCCC3CCCCC3)CO2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
CHEMBL58332 205575 0 None - 1 Human 7.8 pKd = 7.8 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 531 14 2 5 6.2 O=C(O)CCCC/C=C(\c1ccc(C2=N[C@H](C(=O)NCCCCC3CCCCC3)CO2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
15458912 107370 0 None - 1 Human 5.8 pKd = 5.8 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 529 14 2 5 7.3 O=C(O)CCCC/C=C(\c1cccnc1)c1ccccc1-c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/s0960-894x(98)00353-9
CHEMBL291789 107370 0 None - 1 Human 5.8 pKd = 5.8 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 529 14 2 5 7.3 O=C(O)CCCC/C=C(\c1cccnc1)c1ccccc1-c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/s0960-894x(98)00353-9
44301194 107339 0 None - 1 Human 6.8 pKd = 6.8 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 461 13 2 5 5.7 CCCCCNC(=O)c1coc(-c2ccc(/C(=C\CCCCC(=O)O)c3cccnc3)cc2)n1 10.1016/s0960-894x(98)00353-9
CHEMBL291539 107339 0 None - 1 Human 6.8 pKd = 6.8 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 461 13 2 5 5.7 CCCCCNC(=O)c1coc(-c2ccc(/C(=C\CCCCC(=O)O)c3cccnc3)cc2)n1 10.1016/s0960-894x(98)00353-9
19875405 105877 0 None - 1 Human 7.8 pKd = 7.8 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 508 12 2 5 5.7 O=C(O)Cc1cccc(CCC2C3CCC(O3)C2c2nc(C(=O)NCCCCC3CCCCC3)co2)c1 10.1021/jm00062a013
CHEMBL280786 105877 0 None - 1 Human 7.8 pKd = 7.8 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 508 12 2 5 5.7 O=C(O)Cc1cccc(CCC2C3CCC(O3)C2c2nc(C(=O)NCCCCC3CCCCC3)co2)c1 10.1021/jm00062a013
54758054 72224 0 None 20 2 Mouse 7.8 pKd = 7.8 Binding
Displacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 420 8 3 6 1.8 O=c1c(O)c(NCc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)c1=O 10.1021/jm200980u
CHEMBL1829802 72224 0 None 20 2 Mouse 7.8 pKd = 7.8 Binding
Displacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 420 8 3 6 1.8 O=c1c(O)c(NCc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)c1=O 10.1021/jm200980u
13799369 212347 0 None - 1 Human 7.8 pKd = 7.8 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 436 16 3 4 3.6 CCCCCCCC(=O)NCC(=O)NCC1C2CCC(O2)C1C/C=C/CCCC(=O)O 10.1021/jm00171a021
CHEMBL81263 212347 0 None - 1 Human 7.8 pKd = 7.8 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 436 16 3 4 3.6 CCCCCCCC(=O)NCC(=O)NCC1C2CCC(O2)C1C/C=C/CCCC(=O)O 10.1021/jm00171a021
44209494 215077 0 None - 1 Human 6.8 pKd = 6.8 Binding
The compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranesThe compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranes
ChEMBL 407 7 3 4 3.5 O=C(O)Cc1cccc(CC2C3CCC(O3)C2/C=N/NC(=O)Nc2ccccc2)c1 10.1021/jm00113a030
CHEMBL99041 215077 0 None - 1 Human 6.8 pKd = 6.8 Binding
The compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranesThe compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranes
ChEMBL 407 7 3 4 3.5 O=C(O)Cc1cccc(CC2C3CCC(O3)C2/C=N/NC(=O)Nc2ccccc2)c1 10.1021/jm00113a030
15052910 198705 1 None - 1 Human 6.8 pKd = 6.8 Binding
Tested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligandTested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligand
ChEMBL 313 11 2 3 2.8 O=C(O)CCCCCCCCNS(=O)(=O)c1ccccc1 10.1016/S0960-894X(01)80794-0
CHEMBL52003 198705 1 None - 1 Human 6.8 pKd = 6.8 Binding
Tested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligandTested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligand
ChEMBL 313 11 2 3 2.8 O=C(O)CCCCCCCCNS(=O)(=O)c1ccccc1 10.1016/S0960-894X(01)80794-0
19875358 106773 0 None - 1 Human 7.7 pKd = 7.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 494 11 2 5 5.7 O=C(O)c1cccc(CCC2C3CCC(O3)C2c2nc(C(=O)NCCCCC3CCCCC3)co2)c1 10.1021/jm00062a013
CHEMBL286708 106773 0 None - 1 Human 7.7 pKd = 7.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 494 11 2 5 5.7 O=C(O)c1cccc(CCC2C3CCC(O3)C2c2nc(C(=O)NCCCCC3CCCCC3)co2)c1 10.1021/jm00062a013
44301250 209071 0 None - 1 Human 5.7 pKd = 5.7 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 531 14 2 5 6.2 O=C(O)CCCC/C=C(/c1cccnc1)c1ccccc1C1=N[C@@H](C(=O)NCCCCC2CCCCC2)CO1 10.1016/s0960-894x(98)00353-9
CHEMBL61021 209071 0 None - 1 Human 5.7 pKd = 5.7 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 531 14 2 5 6.2 O=C(O)CCCC/C=C(/c1cccnc1)c1ccccc1C1=N[C@@H](C(=O)NCCCCC2CCCCC2)CO1 10.1016/s0960-894x(98)00353-9
54758053 72223 0 None 17 2 Mouse 7.7 pKd = 7.7 Binding
Displacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 391 8 2 5 2.2 O=S(=O)(NCCc1cccc(CCc2nn[nH]n2)c1)c1ccc(Cl)cc1 10.1021/jm200980u
CHEMBL1829801 72223 0 None 17 2 Mouse 7.7 pKd = 7.7 Binding
Displacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 391 8 2 5 2.2 O=S(=O)(NCCc1cccc(CCc2nn[nH]n2)c1)c1ccc(Cl)cc1 10.1021/jm200980u
18944178 66128 0 None - 1 Human 7.7 pKd = 7.7 Binding
Dissociation constant was determined from radioligand binding studies in human platelet membranes using Thromboxane A2 receptor radioligand [3H]-SQ 29,548.Dissociation constant was determined from radioligand binding studies in human platelet membranes using Thromboxane A2 receptor radioligand [3H]-SQ 29,548.
ChEMBL 488 12 2 4 6.4 O=C(O)CCc1ccccc1Cc1ccccc1-c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/S0960-894X(00)80592-2
CHEMBL170747 66128 0 None - 1 Human 7.7 pKd = 7.7 Binding
Dissociation constant was determined from radioligand binding studies in human platelet membranes using Thromboxane A2 receptor radioligand [3H]-SQ 29,548.Dissociation constant was determined from radioligand binding studies in human platelet membranes using Thromboxane A2 receptor radioligand [3H]-SQ 29,548.
ChEMBL 488 12 2 4 6.4 O=C(O)CCc1ccccc1Cc1ccccc1-c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/S0960-894X(00)80592-2
19875392 106871 0 None - 1 Human 7.7 pKd = 7.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 426 7 2 5 3.7 CC(C)(C)NC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
CHEMBL287421 106871 0 None - 1 Human 7.7 pKd = 7.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 426 7 2 5 3.7 CC(C)(C)NC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
19813457 111317 0 None - 1 Human 7.7 pKd = 7.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 494 11 2 5 5.3 O=C(O)Cc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1021/jm00062a013
CHEMBL31043 111317 0 None - 1 Human 7.7 pKd = 7.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 494 11 2 5 5.3 O=C(O)Cc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1021/jm00062a013
44461598 112630 0 None - 1 Human 8.6 pKd = 8.6 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 476 15 3 4 4.4 O=C(O)CCC/C=C/CC1C2CCC(O2)C1CNC(=O)CNC(=O)CCCCC1CCCCC1 10.1021/jm00171a021
CHEMBL312732 112630 0 None - 1 Human 8.6 pKd = 8.6 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 476 15 3 4 4.4 O=C(O)CCC/C=C/CC1C2CCC(O2)C1CNC(=O)CNC(=O)CCCCC1CCCCC1 10.1021/jm00171a021
19875446 106828 0 None - 1 Human 8.5 pKd = 8.5 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 548 13 2 6 5.7 CSc1ccc(CCCCNC(=O)c2coc(C3C4CCC(O4)C3Cc3ccccc3CCC(=O)O)n2)cc1 10.1021/jm00062a013
CHEMBL287068 106828 0 None - 1 Human 8.5 pKd = 8.5 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 548 13 2 6 5.7 CSc1ccc(CCCCNC(=O)c2coc(C3C4CCC(O4)C3Cc3ccccc3CCC(=O)O)n2)cc1 10.1021/jm00062a013
44279758 114263 0 None - 1 Human 8.5 pKd = 8.5 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 454 9 2 5 4.4 CC(C)(C)CCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
CHEMBL31850 114263 0 None - 1 Human 8.5 pKd = 8.5 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 454 9 2 5 4.4 CC(C)(C)CCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
6913677 192110 1 None - 1 Human 8.5 pKd = 8.5 Binding
Tested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligandTested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligand
ChEMBL 377 9 2 3 3.6 O=C(O)CCC/C=C\CC1C2CCC(C2)C1NS(=O)(=O)c1ccccc1 10.1016/S0960-894X(01)80794-0
CHEMBL48597 192110 1 None - 1 Human 8.5 pKd = 8.5 Binding
Tested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligandTested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligand
ChEMBL 377 9 2 3 3.6 O=C(O)CCC/C=C\CC1C2CCC(C2)C1NS(=O)(=O)c1ccccc1 10.1016/S0960-894X(01)80794-0
44279913 109831 0 None - 1 Human 7.7 pKd = 7.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 456 12 3 6 3.1 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCCO)co1 10.1021/jm00062a013
CHEMBL30727 109831 0 None - 1 Human 7.7 pKd = 7.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 456 12 3 6 3.1 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCCO)co1 10.1021/jm00062a013
54669847 72227 0 None -18 2 Human 6.7 pKd = 6.7 Binding
Displacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 405 7 2 4 3.4 O=C1C=C(O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1 10.1021/jm200980u
CHEMBL1829805 72227 0 None -18 2 Human 6.7 pKd = 6.7 Binding
Displacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 405 7 2 4 3.4 O=C1C=C(O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1 10.1021/jm200980u
44329879 214532 0 None - 1 Human 7.7 pKd = 7.7 Binding
The compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranesThe compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranes
ChEMBL 435 9 3 4 4.2 O=C(O)CCCc1ccccc1CC1C2CCC(O2)C1/C=N/NC(=O)Nc1ccccc1 10.1021/jm00113a030
CHEMBL95867 214532 0 None - 1 Human 7.7 pKd = 7.7 Binding
The compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranesThe compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranes
ChEMBL 435 9 3 4 4.2 O=C(O)CCCc1ccccc1CC1C2CCC(O2)C1/C=N/NC(=O)Nc1ccccc1 10.1021/jm00113a030
19875478 109130 0 None - 1 Human 7.7 pKd = 7.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 551 13 3 6 4.5 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC(=O)NC2CCCCC2)co1 10.1021/jm00062a013
CHEMBL30377 109130 0 None - 1 Human 7.7 pKd = 7.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 551 13 3 6 4.5 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC(=O)NC2CCCCC2)co1 10.1021/jm00062a013
19875474 116423 0 None - 1 Human 7.7 pKd = 7.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 509 12 2 6 4.2 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCN2CCCCC2)co1 10.1021/jm00062a013
CHEMBL2368531 116423 0 None - 1 Human 7.7 pKd = 7.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 509 12 2 6 4.2 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCN2CCCCC2)co1 10.1021/jm00062a013
CHEMBL32237 116423 0 None - 1 Human 7.7 pKd = 7.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 509 12 2 6 4.2 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCN2CCCCC2)co1 10.1021/jm00062a013
18666327 91435 0 None - 1 Human 7.6 pKd = 7.6 Binding
Binding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligandBinding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligand
ChEMBL 480 12 2 4 6.3 O=C(O)CCc1ccccc1C[C@@H]1CCC[C@@H]1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/S0960-894X(00)80329-7
CHEMBL22244 91435 0 None - 1 Human 7.6 pKd = 7.6 Binding
Binding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligandBinding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligand
ChEMBL 480 12 2 4 6.3 O=C(O)CCc1ccccc1C[C@@H]1CCC[C@@H]1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/S0960-894X(00)80329-7
44301207 108542 0 None - 1 Human 6.6 pKd = 6.6 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 463 13 2 5 4.6 CCCCCNC(=O)[C@@H]1COC(c2ccc(/C(=C\CCCCC(=O)O)c3cccnc3)cc2)=N1 10.1016/s0960-894x(98)00353-9
CHEMBL299886 108542 0 None - 1 Human 6.6 pKd = 6.6 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 463 13 2 5 4.6 CCCCCNC(=O)[C@@H]1COC(c2ccc(/C(=C\CCCCC(=O)O)c3cccnc3)cc2)=N1 10.1016/s0960-894x(98)00353-9
54669848 72228 0 None 12 2 Mouse 7.6 pKd = 7.6 Binding
Displacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 419 7 2 4 3.8 CC1=C(O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)CC1=O 10.1021/jm200980u
CHEMBL1829806 72228 0 None 12 2 Mouse 7.6 pKd = 7.6 Binding
Displacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 419 7 2 4 3.8 CC1=C(O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)CC1=O 10.1021/jm200980u
10546960 210134 0 None -13 3 Mouse 7.6 pKd = 7.6 Binding
Displacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 367 8 2 3 2.9 O=C(O)CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm200980u
CHEMBL65121 210134 0 None -13 3 Mouse 7.6 pKd = 7.6 Binding
Displacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 367 8 2 3 2.9 O=C(O)CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm200980u
19875366 108481 0 None - 1 Human 7.6 pKd = 7.6 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 412 8 2 5 3.3 CC(C)NC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
CHEMBL29947 108481 0 None - 1 Human 7.6 pKd = 7.6 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 412 8 2 5 3.3 CC(C)NC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
44461401 112402 0 None - 1 Human 7.6 pKd = 7.6 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 454 15 3 4 5.6 CCCCCC/C(S)=N/C/C(S)=N/CC1C2CC[C@@H](O2)C1C/C=C/CCCC(=O)O 10.1021/jm00171a021
CHEMBL312360 112402 0 None - 1 Human 7.6 pKd = 7.6 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 454 15 3 4 5.6 CCCCCC/C(S)=N/C/C(S)=N/CC1C2CC[C@@H](O2)C1C/C=C/CCCC(=O)O 10.1021/jm00171a021
18675853 109972 0 None - 1 Human 8.5 pKd = 8.5 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 510 12 2 6 5.1 O=C(O)COc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1021/jm00062a013
CHEMBL30832 109972 0 None - 1 Human 8.5 pKd = 8.5 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 510 12 2 6 5.1 O=C(O)COc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1021/jm00062a013
44458568 96223 0 None - 1 Human 8.5 pKd = 8.5 Binding
Binding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligandBinding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligand
ChEMBL 466 9 2 4 5.4 O=C(O)CCc1ccccc1C[C@H]1CCC[C@@H]1c1nc(C(=O)NCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80329-7
CHEMBL23711 96223 0 None - 1 Human 8.5 pKd = 8.5 Binding
Binding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligandBinding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligand
ChEMBL 466 9 2 4 5.4 O=C(O)CCc1ccccc1C[C@H]1CCC[C@@H]1c1nc(C(=O)NCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80329-7
19875414 109586 0 None - 1 Human 8.4 pKd = 8.4 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 520 12 2 5 5.1 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCc2ccc(F)cc2)co1 10.1021/jm00062a013
CHEMBL30537 109586 0 None - 1 Human 8.4 pKd = 8.4 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 520 12 2 5 5.1 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCc2ccc(F)cc2)co1 10.1021/jm00062a013
18944131 93970 0 None - 1 Human 7.5 pKd = 7.5 Binding
In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548
ChEMBL 484 10 2 6 4.0 O=C(O)CCc1ccccc1CC1OCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
CHEMBL23273 93970 0 None - 1 Human 7.5 pKd = 7.5 Binding
In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548
ChEMBL 484 10 2 6 4.0 O=C(O)CCc1ccccc1CC1OCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
54669848 72228 0 None -12 2 Human 6.5 pKd = 6.5 Binding
Displacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 419 7 2 4 3.8 CC1=C(O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)CC1=O 10.1021/jm200980u
CHEMBL1829806 72228 0 None -12 2 Human 6.5 pKd = 6.5 Binding
Displacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 419 7 2 4 3.8 CC1=C(O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)CC1=O 10.1021/jm200980u
15462454 203820 0 None - 1 Human 7.5 pKd = 7.5 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 515 13 2 5 6.9 O=C(O)CCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
CHEMBL56722 203820 0 None - 1 Human 7.5 pKd = 7.5 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 515 13 2 5 6.9 O=C(O)CCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
54758053 72223 0 None -17 2 Human 6.5 pKd = 6.5 Binding
Displacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 391 8 2 5 2.2 O=S(=O)(NCCc1cccc(CCc2nn[nH]n2)c1)c1ccc(Cl)cc1 10.1021/jm200980u
CHEMBL1829801 72223 0 None -17 2 Human 6.5 pKd = 6.5 Binding
Displacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 391 8 2 5 2.2 O=S(=O)(NCCc1cccc(CCc2nn[nH]n2)c1)c1ccc(Cl)cc1 10.1021/jm200980u
54758054 72224 0 None -20 2 Human 6.5 pKd = 6.5 Binding
Displacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 420 8 3 6 1.8 O=c1c(O)c(NCc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)c1=O 10.1021/jm200980u
CHEMBL1829802 72224 0 None -20 2 Human 6.5 pKd = 6.5 Binding
Displacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 420 8 3 6 1.8 O=c1c(O)c(NCc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)c1=O 10.1021/jm200980u
44280058 106101 0 None - 1 Human 7.4 pKd = 7.4 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 536 12 2 5 6.3 CC(C)(Cc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1)C(=O)O 10.1021/jm00062a013
CHEMBL282186 106101 0 None - 1 Human 7.4 pKd = 7.4 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 536 12 2 5 6.3 CC(C)(Cc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1)C(=O)O 10.1021/jm00062a013
44295187 195519 0 None - 1 Human 7.4 pKd = 7.4 Binding
Tested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligandTested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligand
ChEMBL 351 9 2 3 3.3 O=C(O)CCC/C=C\C[C@H]1CCC[C@H]1NS(=O)(=O)c1ccccc1 10.1016/S0960-894X(01)80794-0
CHEMBL50507 195519 0 None - 1 Human 7.4 pKd = 7.4 Binding
Tested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligandTested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligand
ChEMBL 351 9 2 3 3.3 O=C(O)CCC/C=C\C[C@H]1CCC[C@H]1NS(=O)(=O)c1ccccc1 10.1016/S0960-894X(01)80794-0
44458583 172496 0 None - 1 Human 7.4 pKd = 7.4 Binding
Binding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligandBinding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligand
ChEMBL 466 10 2 4 5.4 C/C(Cc1ccccc1CCC(=O)O)=C(\C)c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80329-7
CHEMBL424587 172496 0 None - 1 Human 7.4 pKd = 7.4 Binding
Binding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligandBinding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligand
ChEMBL 466 10 2 4 5.4 C/C(Cc1ccccc1CCC(=O)O)=C(\C)c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80329-7
15462461 208403 0 None - 1 Human 6.4 pKd = 6.4 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 483 11 2 5 4.6 O=C(O)CCCC/C=C(\c1ccc(C2=N[C@H](C(=O)NCc3ccccc3)CO2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
CHEMBL60587 208403 0 None - 1 Human 6.4 pKd = 6.4 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 483 11 2 5 4.6 O=C(O)CCCC/C=C(\c1ccc(C2=N[C@H](C(=O)NCc3ccccc3)CO2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
44329690 114255 0 None - 1 Human 7.4 pKd = 7.4 Binding
The compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranesThe compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranes
ChEMBL 385 9 3 4 3.8 O=C(O)CCC/C=C\CC1C2CCC(O2)C1/C=N/NC(=O)Nc1ccccc1 10.1021/jm00113a030
CHEMBL318426 114255 0 None - 1 Human 7.4 pKd = 7.4 Binding
The compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranesThe compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranes
ChEMBL 385 9 3 4 3.8 O=C(O)CCC/C=C\CC1C2CCC(O2)C1/C=N/NC(=O)Nc1ccccc1 10.1021/jm00113a030
21865528 106239 5 None - 1 Human 8.4 pKd = 8.4 Binding
In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548
ChEMBL 440 11 2 5 4.1 CCCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1016/S0960-894X(00)80330-3
CHEMBL283100 106239 5 None - 1 Human 8.4 pKd = 8.4 Binding
In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548
ChEMBL 440 11 2 5 4.1 CCCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1016/S0960-894X(00)80330-3
21865528 106239 5 None - 1 Human 8.4 pKd = 8.4 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 440 11 2 5 4.1 CCCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
CHEMBL283100 106239 5 None - 1 Human 8.4 pKd = 8.4 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 440 11 2 5 4.1 CCCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
1987 8770 19 None 1 2 Rat 8.4 pKd = 8.4 Binding
Inhibition of [3H]-SQ 29,548 radioligand binding to thromboxane A2 (TXA2) receptor of human platelet membranesInhibition of [3H]-SQ 29,548 radioligand binding to thromboxane A2 (TXA2) receptor of human platelet membranes
ChEMBL 440 11 2 5 4.1 CCCCCNC(=O)c1coc(n1)[C@@H]1[C@H]2CC[C@@H]([C@@H]1Cc1ccccc1CCC(=O)O)O2 10.1016/S0960-894X(00)80658-7
3037233 8770 19 None 1 2 Rat 8.4 pKd = 8.4 Binding
Inhibition of [3H]-SQ 29,548 radioligand binding to thromboxane A2 (TXA2) receptor of human platelet membranesInhibition of [3H]-SQ 29,548 radioligand binding to thromboxane A2 (TXA2) receptor of human platelet membranes
ChEMBL 440 11 2 5 4.1 CCCCCNC(=O)c1coc(n1)[C@@H]1[C@H]2CC[C@@H]([C@@H]1Cc1ccccc1CCC(=O)O)O2 10.1016/S0960-894X(00)80658-7
CHEMBL3301673 8770 19 None 1 2 Rat 8.4 pKd = 8.4 Binding
Inhibition of [3H]-SQ 29,548 radioligand binding to thromboxane A2 (TXA2) receptor of human platelet membranesInhibition of [3H]-SQ 29,548 radioligand binding to thromboxane A2 (TXA2) receptor of human platelet membranes
ChEMBL 440 11 2 5 4.1 CCCCCNC(=O)c1coc(n1)[C@@H]1[C@H]2CC[C@@H]([C@@H]1Cc1ccccc1CCC(=O)O)O2 10.1016/S0960-894X(00)80658-7
DB12321 8770 19 None 1 2 Rat 8.4 pKd = 8.4 Binding
Inhibition of [3H]-SQ 29,548 radioligand binding to thromboxane A2 (TXA2) receptor of human platelet membranesInhibition of [3H]-SQ 29,548 radioligand binding to thromboxane A2 (TXA2) receptor of human platelet membranes
ChEMBL 440 11 2 5 4.1 CCCCCNC(=O)c1coc(n1)[C@@H]1[C@H]2CC[C@@H]([C@@H]1Cc1ccccc1CCC(=O)O)O2 10.1016/S0960-894X(00)80658-7
44461226 212606 0 None - 1 Human 8.4 pKd = 8.4 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 516 13 3 5 4.3 CC(C)(C)c1ccc(SCC(=O)NCC(=O)NCC2C3CCC(O3)C2C/C=C/CCCC(=O)O)cc1 10.1021/jm00171a021
CHEMBL83366 212606 0 None - 1 Human 8.4 pKd = 8.4 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 516 13 3 5 4.3 CC(C)(C)c1ccc(SCC(=O)NCC(=O)NCC2C3CCC(O3)C2C/C=C/CCCC(=O)O)cc1 10.1021/jm00171a021
44458582 172271 0 None - 1 Human 8.4 pKd = 8.4 Binding
Binding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligandBinding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligand
ChEMBL 480 12 2 4 6.3 O=C(O)CCc1ccccc1CC1CCC[C@H]1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/S0960-894X(00)80329-7
CHEMBL424031 172271 0 None - 1 Human 8.4 pKd = 8.4 Binding
Binding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligandBinding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligand
ChEMBL 480 12 2 4 6.3 O=C(O)CCc1ccccc1CC1CCC[C@H]1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/S0960-894X(00)80329-7
14952432 112842 0 None - 1 Human 8.4 pKd = 8.4 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 452 8 2 5 4.3 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NC2CCCCC2)co1 10.1021/jm00062a013
CHEMBL31334 112842 0 None - 1 Human 8.4 pKd = 8.4 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 452 8 2 5 4.3 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NC2CCCCC2)co1 10.1021/jm00062a013
44279724 169399 0 None - 1 Human 8.3 pKd = 8.3 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 464 12 2 5 4.1 C#CCCCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
CHEMBL416943 169399 0 None - 1 Human 8.3 pKd = 8.3 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 464 12 2 5 4.1 C#CCCCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
44279891 105949 0 None - 1 Human 8.3 pKd = 8.3 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 494 11 2 5 4.7 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC(F)(F)F)co1 10.1021/jm00062a013
CHEMBL281293 105949 0 None - 1 Human 8.3 pKd = 8.3 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 494 11 2 5 4.7 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC(F)(F)F)co1 10.1021/jm00062a013
13799389 212083 0 None - 1 Human 7.4 pKd = 7.4 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 460 13 3 5 3.0 O=C(O)CCC/C=C/CC1C2CCC(O2)C1CNC(=O)CNC(=O)CSc1ccccc1 10.1021/jm00171a021
CHEMBL79278 212083 0 None - 1 Human 7.4 pKd = 7.4 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 460 13 3 5 3.0 O=C(O)CCC/C=C/CC1C2CCC(O2)C1CNC(=O)CNC(=O)CSc1ccccc1 10.1021/jm00171a021
71450971 86392 0 None - 1 Human 6.4 pKd = 6.4 Binding
Binding affinity of Thromboxane A2 (TXA2) receptor using [3H]-SQ 29,548 radioligand in washed human plateletsBinding affinity of Thromboxane A2 (TXA2) receptor using [3H]-SQ 29,548 radioligand in washed human platelets
ChEMBL 282 2 0 2 4.4 CC1(C)C2CC[C@@H](Cc3cccc4ccc(=O)oc34)C1C2 10.1016/0960-894X(95)00284-Z
CHEMBL2114959 86392 0 None - 1 Human 6.4 pKd = 6.4 Binding
Binding affinity of Thromboxane A2 (TXA2) receptor using [3H]-SQ 29,548 radioligand in washed human plateletsBinding affinity of Thromboxane A2 (TXA2) receptor using [3H]-SQ 29,548 radioligand in washed human platelets
ChEMBL 282 2 0 2 4.4 CC1(C)C2CC[C@@H](Cc3cccc4ccc(=O)oc34)C1C2 10.1016/0960-894X(95)00284-Z
18944131 93970 0 None - 1 Human 7.4 pKd = 7.4 Binding
In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548
ChEMBL 484 10 2 6 4.0 O=C(O)CCc1ccccc1CC1OCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
CHEMBL23273 93970 0 None - 1 Human 7.4 pKd = 7.4 Binding
In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548
ChEMBL 484 10 2 6 4.0 O=C(O)CCc1ccccc1CC1OCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
14952419 123307 0 None - 1 Human 7.4 pKd = 7.4 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 384 7 2 5 2.6 CNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
CHEMBL33621 123307 0 None - 1 Human 7.4 pKd = 7.4 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 384 7 2 5 2.6 CNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
44387219 67300 0 None - 1 Human 7.3 pKd = 7.3 Binding
Inhibition of specific binding of HSQ(5,6-di-3H-SQ 29,548) in washed plateletsInhibition of specific binding of HSQ(5,6-di-3H-SQ 29,548) in washed platelets
ChEMBL 324 11 1 3 4.3 C=CCCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL175751 67300 0 None - 1 Human 7.3 pKd = 7.3 Binding
Inhibition of specific binding of HSQ(5,6-di-3H-SQ 29,548) in washed plateletsInhibition of specific binding of HSQ(5,6-di-3H-SQ 29,548) in washed platelets
ChEMBL 324 11 1 3 4.3 C=CCCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
13799369 212347 0 None - 1 Human 7.3 pKd = 7.3 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 436 16 3 4 3.6 CCCCCCCC(=O)NCC(=O)NCC1C2CCC(O2)C1C/C=C/CCCC(=O)O 10.1021/jm00171a021
CHEMBL81263 212347 0 None - 1 Human 7.3 pKd = 7.3 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 436 16 3 4 3.6 CCCCCCCC(=O)NCC(=O)NCC1C2CCC(O2)C1C/C=C/CCCC(=O)O 10.1021/jm00171a021
14952425 170040 0 None - 1 Human 8.2 pKd = 8.2 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 510 16 2 5 6.1 CCCCCCCCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
CHEMBL418585 170040 0 None - 1 Human 8.2 pKd = 8.2 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 510 16 2 5 6.1 CCCCCCCCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
44301170 206808 0 None - 1 Human 7.3 pKd = 7.3 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 531 14 2 5 6.2 O=C(O)CCCC/C=C(/c1ccc(C2=N[C@@H](C(=O)NCCCCC3CCCCC3)CO2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
CHEMBL59547 206808 0 None - 1 Human 7.3 pKd = 7.3 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 531 14 2 5 6.2 O=C(O)CCCC/C=C(/c1ccc(C2=N[C@@H](C(=O)NCCCCC3CCCCC3)CO2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
15458911 107707 0 None - 1 Human 6.3 pKd = 6.3 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 529 14 2 5 7.3 O=C(O)CCCC/C=C(/c1cccnc1)c1ccccc1-c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/s0960-894x(98)00353-9
CHEMBL293971 107707 0 None - 1 Human 6.3 pKd = 6.3 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 529 14 2 5 7.3 O=C(O)CCCC/C=C(/c1cccnc1)c1ccccc1-c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/s0960-894x(98)00353-9
19838907 214537 0 None - 1 Human 8.2 pKd = 8.2 Binding
The compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranesThe compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranes
ChEMBL 423 8 3 5 3.3 O=C(O)COc1ccccc1CC1C2CCC(O2)C1/C=N/NC(=O)Nc1ccccc1 10.1021/jm00113a030
CHEMBL95884 214537 0 None - 1 Human 8.2 pKd = 8.2 Binding
The compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranesThe compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranes
ChEMBL 423 8 3 5 3.3 O=C(O)COc1ccccc1CC1C2CCC(O2)C1/C=N/NC(=O)Nc1ccccc1 10.1021/jm00113a030
18944163 91826 0 None - 1 Human 7.2 pKd = 7.2 Binding
Binding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligandBinding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligand
ChEMBL 492 10 2 4 5.9 O=C(O)CCc1ccccc1CC1=C(c2nc(C(=O)NCCc3ccc(Cl)cc3)co2)CCCC1 10.1016/S0960-894X(00)80329-7
CHEMBL22418 91826 0 None - 1 Human 7.2 pKd = 7.2 Binding
Binding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligandBinding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligand
ChEMBL 492 10 2 4 5.9 O=C(O)CCc1ccccc1CC1=C(c2nc(C(=O)NCCc3ccc(Cl)cc3)co2)CCCC1 10.1016/S0960-894X(00)80329-7
15462456 204769 0 None - 1 Human 6.2 pKd = 6.2 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 529 14 2 5 7.3 O=C(O)CCCC/C=C(\c1cccnc1)c1cccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)c1 10.1016/s0960-894x(98)00353-9
CHEMBL57359 204769 0 None - 1 Human 6.2 pKd = 6.2 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 529 14 2 5 7.3 O=C(O)CCCC/C=C(\c1cccnc1)c1cccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)c1 10.1016/s0960-894x(98)00353-9
44295061 195700 0 None - 1 Human 7.2 pKd = 7.2 Binding
Tested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligandTested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligand
ChEMBL 311 10 2 3 2.6 O=C(O)CCC/C=C/CCCNS(=O)(=O)c1ccccc1 10.1016/S0960-894X(01)80794-0
CHEMBL50785 195700 0 None - 1 Human 7.2 pKd = 7.2 Binding
Tested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligandTested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligand
ChEMBL 311 10 2 3 2.6 O=C(O)CCC/C=C/CCCNS(=O)(=O)c1ccccc1 10.1016/S0960-894X(01)80794-0
44295209 108645 0 None - 1 Human 8.1 pKd = 8.1 Binding
Tested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligandTested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligand
ChEMBL 351 9 2 3 3.3 O=C(O)CCC/C=C\C[C@H]1CCC[C@@H]1NS(=O)(=O)c1ccccc1 10.1016/S0960-894X(01)80794-0
CHEMBL300681 108645 0 None - 1 Human 8.1 pKd = 8.1 Binding
Tested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligandTested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligand
ChEMBL 351 9 2 3 3.3 O=C(O)CCC/C=C\C[C@H]1CCC[C@@H]1NS(=O)(=O)c1ccccc1 10.1016/S0960-894X(01)80794-0
71454591 86488 0 None - 1 Human 8.1 pKd = 8.1 Binding
Binding affinity was determined for Thromboxane A2 receptor in human platelet membrane in presence of [3H]-SQ-29,548 radioligandBinding affinity was determined for Thromboxane A2 receptor in human platelet membrane in presence of [3H]-SQ-29,548 radioligand
ChEMBL 509 11 2 6 4.7 O=C(O)CCc1ccccc1C(=O)N1C(=O)CCC1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/S0960-894X(00)80328-5
CHEMBL2115542 86488 0 None - 1 Human 8.1 pKd = 8.1 Binding
Binding affinity was determined for Thromboxane A2 receptor in human platelet membrane in presence of [3H]-SQ-29,548 radioligandBinding affinity was determined for Thromboxane A2 receptor in human platelet membrane in presence of [3H]-SQ-29,548 radioligand
ChEMBL 509 11 2 6 4.7 O=C(O)CCc1ccccc1C(=O)N1C(=O)CCC1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/S0960-894X(00)80328-5
44387220 69166 0 None - 1 Human 7.1 pKd = 7.1 Binding
Inhibition of specific binding of HSQ(5,6-di-3H-SQ 29,548) in washed plateletsInhibition of specific binding of HSQ(5,6-di-3H-SQ 29,548) in washed platelets
ChEMBL 310 10 1 3 3.9 C=CCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL177949 69166 0 None - 1 Human 7.1 pKd = 7.1 Binding
Inhibition of specific binding of HSQ(5,6-di-3H-SQ 29,548) in washed plateletsInhibition of specific binding of HSQ(5,6-di-3H-SQ 29,548) in washed platelets
ChEMBL 310 10 1 3 3.9 C=CCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
15462460 208623 0 None - 1 Human 6.1 pKd = 6.1 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 445 11 2 5 5.0 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCC3CC3)co2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
CHEMBL60710 208623 0 None - 1 Human 6.1 pKd = 6.1 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 445 11 2 5 5.0 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCC3CC3)co2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
44210947 105892 0 None - 1 Human 8.1 pKd = 8.1 Binding
In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548
ChEMBL 498 10 2 6 4.2 O=C(O)CCc1ccccc1CC1COCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
CHEMBL280890 105892 0 None - 1 Human 8.1 pKd = 8.1 Binding
In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548
ChEMBL 498 10 2 6 4.2 O=C(O)CCc1ccccc1CC1COCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
18944131 93970 0 None - 1 Human 8.1 pKd = 8.1 Binding
In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548
ChEMBL 484 10 2 6 4.0 O=C(O)CCc1ccccc1CC1OCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
CHEMBL23273 93970 0 None - 1 Human 8.1 pKd = 8.1 Binding
In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548
ChEMBL 484 10 2 6 4.0 O=C(O)CCc1ccccc1CC1OCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
13799367 212452 0 None - 1 Human 8.1 pKd = 8.1 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 450 17 3 4 4.0 CCCCCCCCC(=O)NCC(=O)NCC1C2CCC(O2)C1C/C=C/CCCC(=O)O 10.1021/jm00171a021
CHEMBL82146 212452 0 None - 1 Human 8.1 pKd = 8.1 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 450 17 3 4 4.0 CCCCCCCCC(=O)NCC(=O)NCC1C2CCC(O2)C1C/C=C/CCCC(=O)O 10.1021/jm00171a021
5284442 103950 30 None -1 2 Human 5.1 pKd = 5.1 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 281 7 1 2 4.2 O=C(O)CCCC/C=C(\c1ccccc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
CHEMBL26820 103950 30 None -1 2 Human 5.1 pKd = 5.1 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 281 7 1 2 4.2 O=C(O)CCCC/C=C(\c1ccccc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
44301140 107857 0 None - 1 Human 6.1 pKd = 6.1 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 531 14 2 5 6.2 O=C(O)CCCC/C=C(\c1cccnc1)c1cccc(C2=N[C@@H](C(=O)NCCCCC3CCCCC3)CO2)c1 10.1016/s0960-894x(98)00353-9
CHEMBL294850 107857 0 None - 1 Human 6.1 pKd = 6.1 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 531 14 2 5 6.2 O=C(O)CCCC/C=C(\c1cccnc1)c1cccc(C2=N[C@@H](C(=O)NCCCCC3CCCCC3)CO2)c1 10.1016/s0960-894x(98)00353-9
9958626 108480 0 None - 1 Human 8.0 pKd = 8 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 529 14 2 5 7.3 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
CHEMBL299467 108480 0 None - 1 Human 8.0 pKd = 8 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 529 14 2 5 7.3 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
15852309 169995 0 None - 1 Human 7.0 pKd = 7.0 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 501 12 2 5 6.5 O=C(O)CC/C=C(\c1ccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
CHEMBL418323 169995 0 None - 1 Human 7.0 pKd = 7.0 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 501 12 2 5 6.5 O=C(O)CC/C=C(\c1ccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
44385711 67231 0 None - 1 Human 7.0 pKd = 7.0 Binding
Inhibition of specific binding of HSQ(5,6-di-3H-SQ 29,548) in washed plateletsInhibition of specific binding of HSQ(5,6-di-3H-SQ 29,548) in washed platelets
ChEMBL 312 10 1 3 4.1 CCCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL175303 67231 0 None - 1 Human 7.0 pKd = 7.0 Binding
Inhibition of specific binding of HSQ(5,6-di-3H-SQ 29,548) in washed plateletsInhibition of specific binding of HSQ(5,6-di-3H-SQ 29,548) in washed platelets
ChEMBL 312 10 1 3 4.1 CCCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
123879 10060 82 None 3 4 Human 9.2 pKi = 9.2 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2010.11.015
1910 10060 82 None 3 4 Human 9.2 pKi = 9.2 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2010.11.015
1911 10060 82 None 3 4 Human 9.2 pKi = 9.2 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2010.11.015
2354 10060 82 None 3 4 Human 9.2 pKi = 9.2 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2010.11.015
CHEMBL361812 10060 82 None 3 4 Human 9.2 pKi = 9.2 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2010.11.015
DB13036 10060 82 None 3 4 Human 9.2 pKi = 9.2 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2010.11.015
11597294 172955 4 None 1 8 Human 9.1 pKi = 9.1 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 435 4 1 2 5.7 O=C(O)C[C@H]1CCc2c1n(Cc1ccc(Cl)cc1)c1c(Br)cc(F)cc21 10.1021/jm0603668
CHEMBL426387 172955 4 None 1 8 Human 9.1 pKi = 9.1 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 435 4 1 2 5.7 O=C(O)C[C@H]1CCc2c1n(Cc1ccc(Cl)cc1)c1c(Br)cc(F)cc21 10.1021/jm0603668
10369249 174651 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 515 6 2 5 5.7 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc(C(=O)NCc4ccccc4)ccc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL431075 174651 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 515 6 2 5 5.7 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc(C(=O)NCc4ccccc4)ccc31)c1ccccc1CO2 10.1021/jm00096a017
14372497 84081 0 None 6 2 Human 8.8 pKi = 8.8 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 389 4 1 2 5.5 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1c(F)cc(F)cc21 10.1016/j.bmcl.2006.02.062
CHEMBL208260 84081 0 None 6 2 Human 8.8 pKi = 8.8 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 389 4 1 2 5.5 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1c(F)cc(F)cc21 10.1016/j.bmcl.2006.02.062
10365193 172512 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 427 4 1 6 4.7 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc([N+](=O)[O-])ccc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL424621 172512 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 427 4 1 6 4.7 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc([N+](=O)[O-])ccc31)c1ccccc1CO2 10.1021/jm00096a017
10094735 16939 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 439 6 2 5 4.9 Cc1ccsc1C(=O)NCCSC1c2ccccc2COc2ccc(C(=O)O)cc21 10.1021/jm00096a016
CHEMBL115924 16939 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 439 6 2 5 4.9 Cc1ccsc1C(=O)NCCSC1c2ccccc2COc2ccc(C(=O)O)cc21 10.1021/jm00096a016
9984004 18099 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 515 6 2 5 5.7 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ccc(C(=O)NCc4ccccc4)cc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL117943 18099 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 515 6 2 5 5.7 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ccc(C(=O)NCc4ccccc4)cc31)c1ccccc1CO2 10.1021/jm00096a017
11495634 21677 13 None -1 4 Human 8.0 pKi = 8 Binding
Inhibition of TP receptorInhibition of TP receptor
ChEMBL 405 6 1 3 5.4 O=C(O)c1cccc(Cc2cc(Cl)ccc2OCc2ccc(Cl)cc2F)n1 10.1016/j.bmcl.2009.02.112
CHEMBL1207972 21677 13 None -1 4 Human 8.0 pKi = 8 Binding
Inhibition of TP receptorInhibition of TP receptor
ChEMBL 405 6 1 3 5.4 O=C(O)c1cccc(Cc2cc(Cl)ccc2OCc2ccc(Cl)cc2F)n1 10.1016/j.bmcl.2009.02.112
CHEMBL467114 21677 13 None -1 4 Human 8.0 pKi = 8 Binding
Inhibition of TP receptorInhibition of TP receptor
ChEMBL 405 6 1 3 5.4 O=C(O)c1cccc(Cc2cc(Cl)ccc2OCc2ccc(Cl)cc2F)n1 10.1016/j.bmcl.2009.02.112
10094735 16939 0 None - 1 Human 8.0 pKi = 8 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 439 6 2 5 4.9 Cc1ccsc1C(=O)NCCSC1c2ccccc2COc2ccc(C(=O)O)cc21 10.1021/jm00096a016
CHEMBL115924 16939 0 None - 1 Human 8.0 pKi = 8 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 439 6 2 5 4.9 Cc1ccsc1C(=O)NCCSC1c2ccccc2COc2ccc(C(=O)O)cc21 10.1021/jm00096a016
53323267 63598 0 None -1 2 Human 8.0 pKi = 8.0 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 402 5 2 4 2.7 O=C(O)Cc1c2n(c3ccccc13)C[C@H](NS(=O)(=O)c1ccc(F)cc1)CC2 10.1016/j.bmcl.2010.11.015
CHEMBL1643785 63598 0 None -1 2 Human 8.0 pKi = 8.0 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 402 5 2 4 2.7 O=C(O)Cc1c2n(c3ccccc13)C[C@H](NS(=O)(=O)c1ccc(F)cc1)CC2 10.1016/j.bmcl.2010.11.015
9868012 130627 0 None -50 2 Human 7.0 pKi = 7 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 420 6 1 3 7.0 O=C(O)c1cccc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)c1 10.1016/j.bmcl.2004.12.005
CHEMBL362543 130627 0 None -50 2 Human 7.0 pKi = 7 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 420 6 1 3 7.0 O=C(O)c1cccc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)c1 10.1016/j.bmcl.2004.12.005
44411552 83861 0 None -24 2 Human 7.0 pKi = 7 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 524 6 1 4 4.9 CN(C)S(=O)(=O)c1cc(Br)c2c(c1)c1c(n2Cc2ccc(Cl)cc2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
CHEMBL207451 83861 0 None -24 2 Human 7.0 pKi = 7 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 524 6 1 4 4.9 CN(C)S(=O)(=O)c1cc(Br)c2c(c1)c1c(n2Cc2ccc(Cl)cc2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
10548754 23155 0 None -154 2 Human 6.0 pKi = 6 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 396 2 4 4 2.7 Nc1ccc(CC2NCCc3cc(O)c(O)cc32)cc1I 10.1021/jm960208o
CHEMBL122990 23155 0 None -154 2 Human 6.0 pKi = 6 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 396 2 4 4 2.7 Nc1ccc(CC2NCCc3cc(O)c(O)cc32)cc1I 10.1021/jm960208o
53321924 63609 0 None -190 3 Human 6.0 pKi = 6.0 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 432 5 1 4 3.6 CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(Cl)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL1643796 63609 0 None -190 3 Human 6.0 pKi = 6.0 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 432 5 1 4 3.6 CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(Cl)cc1 10.1016/j.bmcl.2010.11.015
35028115 148777 5 None -109 2 Human 6.0 pKi = 6.0 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 435 5 1 4 4.4 CS(=O)(=O)c1cc(F)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@H](CC(=O)O)CC3 10.1021/jm0603668
CHEMBL387477 148777 5 None -109 2 Human 6.0 pKi = 6.0 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 435 5 1 4 4.4 CS(=O)(=O)c1cc(F)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@H](CC(=O)O)CC3 10.1021/jm0603668
3078930 171681 5 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 449 7 2 5 4.5 COc1ccccc1C(=O)NCCSC1c2ccccc2COc2ccc(C(=O)O)cc21 10.1021/jm00096a016
CHEMBL422253 171681 5 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 449 7 2 5 4.5 COc1ccccc1C(=O)NCCSC1c2ccccc2COc2ccc(C(=O)O)cc21 10.1021/jm00096a016
10047807 16565 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 421 5 2 4 3.7 O=C(O)c1ccc2c(c1)/C(=C/CNS(=O)(=O)c1ccccc1)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL113670 16565 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 421 5 2 4 3.7 O=C(O)c1ccc2c(c1)/C(=C/CNS(=O)(=O)c1ccccc1)c1ccccc1CO2 10.1021/jm00096a017
3078930 171681 5 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 449 7 2 5 4.5 COc1ccccc1C(=O)NCCSC1c2ccccc2COc2ccc(C(=O)O)cc21 10.1021/jm00096a016
CHEMBL422253 171681 5 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 449 7 2 5 4.5 COc1ccccc1C(=O)NCCSC1c2ccccc2COc2ccc(C(=O)O)cc21 10.1021/jm00096a016
14953108 104991 0 None - 1 Human 8.0 pKi = 8.0 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 418 6 1 3 5.0 CC(C)(CC(=O)O)Cc1nc2ccccc2n1Cc1ccc(Br)cc1F 10.1021/jm00061a008
CHEMBL274287 104991 0 None - 1 Human 8.0 pKi = 8.0 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 418 6 1 3 5.0 CC(C)(CC(=O)O)Cc1nc2ccccc2n1Cc1ccc(Br)cc1F 10.1021/jm00061a008
10181442 103114 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 435 5 1 4 4.4 CS(=O)(=O)c1cc(F)cc2c1c(Cc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL261501 103114 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 435 5 1 4 4.4 CS(=O)(=O)c1cc(F)cc2c1c(Cc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
44411606 83928 0 None -112 2 Human 6.0 pKi = 6.0 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 442 5 1 5 4.1 CS(=O)(=O)c1cc(C#N)c2c(c1)c1c(n2Cc2ccc(Cl)cc2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
CHEMBL207805 83928 0 None -112 2 Human 6.0 pKi = 6.0 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 442 5 1 5 4.1 CS(=O)(=O)c1cc(C#N)c2c(c1)c1c(n2Cc2ccc(Cl)cc2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
9895436 113793 0 None -61 7 Human 6.0 pKi = 6.0 Binding
Compound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assayCompound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assay
ChEMBL 628 8 1 4 7.4 CC(C)(Cc1ccccc1)C(=O)NS(=O)(=O)c1ccccc1-c1ccc(CN2C(=O)c3ccccc3CCc3ccccc32)cc1 10.1016/s0960-894x(99)00465-5
CHEMBL315391 113793 0 None -61 7 Human 6.0 pKi = 6.0 Binding
Compound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assayCompound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assay
ChEMBL 628 8 1 4 7.4 CC(C)(Cc1ccccc1)C(=O)NS(=O)(=O)c1ccccc1-c1ccc(CN2C(=O)c3ccccc3CCc3ccccc32)cc1 10.1016/s0960-894x(99)00465-5
44338286 13002 0 None -85 2 Human 4.9 pKi = 4.9 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 422 6 1 4 6.3 CC(C)(O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL108146 13002 0 None -85 2 Human 4.9 pKi = 4.9 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 422 6 1 4 6.3 CC(C)(O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
10024655 117373 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 412 4 1 5 4.8 COc1ccc2ncn(C/C=C3\c4ccccc4COc4ccc(C(=O)O)cc43)c2c1 10.1021/jm00096a017
CHEMBL325523 117373 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 412 4 1 5 4.8 COc1ccc2ncn(C/C=C3\c4ccccc4COc4ccc(C(=O)O)cc43)c2c1 10.1021/jm00096a017
14953092 67224 0 None - 1 Human 7.9 pKi = 7.9 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 424 6 1 3 6.1 CC(C)(CC(=O)O)Cc1nc2cc(Cl)ccc2n1Cc1ccc(Cl)c(Cl)c1 10.1021/jm00061a008
CHEMBL17528 67224 0 None - 1 Human 7.9 pKi = 7.9 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 424 6 1 3 6.1 CC(C)(CC(=O)O)Cc1nc2cc(Cl)ccc2n1Cc1ccc(Cl)c(Cl)c1 10.1021/jm00061a008
14953089 67836 0 None - 1 Human 7.9 pKi = 7.9 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 418 6 1 3 5.0 CC(C)(CC(=O)O)Cc1nc2cc(F)ccc2n1Cc1ccc(Br)cc1 10.1021/jm00061a008
CHEMBL17640 67836 0 None - 1 Human 7.9 pKi = 7.9 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 418 6 1 3 5.0 CC(C)(CC(=O)O)Cc1nc2cc(F)ccc2n1Cc1ccc(Br)cc1 10.1021/jm00061a008
10207799 71849 0 None -28 2 Human 6.9 pKi = 6.9 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 475 6 1 4 7.3 OC(c1cncc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)c1)C(F)(F)F 10.1016/j.bmcl.2004.12.005
CHEMBL182368 71849 0 None -28 2 Human 6.9 pKi = 6.9 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 475 6 1 4 7.3 OC(c1cncc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)c1)C(F)(F)F 10.1016/j.bmcl.2004.12.005
44392527 129679 0 None -97 2 Human 5.9 pKi = 5.9 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 524 8 1 4 8.2 CC(NC(=O)c1cccc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)c1)c1cccnc1 10.1016/j.bmcl.2004.12.005
CHEMBL360592 129679 0 None -97 2 Human 5.9 pKi = 5.9 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 524 8 1 4 8.2 CC(NC(=O)c1cccc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)c1)c1cccnc1 10.1016/j.bmcl.2004.12.005
11408533 148105 0 None -467 3 Human 5.9 pKi = 5.9 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 459 6 1 5 4.5 CC(=O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1016/j.bmcl.2006.02.062
CHEMBL383484 148105 0 None -467 3 Human 5.9 pKi = 5.9 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 459 6 1 5 4.5 CC(=O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1016/j.bmcl.2006.02.062
11408533 148105 0 None -467 3 Human 5.9 pKi = 5.9 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 459 6 1 5 4.5 CC(=O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1021/jm0603668
CHEMBL383484 148105 0 None -467 3 Human 5.9 pKi = 5.9 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 459 6 1 5 4.5 CC(=O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1021/jm0603668
11189801 196391 0 None -5888 2 Human 4.9 pKi = 4.9 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 436 5 1 6 4.2 CS(=O)(=O)c1nccc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL514802 196391 0 None -5888 2 Human 4.9 pKi = 4.9 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 436 5 1 6 4.2 CS(=O)(=O)c1nccc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
53323268 63601 0 None -251 3 Human 5.9 pKi = 5.9 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 456 7 1 4 3.8 O=C(O)Cc1c2n(c3ccccc13)C[C@H](N(CC1CC1)S(=O)(=O)c1ccc(F)cc1)CC2 10.1016/j.bmcl.2010.11.015
CHEMBL1643788 63601 0 None -251 3 Human 5.9 pKi = 5.9 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 456 7 1 4 3.8 O=C(O)Cc1c2n(c3ccccc13)C[C@H](N(CC1CC1)S(=O)(=O)c1ccc(F)cc1)CC2 10.1016/j.bmcl.2010.11.015
14953096 71044 0 None - 1 Human 7.9 pKi = 7.9 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 434 6 1 3 5.5 CC(C)(CC(=O)O)Cc1nc2cc(Cl)ccc2n1Cc1ccc(Br)cc1 10.1021/jm00061a008
CHEMBL18093 71044 0 None - 1 Human 7.9 pKi = 7.9 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 434 6 1 3 5.5 CC(C)(CC(=O)O)Cc1nc2cc(Cl)ccc2n1Cc1ccc(Br)cc1 10.1021/jm00061a008
44591807 199346 0 None -6 2 Human 7.9 pKi = 7.9 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 448 5 1 4 7.0 CC(C)c1ccnc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL521290 199346 0 None -6 2 Human 7.9 pKi = 7.9 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 448 5 1 4 7.0 CC(C)c1ccnc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
16049493 85045 0 None -75 2 Human 6.9 pKi = 6.9 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 415 5 1 3 5.0 C[S@+]([O-])c1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
CHEMBL210707 85045 0 None -75 2 Human 6.9 pKi = 6.9 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 415 5 1 3 5.0 C[S@+]([O-])c1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
10409291 170645 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 410 3 1 4 5.4 Cc1cc2ncn(C/C=C3\c4cc(C(=O)O)ccc4COc4ccccc43)c2cc1C 10.1021/jm00096a017
CHEMBL420678 170645 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 410 3 1 4 5.4 Cc1cc2ncn(C/C=C3\c4cc(C(=O)O)ccc4COc4ccccc43)c2cc1C 10.1021/jm00096a017
51550 212529 14 None -11 2 Human 5.9 pKi = 5.9 Binding
Compound was tested for its binding affinity at Thromboxane A2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets at 0.1 uMCompound was tested for its binding affinity at Thromboxane A2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets at 0.1 uM
ChEMBL 335 8 2 4 1.7 O=C(O)COc1ccc(CCNS(=O)(=O)c2ccccc2)cc1 10.1021/jm00096a016
CHEMBL8273 212529 14 None -11 2 Human 5.9 pKi = 5.9 Binding
Compound was tested for its binding affinity at Thromboxane A2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets at 0.1 uMCompound was tested for its binding affinity at Thromboxane A2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets at 0.1 uM
ChEMBL 335 8 2 4 1.7 O=C(O)COc1ccc(CCNS(=O)(=O)c2ccccc2)cc1 10.1021/jm00096a016
51550 212529 14 None -11 2 Human 5.9 pKi = 5.9 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 335 8 2 4 1.7 O=C(O)COc1ccc(CCNS(=O)(=O)c2ccccc2)cc1 10.1021/jm00096a016
CHEMBL8273 212529 14 None -11 2 Human 5.9 pKi = 5.9 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 335 8 2 4 1.7 O=C(O)COc1ccc(CCNS(=O)(=O)c2ccccc2)cc1 10.1021/jm00096a016
53321923 63594 0 None -234 3 Human 5.9 pKi = 5.9 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 484 5 1 4 4.4 CN([C@@H]1CCc2c(CC(=O)O)c3c(Cl)cc(Cl)cc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL1643781 63594 0 None -234 3 Human 5.9 pKi = 5.9 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 484 5 1 4 4.4 CN([C@@H]1CCc2c(CC(=O)O)c3c(Cl)cc(Cl)cc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
53322785 63603 0 None -363 3 Human 5.9 pKi = 5.9 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 484 6 1 4 4.0 O=C(O)Cc1c2n(c3ccccc13)C[C@H](N(CC(F)(F)F)S(=O)(=O)c1ccc(F)cc1)CC2 10.1016/j.bmcl.2010.11.015
CHEMBL1643790 63603 0 None -363 3 Human 5.9 pKi = 5.9 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 484 6 1 4 4.0 O=C(O)Cc1c2n(c3ccccc13)C[C@H](N(CC(F)(F)F)S(=O)(=O)c1ccc(F)cc1)CC2 10.1016/j.bmcl.2010.11.015
10136631 168013 1 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 415 5 1 3 6.4 O=C(O)CC1CCn2c1c(Sc1ccc(Cl)cc1)c1c(C3CC3)cc(F)cc12 10.1016/j.bmcl.2008.03.015
CHEMBL411847 168013 1 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 415 5 1 3 6.4 O=C(O)CC1CCn2c1c(Sc1ccc(Cl)cc1)c1c(C3CC3)cc(F)cc12 10.1016/j.bmcl.2008.03.015
11384493 10609 38 None -1071 3 Human 5.9 pKi = 5.9 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 416 5 1 4 3.0 OC(=O)Cn1c2CCC(Cc2c2c1cccc2)N(S(=O)(=O)c1ccc(cc1)F)C 10.1016/j.bmcl.2010.11.015
1905 10609 38 None -1071 3 Human 5.9 pKi = 5.9 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 416 5 1 4 3.0 OC(=O)Cn1c2CCC(Cc2c2c1cccc2)N(S(=O)(=O)c1ccc(cc1)F)C 10.1016/j.bmcl.2010.11.015
CHEMBL1643768 10609 38 None -1071 3 Human 5.9 pKi = 5.9 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 416 5 1 4 3.0 OC(=O)Cn1c2CCC(Cc2c2c1cccc2)N(S(=O)(=O)c1ccc(cc1)F)C 10.1016/j.bmcl.2010.11.015
11755897 16761 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 505 7 2 5 5.2 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccc3ccccc3c1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL114838 16761 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 505 7 2 5 5.2 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccc3ccccc3c1)c1ccccc1CO2 10.1021/jm00096a016
10028935 118108 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 500 8 2 7 4.0 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1cccc([N+](=O)[O-])c1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL326808 118108 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 500 8 2 7 4.0 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1cccc([N+](=O)[O-])c1)c1ccccc1CO2 10.1021/jm00096a016
11269563 148388 0 None -12 5 Human 7.9 pKi = 7.9 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 399 5 1 3 5.2 CC(=O)c1cc(F)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1021/jm0603668
CHEMBL385126 148388 0 None -12 5 Human 7.9 pKi = 7.9 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 399 5 1 3 5.2 CC(=O)c1cc(F)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1021/jm0603668
11755897 16761 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 505 7 2 5 5.2 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccc3ccccc3c1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL114838 16761 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 505 7 2 5 5.2 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccc3ccccc3c1)c1ccccc1CO2 10.1021/jm00096a016
10028935 118108 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 500 8 2 7 4.0 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1cccc([N+](=O)[O-])c1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL326808 118108 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 500 8 2 7 4.0 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1cccc([N+](=O)[O-])c1)c1ccccc1CO2 10.1021/jm00096a016
44392460 130723 0 None -11 3 Human 6.9 pKi = 6.9 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 421 6 1 4 6.4 O=C(O)c1cccc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)n1 10.1016/j.bmcl.2004.12.005
CHEMBL362851 130723 0 None -11 3 Human 6.9 pKi = 6.9 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 421 6 1 4 6.4 O=C(O)c1cccc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)n1 10.1016/j.bmcl.2004.12.005
44411890 84052 0 None -36 2 Human 6.9 pKi = 6.9 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 491 7 1 3 6.5 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1c([S+]([O-])Cc3ccccc3)cccc21 10.1016/j.bmcl.2006.02.062
CHEMBL208083 84052 0 None -36 2 Human 6.9 pKi = 6.9 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 491 7 1 3 6.5 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1c([S+]([O-])Cc3ccccc3)cccc21 10.1016/j.bmcl.2006.02.062
14953120 66344 0 None - 1 Human 6.9 pKi = 6.9 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 372 4 1 3 4.8 O=C(O)[C@H]1CCC[C@@H]1c1nc2cc(F)ccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
CHEMBL17178 66344 0 None - 1 Human 6.9 pKi = 6.9 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 372 4 1 3 4.8 O=C(O)[C@H]1CCC[C@@H]1c1nc2cc(F)ccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
10789142 120971 0 None -190 2 Human 5.8 pKi = 5.8 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 438 3 4 4 3.1 CC(=O)Nc1ccc(CC2NCCc3cc(O)c(O)cc32)cc1I 10.1021/jm960208o
CHEMBL332964 120971 0 None -190 2 Human 5.8 pKi = 5.8 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 438 3 4 4 3.1 CC(=O)Nc1ccc(CC2NCCc3cc(O)c(O)cc32)cc1I 10.1021/jm960208o
10074701 176857 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 500 8 2 7 4.0 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1[N+](=O)[O-])c1ccccc1CO2 10.1021/jm00096a016
CHEMBL444330 176857 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 500 8 2 7 4.0 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1[N+](=O)[O-])c1ccccc1CO2 10.1021/jm00096a016
9978044 16875 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 396 3 1 4 5.1 Cc1ccc2c(c1)ncn2C/C=C1\c2ccccc2COc2ccc(C(=O)O)cc21 10.1021/jm00096a017
CHEMBL115536 16875 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 396 3 1 4 5.1 Cc1ccc2c(c1)ncn2C/C=C1\c2ccccc2COc2ccc(C(=O)O)cc21 10.1021/jm00096a017
15025390 21571 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 382 3 1 4 4.8 O=C(O)c1ccc2c(c1)/C(=C\Cn1cnc3ccccc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL1206916 21571 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 382 3 1 4 4.8 O=C(O)c1ccc2c(c1)/C(=C\Cn1cnc3ccccc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL324972 21571 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 382 3 1 4 4.8 O=C(O)c1ccc2c(c1)/C(=C\Cn1cnc3ccccc31)c1ccccc1CO2 10.1021/jm00096a017
10093386 120172 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 416 3 1 4 5.4 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ccc(Cl)cc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL331833 120172 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 416 3 1 4 5.4 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ccc(Cl)cc31)c1ccccc1CO2 10.1021/jm00096a017
71460870 89348 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to TXA2 receptor receptorBinding affinity to TXA2 receptor receptor
ChEMBL 396 4 1 4 4.7 O=C(O)Cc1ccc2c(c1)/C(=C/Cn1cnc3ccccc31)c1ccccc1CO2 10.1021/jm300682j
CHEMBL2178581 89348 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to TXA2 receptor receptorBinding affinity to TXA2 receptor receptor
ChEMBL 396 4 1 4 4.7 O=C(O)Cc1ccc2c(c1)/C(=C/Cn1cnc3ccccc31)c1ccccc1CO2 10.1021/jm300682j
10249316 78991 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition constant against thromboxane A2 receptor to prostaglandin H2 receptorInhibition constant against thromboxane A2 receptor to prostaglandin H2 receptor
ChEMBL 382 3 1 4 4.8 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ccccc31)c1ccccc1CO2 10.1021/jm058225d
CHEMBL198104 78991 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition constant against thromboxane A2 receptor to prostaglandin H2 receptorInhibition constant against thromboxane A2 receptor to prostaglandin H2 receptor
ChEMBL 382 3 1 4 4.8 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ccccc31)c1ccccc1CO2 10.1021/jm058225d
10074701 176857 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 500 8 2 7 4.0 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1[N+](=O)[O-])c1ccccc1CO2 10.1021/jm00096a016
CHEMBL444330 176857 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 500 8 2 7 4.0 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1[N+](=O)[O-])c1ccccc1CO2 10.1021/jm00096a016
14953088 105458 0 None - 1 Human 7.8 pKi = 7.8 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 436 6 1 3 5.2 CC(C)(CC(=O)O)Cc1nc2cc(F)ccc2n1Cc1ccc(Br)cc1F 10.1021/jm00061a008
CHEMBL277516 105458 0 None - 1 Human 7.8 pKi = 7.8 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 436 6 1 3 5.2 CC(C)(CC(=O)O)Cc1nc2cc(F)ccc2n1Cc1ccc(Br)cc1F 10.1021/jm00061a008
10406932 105792 1 None - 1 Human 7.8 pKi = 7.8 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 371 4 1 2 5.4 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1ccc(F)cc21 10.1021/jm00061a008
CHEMBL280107 105792 1 None - 1 Human 7.8 pKi = 7.8 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 371 4 1 2 5.4 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1ccc(F)cc21 10.1021/jm00061a008
9910826 73066 0 None -2 2 Human 6.8 pKi = 6.8 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 434 7 1 3 6.9 O=C(O)Cc1cccc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)c1 10.1016/j.bmcl.2004.12.005
CHEMBL184779 73066 0 None -2 2 Human 6.8 pKi = 6.8 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 434 7 1 3 6.9 O=C(O)Cc1cccc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)c1 10.1016/j.bmcl.2004.12.005
11318288 74726 0 None 5 2 Human 6.8 pKi = 6.8 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 516 10 2 5 6.2 O=C(O)COc1cccc2c(CCSC(c3ccccc3)(c3ccccc3)C(F)(F)F)c(CO)oc12 10.1021/jm050194z
CHEMBL191118 74726 0 None 5 2 Human 6.8 pKi = 6.8 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 516 10 2 5 6.2 O=C(O)COc1cccc2c(CCSC(c3ccccc3)(c3ccccc3)C(F)(F)F)c(CO)oc12 10.1021/jm050194z
44338263 14099 0 None -5 2 Human 5.8 pKi = 5.8 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 408 6 1 4 6.1 CC(O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL108616 14099 0 None -5 2 Human 5.8 pKi = 5.8 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 408 6 1 4 6.1 CC(O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
44338272 14621 0 None -4 2 Human 5.8 pKi = 5.8 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 436 7 0 5 5.7 COC(=O)Cc1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL108979 14621 0 None -4 2 Human 5.8 pKi = 5.8 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 436 7 0 5 5.7 COC(=O)Cc1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
9939791 168697 0 None -125 8 Human 5.8 pKi = 5.8 Binding
Compound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assayCompound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assay
ChEMBL 684 8 1 5 7.2 CO[C@](C(=O)NS(=O)(=O)c1ccccc1-c1ccc(CN2C(=O)c3ccccc3CCc3ccccc32)cc1)(c1ccccc1)C(F)(F)F 10.1016/s0960-894x(99)00465-5
CHEMBL415310 168697 0 None -125 8 Human 5.8 pKi = 5.8 Binding
Compound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assayCompound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assay
ChEMBL 684 8 1 5 7.2 CO[C@](C(=O)NS(=O)(=O)c1ccccc1-c1ccc(CN2C(=O)c3ccccc3CCc3ccccc32)cc1)(c1ccccc1)C(F)(F)F 10.1016/s0960-894x(99)00465-5
53324589 63587 0 None -891 3 Human 5.8 pKi = 5.8 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 484 5 1 4 4.1 CN([C@@H]1CCc2c(CC(=O)O)c3ccc(C(F)(F)F)cc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL1643775 63587 0 None -891 3 Human 5.8 pKi = 5.8 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 484 5 1 4 4.1 CN([C@@H]1CCc2c(CC(=O)O)c3ccc(C(F)(F)F)cc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
53317718 63602 0 None -1122 3 Human 5.8 pKi = 5.8 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 510 7 1 4 4.8 O=C(O)Cc1c2n(c3ccccc13)C[C@H](N(Cc1ccc(F)cc1)S(=O)(=O)c1ccc(F)cc1)CC2 10.1016/j.bmcl.2010.11.015
CHEMBL1643789 63602 0 None -1122 3 Human 5.8 pKi = 5.8 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 510 7 1 4 4.8 O=C(O)Cc1c2n(c3ccccc13)C[C@H](N(Cc1ccc(F)cc1)S(=O)(=O)c1ccc(F)cc1)CC2 10.1016/j.bmcl.2010.11.015
44364273 49001 8 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of radiolabeled U44069 from human TXA2 receptorDisplacement of radiolabeled U44069 from human TXA2 receptor
ChEMBL 350 12 2 3 4.3 CCCCC[C@H](O)/C=C/[C@H]1C2COC(C2)[C@@H]1C/C=C\CCCC(=O)O 10.1021/jm8007618
CHEMBL149724 49001 8 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of radiolabeled U44069 from human TXA2 receptorDisplacement of radiolabeled U44069 from human TXA2 receptor
ChEMBL 350 12 2 3 4.3 CCCCC[C@H](O)/C=C/[C@H]1C2COC(C2)[C@@H]1C/C=C\CCCC(=O)O 10.1021/jm8007618
14953104 105166 0 None - 1 Human 7.8 pKi = 7.8 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 400 6 1 3 4.9 CC(C)(CC(=O)O)Cc1nc2ccccc2n1Cc1ccc(Br)cc1 10.1021/jm00061a008
CHEMBL275382 105166 0 None - 1 Human 7.8 pKi = 7.8 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 400 6 1 3 4.9 CC(C)(CC(=O)O)Cc1nc2ccccc2n1Cc1ccc(Br)cc1 10.1021/jm00061a008
14953080 67045 0 None - 1 Human 6.8 pKi = 6.8 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 384 8 1 3 5.6 CCC(CC)(CC(=O)O)Cc1nc2ccccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
CHEMBL17418 67045 0 None - 1 Human 6.8 pKi = 6.8 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 384 8 1 3 5.6 CCC(CC)(CC(=O)O)Cc1nc2ccccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
22083972 145952 0 None -1862 2 Human 4.8 pKi = 4.8 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 461 6 2 5 4.3 CC(O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CC3 10.1016/j.bmcl.2006.02.062
CHEMBL378744 145952 0 None -1862 2 Human 4.8 pKi = 4.8 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 461 6 2 5 4.3 CC(O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CC3 10.1016/j.bmcl.2006.02.062
65772 67177 8 None -9 6 Human 6.8 pKi = 6.8 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm960208o
CHEMBL174984 67177 8 None -9 6 Human 6.8 pKi = 6.8 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm960208o
10742144 66431 0 None - 1 Human 4.8 pKi = 4.8 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 449 8 2 6 4.5 COc1cc(CC2c3cc(O)c(O)cc3CCN2CCc2ccccc2)cc(OC)c1OC 10.1021/jm950896w
CHEMBL172163 66431 0 None - 1 Human 4.8 pKi = 4.8 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 449 8 2 6 4.5 COc1cc(CC2c3cc(O)c(O)cc3CCN2CCc2ccccc2)cc(OC)c1OC 10.1021/jm950896w
10074062 16723 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 484 5 1 4 6.9 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc(-c3ccccc3)c1-c1ccccc1)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL114666 16723 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 484 5 1 4 6.9 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc(-c3ccccc3)c1-c1ccccc1)c1ccccc1CO2 10.1021/jm00096a017
11476788 168053 0 None -1 6 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 463 5 1 5 4.4 CS(=O)(=O)c1cc(F)cc2c1c(C(=O)c1ccc(Cl)cc1)c1n2CCC[C@@H]1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL412070 168053 0 None -1 6 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 463 5 1 5 4.4 CS(=O)(=O)c1cc(F)cc2c1c(C(=O)c1ccc(Cl)cc1)c1n2CCC[C@@H]1CC(=O)O 10.1016/j.bmcl.2008.03.015
44591513 190876 0 None -1862 2 Human 5.8 pKi = 5.8 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 420 5 1 4 6.0 CCc1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL482550 190876 0 None -1862 2 Human 5.8 pKi = 5.8 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 420 5 1 4 6.0 CCc1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
10458078 117211 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 485 8 2 6 4.1 COc1ccc(S(=O)(=O)NCCSC2c3ccccc3COc3ccc(C(=O)O)cc32)cc1 10.1021/jm00096a016
CHEMBL324583 117211 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 485 8 2 6 4.1 COc1ccc(S(=O)(=O)NCCSC2c3ccccc3COc3ccc(C(=O)O)cc32)cc1 10.1021/jm00096a016
10023647 17639 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 396 3 1 4 5.1 Cc1cccc2c1ncn2C/C=C1\c2ccccc2COc2ccc(C(=O)O)cc21 10.1021/jm00096a017
CHEMBL117242 17639 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 396 3 1 4 5.1 Cc1cccc2c1ncn2C/C=C1\c2ccccc2COc2ccc(C(=O)O)cc21 10.1021/jm00096a017
10051178 117435 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 488 5 2 5 5.8 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ccc(C(O)c4ccccc4)cc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL325868 117435 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 488 5 2 5 5.8 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ccc(C(O)c4ccccc4)cc31)c1ccccc1CO2 10.1021/jm00096a017
1880 9042 41 None 2 3 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 375 4 1 3 5.5 OC(=O)CC1CCn2c1c(Sc1ccc(cc1)Cl)c1c2cc(cc1)F 10.1016/j.bmcl.2008.03.015
44450494 9042 41 None 2 3 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 375 4 1 3 5.5 OC(=O)CC1CCn2c1c(Sc1ccc(cc1)Cl)c1c2cc(cc1)F 10.1016/j.bmcl.2008.03.015
CHEMBL264421 9042 41 None 2 3 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 375 4 1 3 5.5 OC(=O)CC1CCn2c1c(Sc1ccc(cc1)Cl)c1c2cc(cc1)F 10.1016/j.bmcl.2008.03.015
10226143 102618 1 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 453 4 1 3 6.3 O=C(O)CC1CCn2c1c(Sc1ccc(Cl)cc1)c1c(Br)cc(F)cc12 10.1016/j.bmcl.2008.03.015
CHEMBL258968 102618 1 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 453 4 1 3 6.3 O=C(O)CC1CCn2c1c(Sc1ccc(Cl)cc1)c1c(Br)cc(F)cc12 10.1016/j.bmcl.2008.03.015
10458078 117211 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 485 8 2 6 4.1 COc1ccc(S(=O)(=O)NCCSC2c3ccccc3COc3ccc(C(=O)O)cc32)cc1 10.1021/jm00096a016
CHEMBL324583 117211 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 485 8 2 6 4.1 COc1ccc(S(=O)(=O)NCCSC2c3ccccc3COc3ccc(C(=O)O)cc32)cc1 10.1021/jm00096a016
10480515 191112 0 None -9 2 Human 7.8 pKi = 7.8 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 484 5 1 6 5.3 CS(=O)(=O)c1ccnc2c1c(Sc1cccc(Cl)c1Cl)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL484327 191112 0 None -9 2 Human 7.8 pKi = 7.8 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 484 5 1 6 5.3 CS(=O)(=O)c1ccnc2c1c(Sc1cccc(Cl)c1Cl)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
14953077 71945 0 None - 1 Human 5.8 pKi = 5.8 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 360 5 1 3 4.5 CC(C)(Cc1nc2cc(F)ccc2n1Cc1ccc(Cl)cc1)C(=O)O 10.1021/jm00061a008
CHEMBL18245 71945 0 None - 1 Human 5.8 pKi = 5.8 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 360 5 1 3 4.5 CC(C)(Cc1nc2cc(F)ccc2n1Cc1ccc(Cl)cc1)C(=O)O 10.1021/jm00061a008
10342667 191827 0 None -28 2 Human 6.8 pKi = 6.8 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 430 5 1 6 4.3 Cc1ccc(Sc2c3n(c4nccc(S(C)(=O)=O)c24)CCCC3CC(=O)O)cc1 10.1016/j.bmcl.2009.03.010
CHEMBL485535 191827 0 None -28 2 Human 6.8 pKi = 6.8 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 430 5 1 6 4.3 Cc1ccc(Sc2c3n(c4nccc(S(C)(=O)=O)c24)CCCC3CC(=O)O)cc1 10.1016/j.bmcl.2009.03.010
14372505 148060 0 None -61 2 Human 6.8 pKi = 6.8 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 415 5 1 3 5.0 C[S+]([O-])c1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
CHEMBL383224 148060 0 None -61 2 Human 6.8 pKi = 6.8 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 415 5 1 3 5.0 C[S+]([O-])c1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
65772 67177 8 None -9 6 Human 6.8 pKi = 6.8 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm950896w
CHEMBL174984 67177 8 None -9 6 Human 6.8 pKi = 6.8 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm950896w
10051943 23097 0 None -588 3 Human 6.8 pKi = 6.8 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 507 2 3 3 3.7 Oc1cc2c(cc1O)C(Cc1cc(I)cc(I)c1)NCC2 10.1021/jm960208o
CHEMBL122757 23097 0 None -588 3 Human 6.8 pKi = 6.8 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 507 2 3 3 3.7 Oc1cc2c(cc1O)C(Cc1cc(I)cc(I)c1)NCC2 10.1021/jm960208o
10097814 16747 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 509 9 2 7 4.6 COc1ccc(C(=O)NCCSC2c3ccccc3COc3ccc(C(=O)O)cc32)c(OC)c1OC 10.1021/jm00096a016
CHEMBL114785 16747 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 509 9 2 7 4.6 COc1ccc(C(=O)NCCSC2c3ccccc3COc3ccc(C(=O)O)cc32)c(OC)c1OC 10.1021/jm00096a016
10319482 117372 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 412 4 1 4 5.5 Cc1cc2ncn(CCC3c4ccccc4COc4ccc(C(=O)O)cc43)c2cc1C 10.1021/jm00096a017
CHEMBL325521 117372 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 412 4 1 4 5.5 Cc1cc2ncn(CCC3c4ccccc4COc4ccc(C(=O)O)cc43)c2cc1C 10.1021/jm00096a017
10097814 16747 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 509 9 2 7 4.6 COc1ccc(C(=O)NCCSC2c3ccccc3COc3ccc(C(=O)O)cc32)c(OC)c1OC 10.1021/jm00096a016
CHEMBL114785 16747 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 509 9 2 7 4.6 COc1ccc(C(=O)NCCSC2c3ccccc3COc3ccc(C(=O)O)cc32)c(OC)c1OC 10.1021/jm00096a016
44411555 83819 0 None -177 2 Human 6.8 pKi = 6.8 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 546 5 1 5 5.6 CS(=O)(=O)c1cc(Br)c2c(c1)c1c(n2Cc2ccc3ccc(Cl)cc3n2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
CHEMBL207201 83819 0 None -177 2 Human 6.8 pKi = 6.8 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 546 5 1 5 5.6 CS(=O)(=O)c1cc(Br)c2c(c1)c1c(n2Cc2ccc3ccc(Cl)cc3n2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
11260506 74314 0 None 19 2 Human 6.8 pKi = 6.8 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 476 11 2 5 6.0 CCC(SCCc1c(CO)oc2c(OCC(=O)O)cccc12)(c1ccccc1)c1ccccc1 10.1021/jm050194z
CHEMBL189694 74314 0 None 19 2 Human 6.8 pKi = 6.8 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 476 11 2 5 6.0 CCC(SCCc1c(CO)oc2c(OCC(=O)O)cccc12)(c1ccccc1)c1ccccc1 10.1021/jm050194z
10024547 117264 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 410 3 1 4 5.4 Cc1cc2ncn(C/C=C3\c4ccccc4COc4cc(C(=O)O)ccc43)c2cc1C 10.1021/jm00096a017
CHEMBL324816 117264 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 410 3 1 4 5.4 Cc1cc2ncn(C/C=C3\c4ccccc4COc4cc(C(=O)O)ccc43)c2cc1C 10.1021/jm00096a017
44411798 145839 0 None -77 2 Human 5.8 pKi = 5.8 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 443 6 1 3 5.8 CC(C)[S+]([O-])c1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
CHEMBL378628 145839 0 None -77 2 Human 5.8 pKi = 5.8 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 443 6 1 3 5.8 CC(C)[S+]([O-])c1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
53317569 63595 0 None -489 3 Human 5.7 pKi = 5.7 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 468 5 1 4 3.8 CN([C@@H]1CCc2c(CC(=O)O)c3cc(F)c(Cl)cc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL1643782 63595 0 None -489 3 Human 5.7 pKi = 5.7 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 468 5 1 4 3.8 CN([C@@H]1CCc2c(CC(=O)O)c3cc(F)c(Cl)cc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
44591563 198687 0 None -478 2 Human 6.7 pKi = 6.7 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 468 5 1 4 7.2 CC(C)c1nccc2c1c(Sc1cc(Cl)c(Cl)cc1Cl)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL520007 198687 0 None -478 2 Human 6.7 pKi = 6.7 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 468 5 1 4 7.2 CC(C)c1nccc2c1c(Sc1cc(Cl)c(Cl)cc1Cl)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
10414389 23269 0 None -120 2 Human 6.7 pKi = 6.7 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 522 2 4 4 3.3 Nc1c(I)cc(CC2NCCc3cc(O)c(O)cc32)cc1I 10.1021/jm960208o
CHEMBL123596 23269 0 None -120 2 Human 6.7 pKi = 6.7 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 522 2 4 4 3.3 Nc1c(I)cc(CC2NCCc3cc(O)c(O)cc32)cc1I 10.1021/jm960208o
53320595 63583 0 None -407 3 Human 5.7 pKi = 5.7 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 434 5 1 4 3.2 CN([C@@H]1CCc2c(CC(=O)O)c3cc(F)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL1643771 63583 0 None -407 3 Human 5.7 pKi = 5.7 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 434 5 1 4 3.2 CN([C@@H]1CCc2c(CC(=O)O)c3cc(F)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
10477535 117123 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 426 4 2 5 4.5 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ccc(C(=O)O)cc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL324046 117123 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 426 4 2 5 4.5 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ccc(C(=O)O)cc31)c1ccccc1CO2 10.1021/jm00096a017
9806791 22327 0 None -1621 2 Human 4.7 pKi = 4.7 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 523 2 4 4 3.4 Oc1cc2c(cc1O)C(Cc1cc(I)c(O)c(I)c1)NCC2 10.1021/jm960208o
CHEMBL121964 22327 0 None -1621 2 Human 4.7 pKi = 4.7 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 523 2 4 4 3.4 Oc1cc2c(cc1O)C(Cc1cc(I)c(O)c(I)c1)NCC2 10.1021/jm960208o
44450427 102535 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 471 5 1 5 5.1 CS(=O)(=O)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1F)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL258498 102535 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 471 5 1 5 5.1 CS(=O)(=O)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1F)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
10026771 121198 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 450 3 1 4 5.8 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc(C(F)(F)F)ccc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL333159 121198 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 450 3 1 4 5.8 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc(C(F)(F)F)ccc31)c1ccccc1CO2 10.1021/jm00096a017
15157538 145603 0 None 1 2 Human 8.7 pKi = 8.7 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 431 4 1 2 6.0 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1c(Br)cccc21 10.1016/j.bmcl.2006.02.062
CHEMBL378125 145603 0 None 1 2 Human 8.7 pKi = 8.7 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 431 4 1 2 6.0 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1c(Br)cccc21 10.1016/j.bmcl.2006.02.062
15157534 83506 0 None 15 2 Human 8.6 pKi = 8.6 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 353 4 1 2 5.2 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1ccccc21 10.1016/j.bmcl.2006.02.062
CHEMBL206631 83506 0 None 15 2 Human 8.6 pKi = 8.6 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 353 4 1 2 5.2 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1ccccc21 10.1016/j.bmcl.2006.02.062
14372504 145064 0 None -2 2 Human 8.6 pKi = 8.6 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 399 5 1 3 6.0 CSc1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
CHEMBL377072 145064 0 None -2 2 Human 8.6 pKi = 8.6 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 399 5 1 3 6.0 CSc1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
10251861 16827 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 426 3 1 6 4.5 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc4c(cc31)OCO4)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL115241 16827 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 426 3 1 6 4.5 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc4c(cc31)OCO4)c1ccccc1CO2 10.1021/jm00096a017
5311396 172029 3 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 410 3 1 4 5.4 Cc1cc2ncn(C/C=C3\c4ccccc4COc4ccc(C(=O)O)cc43)c2cc1C 10.1021/jm00096a017
CHEMBL422964 172029 3 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 410 3 1 4 5.4 Cc1cc2ncn(C/C=C3\c4ccccc4COc4ccc(C(=O)O)cc43)c2cc1C 10.1021/jm00096a017
3356 9060 73 None -38 8 Human 8.5 pKi = 8.5 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1021/jm0603668
4326 9060 73 None -38 8 Human 8.5 pKi = 8.5 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1021/jm0603668
9867642 9060 73 None -38 8 Human 8.5 pKi = 8.5 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1021/jm0603668
CHEMBL426559 9060 73 None -38 8 Human 8.5 pKi = 8.5 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1021/jm0603668
DB11629 9060 73 None -38 8 Human 8.5 pKi = 8.5 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1021/jm0603668
11756528 16678 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 523 7 2 5 5.1 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccc(C(F)(F)F)cc1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL114363 16678 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 523 7 2 5 5.1 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccc(C(F)(F)F)cc1)c1ccccc1CO2 10.1021/jm00096a016
11756528 16678 0 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 523 7 2 5 5.1 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccc(C(F)(F)F)cc1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL114363 16678 0 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 523 7 2 5 5.1 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccc(C(F)(F)F)cc1)c1ccccc1CO2 10.1021/jm00096a016
14953097 170035 0 None - 1 Human 7.7 pKi = 7.7 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 386 7 1 4 4.8 COc1ccc(Cn2c(CC(C)(C)CC(=O)O)nc3cc(Cl)ccc32)cc1 10.1021/jm00061a008
CHEMBL418552 170035 0 None - 1 Human 7.7 pKi = 7.7 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 386 7 1 4 4.8 COc1ccc(Cn2c(CC(C)(C)CC(=O)O)nc3cc(Cl)ccc32)cc1 10.1021/jm00061a008
44392477 71848 0 None 1 2 Human 6.7 pKi = 6.7 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 543 6 1 4 8.0 OC(c1cncc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)c1)(C(F)(F)F)C(F)(F)F 10.1016/j.bmcl.2004.12.005
CHEMBL182367 71848 0 None 1 2 Human 6.7 pKi = 6.7 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 543 6 1 4 8.0 OC(c1cncc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)c1)(C(F)(F)F)C(F)(F)F 10.1016/j.bmcl.2004.12.005
18476686 83301 0 None -117 2 Human 6.7 pKi = 6.7 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 495 5 1 4 5.0 CS(=O)(=O)c1cc(Br)c2c(c1)c1c(n2Cc2ccc(Cl)cc2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
CHEMBL206040 83301 0 None -117 2 Human 6.7 pKi = 6.7 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 495 5 1 4 5.0 CS(=O)(=O)c1cc(Br)c2c(c1)c1c(n2Cc2ccc(Cl)cc2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
10297505 166059 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 447 7 1 4 6.6 CCC(OC)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL409939 166059 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 447 7 1 4 6.6 CCC(OC)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
44338237 14936 0 None -2 2 Human 5.7 pKi = 5.7 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 435 6 0 4 5.7 CN(C)C(=O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL109189 14936 0 None -2 2 Human 5.7 pKi = 5.7 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 435 6 0 4 5.7 CN(C)C(=O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
44338236 115918 0 None -1 2 Human 5.7 pKi = 5.7 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 442 6 0 5 5.4 CS(=O)(=O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL321405 115918 0 None -1 2 Human 5.7 pKi = 5.7 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 442 6 0 5 5.4 CS(=O)(=O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
11743676 190968 0 None -3981 2 Human 5.7 pKi = 5.7 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 434 5 1 4 6.6 CC(C)c1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL483159 190968 0 None -3981 2 Human 5.7 pKi = 5.7 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 434 5 1 4 6.6 CC(C)c1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
3086644 71605 7 None - 1 Human 7.7 pKi = 7.7 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 391 6 1 4 4.8 CC(C)(CC(=O)O)Cc1nc2cc(Cl)cnc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
CHEMBL18197 71605 7 None - 1 Human 7.7 pKi = 7.7 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 391 6 1 4 4.8 CC(C)(CC(=O)O)Cc1nc2cc(Cl)cnc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
44411896 83754 0 None -6 2 Human 5.7 pKi = 5.7 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 417 5 1 4 4.3 CS(=O)(=O)c1ccc2c(c1)c1c(n2Cc2ccc(Cl)cc2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
CHEMBL207104 83754 0 None -6 2 Human 5.7 pKi = 5.7 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 417 5 1 4 4.3 CS(=O)(=O)c1ccc2c(c1)c1c(n2Cc2ccc(Cl)cc2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
9874010 213969 0 None -123 8 Human 5.7 pKi = 5.7 Binding
Compound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assayCompound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assay
ChEMBL 629 8 1 4 6.9 CN(CCc1ccccc1)C(=O)NS(=O)(=O)c1ccccc1-c1ccc(CN2C(=O)c3ccccc3CCc3ccccc32)cc1 10.1016/s0960-894x(99)00465-5
CHEMBL92539 213969 0 None -123 8 Human 5.7 pKi = 5.7 Binding
Compound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assayCompound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assay
ChEMBL 629 8 1 4 6.9 CN(CCc1ccccc1)C(=O)NS(=O)(=O)c1ccccc1-c1ccc(CN2C(=O)c3ccccc3CCc3ccccc32)cc1 10.1016/s0960-894x(99)00465-5
53324111 63610 0 None -52 3 Human 5.7 pKi = 5.7 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 466 5 1 4 3.9 CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(C(F)(F)F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL1643797 63610 0 None -52 3 Human 5.7 pKi = 5.7 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 466 5 1 4 3.9 CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(C(F)(F)F)cc1 10.1016/j.bmcl.2010.11.015
53319321 63599 0 None -1174 3 Human 5.7 pKi = 5.7 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 430 6 1 4 3.4 CCN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL1643786 63599 0 None -1174 3 Human 5.7 pKi = 5.7 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 430 6 1 4 3.4 CCN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
53325908 63596 0 None -1348 3 Human 5.7 pKi = 5.7 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 434 5 1 4 3.2 CN([C@@H]1CCc2c(CC(=O)O)c3cccc(F)c3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL1643783 63596 0 None -1348 3 Human 5.7 pKi = 5.7 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 434 5 1 4 3.2 CN([C@@H]1CCc2c(CC(=O)O)c3cccc(F)c3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
10161062 165597 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 449 6 1 4 4.6 CS(=O)(=O)c1cc(F)cc2c1c(CCc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL409451 165597 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 449 6 1 4 4.6 CS(=O)(=O)c1cc(F)cc2c1c(CCc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
11306423 9303 8 None -52 2 Human 6.7 pKi = 6.7 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 491 6 2 5 6.4 Clc1ccc(c(c1)c1ccsc1c1cncc(c1)C(C(F)(F)F)(O)O)OCc1ccccc1 10.1016/j.bmcl.2004.12.005
6068 9303 8 None -52 2 Human 6.7 pKi = 6.7 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 491 6 2 5 6.4 Clc1ccc(c(c1)c1ccsc1c1cncc(c1)C(C(F)(F)F)(O)O)OCc1ccccc1 10.1016/j.bmcl.2004.12.005
CHEMBL185346 9303 8 None -52 2 Human 6.7 pKi = 6.7 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 491 6 2 5 6.4 Clc1ccc(c(c1)c1ccsc1c1cncc(c1)C(C(F)(F)F)(O)O)OCc1ccccc1 10.1016/j.bmcl.2004.12.005
44411799 85060 0 None -50 2 Human 6.7 pKi = 6.7 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 586 5 1 6 6.3 CS(=O)(=O)c1cc(Br)c2c(c1)c1c(n2Cc2ccc3sc(Cl)c(Cl)c3n2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
CHEMBL210744 85060 0 None -50 2 Human 6.7 pKi = 6.7 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 586 5 1 6 6.3 CS(=O)(=O)c1cc(Br)c2c(c1)c1c(n2Cc2ccc3sc(Cl)c(Cl)c3n2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
44338326 13314 0 None -38 2 Human 5.7 pKi = 5.7 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 404 6 0 4 5.3 COC(=O)c1ccc(CCc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL108289 13314 0 None -38 2 Human 5.7 pKi = 5.7 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 404 6 0 4 5.3 COC(=O)c1ccc(CCc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
10204462 103312 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 453 5 1 5 5.0 CS(=O)(=O)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL262869 103312 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 453 5 1 5 5.0 CS(=O)(=O)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
10363348 16807 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 396 3 1 4 5.1 Cc1ccc2ncn(C/C=C3\c4ccccc4COc4ccc(C(=O)O)cc43)c2c1 10.1021/jm00096a017
CHEMBL115111 16807 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 396 3 1 4 5.1 Cc1ccc2ncn(C/C=C3\c4ccccc4COc4ccc(C(=O)O)cc43)c2c1 10.1021/jm00096a017
14953067 68129 0 None - 1 Human 7.6 pKi = 7.6 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 388 7 1 3 5.3 CC(C)(CCC(=O)O)Cc1nc2cc(F)ccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
CHEMBL17677 68129 0 None - 1 Human 7.6 pKi = 7.6 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 388 7 1 3 5.3 CC(C)(CCC(=O)O)Cc1nc2cc(F)ccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
14953084 169917 0 None - 1 Human 7.6 pKi = 7.6 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 390 6 1 3 5.4 CC(C)(CC(=O)O)Cc1nc2cc(Cl)ccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
CHEMBL417820 169917 0 None - 1 Human 7.6 pKi = 7.6 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 390 6 1 3 5.4 CC(C)(CC(=O)O)Cc1nc2cc(Cl)ccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
10254794 198996 0 None -17 2 Human 7.6 pKi = 7.6 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 484 5 1 6 5.3 CS(=O)(=O)c1ccnc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL520480 198996 0 None -17 2 Human 7.6 pKi = 7.6 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 484 5 1 6 5.3 CS(=O)(=O)c1ccnc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
9953978 73093 0 None -14 2 Human 6.6 pKi = 6.6 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 421 6 1 4 6.4 O=C(O)c1cncc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)c1 10.1016/j.bmcl.2004.12.005
CHEMBL184947 73093 0 None -14 2 Human 6.6 pKi = 6.6 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 421 6 1 4 6.4 O=C(O)c1cncc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)c1 10.1016/j.bmcl.2004.12.005
22083975 145175 0 None -2 2 Human 5.6 pKi = 5.6 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 446 6 1 4 4.1 CN(C)S(=O)(=O)c1ccc2c(c1)c1c(n2Cc2ccc(Cl)cc2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
CHEMBL377297 145175 0 None -2 2 Human 5.6 pKi = 5.6 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 446 6 1 4 4.1 CN(C)S(=O)(=O)c1ccc2c(c1)c1c(n2Cc2ccc(Cl)cc2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
10073359 191082 0 None -6 2 Human 7.6 pKi = 7.6 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 468 5 1 6 4.7 CS(=O)(=O)c1ccnc2c1c(Sc1ccc(F)cc1Cl)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL484130 191082 0 None -6 2 Human 7.6 pKi = 7.6 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 468 5 1 6 4.7 CS(=O)(=O)c1ccnc2c1c(Sc1ccc(F)cc1Cl)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
10478975 168687 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 451 7 2 4 4.7 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1C=C2 10.1021/jm00096a016
CHEMBL415239 168687 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 451 7 2 4 4.7 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1C=C2 10.1021/jm00096a016
10478975 168687 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 451 7 2 4 4.7 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1C=C2 10.1021/jm00096a016
CHEMBL415239 168687 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 451 7 2 4 4.7 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1C=C2 10.1021/jm00096a016
10162132 102999 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 467 6 1 5 5.3 CCS(=O)(=O)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL260854 102999 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 467 6 1 5 5.3 CCS(=O)(=O)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
10480363 117174 0 None - 1 Human 6.6 pKi = 6.6 Binding
Compound was tested for its binding affinity at Thromboxane A2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsCompound was tested for its binding affinity at Thromboxane A2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 481 8 2 5 4.7 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)/C=C/c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL324364 117174 0 None - 1 Human 6.6 pKi = 6.6 Binding
Compound was tested for its binding affinity at Thromboxane A2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsCompound was tested for its binding affinity at Thromboxane A2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 481 8 2 5 4.7 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)/C=C/c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
10480363 117174 0 None - 1 Human 6.6 pKi = 6.6 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 481 8 2 5 4.7 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)/C=C/c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL324364 117174 0 None - 1 Human 6.6 pKi = 6.6 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 481 8 2 5 4.7 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)/C=C/c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
11166017 73913 0 None -3 2 Human 5.6 pKi = 5.6 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 418 9 1 4 6.0 O=C(O)COc1cccc2c(CSCC(c3ccccc3)c3ccccc3)coc12 10.1021/jm050194z
CHEMBL187544 73913 0 None -3 2 Human 5.6 pKi = 5.6 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 418 9 1 4 6.0 O=C(O)COc1cccc2c(CSCC(c3ccccc3)c3ccccc3)coc12 10.1021/jm050194z
11201307 74665 0 None 21 2 Human 7.6 pKi = 7.6 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 432 9 1 4 6.1 CC(SCCc1coc2c(OCC(=O)O)cccc12)(c1ccccc1)c1ccccc1 10.1021/jm050194z
CHEMBL191056 74665 0 None 21 2 Human 7.6 pKi = 7.6 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 432 9 1 4 6.1 CC(SCCc1coc2c(OCC(=O)O)cccc12)(c1ccccc1)c1ccccc1 10.1021/jm050194z
44411851 84521 0 None -64 2 Human 6.6 pKi = 6.6 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 545 6 1 5 5.3 CS(=O)(=O)c1cc(Br)c2c(c1)c1c(n2Cc2cccc(OC(F)(F)F)c2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
CHEMBL209033 84521 0 None -64 2 Human 6.6 pKi = 6.6 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 545 6 1 5 5.3 CS(=O)(=O)c1cc(Br)c2c(c1)c1c(n2Cc2cccc(OC(F)(F)F)c2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
10116114 132664 0 None -75 8 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-SQ29548 from human TP receptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]-SQ29548 from human TP receptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 470 6 1 6 4.5 Cc1cc2c(CC(=O)O)cccc2n1C(=O)c1ccc(OC[C@@H]2CN(C)c3ccccc3O2)cc1 10.1016/j.bmc.2011.06.014
CHEMBL364841 132664 0 None -75 8 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-SQ29548 from human TP receptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]-SQ29548 from human TP receptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 470 6 1 6 4.5 Cc1cc2c(CC(=O)O)cccc2n1C(=O)c1ccc(OC[C@@H]2CN(C)c3ccccc3O2)cc1 10.1016/j.bmc.2011.06.014
10116114 132664 0 None -75 8 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-SQ29548 from human prostanoid TP receptor expressed in CHO cells after 60 mins by liquid scintillation countingDisplacement of [3H]-SQ29548 from human prostanoid TP receptor expressed in CHO cells after 60 mins by liquid scintillation counting
ChEMBL 470 6 1 6 4.5 Cc1cc2c(CC(=O)O)cccc2n1C(=O)c1ccc(OC[C@@H]2CN(C)c3ccccc3O2)cc1 10.1016/j.bmc.2011.08.007
CHEMBL364841 132664 0 None -75 8 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-SQ29548 from human prostanoid TP receptor expressed in CHO cells after 60 mins by liquid scintillation countingDisplacement of [3H]-SQ29548 from human prostanoid TP receptor expressed in CHO cells after 60 mins by liquid scintillation counting
ChEMBL 470 6 1 6 4.5 Cc1cc2c(CC(=O)O)cccc2n1C(=O)c1ccc(OC[C@@H]2CN(C)c3ccccc3O2)cc1 10.1016/j.bmc.2011.08.007
10322452 16758 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 469 7 2 5 4.4 Cc1ccc(S(=O)(=O)NCCSC2c3ccccc3COc3ccc(C(=O)O)cc32)cc1 10.1021/jm00096a016
CHEMBL114826 16758 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 469 7 2 5 4.4 Cc1ccc(S(=O)(=O)NCCSC2c3ccccc3COc3ccc(C(=O)O)cc32)cc1 10.1021/jm00096a016
10322452 16758 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 469 7 2 5 4.4 Cc1ccc(S(=O)(=O)NCCSC2c3ccccc3COc3ccc(C(=O)O)cc32)cc1 10.1021/jm00096a016
CHEMBL114826 16758 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 469 7 2 5 4.4 Cc1ccc(S(=O)(=O)NCCSC2c3ccccc3COc3ccc(C(=O)O)cc32)cc1 10.1021/jm00096a016
10297616 103166 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 449 6 1 4 7.0 CSC(C)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL261811 103166 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 449 6 1 4 7.0 CSC(C)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
44411635 85002 0 None -1 2 Human 5.6 pKi = 5.6 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 539 6 1 6 3.8 CS(=O)(=O)c1ccc(Cn2c3c(c4cc(S(C)(=O)=O)cc(Br)c42)CCC3CC(=O)O)cc1 10.1016/j.bmcl.2006.02.062
CHEMBL210588 85002 0 None -1 2 Human 5.6 pKi = 5.6 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 539 6 1 6 3.8 CS(=O)(=O)c1ccc(Cn2c3c(c4cc(S(C)(=O)=O)cc(Br)c42)CCC3CC(=O)O)cc1 10.1016/j.bmcl.2006.02.062
10112823 102903 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 419 5 2 4 5.6 CC(O)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL260400 102903 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 419 5 2 4 5.6 CC(O)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
10410551 117172 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 432 3 1 4 5.9 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc4ccccc4cc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL324331 117172 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 432 3 1 4 5.9 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc4ccccc4cc31)c1ccccc1CO2 10.1021/jm00096a017
9938626 213612 0 None -177 7 Human 5.6 pKi = 5.6 Binding
Compound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assayCompound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assay
ChEMBL 600 7 1 4 6.9 CC(C(=O)NS(=O)(=O)c1ccccc1-c1ccc(CN2C(=O)c3ccccc3CCc3ccccc32)cc1)c1ccccc1 10.1016/s0960-894x(99)00465-5
CHEMBL90491 213612 0 None -177 7 Human 5.6 pKi = 5.6 Binding
Compound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assayCompound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assay
ChEMBL 600 7 1 4 6.9 CC(C(=O)NS(=O)(=O)c1ccccc1-c1ccc(CN2C(=O)c3ccccc3CCc3ccccc32)cc1)c1ccccc1 10.1016/s0960-894x(99)00465-5
11741746 190992 0 None -3981 2 Human 5.6 pKi = 5.6 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 400 5 1 4 5.9 CC(C)c1nccc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL483346 190992 0 None -3981 2 Human 5.6 pKi = 5.6 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 400 5 1 4 5.9 CC(C)c1nccc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
53320618 63614 0 None -446 3 Human 5.6 pKi = 5.6 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 438 5 1 5 3.6 CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(Cl)s1 10.1016/j.bmcl.2010.11.015
CHEMBL1643801 63614 0 None -446 3 Human 5.6 pKi = 5.6 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 438 5 1 5 3.6 CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(Cl)s1 10.1016/j.bmcl.2010.11.015
44450410 163178 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 487 5 1 5 5.3 CS(=O)(=O)c1cc(F)cc2c1c(Sc1ccc(C(F)(F)F)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL406649 163178 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 487 5 1 5 5.3 CS(=O)(=O)c1cc(F)cc2c1c(Sc1ccc(C(F)(F)F)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
53320616 63590 0 None -1202 3 Human 5.5 pKi = 5.5 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 492 6 1 4 4.7 CN([C@@H]1CCc2c(CC(=O)O)c3ccc(-c4ccccc4)cc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL1643778 63590 0 None -1202 3 Human 5.5 pKi = 5.5 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 492 6 1 4 4.7 CN([C@@H]1CCc2c(CC(=O)O)c3ccc(-c4ccccc4)cc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
10407599 17419 0 None - 1 Human 4.5 pKi = 4.5 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 383 3 1 5 4.2 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ncccc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL117036 17419 0 None - 1 Human 4.5 pKi = 4.5 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 383 3 1 5 4.2 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ncccc31)c1ccccc1CO2 10.1021/jm00096a017
44591458 186778 0 None -213 2 Human 5.5 pKi = 5.5 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 392 4 1 4 5.5 O=C(O)CC1CCn2c1c(Sc1ccc(Cl)c(Cl)c1)c1cnccc12 10.1016/j.bmcl.2009.03.010
CHEMBL474702 186778 0 None -213 2 Human 5.5 pKi = 5.5 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 392 4 1 4 5.5 O=C(O)CC1CCn2c1c(Sc1ccc(Cl)c(Cl)c1)c1cnccc12 10.1016/j.bmcl.2009.03.010
10454345 16673 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 412 4 1 5 4.8 COc1ccc2c(c1)ncn2C/C=C1\c2ccccc2COc2ccc(C(=O)O)cc21 10.1021/jm00096a017
CHEMBL114335 16673 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 412 4 1 5 4.8 COc1ccc2c(c1)ncn2C/C=C1\c2ccccc2COc2ccc(C(=O)O)cc21 10.1021/jm00096a017
11744062 16650 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 442 5 1 6 4.8 COc1cc2ncn(C/C=C3\c4ccccc4COc4ccc(C(=O)O)cc43)c2cc1OC 10.1021/jm00096a017
CHEMBL114213 16650 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 442 5 1 6 4.8 COc1cc2ncn(C/C=C3\c4ccccc4COc4ccc(C(=O)O)cc43)c2cc1OC 10.1021/jm00096a017
9978920 16822 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 410 3 1 4 5.4 Cc1ccc2c(ncn2C/C=C2\c3ccccc3COc3ccc(C(=O)O)cc32)c1C 10.1021/jm00096a017
CHEMBL115224 16822 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 410 3 1 4 5.4 Cc1ccc2c(ncn2C/C=C2\c3ccccc3COc3ccc(C(=O)O)cc32)c1C 10.1021/jm00096a017
10050461 16770 1 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 471 7 2 5 4.8 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1CS2 10.1021/jm00096a016
CHEMBL114901 16770 1 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 471 7 2 5 4.8 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1CS2 10.1021/jm00096a016
10050461 16770 1 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 471 7 2 5 4.8 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1CS2 10.1021/jm00096a016
CHEMBL114901 16770 1 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 471 7 2 5 4.8 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1CS2 10.1021/jm00096a016
10074101 190874 0 None -2 2 Human 8.4 pKi = 8.4 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 484 5 1 6 5.3 CS(=O)(=O)c1ccnc2c1c(Sc1ccc(Cl)cc1Cl)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL482547 190874 0 None -2 2 Human 8.4 pKi = 8.4 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 484 5 1 6 5.3 CS(=O)(=O)c1ccnc2c1c(Sc1ccc(Cl)cc1Cl)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
10364232 117286 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 410 3 1 4 5.4 Cc1cc(C)c2ncn(C/C=C3\c4ccccc4COc4ccc(C(=O)O)cc43)c2c1 10.1021/jm00096a017
CHEMBL324965 117286 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 410 3 1 4 5.4 Cc1cc(C)c2ncn(C/C=C3\c4ccccc4COc4ccc(C(=O)O)cc43)c2c1 10.1021/jm00096a017
10026942 16710 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 453 7 2 4 4.3 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1CC2 10.1021/jm00096a016
CHEMBL114588 16710 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 453 7 2 4 4.3 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1CC2 10.1021/jm00096a016
10071103 17278 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 426 4 2 5 4.5 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc(C(=O)O)ccc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL116721 17278 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 426 4 2 5 4.5 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc(C(=O)O)ccc31)c1ccccc1CO2 10.1021/jm00096a017
10026942 16710 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 453 7 2 4 4.3 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1CC2 10.1021/jm00096a016
CHEMBL114588 16710 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 453 7 2 4 4.3 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1CC2 10.1021/jm00096a016
9809136 113666 0 None -301 8 Human 5.5 pKi = 5.5 Binding
Compound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assayCompound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assay
ChEMBL 614 7 1 4 7.1 CC(C)(C(=O)NS(=O)(=O)c1ccccc1-c1ccc(CN2C(=O)c3ccccc3CCc3ccccc32)cc1)c1ccccc1 10.1016/s0960-894x(99)00465-5
CHEMBL314533 113666 0 None -301 8 Human 5.5 pKi = 5.5 Binding
Compound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assayCompound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assay
ChEMBL 614 7 1 4 7.1 CC(C)(C(=O)NS(=O)(=O)c1ccccc1-c1ccc(CN2C(=O)c3ccccc3CCc3ccccc32)cc1)c1ccccc1 10.1016/s0960-894x(99)00465-5
9802748 142701 0 None -1584 3 Human 5.5 pKi = 5.5 Binding
Inhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptorInhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptor
ChEMBL 430 6 1 4 3.4 CN([C@@H]1CCc2c(c3ccccc3n2CCC(=O)O)C1)S(=O)(=O)c1ccc(F)cc1 10.1021/jm049036i
CHEMBL373118 142701 0 None -1584 3 Human 5.5 pKi = 5.5 Binding
Inhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptorInhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptor
ChEMBL 430 6 1 4 3.4 CN([C@@H]1CCc2c(c3ccccc3n2CCC(=O)O)C1)S(=O)(=O)c1ccc(F)cc1 10.1021/jm049036i
14953103 69952 0 None - 1 Human 7.5 pKi = 7.5 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 352 7 1 4 4.1 COc1ccc(Cn2c(CC(C)(C)CC(=O)O)nc3ccccc32)cc1 10.1021/jm00061a008
CHEMBL17899 69952 0 None - 1 Human 7.5 pKi = 7.5 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 352 7 1 4 4.1 COc1ccc(Cn2c(CC(C)(C)CC(=O)O)nc3ccccc32)cc1 10.1021/jm00061a008
14953078 105497 0 None - 1 Human 7.5 pKi = 7.5 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 356 6 1 3 4.8 CC(C)(CC(=O)O)Cc1nc2ccccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
CHEMBL277826 105497 0 None - 1 Human 7.5 pKi = 7.5 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 356 6 1 3 4.8 CC(C)(CC(=O)O)Cc1nc2ccccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
44450397 102911 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 463 5 1 4 5.5 CS(=O)(=O)c1cc(F)cc2c1c(-c1cccc(-c3ccccc3)c1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL260468 102911 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 463 5 1 4 5.5 CS(=O)(=O)c1cc(F)cc2c1c(-c1cccc(-c3ccccc3)c1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
11316066 74084 0 None 1 2 Human 6.5 pKi = 6.5 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 418 9 1 4 6.0 O=C(O)COc1cccc2c(CCSC(c3ccccc3)c3ccccc3)coc12 10.1021/jm050194z
CHEMBL188384 74084 0 None 1 2 Human 6.5 pKi = 6.5 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 418 9 1 4 6.0 O=C(O)COc1cccc2c(CCSC(c3ccccc3)c3ccccc3)coc12 10.1021/jm050194z
44338291 13204 0 None -3 2 Human 5.5 pKi = 5.5 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 438 6 0 5 4.8 COC(=O)c1ccc(C[S+]([O-])c2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL108242 13204 0 None -3 2 Human 5.5 pKi = 5.5 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 438 6 0 5 4.8 COC(=O)c1ccc(C[S+]([O-])c2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
11350967 73961 0 None -11 2 Human 5.5 pKi = 5.5 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 432 10 1 4 6.4 O=C(O)COc1cccc2c(CCCSC(c3ccccc3)c3ccccc3)coc12 10.1021/jm050194z
CHEMBL187758 73961 0 None -11 2 Human 5.5 pKi = 5.5 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 432 10 1 4 6.4 O=C(O)COc1cccc2c(CCCSC(c3ccccc3)c3ccccc3)coc12 10.1021/jm050194z
11750835 74223 0 None -5 2 Human 5.5 pKi = 5.5 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 432 10 1 4 6.4 O=C(O)COc1cccc2c(CSCCC(c3ccccc3)c3ccccc3)coc12 10.1021/jm050194z
CHEMBL189063 74223 0 None -5 2 Human 5.5 pKi = 5.5 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 432 10 1 4 6.4 O=C(O)COc1cccc2c(CSCCC(c3ccccc3)c3ccccc3)coc12 10.1021/jm050194z
11407826 130424 0 None -38 2 Human 5.5 pKi = 5.5 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 432 10 1 4 6.0 O=C(O)COc1cccc2c(CCSCC(c3ccccc3)c3ccccc3)coc12 10.1021/jm050194z
CHEMBL361939 130424 0 None -38 2 Human 5.5 pKi = 5.5 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 432 10 1 4 6.0 O=C(O)COc1cccc2c(CCSCC(c3ccccc3)c3ccccc3)coc12 10.1021/jm050194z
11545879 21678 3 None -125 3 Human 6.5 pKi = 6.5 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 381 6 1 3 5.8 CC(C)COc1ccc(Cl)cc1-c1ccccc1-c1cccc(C(=O)O)n1 10.1016/j.bmcl.2008.11.032
CHEMBL1207973 21678 3 None -125 3 Human 6.5 pKi = 6.5 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 381 6 1 3 5.8 CC(C)COc1ccc(Cl)cc1-c1ccccc1-c1cccc(C(=O)O)n1 10.1016/j.bmcl.2008.11.032
CHEMBL467510 21678 3 None -125 3 Human 6.5 pKi = 6.5 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 381 6 1 3 5.8 CC(C)COc1ccc(Cl)cc1-c1ccccc1-c1cccc(C(=O)O)n1 10.1016/j.bmcl.2008.11.032
10225820 163177 1 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 449 5 1 4 5.0 CC(c1ccc(Cl)cc1)c1c2n(c3cc(F)cc(S(C)(=O)=O)c13)CCC2CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL406648 163177 1 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 449 5 1 4 5.0 CC(c1ccc(Cl)cc1)c1c2n(c3cc(F)cc(S(C)(=O)=O)c13)CCC2CC(=O)O 10.1016/j.bmcl.2008.03.015
3078928 117142 1 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 455 7 2 5 4.1 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL324130 117142 1 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 455 7 2 5 4.1 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
3078928 117142 1 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 455 7 2 5 4.1 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL324130 117142 1 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 455 7 2 5 4.1 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1CO2 10.1021/jm00096a017
3078928 117142 1 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 455 7 2 5 4.1 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL324130 117142 1 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 455 7 2 5 4.1 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
10412393 16691 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 469 7 1 5 4.4 CN(CCSC1c2ccccc2COc2ccc(C(=O)O)cc21)S(=O)(=O)c1ccccc1 10.1021/jm00096a016
CHEMBL114424 16691 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 469 7 1 5 4.4 CN(CCSC1c2ccccc2COc2ccc(C(=O)O)cc21)S(=O)(=O)c1ccccc1 10.1021/jm00096a016
10412393 16691 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 469 7 1 5 4.4 CN(CCSC1c2ccccc2COc2ccc(C(=O)O)cc21)S(=O)(=O)c1ccccc1 10.1021/jm00096a016
CHEMBL114424 16691 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 469 7 1 5 4.4 CN(CCSC1c2ccccc2COc2ccc(C(=O)O)cc21)S(=O)(=O)c1ccccc1 10.1021/jm00096a016
44411605 83973 0 None -117 2 Human 6.5 pKi = 6.5 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 499 6 1 4 6.3 CS(=O)(=O)c1cc(C2CCCCC2)c2c(c1)c1c(n2Cc2ccc(Cl)cc2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
CHEMBL207916 83973 0 None -117 2 Human 6.5 pKi = 6.5 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 499 6 1 4 6.3 CS(=O)(=O)c1cc(C2CCCCC2)c2c(c1)c1c(n2Cc2ccc(Cl)cc2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
10495597 66057 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 316 3 4 6 2.1 O=[N+]([O-])c1cc(CC2NCCc3cc(O)c(O)cc32)ccc1O 10.1021/jm950896w
CHEMBL170451 66057 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 316 3 4 6 2.1 O=[N+]([O-])c1cc(CC2NCCc3cc(O)c(O)cc32)ccc1O 10.1021/jm950896w
44591806 190933 0 None -3 2 Human 6.5 pKi = 6.5 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 402 5 1 5 5.2 COc1ccnc2c1c(Sc1ccc(Cl)cc1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL482953 190933 0 None -3 2 Human 6.5 pKi = 6.5 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 402 5 1 5 5.2 COc1ccnc2c1c(Sc1ccc(Cl)cc1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
44411797 146293 0 None -85 2 Human 6.5 pKi = 6.5 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 429 6 1 3 5.4 CC[S+]([O-])c1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
CHEMBL379491 146293 0 None -85 2 Human 6.5 pKi = 6.5 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 429 6 1 3 5.4 CC[S+]([O-])c1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
46890180 13448 0 None -97 2 Human 5.5 pKi = 5.5 Binding
Binding affinity to human thromboxane A2 receptor by radioligand displacement assayBinding affinity to human thromboxane A2 receptor by radioligand displacement assay
ChEMBL 510 7 1 5 4.9 Cc1c(C2c3ccccc3S(=O)(=O)N2CCOc2ccc(Cl)cc2)c2ccccc2n1CC(=O)O 10.1016/j.bmcl.2010.04.046
CHEMBL1083446 13448 0 None -97 2 Human 5.5 pKi = 5.5 Binding
Binding affinity to human thromboxane A2 receptor by radioligand displacement assayBinding affinity to human thromboxane A2 receptor by radioligand displacement assay
ChEMBL 510 7 1 5 4.9 Cc1c(C2c3ccccc3S(=O)(=O)N2CCOc2ccc(Cl)cc2)c2ccccc2n1CC(=O)O 10.1016/j.bmcl.2010.04.046
44591535 190967 0 None -4677 2 Human 5.5 pKi = 5.5 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 446 6 1 4 6.4 O=C(O)CC1CCn2c1c(Sc1ccc(Cl)c(Cl)c1)c1c(CC3CC3)nccc12 10.1016/j.bmcl.2009.03.010
CHEMBL483154 190967 0 None -4677 2 Human 5.5 pKi = 5.5 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 446 6 1 4 6.4 O=C(O)CC1CCn2c1c(Sc1ccc(Cl)c(Cl)c1)c1c(CC3CC3)nccc12 10.1016/j.bmcl.2009.03.010
10683471 66671 0 None - 1 Human 4.5 pKi = 4.5 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 270 2 4 4 2.1 Nc1ccc(CC2NCCc3cc(O)c(O)cc32)cc1 10.1021/jm950896w
CHEMBL173039 66671 0 None - 1 Human 4.5 pKi = 4.5 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 270 2 4 4 2.1 Nc1ccc(CC2NCCc3cc(O)c(O)cc32)cc1 10.1021/jm950896w
10345671 191058 0 None -10 2 Human 7.5 pKi = 7.5 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 494 5 1 6 4.7 CS(=O)(=O)c1ccnc2c1c(Sc1ccc(Br)cc1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL483939 191058 0 None -10 2 Human 7.5 pKi = 7.5 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 494 5 1 6 4.7 CS(=O)(=O)c1ccnc2c1c(Sc1ccc(Br)cc1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
10349225 23156 0 None -40 2 Human 6.5 pKi = 6.5 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 564 3 4 4 3.7 CC(=O)Nc1c(I)cc(CC2NCCc3cc(O)c(O)cc32)cc1I 10.1021/jm960208o
CHEMBL122992 23156 0 None -40 2 Human 6.5 pKi = 6.5 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 564 3 4 4 3.7 CC(=O)Nc1c(I)cc(CC2NCCc3cc(O)c(O)cc32)cc1I 10.1021/jm960208o
44392512 71998 0 None -6 2 Human 6.4 pKi = 6.4 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 432 6 1 5 6.3 N#CC(O)c1cncc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)c1 10.1016/j.bmcl.2004.12.005
CHEMBL182623 71998 0 None -6 2 Human 6.4 pKi = 6.4 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 432 6 1 5 6.3 N#CC(O)c1cncc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)c1 10.1016/j.bmcl.2004.12.005
9933925 146339 0 None -380 2 Human 5.4 pKi = 5.4 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 459 6 1 5 4.5 CC(=O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CC3 10.1016/j.bmcl.2006.02.062
CHEMBL379711 146339 0 None -380 2 Human 5.4 pKi = 5.4 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 459 6 1 5 4.5 CC(=O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CC3 10.1016/j.bmcl.2006.02.062
10114504 102568 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 445 7 1 3 7.5 CCC(CC)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL258714 102568 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 445 7 1 3 7.5 CCC(CC)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
10409168 117923 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 408 4 1 4 5.3 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc(-c3ccccc3)c1)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL326393 117923 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 408 4 1 4 5.3 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc(-c3ccccc3)c1)c1ccccc1CO2 10.1021/jm00096a017
14953098 169942 0 None - 1 Human 7.4 pKi = 7.4 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 418 7 1 5 3.7 CC(C)(CC(=O)O)Cc1nc2cc(F)ccc2n1Cc1ccc(S(C)(=O)=O)cc1 10.1021/jm00061a008
CHEMBL418000 169942 0 None - 1 Human 7.4 pKi = 7.4 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 418 7 1 5 3.7 CC(C)(CC(=O)O)Cc1nc2cc(F)ccc2n1Cc1ccc(S(C)(=O)=O)cc1 10.1021/jm00061a008
44411889 84051 0 None -131 2 Human 5.4 pKi = 5.4 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 424 5 1 3 4.9 CN(C)C(=O)c1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
CHEMBL208082 84051 0 None -131 2 Human 5.4 pKi = 5.4 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 424 5 1 3 4.9 CN(C)C(=O)c1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
44338285 14247 0 None -12 2 Human 5.4 pKi = 5.4 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 406 6 0 4 6.2 CC(=O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL108698 14247 0 None -12 2 Human 5.4 pKi = 5.4 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 406 6 0 4 6.2 CC(=O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
45268455 202916 48 None -1513 4 Human 5.4 pKi = 5.4 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 416 5 1 4 3.0 CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL561132 202916 48 None -1513 4 Human 5.4 pKi = 5.4 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 416 5 1 4 3.0 CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
45268455 202916 48 None -1513 4 Human 5.4 pKi = 5.4 Binding
Displacement of radioligand from prostanoid TP receptor expressed in HEK293 cells by competitive binding assayDisplacement of radioligand from prostanoid TP receptor expressed in HEK293 cells by competitive binding assay
ChEMBL 416 5 1 4 3.0 CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.084
CHEMBL561132 202916 48 None -1513 4 Human 5.4 pKi = 5.4 Binding
Displacement of radioligand from prostanoid TP receptor expressed in HEK293 cells by competitive binding assayDisplacement of radioligand from prostanoid TP receptor expressed in HEK293 cells by competitive binding assay
ChEMBL 416 5 1 4 3.0 CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.084
45268455 202916 48 None -1513 4 Human 5.4 pKi = 5.4 Binding
Selectivity interaction (Prostanoid receptor binding assay) EUB0000297b TBXA2RSelectivity interaction (Prostanoid receptor binding assay) EUB0000297b TBXA2R
ChEMBL 416 5 1 4 3.0 CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.6019/CHEMBL5212743
CHEMBL561132 202916 48 None -1513 4 Human 5.4 pKi = 5.4 Binding
Selectivity interaction (Prostanoid receptor binding assay) EUB0000297b TBXA2RSelectivity interaction (Prostanoid receptor binding assay) EUB0000297b TBXA2R
ChEMBL 416 5 1 4 3.0 CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.6019/CHEMBL5212743
10433093 191309 0 None -1000 2 Human 6.4 pKi = 6.4 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 434 5 1 4 6.6 CC(C)c1nccc2c1c(Sc1ccc(Cl)cc1Cl)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL484779 191309 0 None -1000 2 Human 6.4 pKi = 6.4 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 434 5 1 4 6.6 CC(C)c1nccc2c1c(Sc1ccc(Cl)cc1Cl)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
15947857 162292 7 None -34 7 Human 7.4 pKi = 7.4 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 767 12 1 9 6.3 COc1cccc(OC)c1C1(C(=O)NS(=O)(=O)Cc2ccc(N3Cc4c(c(OCC(F)(F)F)c5cccnc5c4OCC(F)(F)F)C3=O)c(C)c2)CC1 10.1016/j.bmcl.2008.01.103
CHEMBL404199 162292 7 None -34 7 Human 7.4 pKi = 7.4 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 767 12 1 9 6.3 COc1cccc(OC)c1C1(C(=O)NS(=O)(=O)Cc2ccc(N3Cc4c(c(OCC(F)(F)F)c5cccnc5c4OCC(F)(F)F)C3=O)c(C)c2)CC1 10.1016/j.bmcl.2008.01.103
14953114 70256 0 None - 1 Human 7.4 pKi = 7.4 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 357 6 1 4 4.2 CC(C)(CC(=O)O)Cc1nc2cccnc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
CHEMBL17990 70256 0 None - 1 Human 7.4 pKi = 7.4 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 357 6 1 4 4.2 CC(C)(CC(=O)O)Cc1nc2cccnc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
9825028 191148 0 None -9 2 Human 7.4 pKi = 7.4 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 450 5 1 6 4.6 CS(=O)(=O)c1ccnc2c1c(Sc1ccc(Cl)cc1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL484525 191148 0 None -9 2 Human 7.4 pKi = 7.4 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 450 5 1 6 4.6 CS(=O)(=O)c1ccnc2c1c(Sc1ccc(Cl)cc1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
11374485 85744 0 None -32 2 Human 6.4 pKi = 6.4 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 455 6 1 4 6.0 NS(=O)(=O)c1cccc(-c2ccsc2-c2cc(Cl)ccc2OCc2ccccc2)c1 10.1016/j.bmcl.2004.12.005
CHEMBL2113029 85744 0 None -32 2 Human 6.4 pKi = 6.4 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 455 6 1 4 6.0 NS(=O)(=O)c1cccc(-c2ccsc2-c2cc(Cl)ccc2OCc2ccccc2)c1 10.1016/j.bmcl.2004.12.005
53317958 63586 0 None -3630 3 Human 5.4 pKi = 5.4 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 450 5 1 4 3.7 CN([C@@H]1CCc2c(CC(=O)O)c3ccc(Cl)cc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL1643774 63586 0 None -3630 3 Human 5.4 pKi = 5.4 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 450 5 1 4 3.7 CN([C@@H]1CCc2c(CC(=O)O)c3ccc(Cl)cc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
10386146 16612 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 398 3 2 5 4.5 O=C(O)c1ccc2c(c1)/C(=C/Cn1c(O)nc3ccccc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL114034 16612 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 398 3 2 5 4.5 O=C(O)c1ccc2c(c1)/C(=C/Cn1c(O)nc3ccccc31)c1ccccc1CO2 10.1021/jm00096a017
14953090 105402 0 None - 1 Human 8.4 pKi = 8.4 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 370 7 1 4 4.3 COc1ccc(Cn2c(CC(C)(C)CC(=O)O)nc3cc(F)ccc32)cc1 10.1021/jm00061a008
CHEMBL277065 105402 0 None - 1 Human 8.4 pKi = 8.4 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 370 7 1 4 4.3 COc1ccc(Cn2c(CC(C)(C)CC(=O)O)nc3cc(F)ccc32)cc1 10.1021/jm00061a008
10480363 117174 0 None - 1 Human 8.4 pKi = 8.4 Binding
Compound was tested for its binding affinity at Thromboxane A2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsCompound was tested for its binding affinity at Thromboxane A2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 481 8 2 5 4.7 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)/C=C/c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL324364 117174 0 None - 1 Human 8.4 pKi = 8.4 Binding
Compound was tested for its binding affinity at Thromboxane A2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsCompound was tested for its binding affinity at Thromboxane A2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 481 8 2 5 4.7 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)/C=C/c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
10480363 117174 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 481 8 2 5 4.7 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)/C=C/c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL324364 117174 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 481 8 2 5 4.7 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)/C=C/c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
11237257 74381 0 None 446 2 Human 8.4 pKi = 8.4 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 494 10 2 6 4.3 CC(c1ccccc1)(c1ccccc1)S(=O)(=O)CCc1c(CO)oc2c(OCC(=O)O)cccc12 10.1021/jm050194z
CHEMBL190288 74381 0 None 446 2 Human 8.4 pKi = 8.4 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 494 10 2 6 4.3 CC(c1ccccc1)(c1ccccc1)S(=O)(=O)CCc1c(CO)oc2c(OCC(=O)O)cccc12 10.1021/jm050194z
123879 10060 82 None 3 4 Human 8.4 pKi = 8.4 Binding
Inhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptorInhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
1910 10060 82 None 3 4 Human 8.4 pKi = 8.4 Binding
Inhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptorInhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
1911 10060 82 None 3 4 Human 8.4 pKi = 8.4 Binding
Inhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptorInhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
2354 10060 82 None 3 4 Human 8.4 pKi = 8.4 Binding
Inhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptorInhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
CHEMBL361812 10060 82 None 3 4 Human 8.4 pKi = 8.4 Binding
Inhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptorInhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
DB13036 10060 82 None 3 4 Human 8.4 pKi = 8.4 Binding
Inhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptorInhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
11261579 74373 0 None 117 2 Human 8.4 pKi = 8.4 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 462 10 2 5 5.6 CC(SCCc1c(CO)oc2c(OCC(=O)O)cccc12)(c1ccccc1)c1ccccc1 10.1021/jm050194z
CHEMBL190236 74373 0 None 117 2 Human 8.4 pKi = 8.4 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 462 10 2 5 5.6 CC(SCCc1c(CO)oc2c(OCC(=O)O)cccc12)(c1ccccc1)c1ccccc1 10.1021/jm050194z
11743212 23936 0 None -131 7 Human 6.4 pKi = 6.4 Binding
Ability to inhibit the binding of human Thromboxane A2 receptor to TXA2Ability to inhibit the binding of human Thromboxane A2 receptor to TXA2
ChEMBL 426 7 1 3 6.8 O=C(O)C1CC1c1ccccc1-c1csc(-c2ccccc2OCc2ccccc2)c1 10.1016/s0960-894x(03)00794-7
CHEMBL125588 23936 0 None -131 7 Human 6.4 pKi = 6.4 Binding
Ability to inhibit the binding of human Thromboxane A2 receptor to TXA2Ability to inhibit the binding of human Thromboxane A2 receptor to TXA2
ChEMBL 426 7 1 3 6.8 O=C(O)C1CC1c1ccccc1-c1csc(-c2ccccc2OCc2ccccc2)c1 10.1016/s0960-894x(03)00794-7
44338297 115417 0 None 1 2 Human 5.4 pKi = 5.4 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 390 5 0 4 5.1 COC(=O)c1ccc(Cc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL320734 115417 0 None 1 2 Human 5.4 pKi = 5.4 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 390 5 0 4 5.1 COC(=O)c1ccc(Cc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
44591762 198598 0 None -26 2 Human 7.4 pKi = 7.4 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 466 5 1 6 5.1 CS(=O)(=O)c1ccnc2c1c(Sc1cccc3ccccc13)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL519862 198598 0 None -26 2 Human 7.4 pKi = 7.4 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 466 5 1 6 5.1 CS(=O)(=O)c1ccnc2c1c(Sc1cccc3ccccc13)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
44591515 190909 0 None -524 2 Human 6.4 pKi = 6.4 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 432 5 1 4 6.3 O=C(O)CC1CCn2c1c(Sc1ccc(Cl)c(Cl)c1)c1c(C3CC3)nccc12 10.1016/j.bmcl.2009.03.010
CHEMBL482744 190909 0 None -524 2 Human 6.4 pKi = 6.4 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 432 5 1 4 6.3 O=C(O)CC1CCn2c1c(Sc1ccc(Cl)c(Cl)c1)c1c(C3CC3)nccc12 10.1016/j.bmcl.2009.03.010
15680093 71620 0 None - 1 Human 7.4 pKi = 7.4 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 400 6 1 3 5.5 O=C(O)CC1(Cc2nc3cc(F)ccc3n2Cc2ccc(Cl)cc2)CCCC1 10.1021/jm00061a008
CHEMBL18206 71620 0 None - 1 Human 7.4 pKi = 7.4 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 400 6 1 3 5.5 O=C(O)CC1(Cc2nc3cc(F)ccc3n2Cc2ccc(Cl)cc2)CCCC1 10.1021/jm00061a008
40517075 16029 1 None 1 2 Human 5.4 pKi = 5.4 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 364 5 0 3 6.0 Clc1ccc(Cn2c(SCc3ccccc3)nc3ccccc32)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL110774 16029 1 None 1 2 Human 5.4 pKi = 5.4 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 364 5 0 3 6.0 Clc1ccc(Cn2c(SCc3ccccc3)nc3ccccc32)cc1 10.1016/j.bmcl.2004.04.005
53323266 63597 0 None -107 3 Human 6.4 pKi = 6.4 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 452 5 1 4 3.3 CN([C@@H]1CCc2c(CC(=O)O)c3cc(F)cc(F)c3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL1643784 63597 0 None -107 3 Human 6.4 pKi = 6.4 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 452 5 1 4 3.3 CN([C@@H]1CCc2c(CC(=O)O)c3cc(F)cc(F)c3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
10364780 117411 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 419 6 2 4 4.5 O=C(O)c1ccc2c(c1)C(SCCNC(=O)c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL325743 117411 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 419 6 2 4 4.5 O=C(O)c1ccc2c(c1)C(SCCNC(=O)c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
10364780 117411 0 None - 1 Human 7.4 pKi = 7.4 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 419 6 2 4 4.5 O=C(O)c1ccc2c(c1)C(SCCNC(=O)c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL325743 117411 0 None - 1 Human 7.4 pKi = 7.4 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 419 6 2 4 4.5 O=C(O)c1ccc2c(c1)C(SCCNC(=O)c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
10092137 117104 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 396 3 1 4 5.1 Cc1cccc2ncn(C/C=C3\c4ccccc4COc4ccc(C(=O)O)cc43)c12 10.1021/jm00096a017
CHEMBL323926 117104 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 396 3 1 4 5.1 Cc1cccc2ncn(C/C=C3\c4ccccc4COc4ccc(C(=O)O)cc43)c12 10.1021/jm00096a017
10430971 172110 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 398 3 2 5 4.5 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3c(O)cccc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL423511 172110 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 398 3 2 5 4.5 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3c(O)cccc31)c1ccccc1CO2 10.1021/jm00096a017
10136760 166400 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 417 5 1 3 6.7 CC(C)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL410338 166400 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 417 5 1 3 6.7 CC(C)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
9871887 109977 0 None -22 4 Human 7.3 pKi = 7.3 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 537 3 3 4 3.7 COc1c(I)cc(CC2NCCc3cc(O)c(O)cc32)cc1I 10.1021/jm960208o
CHEMBL308351 109977 0 None -22 4 Human 7.3 pKi = 7.3 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 537 3 3 4 3.7 COc1c(I)cc(CC2NCCc3cc(O)c(O)cc32)cc1I 10.1021/jm960208o
44591537 198007 0 None -537 2 Human 6.3 pKi = 6.3 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 448 5 1 4 7.0 CC(C)c1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL518988 198007 0 None -537 2 Human 6.3 pKi = 6.3 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 448 5 1 4 7.0 CC(C)c1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
10095579 108108 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 456 7 2 6 3.5 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1cccnc1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL296720 108108 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 456 7 2 6 3.5 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1cccnc1)c1ccccc1CO2 10.1021/jm00096a016
9801972 84913 0 None -25 2 Human 7.3 pKi = 7.3 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 415 5 1 3 5.0 C[S@@+]([O-])c1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
CHEMBL210356 84913 0 None -25 2 Human 7.3 pKi = 7.3 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 415 5 1 3 5.0 C[S@@+]([O-])c1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
10095579 108108 0 None - 1 Human 7.3 pKi = 7.3 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 456 7 2 6 3.5 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1cccnc1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL296720 108108 0 None - 1 Human 7.3 pKi = 7.3 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 456 7 2 6 3.5 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1cccnc1)c1ccccc1CO2 10.1021/jm00096a016
10476586 14918 0 None -1 2 Human 5.3 pKi = 5.3 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 408 6 1 4 5.7 O=C(O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL109179 14918 0 None -1 2 Human 5.3 pKi = 5.3 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 408 6 1 4 5.7 O=C(O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
10204113 102774 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 447 6 2 4 6.2 CC(C)C(O)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL259650 102774 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 447 6 2 4 6.2 CC(C)C(O)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
14953087 170068 0 None - 1 Human 8.3 pKi = 8.3 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 386 7 1 4 5.0 CSc1ccc(Cn2c(CC(C)(C)CC(=O)O)nc3cc(F)ccc32)cc1 10.1021/jm00061a008
CHEMBL418730 170068 0 None - 1 Human 8.3 pKi = 8.3 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 386 7 1 4 5.0 CSc1ccc(Cn2c(CC(C)(C)CC(=O)O)nc3cc(F)ccc32)cc1 10.1021/jm00061a008
9980414 117157 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 435 6 3 5 4.2 O=C(O)c1ccc2c(c1)C(SCCNC(=O)c1ccccc1O)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL324256 117157 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 435 6 3 5 4.2 O=C(O)c1ccc2c(c1)C(SCCNC(=O)c1ccccc1O)c1ccccc1CO2 10.1021/jm00096a016
44411688 84955 0 None -2 2 Human 8.3 pKi = 8.3 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 431 5 1 4 4.6 CS(=O)(=O)c1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
CHEMBL210471 84955 0 None -2 2 Human 8.3 pKi = 8.3 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 431 5 1 4 4.6 CS(=O)(=O)c1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
9980414 117157 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 435 6 3 5 4.2 O=C(O)c1ccc2c(c1)C(SCCNC(=O)c1ccccc1O)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL324256 117157 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 435 6 3 5 4.2 O=C(O)c1ccc2c(c1)C(SCCNC(=O)c1ccccc1O)c1ccccc1CO2 10.1021/jm00096a016
1888 10672 29 None 2 17 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]SQ29548 from thromboxane A2 receptorDisplacement of [3H]SQ29548 from thromboxane A2 receptor
ChEMBL 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 10.1021/np50094a001
1974 10672 29 None 2 17 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]SQ29548 from thromboxane A2 receptorDisplacement of [3H]SQ29548 from thromboxane A2 receptor
ChEMBL 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 10.1021/np50094a001
5311493 10672 29 None 2 17 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]SQ29548 from thromboxane A2 receptorDisplacement of [3H]SQ29548 from thromboxane A2 receptor
ChEMBL 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 10.1021/np50094a001
CHEMBL521784 10672 29 None 2 17 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]SQ29548 from thromboxane A2 receptorDisplacement of [3H]SQ29548 from thromboxane A2 receptor
ChEMBL 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 10.1021/np50094a001
3078925 117513 6 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 461 7 2 6 4.1 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1cccs1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL326047 117513 6 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 461 7 2 6 4.1 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1cccs1)c1ccccc1CO2 10.1021/jm00096a016
3078925 117513 6 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 461 7 2 6 4.1 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1cccs1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL326047 117513 6 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 461 7 2 6 4.1 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1cccs1)c1ccccc1CO2 10.1021/jm00096a016
24765153 191308 0 None -7762 8 Human 5.3 pKi = 5.3 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 434 5 1 4 6.6 CC(C)c1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CC[C@H]1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL484778 191308 0 None -7762 8 Human 5.3 pKi = 5.3 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 434 5 1 4 6.6 CC(C)c1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CC[C@H]1CC(=O)O 10.1016/j.bmcl.2009.03.010
11202399 133613 0 None - 1 Human 7.3 pKi = 7.3 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 478 10 2 5 4.6 CC(c1ccccc1)(c1ccccc1)[S+]([O-])CCc1c(CO)oc2c(OCC(=O)O)cccc12 10.1021/jm050194z
CHEMBL365501 133613 0 None - 1 Human 7.3 pKi = 7.3 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 478 10 2 5 4.6 CC(c1ccccc1)(c1ccccc1)[S+]([O-])CCc1c(CO)oc2c(OCC(=O)O)cccc12 10.1021/jm050194z
44271957 70649 0 None - 1 Human 6.3 pKi = 6.3 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 384 4 1 3 5.0 O=C(O)[C@@H]1CC=CC[C@@H]1c1nc2cc(F)ccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
CHEMBL18037 70649 0 None - 1 Human 6.3 pKi = 6.3 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 384 4 1 3 5.0 O=C(O)[C@@H]1CC=CC[C@@H]1c1nc2cc(F)ccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
11292620 75967 0 None -1 2 Human 5.3 pKi = 5.3 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 404 8 1 4 5.9 O=C(O)COc1cccc2c(CSC(c3ccccc3)c3ccccc3)coc12 10.1021/jm050194z
CHEMBL192661 75967 0 None -1 2 Human 5.3 pKi = 5.3 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 404 8 1 4 5.9 O=C(O)COc1cccc2c(CSC(c3ccccc3)c3ccccc3)coc12 10.1021/jm050194z
10276571 165865 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 463 5 1 5 4.4 CS(=O)(=O)c1cc(F)cc2c1c(C(=O)c1ccc(Cl)cc1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL409737 165865 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 463 5 1 5 4.4 CS(=O)(=O)c1cc(F)cc2c1c(C(=O)c1ccc(Cl)cc1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
14953073 71786 0 None - 1 Human 7.3 pKi = 7.3 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 372 6 1 3 4.7 O=C(O)CC1(Cc2nc3cc(F)ccc3n2Cc2ccc(Cl)cc2)CC1 10.1021/jm00061a008
CHEMBL18232 71786 0 None - 1 Human 7.3 pKi = 7.3 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 372 6 1 3 4.7 O=C(O)CC1(Cc2nc3cc(F)ccc3n2Cc2ccc(Cl)cc2)CC1 10.1021/jm00061a008
11270709 145042 0 None -144 2 Human 6.3 pKi = 6.3 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 443 6 1 4 4.9 C=Cc1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CC3 10.1016/j.bmcl.2006.02.062
CHEMBL377055 145042 0 None -144 2 Human 6.3 pKi = 6.3 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 443 6 1 4 4.9 C=Cc1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CC3 10.1016/j.bmcl.2006.02.062
10456444 16714 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 450 3 1 4 6.1 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc(Cl)c(Cl)cc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL114614 16714 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 450 3 1 4 6.1 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc(Cl)c(Cl)cc31)c1ccccc1CO2 10.1021/jm00096a017
5036 108342 26 None -9 3 Human 7.3 pKi = 7.3 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 416 6 2 4 3.1 O=C(O)CCn1c2c(c3ccccc31)CC(NS(=O)(=O)c1ccc(F)cc1)CC2 10.1016/j.bmcl.2010.11.015
CHEMBL298483 108342 26 None -9 3 Human 7.3 pKi = 7.3 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 416 6 2 4 3.1 O=C(O)CCn1c2c(c3ccccc31)CC(NS(=O)(=O)c1ccc(F)cc1)CC2 10.1016/j.bmcl.2010.11.015
10577317 22284 0 None -2691 2 Human 5.3 pKi = 5.3 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 500 4 4 4 4.4 O=C(Nc1ccc(CC2NCCc3cc(O)c(O)cc32)cc1I)c1ccccc1 10.1021/jm960208o
CHEMBL121704 22284 0 None -2691 2 Human 5.3 pKi = 5.3 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 500 4 4 4 4.4 O=C(Nc1ccc(CC2NCCc3cc(O)c(O)cc32)cc1I)c1ccccc1 10.1021/jm960208o
11545850 77011 0 None -1047 3 Human 6.3 pKi = 6.3 Binding
Inhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptorInhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptor
ChEMBL 402 5 2 4 2.7 O=C(O)Cn1c2c(c3ccccc31)C[C@H](NS(=O)(=O)c1ccc(F)cc1)CC2 10.1021/jm049036i
CHEMBL194085 77011 0 None -1047 3 Human 6.3 pKi = 6.3 Binding
Inhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptorInhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptor
ChEMBL 402 5 2 4 2.7 O=C(O)Cn1c2c(c3ccccc31)C[C@H](NS(=O)(=O)c1ccc(F)cc1)CC2 10.1021/jm049036i
14953076 105066 0 None - 1 Human 5.3 pKi = 5.3 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 332 5 1 3 3.9 O=C(O)CCc1nc2cc(F)ccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
CHEMBL274749 105066 0 None - 1 Human 5.3 pKi = 5.3 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 332 5 1 3 3.9 O=C(O)CCc1nc2cc(F)ccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
10276868 165598 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 469 5 1 5 5.5 CS(=O)(=O)c1cc(F)cc2c1c(Sc1ccc3ccccc3c1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL409452 165598 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 469 5 1 5 5.5 CS(=O)(=O)c1cc(F)cc2c1c(Sc1ccc3ccccc3c1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
44591516 190965 0 None -588 2 Human 6.2 pKi = 6.2 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 460 6 1 4 6.8 O=C(O)CC1CCCn2c1c(Sc1ccc(Cl)c(Cl)c1)c1c(CC3CC3)nccc12 10.1016/j.bmcl.2009.03.010
CHEMBL483152 190965 0 None -588 2 Human 6.2 pKi = 6.2 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 460 6 1 4 6.8 O=C(O)CC1CCCn2c1c(Sc1ccc(Cl)c(Cl)c1)c1c(CC3CC3)nccc12 10.1016/j.bmcl.2009.03.010
11742673 117291 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 416 3 1 4 5.4 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc(Cl)ccc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL325032 117291 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 416 3 1 4 5.4 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc(Cl)ccc31)c1ccccc1CO2 10.1021/jm00096a017
14953093 70280 0 None - 1 Human 8.2 pKi = 8.2 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 402 7 1 4 5.5 CSc1ccc(Cn2c(CC(C)(C)CC(=O)O)nc3cc(Cl)ccc32)cc1 10.1021/jm00061a008
CHEMBL18000 70280 0 None - 1 Human 8.2 pKi = 8.2 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 402 7 1 4 5.5 CSc1ccc(Cn2c(CC(C)(C)CC(=O)O)nc3cc(Cl)ccc32)cc1 10.1021/jm00061a008
14953086 71987 0 None - 1 Human 8.2 pKi = 8.2 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 408 6 1 3 5.6 CC(C)(CC(=O)O)Cc1nc2cc(F)ccc2n1Cc1ccc(Cl)c(Cl)c1 10.1021/jm00061a008
CHEMBL18257 71987 0 None - 1 Human 8.2 pKi = 8.2 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 408 6 1 3 5.6 CC(C)(CC(=O)O)Cc1nc2cc(F)ccc2n1Cc1ccc(Cl)c(Cl)c1 10.1021/jm00061a008
10253895 16670 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 464 7 3 4 5.2 O=C(O)c1ccc2c(c1)C(SCC/N=C(\S)NCc1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL114324 16670 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 464 7 3 4 5.2 O=C(O)c1ccc2c(c1)C(SCC/N=C(\S)NCc1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
11744063 16598 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 442 5 1 6 4.8 COc1cc(OC)c2c(c1)ncn2C/C=C1\c2ccccc2COc2ccc(C(=O)O)cc21 10.1021/jm00096a017
CHEMBL113944 16598 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 442 5 1 6 4.8 COc1cc(OC)c2c(c1)ncn2C/C=C1\c2ccccc2COc2ccc(C(=O)O)cc21 10.1021/jm00096a017
10480645 17910 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 488 5 2 5 5.8 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc(C(O)c4ccccc4)ccc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL117821 17910 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 488 5 2 5 5.8 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc(C(O)c4ccccc4)ccc31)c1ccccc1CO2 10.1021/jm00096a017
10253895 16670 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 464 7 3 4 5.2 O=C(O)c1ccc2c(c1)C(SCC/N=C(\S)NCc1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL114324 16670 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 464 7 3 4 5.2 O=C(O)c1ccc2c(c1)C(SCC/N=C(\S)NCc1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
10480363 117174 0 None - 1 Human 8.2 pKi = 8.2 Binding
Compound was tested for its binding affinity at Thromboxane A2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets at 0.1 uMCompound was tested for its binding affinity at Thromboxane A2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets at 0.1 uM
ChEMBL 481 8 2 5 4.7 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)/C=C/c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL324364 117174 0 None - 1 Human 8.2 pKi = 8.2 Binding
Compound was tested for its binding affinity at Thromboxane A2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets at 0.1 uMCompound was tested for its binding affinity at Thromboxane A2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets at 0.1 uM
ChEMBL 481 8 2 5 4.7 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)/C=C/c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
10480363 117174 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 481 8 2 5 4.7 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)/C=C/c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL324364 117174 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 481 8 2 5 4.7 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)/C=C/c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
44411791 84846 0 None -1 2 Human 8.2 pKi = 8.2 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 381 5 1 3 5.1 O=Cc1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
CHEMBL210045 84846 0 None -1 2 Human 8.2 pKi = 8.2 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 381 5 1 3 5.1 O=Cc1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
3078923 16629 5 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 533 7 2 5 4.8 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1cc(Br)ccc1CO2 10.1021/jm00096a016
CHEMBL114102 16629 5 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 533 7 2 5 4.8 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1cc(Br)ccc1CO2 10.1021/jm00096a016
3078923 16629 5 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 533 7 2 5 4.8 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1cc(Br)ccc1CO2 10.1021/jm00096a016
CHEMBL114102 16629 5 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 533 7 2 5 4.8 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1cc(Br)ccc1CO2 10.1021/jm00096a016
10456399 16654 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 450 3 1 4 5.8 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ccc(C(F)(F)F)cc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL114257 16654 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 450 3 1 4 5.8 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ccc(C(F)(F)F)cc31)c1ccccc1CO2 10.1021/jm00096a017
14953106 70114 0 None - 1 Human 7.2 pKi = 7.2 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 367 7 1 5 4.0 CC(C)(CC(=O)O)Cc1nc2ccccc2n1Cc1ccc([N+](=O)[O-])cc1 10.1021/jm00061a008
CHEMBL17941 70114 0 None - 1 Human 7.2 pKi = 7.2 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 367 7 1 5 4.0 CC(C)(CC(=O)O)Cc1nc2ccccc2n1Cc1ccc([N+](=O)[O-])cc1 10.1021/jm00061a008
10359399 17296 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 332 3 1 4 3.6 O=C(O)c1ccc2c(c1)/C(=C/Cn1ccnc1)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL116869 17296 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 332 3 1 4 3.6 O=C(O)c1ccc2c(c1)/C(=C/Cn1ccnc1)c1ccccc1CO2 10.1021/jm00096a017
44338319 13979 0 None -5 2 Human 5.2 pKi = 5.2 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 405 6 1 5 5.1 COC(=O)c1ccc(CNc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL108564 13979 0 None -5 2 Human 5.2 pKi = 5.2 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 405 6 1 5 5.1 COC(=O)c1ccc(CNc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
9917280 21312 0 None -39810 2 Human 4.2 pKi = 4.2 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 633 2 3 3 4.3 Oc1cc2c(cc1O)C(Cc1cc(I)c(I)c(I)c1)NCC2 10.1021/jm960208o
CHEMBL120278 21312 0 None -39810 2 Human 4.2 pKi = 4.2 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 633 2 3 3 4.3 Oc1cc2c(cc1O)C(Cc1cc(I)c(I)c(I)c1)NCC2 10.1021/jm960208o
50898361 63647 0 None -48 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 549 7 2 5 5.4 Cc1ccc(S(=O)(=O)NC(=O)NCCc2ccc(-c3c(C(=O)N(C)C)sc4c(C)cc(C)cc34)cc2)cc1 10.1016/j.bmcl.2010.11.118
CHEMBL1644003 63647 0 None -48 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 549 7 2 5 5.4 Cc1ccc(S(=O)(=O)NC(=O)NCCc2ccc(-c3c(C(=O)N(C)C)sc4c(C)cc(C)cc34)cc2)cc1 10.1016/j.bmcl.2010.11.118
23964891 14227 0 None - 1 Human 5.2 pKi = 5.2 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 382 5 0 3 6.2 Fc1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL108678 14227 0 None - 1 Human 5.2 pKi = 5.2 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 382 5 0 3 6.2 Fc1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
44591562 191307 0 None -9120 2 Human 5.2 pKi = 5.2 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 434 5 1 4 6.3 CC(C)c1nccc2c1c(Sc1ccc(C(F)(F)F)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL484777 191307 0 None -9120 2 Human 5.2 pKi = 5.2 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 434 5 1 4 6.3 CC(C)c1nccc2c1c(Sc1ccc(C(F)(F)F)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
44331597 215180 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human platelet TXA2 receptors as ability to displace binding [3H]SQ-29,548Binding affinity to human platelet TXA2 receptors as ability to displace binding [3H]SQ-29,548
ChEMBL 737 20 6 8 4.0 [N-]=[N+]=Nc1ccc(CCCC(=O)NCC(=O)NCC2C3CCC(O3)C2C/C=C\CCCC(=O)NNC(=O)CCCC[C@H]2SC[C@H]3NC(=O)N[C@H]32)cc1 10.1016/s0960-894x(99)00511-9
CHEMBL99695 215180 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human platelet TXA2 receptors as ability to displace binding [3H]SQ-29,548Binding affinity to human platelet TXA2 receptors as ability to displace binding [3H]SQ-29,548
ChEMBL 737 20 6 8 4.0 [N-]=[N+]=Nc1ccc(CCCC(=O)NCC(=O)NCC2C3CCC(O3)C2C/C=C\CCCC(=O)NNC(=O)CCCC[C@H]2SC[C@H]3NC(=O)N[C@H]32)cc1 10.1016/s0960-894x(99)00511-9
44591536 198006 0 None -549 2 Human 6.2 pKi = 6.2 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 448 6 1 4 6.8 CCCc1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL518987 198006 0 None -549 2 Human 6.2 pKi = 6.2 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 448 6 1 4 6.8 CCCc1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
10251769 16749 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 424 4 1 4 5.3 Cc1cc2ncn(C/C=C3\c4ccccc4COc4ccc(CC(=O)O)cc43)c2cc1C 10.1021/jm00096a017
CHEMBL114798 16749 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 424 4 1 4 5.3 Cc1cc2ncn(C/C=C3\c4ccccc4COc4ccc(CC(=O)O)cc43)c2cc1C 10.1021/jm00096a017
1986 8094 50 None - 1 Human 7.2 pKi = 7.2 Binding
Compound was tested for its binding affinity at Thromboxane A2/ Prostaglandin H2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsCompound was tested for its binding affinity at Thromboxane A2/ Prostaglandin H2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 353 7 2 3 2.5 OC(=O)Cc1ccc(cc1)CCNS(=O)(=O)c1ccc(cc1)Cl 10.1021/jm00096a017
54343 8094 50 None - 1 Human 7.2 pKi = 7.2 Binding
Compound was tested for its binding affinity at Thromboxane A2/ Prostaglandin H2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsCompound was tested for its binding affinity at Thromboxane A2/ Prostaglandin H2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 353 7 2 3 2.5 OC(=O)Cc1ccc(cc1)CCNS(=O)(=O)c1ccc(cc1)Cl 10.1021/jm00096a017
CHEMBL71685 8094 50 None - 1 Human 7.2 pKi = 7.2 Binding
Compound was tested for its binding affinity at Thromboxane A2/ Prostaglandin H2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsCompound was tested for its binding affinity at Thromboxane A2/ Prostaglandin H2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 353 7 2 3 2.5 OC(=O)Cc1ccc(cc1)CCNS(=O)(=O)c1ccc(cc1)Cl 10.1021/jm00096a017
15948325 9304 45 None -512 6 Human 6.2 pKi = 6.2 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 603 11 1 8 4.7 CCOc1c2CN(C(=O)c2c(c2c1nccc2)OCC)c1ccc(cc1C)CS(=O)(=O)NC(=O)Cc1ccccc1OC 10.1016/j.bmcl.2008.01.103
5856 9304 45 None -512 6 Human 6.2 pKi = 6.2 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 603 11 1 8 4.7 CCOc1c2CN(C(=O)c2c(c2c1nccc2)OCC)c1ccc(cc1C)CS(=O)(=O)NC(=O)Cc1ccccc1OC 10.1016/j.bmcl.2008.01.103
CHEMBL402162 9304 45 None -512 6 Human 6.2 pKi = 6.2 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 603 11 1 8 4.7 CCOc1c2CN(C(=O)c2c(c2c1nccc2)OCC)c1ccc(cc1C)CS(=O)(=O)NC(=O)Cc1ccccc1OC 10.1016/j.bmcl.2008.01.103
10047167 85242 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 410 3 1 4 5.4 Cc1cc2ncn(C/C=C3/c4ccccc4COc4ccc(C(=O)O)cc43)c2cc1C 10.1021/jm00096a017
CHEMBL2111756 85242 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 410 3 1 4 5.4 Cc1cc2ncn(C/C=C3/c4ccccc4COc4ccc(C(=O)O)cc43)c2cc1C 10.1021/jm00096a017
10458032 198998 0 None -17 2 Human 7.2 pKi = 7.2 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 484 5 1 6 5.0 CS(=O)(=O)c1ccnc2c1c(Sc1ccc(C(F)(F)F)cc1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL520481 198998 0 None -17 2 Human 7.2 pKi = 7.2 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 484 5 1 6 5.0 CS(=O)(=O)c1ccnc2c1c(Sc1ccc(C(F)(F)F)cc1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
11742649 190908 0 None -39 2 Human 6.2 pKi = 6.2 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 416 5 1 6 3.9 CS(=O)(=O)c1ccnc2c1c(Sc1ccccc1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL482743 190908 0 None -39 2 Human 6.2 pKi = 6.2 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 416 5 1 6 3.9 CS(=O)(=O)c1ccnc2c1c(Sc1ccccc1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
53326879 63584 0 None -5 2 Human 5.2 pKi = 5.2 Binding
Selectivity interaction (Prostanoid receptor binding assay) EUB0000334a TBXA2RSelectivity interaction (Prostanoid receptor binding assay) EUB0000334a TBXA2R
ChEMBL 494 6 1 6 2.4 CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.6019/CHEMBL5212743
CHEMBL1643772 63584 0 None -5 2 Human 5.2 pKi = 5.2 Binding
Selectivity interaction (Prostanoid receptor binding assay) EUB0000334a TBXA2RSelectivity interaction (Prostanoid receptor binding assay) EUB0000334a TBXA2R
ChEMBL 494 6 1 6 2.4 CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.6019/CHEMBL5212743
51550 212529 14 None -11 2 Human 6.2 pKi = 6.2 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 335 8 2 4 1.7 O=C(O)COc1ccc(CCNS(=O)(=O)c2ccccc2)cc1 10.1021/jm00061a008
CHEMBL8273 212529 14 None -11 2 Human 6.2 pKi = 6.2 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 335 8 2 4 1.7 O=C(O)COc1ccc(CCNS(=O)(=O)c2ccccc2)cc1 10.1021/jm00061a008
14953071 105029 0 None - 1 Human 6.2 pKi = 6.2 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 378 5 1 4 4.8 CC(C)(Sc1nc2cc(F)ccc2n1Cc1ccc(Cl)cc1)C(=O)O 10.1021/jm00061a008
CHEMBL274485 105029 0 None - 1 Human 6.2 pKi = 6.2 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 378 5 1 4 4.8 CC(C)(Sc1nc2cc(F)ccc2n1Cc1ccc(Cl)cc1)C(=O)O 10.1021/jm00061a008
25003075 13610 18 None -23988 7 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in HEK293-EBNA cells after 60 mins by scintillation countingDisplacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in HEK293-EBNA cells after 60 mins by scintillation counting
ChEMBL 478 6 2 3 5.8 O=C(O)c1ccc(C2(NC(=O)c3cccc4ccn(Cc5ccc(C(F)(F)F)cc5)c34)CC2)cc1 10.1016/j.bmcl.2010.04.065
CHEMBL1084009 13610 18 None -23988 7 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in HEK293-EBNA cells after 60 mins by scintillation countingDisplacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in HEK293-EBNA cells after 60 mins by scintillation counting
ChEMBL 478 6 2 3 5.8 O=C(O)c1ccc(C2(NC(=O)c3cccc4ccn(Cc5ccc(C(F)(F)F)cc5)c34)CC2)cc1 10.1016/j.bmcl.2010.04.065
10158956 103106 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 417 5 1 4 5.8 CC(=O)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL261471 103106 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 417 5 1 4 5.8 CC(=O)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
44450496 166729 1 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 477 5 1 5 4.8 CS(=O)(=O)c1cc(F)cc2c1c(C(=O)c1ccc(Cl)cc1)c1n2CCCCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL410736 166729 1 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 477 5 1 5 4.8 CS(=O)(=O)c1cc(F)cc2c1c(C(=O)c1ccc(Cl)cc1)c1n2CCCCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
25817650 69968 1 None -7244 3 Human 5.2 pKi = 5.2 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 416 5 1 4 3.0 CN([C@@H]1CCc2c(c3ccccc3n2CC(=O)O)C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL179036 69968 1 None -7244 3 Human 5.2 pKi = 5.2 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 416 5 1 4 3.0 CN([C@@H]1CCc2c(c3ccccc3n2CC(=O)O)C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
44591512 199329 0 None -691 2 Human 6.2 pKi = 6.2 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 434 5 1 4 6.4 CCc1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL521122 199329 0 None -691 2 Human 6.2 pKi = 6.2 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 434 5 1 4 6.4 CCc1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
10344683 195641 0 None -4897 2 Human 5.2 pKi = 5.2 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 470 5 1 6 4.9 CS(=O)(=O)c1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL506909 195641 0 None -4897 2 Human 5.2 pKi = 5.2 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 470 5 1 6 4.9 CS(=O)(=O)c1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
10225819 103024 0 None - 1 Human 5.2 pKi = 5.2 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 449 5 1 5 4.0 CS(=O)(=O)c1cc(F)cc2c1c(C(=O)c1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL261008 103024 0 None - 1 Human 5.2 pKi = 5.2 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 449 5 1 5 4.0 CS(=O)(=O)c1cc(F)cc2c1c(C(=O)c1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
44591457 195847 0 None -8 2 Human 8.2 pKi = 8.2 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 414 5 1 4 6.3 CC(C)c1ccnc2c1c(Sc1ccc(Cl)cc1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL509685 195847 0 None -8 2 Human 8.2 pKi = 8.2 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 414 5 1 4 6.3 CC(C)c1ccnc2c1c(Sc1ccc(Cl)cc1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
14953115 105690 0 None - 1 Human 8.2 pKi = 8.2 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 403 7 1 5 4.9 CSc1ccc(Cn2c(CC(C)(C)CC(=O)O)nc3cc(Cl)cnc32)cc1 10.1021/jm00061a008
CHEMBL279348 105690 0 None - 1 Human 8.2 pKi = 8.2 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 403 7 1 5 4.9 CSc1ccc(Cn2c(CC(C)(C)CC(=O)O)nc3cc(Cl)cnc32)cc1 10.1021/jm00061a008
10251338 118112 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 416 5 2 4 5.2 O=C(O)c1ccc2c(c1)C(SCCc1nc3ccccc3[nH]1)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL326856 118112 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 416 5 2 4 5.2 O=C(O)c1ccc2c(c1)C(SCCc1nc3ccccc3[nH]1)c1ccccc1CO2 10.1021/jm00096a017
10366462 16700 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 449 7 2 5 5.0 O=C(NCCSC1c2ccccc2COc2ccc(C(=O)O)cc21)OCc1ccccc1 10.1021/jm00096a016
CHEMBL114473 16700 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 449 7 2 5 5.0 O=C(NCCSC1c2ccccc2COc2ccc(C(=O)O)cc21)OCc1ccccc1 10.1021/jm00096a016
10366462 16700 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 449 7 2 5 5.0 O=C(NCCSC1c2ccccc2COc2ccc(C(=O)O)cc21)OCc1ccccc1 10.1021/jm00096a016
CHEMBL114473 16700 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 449 7 2 5 5.0 O=C(NCCSC1c2ccccc2COc2ccc(C(=O)O)cc21)OCc1ccccc1 10.1021/jm00096a016
44411809 84146 0 None 2 2 Human 8.1 pKi = 8.1 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 383 5 2 3 4.7 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1c(CO)cccc21 10.1016/j.bmcl.2006.02.062
CHEMBL208596 84146 0 None 2 2 Human 8.1 pKi = 8.1 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 383 5 2 3 4.7 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1c(CO)cccc21 10.1016/j.bmcl.2006.02.062
14953072 105596 0 None - 1 Human 8.1 pKi = 8.1 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 374 6 1 3 4.9 CC(C)(CC(=O)O)Cc1nc2cc(F)ccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
CHEMBL278653 105596 0 None - 1 Human 8.1 pKi = 8.1 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 374 6 1 3 4.9 CC(C)(CC(=O)O)Cc1nc2cc(F)ccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
44338292 13205 0 None -2 2 Human 5.2 pKi = 5.2 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 376 4 0 4 5.2 COC(=O)c1ccc(-c2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL108243 13205 0 None -2 2 Human 5.2 pKi = 5.2 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 376 4 0 4 5.2 COC(=O)c1ccc(-c2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
11294166 83820 0 None -3890 3 Human 5.2 pKi = 5.2 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 461 6 2 5 4.3 CC(O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1016/j.bmcl.2006.02.062
CHEMBL207203 83820 0 None -3890 3 Human 5.2 pKi = 5.2 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 461 6 2 5 4.3 CC(O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1016/j.bmcl.2006.02.062
11294166 83820 0 None -3890 3 Human 5.2 pKi = 5.2 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 461 6 2 5 4.3 CC(O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1021/jm0603668
CHEMBL207203 83820 0 None -3890 3 Human 5.2 pKi = 5.2 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 461 6 2 5 4.3 CC(O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1021/jm0603668
44450497 167333 0 None -3 2 Human 5.1 pKi = 5.1 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 463 5 1 5 4.4 CS(=O)(=O)c1cc(F)cc2c1c(C(=O)c1ccc(Cl)cc1)c1n2CCC[C@H]1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL411255 167333 0 None -3 2 Human 5.1 pKi = 5.1 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 463 5 1 5 4.4 CS(=O)(=O)c1cc(F)cc2c1c(C(=O)c1ccc(Cl)cc1)c1n2CCC[C@H]1CC(=O)O 10.1016/j.bmcl.2008.03.015
53316671 63591 0 None -288 3 Human 6.1 pKi = 6.1 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 452 5 1 4 3.3 CN([C@@H]1CCc2c(CC(=O)O)c3cc(F)c(F)cc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL1643779 63591 0 None -288 3 Human 6.1 pKi = 6.1 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 452 5 1 4 3.3 CN([C@@H]1CCc2c(CC(=O)O)c3cc(F)c(F)cc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
11454655 74548 0 None 79 2 Human 7.1 pKi = 7.1 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 490 12 2 5 6.1 CC(SCCc1c(CCCO)oc2c(OCC(=O)O)cccc12)(c1ccccc1)c1ccccc1 10.1021/jm050194z
CHEMBL190840 74548 0 None 79 2 Human 7.1 pKi = 7.1 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 490 12 2 5 6.1 CC(SCCc1c(CCCO)oc2c(OCC(=O)O)cccc12)(c1ccccc1)c1ccccc1 10.1021/jm050194z
53317957 63585 0 None -660 3 Human 6.1 pKi = 6.1 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 434 5 1 4 3.2 CN([C@@H]1CCc2c(CC(=O)O)c3ccc(F)cc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL1643773 63585 0 None -660 3 Human 6.1 pKi = 6.1 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 434 5 1 4 3.2 CN([C@@H]1CCc2c(CC(=O)O)c3ccc(F)cc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
22083978 83901 0 None -162 2 Human 6.1 pKi = 6.1 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 499 6 1 5 6.0 CS(=O)(=O)c1cc(-c2cccs2)c2c(c1)c1c(n2Cc2ccc(Cl)cc2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
CHEMBL207689 83901 0 None -162 2 Human 6.1 pKi = 6.1 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 499 6 1 5 6.0 CS(=O)(=O)c1cc(-c2cccs2)c2c(c1)c1c(n2Cc2ccc(Cl)cc2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
71450058 89349 0 None -37 2 Human 6.1 pKi = 6.1 Binding
Binding affinity to TXA2 receptor receptorBinding affinity to TXA2 receptor receptor
ChEMBL 453 6 1 3 5.6 O=C(O)Cc1ccc2c(c1)/C(=C/CN1CCCC(Cc3ccccc3)C1)c1ccccc1CO2 10.1021/jm300682j
CHEMBL2178582 89349 0 None -37 2 Human 6.1 pKi = 6.1 Binding
Binding affinity to TXA2 receptor receptorBinding affinity to TXA2 receptor receptor
ChEMBL 453 6 1 3 5.6 O=C(O)Cc1ccc2c(c1)/C(=C/CN1CCCC(Cc3ccccc3)C1)c1ccccc1CO2 10.1021/jm300682j
44404954 142043 0 None -48 3 Human 6.1 pKi = 6.1 Binding
Inhibition constant against thromboxane A2 receptor to prostaglandin H2 receptorInhibition constant against thromboxane A2 receptor to prostaglandin H2 receptor
ChEMBL 453 6 1 3 5.6 O=C(O)Cc1ccc2c(c1)/C(=C\CN1CCC(Cc3ccccc3)CC1)c1ccccc1CO2 10.1021/jm058225d
CHEMBL372588 142043 0 None -48 3 Human 6.1 pKi = 6.1 Binding
Inhibition constant against thromboxane A2 receptor to prostaglandin H2 receptorInhibition constant against thromboxane A2 receptor to prostaglandin H2 receptor
ChEMBL 453 6 1 3 5.6 O=C(O)Cc1ccc2c(c1)/C(=C\CN1CCC(Cc3ccccc3)CC1)c1ccccc1CO2 10.1021/jm058225d
44411814 85012 0 None -218 2 Human 6.1 pKi = 6.1 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 495 5 1 4 5.0 CS(=O)(=O)c1cc(Br)c2c(c1)c1c(n2Cc2cccc(Cl)c2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
CHEMBL210615 85012 0 None -218 2 Human 6.1 pKi = 6.1 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 495 5 1 4 5.0 CS(=O)(=O)c1cc(Br)c2c(c1)c1c(n2Cc2cccc(Cl)c2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
10455224 17239 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 427 9 2 4 4.2 O=C(O)c1cccc(C(SCCNS(=O)(=O)c2ccccc2)c2ccccc2)c1 10.1021/jm00096a016
CHEMBL116465 17239 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 427 9 2 4 4.2 O=C(O)c1cccc(C(SCCNS(=O)(=O)c2ccccc2)c2ccccc2)c1 10.1021/jm00096a016
10455224 17239 0 None - 1 Human 7.1 pKi = 7.1 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 427 9 2 4 4.2 O=C(O)c1cccc(C(SCCNS(=O)(=O)c2ccccc2)c2ccccc2)c1 10.1021/jm00096a016
CHEMBL116465 17239 0 None - 1 Human 7.1 pKi = 7.1 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 427 9 2 4 4.2 O=C(O)c1cccc(C(SCCNS(=O)(=O)c2ccccc2)c2ccccc2)c1 10.1021/jm00096a016
11374965 75968 0 None 2 2 Human 7.1 pKi = 7.1 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 476 11 2 5 5.7 CC(SCCc1c(CCO)oc2c(OCC(=O)O)cccc12)(c1ccccc1)c1ccccc1 10.1021/jm050194z
CHEMBL192662 75968 0 None 2 2 Human 7.1 pKi = 7.1 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 476 11 2 5 5.7 CC(SCCc1c(CCO)oc2c(OCC(=O)O)cccc12)(c1ccccc1)c1ccccc1 10.1021/jm050194z
10432190 190875 0 None -6 2 Human 7.1 pKi = 7.1 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 418 5 1 5 5.9 CSc1ccnc2c1c(Sc1ccc(Cl)cc1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL482548 190875 0 None -6 2 Human 7.1 pKi = 7.1 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 418 5 1 5 5.9 CSc1ccnc2c1c(Sc1ccc(Cl)cc1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
46890179 13829 0 None -269 2 Human 5.1 pKi = 5.1 Binding
Binding affinity to human thromboxane A2 receptor by radioligand displacement assayBinding affinity to human thromboxane A2 receptor by radioligand displacement assay
ChEMBL 476 7 1 5 4.2 Cc1c(C2c3ccccc3S(=O)(=O)N2CCOc2ccccc2)c2ccccc2n1CC(=O)O 10.1016/j.bmcl.2010.04.046
CHEMBL1084903 13829 0 None -269 2 Human 5.1 pKi = 5.1 Binding
Binding affinity to human thromboxane A2 receptor by radioligand displacement assayBinding affinity to human thromboxane A2 receptor by radioligand displacement assay
ChEMBL 476 7 1 5 4.2 Cc1c(C2c3ccccc3S(=O)(=O)N2CCOc2ccccc2)c2ccccc2n1CC(=O)O 10.1016/j.bmcl.2010.04.046
10431100 174863 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 400 3 1 4 4.9 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc(F)ccc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL432602 174863 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 400 3 1 4 4.9 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc(F)ccc31)c1ccccc1CO2 10.1021/jm00096a017
44271646 69765 0 None - 1 Human 6.1 pKi = 6.1 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 358 4 1 3 4.5 O=C(O)[C@H]1CC[C@@H]1c1nc2cc(F)ccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
CHEMBL17861 69765 0 None - 1 Human 6.1 pKi = 6.1 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 358 4 1 3 4.5 O=C(O)[C@H]1CC[C@@H]1c1nc2cc(F)ccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
44411984 84095 0 None -107 2 Human 6.1 pKi = 6.1 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 517 5 1 4 5.7 CC(C)(C)c1ccc(Cn2c3c(c4cc(S(C)(=O)=O)cc(Br)c42)CCC3CC(=O)O)cc1 10.1016/j.bmcl.2006.02.062
CHEMBL208319 84095 0 None -107 2 Human 6.1 pKi = 6.1 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 517 5 1 4 5.7 CC(C)(C)c1ccc(Cn2c3c(c4cc(S(C)(=O)=O)cc(Br)c42)CCC3CC(=O)O)cc1 10.1016/j.bmcl.2006.02.062
10834286 121238 0 None -19 2 Human 4.1 pKi = 4.1 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 391 2 3 3 4.6 Oc1cc2c(cc1O)C(Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1)NCC2 10.1021/jm960208o
CHEMBL333438 121238 0 None -19 2 Human 4.1 pKi = 4.1 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 391 2 3 3 4.6 Oc1cc2c(cc1O)C(Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1)NCC2 10.1021/jm960208o
14953075 105217 0 None - 1 Human 6.1 pKi = 6.1 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 414 6 1 3 5.8 O=C(O)CC1(Cc2nc3cc(F)ccc3n2Cc2ccc(Cl)cc2)CCCCC1 10.1021/jm00061a008
CHEMBL275651 105217 0 None - 1 Human 6.1 pKi = 6.1 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 414 6 1 3 5.8 O=C(O)CC1(Cc2nc3cc(F)ccc3n2Cc2ccc(Cl)cc2)CCCCC1 10.1021/jm00061a008
10456019 170270 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 442 5 1 6 4.8 COc1cc(OC)c2ncn(C/C=C3\c4ccccc4COc4ccc(C(=O)O)cc43)c2c1 10.1021/jm00096a017
CHEMBL420136 170270 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 442 5 1 6 4.8 COc1cc(OC)c2ncn(C/C=C3\c4ccccc4COc4ccc(C(=O)O)cc43)c2c1 10.1021/jm00096a017
44411567 145621 0 None 1 2 Human 7.1 pKi = 7.1 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 472 6 2 3 6.5 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1c(C(=O)Nc3ccccc3)cccc21 10.1016/j.bmcl.2006.02.062
CHEMBL378151 145621 0 None 1 2 Human 7.1 pKi = 7.1 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 472 6 2 3 6.5 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1c(C(=O)Nc3ccccc3)cccc21 10.1016/j.bmcl.2006.02.062
11282319 74438 0 None 8 2 Human 7.1 pKi = 7.1 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 448 10 2 5 5.5 O=C(O)COc1cccc2c(CCSC(c3ccccc3)c3ccccc3)c(CO)oc12 10.1021/jm050194z
CHEMBL190708 74438 0 None 8 2 Human 7.1 pKi = 7.1 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 448 10 2 5 5.5 O=C(O)COc1cccc2c(CCSC(c3ccccc3)c3ccccc3)c(CO)oc12 10.1021/jm050194z
53323246 63582 0 None -81 3 Human 6.1 pKi = 6.1 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 434 5 1 4 3.2 CN([C@@H]1CCc2c(CC(=O)O)c3c(F)cccc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL1643770 63582 0 None -81 3 Human 6.1 pKi = 6.1 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 434 5 1 4 3.2 CN([C@@H]1CCc2c(CC(=O)O)c3c(F)cccc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
15157541 103913 0 None -5 2 Human 8.0 pKi = 8.0 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 395 5 1 2 6.4 CC(C)c1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
CHEMBL267820 103913 0 None -5 2 Human 8.0 pKi = 8.0 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 395 5 1 2 6.4 CC(C)c1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
10365194 17199 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 427 4 1 6 4.7 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ccc([N+](=O)[O-])cc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL116342 17199 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 427 4 1 6 4.7 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ccc([N+](=O)[O-])cc31)c1ccccc1CO2 10.1021/jm00096a017
10001037 16826 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 400 3 1 4 4.9 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ccc(F)cc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL115238 16826 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 400 3 1 4 4.9 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ccc(F)cc31)c1ccccc1CO2 10.1021/jm00096a017
44338308 15923 0 None 3 2 Human 6.1 pKi = 6.1 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 391 5 1 5 5.3 COC(=O)c1ccc(Nc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL110063 15923 0 None 3 2 Human 6.1 pKi = 6.1 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 391 5 1 5 5.3 COC(=O)c1ccc(Nc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
53320617 63600 0 None -575 3 Human 6.0 pKi = 6.0 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 472 9 1 4 4.6 CCCCCN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL1643787 63600 0 None -575 3 Human 6.0 pKi = 6.0 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 472 9 1 4 4.6 CCCCCN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
44338387 117215 1 None -61 2 Human 5.0 pKi = 5.0 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 422 6 0 5 5.8 COC(=O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL324619 117215 1 None -61 2 Human 5.0 pKi = 5.0 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 422 6 0 5 5.8 COC(=O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
10029290 16655 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 509 9 2 7 4.6 COc1cc(C(=O)NCCSC2c3ccccc3COc3ccc(C(=O)O)cc32)cc(OC)c1OC 10.1021/jm00096a016
CHEMBL114260 16655 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 509 9 2 7 4.6 COc1cc(C(=O)NCCSC2c3ccccc3COc3ccc(C(=O)O)cc32)cc(OC)c1OC 10.1021/jm00096a016
10029290 16655 0 None - 1 Human 7.0 pKi = 7.0 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 509 9 2 7 4.6 COc1cc(C(=O)NCCSC2c3ccccc3COc3ccc(C(=O)O)cc32)cc(OC)c1OC 10.1021/jm00096a016
CHEMBL114260 16655 0 None - 1 Human 7.0 pKi = 7.0 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 509 9 2 7 4.6 COc1cc(C(=O)NCCSC2c3ccccc3COc3ccc(C(=O)O)cc32)cc(OC)c1OC 10.1021/jm00096a016
11519006 109263 0 None -151 6 Human 6.0 pKi = 6.0 Binding
Inhibition of [3H]SQ-29,548 binding to human Prostanoid TP receptorInhibition of [3H]SQ-29,548 binding to human Prostanoid TP receptor
ChEMBL 481 8 1 5 6.1 O=C(O)COc1cccc(C[C@@H]2CCC[C@H]3O[C@]23c2nc(-c3ccccc3)c(-c3ccccc3)o2)c1 10.1016/j.bmcl.2005.04.076
CHEMBL2373410 109263 0 None -151 6 Human 6.0 pKi = 6.0 Binding
Inhibition of [3H]SQ-29,548 binding to human Prostanoid TP receptorInhibition of [3H]SQ-29,548 binding to human Prostanoid TP receptor
ChEMBL 481 8 1 5 6.1 O=C(O)COc1cccc(C[C@@H]2CCC[C@H]3O[C@]23c2nc(-c3ccccc3)c(-c3ccccc3)o2)c1 10.1016/j.bmcl.2005.04.076
CHEMBL3040272 109263 0 None -151 6 Human 6.0 pKi = 6.0 Binding
Inhibition of [3H]SQ-29,548 binding to human Prostanoid TP receptorInhibition of [3H]SQ-29,548 binding to human Prostanoid TP receptor
ChEMBL 481 8 1 5 6.1 O=C(O)COc1cccc(C[C@@H]2CCC[C@H]3O[C@]23c2nc(-c3ccccc3)c(-c3ccccc3)o2)c1 10.1016/j.bmcl.2005.04.076
44338389 12729 0 None -8 2 Human 5.0 pKi = 5.0 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 422 6 0 5 5.8 COC(=O)c1cccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)c1 10.1016/j.bmcl.2004.04.005
CHEMBL107988 12729 0 None -8 2 Human 5.0 pKi = 5.0 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 422 6 0 5 5.8 COC(=O)c1cccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)c1 10.1016/j.bmcl.2004.04.005
44138108 191064 0 None -2884 6 Human 6.0 pKi = 6.0 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 434 5 1 4 6.6 CC(C)c1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CC[C@@H]1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL483991 191064 0 None -2884 6 Human 6.0 pKi = 6.0 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 434 5 1 4 6.6 CC(C)c1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CC[C@@H]1CC(=O)O 10.1016/j.bmcl.2009.03.010
44338257 16081 0 None 4 2 Human 6.0 pKi = 6.0 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 389 5 0 4 5.9 N#Cc1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL111006 16081 0 None 4 2 Human 6.0 pKi = 6.0 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 389 5 0 4 5.9 N#Cc1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
10590325 136454 0 None - 1 Human 5.0 pKi = 5.0 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 300 3 3 5 2.4 O=[N+]([O-])c1ccc(CC2NCCc3cc(O)c(O)cc32)cc1 10.1021/jm950896w
CHEMBL367394 136454 0 None - 1 Human 5.0 pKi = 5.0 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 300 3 3 5 2.4 O=[N+]([O-])c1ccc(CC2NCCc3cc(O)c(O)cc32)cc1 10.1021/jm950896w
44411813 146024 0 None -3 2 Human 7.0 pKi = 7.0 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 477 6 1 3 6.4 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1c([S+]([O-])c3ccccc3)cccc21 10.1016/j.bmcl.2006.02.062
CHEMBL378929 146024 0 None -3 2 Human 7.0 pKi = 7.0 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 477 6 1 3 6.4 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1c([S+]([O-])c3ccccc3)cccc21 10.1016/j.bmcl.2006.02.062
53319320 63593 0 None -954 3 Human 6.0 pKi = 6.0 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 452 5 1 4 3.3 CN([C@@H]1CCc2c(CC(=O)O)c3ccc(F)c(F)c3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL1643780 63593 0 None -954 3 Human 6.0 pKi = 6.0 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 452 5 1 4 3.3 CN([C@@H]1CCc2c(CC(=O)O)c3ccc(F)c(F)c3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
14372503 85076 0 None -12 2 Human 6.0 pKi = 6 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 431 5 1 4 4.6 CS(=O)(=O)c1ccc2c(c1)c1c(n2Cc2ccc(Cl)cc2)C(CC(=O)O)CCC1 10.1016/j.bmcl.2006.02.062
CHEMBL210807 85076 0 None -12 2 Human 6.0 pKi = 6 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 431 5 1 4 4.6 CS(=O)(=O)c1ccc2c(c1)c1c(n2Cc2ccc(Cl)cc2)C(CC(=O)O)CCC1 10.1016/j.bmcl.2006.02.062
44591514 198558 0 None -398 2 Human 6.0 pKi = 6 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 446 5 1 4 6.7 O=C(O)CC1CCCn2c1c(Sc1ccc(Cl)c(Cl)c1)c1c(C3CC3)nccc12 10.1016/j.bmcl.2009.03.010
CHEMBL519803 198558 0 None -398 2 Human 6.0 pKi = 6 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 446 5 1 4 6.7 O=C(O)CC1CCCn2c1c(Sc1ccc(Cl)c(Cl)c1)c1c(C3CC3)nccc12 10.1016/j.bmcl.2009.03.010
10028338 186599 0 None -776 2 Human 6.0 pKi = 6 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 484 5 1 6 5.3 CS(=O)(=O)c1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL474502 186599 0 None -776 2 Human 6.0 pKi = 6 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 484 5 1 6 5.3 CS(=O)(=O)c1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
65772 67177 8 None -9 6 Human 8.2 pIC50 = 8.2 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
Drug Central 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC None
CHEMBL174984 67177 8 None -9 6 Human 8.2 pIC50 = 8.2 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
Drug Central 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC None
2449 211009 94 None - 0 Human 8.1 pIC50 = 8.1 Binding
In vitro concentration that reduced specific binding of [3H]U-440619 to guinea pig platelet receptor, TXA2 by 50%In vitro concentration that reduced specific binding of [3H]U-440619 to guinea pig platelet receptor, TXA2 by 50%
Drug Central 354 8 1 3 4.6 CC1=C(C)C(=O)C(C(CCCCCC(=O)O)c2ccccc2)=C(C)C1=O None
CHEMBL70972 211009 94 None - 0 Human 8.1 pIC50 = 8.1 Binding
In vitro concentration that reduced specific binding of [3H]U-440619 to guinea pig platelet receptor, TXA2 by 50%In vitro concentration that reduced specific binding of [3H]U-440619 to guinea pig platelet receptor, TXA2 by 50%
Drug Central 354 8 1 3 4.6 CC1=C(C)C(=O)C(C(CCCCCC(=O)O)c2ccccc2)=C(C)C1=O None
DB06739 211009 94 None - 0 Human 8.1 pIC50 = 8.1 Binding
In vitro concentration that reduced specific binding of [3H]U-440619 to guinea pig platelet receptor, TXA2 by 50%In vitro concentration that reduced specific binding of [3H]U-440619 to guinea pig platelet receptor, TXA2 by 50%
Drug Central 354 8 1 3 4.6 CC1=C(C)C(=O)C(C(CCCCCC(=O)O)c2ccccc2)=C(C)C1=O None
6069 6790 0 None -8 8 Human 7.0 pKd = 7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 386 12 2 3 4.7 CCCCC[C@@H](/C=C/[C@H]1C[C@@H]2O[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2(F)F)O 2748606
73755171 6790 0 None -8 8 Human 7.0 pKd = 7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 386 12 2 3 4.7 CCCCC[C@@H](/C=C/[C@H]1C[C@@H]2O[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2(F)F)O 2748606
1980 10434 0 None -8 9 Human 7.8 pKd = 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 10634944
1980 10434 0 None -8 9 Human 7.8 pKd = 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 16604093
1985 10434 0 None -8 9 Human 7.8 pKd = 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 10634944
1985 10434 0 None -8 9 Human 7.8 pKd = 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 16604093
6437074 10434 0 None -8 9 Human 7.8 pKd = 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 10634944
6437074 10434 0 None -8 9 Human 7.8 pKd = 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 16604093
1938 8750 18 None -1 4 Human 9.1 pKd = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 512 11 2 4 4.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1/C=C/[C@H](COc1ccc(cc1)I)O)O2 1830308
5311175 8750 18 None -1 4 Human 9.1 pKd = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 512 11 2 4 4.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1/C=C/[C@H](COc1ccc(cc1)I)O)O2 1830308
CHEMBL2113346 8750 18 None -1 4 Human 9.1 pKd = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 512 11 2 4 4.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1/C=C/[C@H](COc1ccc(cc1)I)O)O2 1830308
22524604 8859 0 None - 1 Human 9.3 pKd = 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 531 9 2 3 4.8 OC(=O)CCC/C=C\C[C@@H]1[C@H](C[C@@H]2C[C@H]1C2(C)C)NS(=O)(=O)c1ccc(cc1)I 1386885
3332 8859 0 None - 1 Human 9.3 pKd = 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 531 9 2 3 4.8 OC(=O)CCC/C=C\C[C@@H]1[C@H](C[C@@H]2C[C@H]1C2(C)C)NS(=O)(=O)c1ccc(cc1)I 1386885
1888 10672 29 None 2 17 Human 7.8 pKd None 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 10634944
1974 10672 29 None 2 17 Human 7.8 pKd None 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 10634944
5311493 10672 29 None 2 17 Human 7.8 pKd None 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 10634944
CHEMBL521784 10672 29 None 2 17 Human 7.8 pKd None 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 10634944
134694160 8243 0 None -1 2 Mouse 8.5 pKd None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1375456
1979 8243 0 None -1 2 Mouse 8.5 pKd None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1375456
1984 8243 0 None -1 2 Mouse 8.5 pKd None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1375456
3165 8243 0 None -1 2 Mouse 8.5 pKd None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1375456
5312138 8243 0 None -1 2 Mouse 8.5 pKd None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1375456
CHEMBL3301671 8243 0 None -1 2 Mouse 8.5 pKd None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1375456
134694160 8243 0 None 1 2 Human 8.9 pKd None 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1825698
1979 8243 0 None 1 2 Human 8.9 pKd None 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1825698
1984 8243 0 None 1 2 Human 8.9 pKd None 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1825698
3165 8243 0 None 1 2 Human 8.9 pKd None 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1825698
5312138 8243 0 None 1 2 Human 8.9 pKd None 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1825698
CHEMBL3301671 8243 0 None 1 2 Human 8.9 pKd None 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1825698
1980 10434 0 None 8 9 Rat 9.0 pKd None 9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 7635958
1985 10434 0 None 8 9 Rat 9.0 pKd None 9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 7635958
6437074 10434 0 None 8 9 Rat 9.0 pKd None 9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 7635958
135398737 7745 93 3H-SQ 29548 -416 90 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 7745 93 3H-SQ 29548 -416 90 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 7745 93 3H-SQ 29548 -416 90 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 7745 93 3H-SQ 29548 -416 90 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 7745 93 3H-SQ 29548 -416 90 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
1222 8445 49 3H-SQ 29548 -1659 32 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
3396 8445 49 3H-SQ 29548 -1659 32 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
85 8445 49 3H-SQ 29548 -1659 32 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
CHEMBL46516 8445 49 3H-SQ 29548 -1659 32 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
DB04842 8445 49 3H-SQ 29548 -1659 32 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
1353 8692 93 3H-SQ 29548 -691 85 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
3559 8692 93 3H-SQ 29548 -691 85 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
86 8692 93 3H-SQ 29548 -691 85 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
CHEMBL54 8692 93 3H-SQ 29548 -691 85 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
DB00502 8692 93 3H-SQ 29548 -691 85 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
135398745 9688 112 3H-SQ 29548 -512 65 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
47 9688 112 3H-SQ 29548 -512 65 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
CHEMBL715 9688 112 3H-SQ 29548 -512 65 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
DB00334 9688 112 3H-SQ 29548 -512 65 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
2181 9902 46 3H-SQ 29548 -831 34 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
4830 9902 46 3H-SQ 29548 -831 34 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
92 9902 46 3H-SQ 29548 -831 34 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
CHEMBL440294 9902 46 3H-SQ 29548 -831 34 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
DB09286 9902 46 3H-SQ 29548 -831 34 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
2337 10030 77 3H-SQ 29548 -112 62 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
50 10030 77 3H-SQ 29548 -112 62 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
5002 10030 77 3H-SQ 29548 -112 62 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
CHEMBL716 10030 77 3H-SQ 29548 -112 62 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
DB01224 10030 77 3H-SQ 29548 -112 62 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
2389 10104 118 3H-SQ 29548 -2691 66 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 10104 118 3H-SQ 29548 -2691 66 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 10104 118 3H-SQ 29548 -2691 66 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 10104 118 3H-SQ 29548 -2691 66 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 10104 118 3H-SQ 29548 -2691 66 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
2435 10362 83 3H-SQ 29548 -1949 48 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
60149 10362 83 3H-SQ 29548 -1949 48 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
98 10362 83 3H-SQ 29548 -1949 48 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
CHEMBL12713 10362 83 3H-SQ 29548 -1949 48 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
DB06144 10362 83 3H-SQ 29548 -1949 48 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
2865 10915 73 3H-SQ 29548 -2041 53 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
59 10915 73 3H-SQ 29548 -2041 53 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
60854 10915 73 3H-SQ 29548 -2041 53 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
CHEMBL708 10915 73 3H-SQ 29548 -2041 53 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
DB00246 10915 73 3H-SQ 29548 -2041 53 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
103 10925 61 3H-SQ 29548 -831 53 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
2875 10925 61 3H-SQ 29548 -831 53 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
5736 10925 61 3H-SQ 29548 -831 53 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL285802 10925 61 3H-SQ 29548 -831 53 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
DB09225 10925 61 3H-SQ 29548 -831 53 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
115237 62359 119 3H-SQ 29548 -4265 54 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
CHEMBL1621 62359 119 3H-SQ 29548 -4265 54 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
DB01267 62359 119 3H-SQ 29548 -4265 54 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
3036780 114308 20 3H-SQ 29548 -5888 53 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
46780481 114308 20 3H-SQ 29548 -5888 53 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
9903970 114308 20 3H-SQ 29548 -5888 53 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3187365 114308 20 3H-SQ 29548 -5888 53 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3544974 114308 20 3H-SQ 29548 -5888 53 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL504548 114308 20 3H-SQ 29548 -5888 53 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
DB06216 114308 20 3H-SQ 29548 -5888 53 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
1881 9853 0 3H-15(S)9,11-epoxymethano PGH2 -4570 21 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O None
1891 9853 0 3H-15(S)9,11-epoxymethano PGH2 -4570 21 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O None
448457 9853 0 3H-15(S)9,11-epoxymethano PGH2 -4570 21 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O None
CHEMBL1235252 9853 0 3H-15(S)9,11-epoxymethano PGH2 -4570 21 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O None
DB02056 9853 0 3H-15(S)9,11-epoxymethano PGH2 -4570 21 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O None
138 9855 88 3H-15(S)9,11-epoxymethano PGH2 -10000 18 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 354 13 3 4 3.5 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O None
149351 9855 88 3H-15(S)9,11-epoxymethano PGH2 -10000 18 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 354 13 3 4 3.5 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O None
1882 9855 88 3H-15(S)9,11-epoxymethano PGH2 -10000 18 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 354 13 3 4 3.5 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O None
5280723 9855 88 3H-15(S)9,11-epoxymethano PGH2 -10000 18 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 354 13 3 4 3.5 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O None
CHEMBL495 9855 88 3H-15(S)9,11-epoxymethano PGH2 -10000 18 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 354 13 3 4 3.5 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O None
DB00770 9855 88 3H-15(S)9,11-epoxymethano PGH2 -10000 18 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 354 13 3 4 3.5 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O None
1883 9856 75 3H-15(S)9,11-epoxymethano PGH2 -10000 24 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O None
1916 9856 75 3H-15(S)9,11-epoxymethano PGH2 -10000 24 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O None
5280360 9856 75 3H-15(S)9,11-epoxymethano PGH2 -10000 24 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O None
913 9856 75 3H-15(S)9,11-epoxymethano PGH2 -10000 24 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O None
CHEMBL548 9856 75 3H-15(S)9,11-epoxymethano PGH2 -10000 24 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O None
DB00917 9856 75 3H-15(S)9,11-epoxymethano PGH2 -10000 24 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O None
1884 9857 52 3H-15(S)9,11-epoxymethano PGH2 -3019 22 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O None
5280363 9857 52 3H-15(S)9,11-epoxymethano PGH2 -3019 22 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O None
912 9857 52 3H-15(S)9,11-epoxymethano PGH2 -3019 22 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O None
CHEMBL815 9857 52 3H-15(S)9,11-epoxymethano PGH2 -3019 22 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O None
DB12789 9857 52 3H-15(S)9,11-epoxymethano PGH2 -3019 22 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O None
243 9976 91 3H-SQ 29548 -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
3052762 9976 91 3H-SQ 29548 -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
3502 9976 91 3H-SQ 29548 -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
CHEMBL117287 9976 91 3H-SQ 29548 -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
DB06480 9976 91 3H-SQ 29548 -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
44208932 147485 7 UNDEFINED -89125 37 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 475 5 1 3 6.8 Cc1ccc(Cn2nc(C(=O)NC3C4(C)CCC(C4)C3(C)C)cc2-c2ccc(Cl)c(C)c2)cc1 None
CHEMBL381689 147485 7 UNDEFINED -89125 37 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 475 5 1 3 6.8 Cc1ccc(Cn2nc(C(=O)NC3C4(C)CCC(C4)C3(C)C)cc2-c2ccc(Cl)c(C)c2)cc1 None
None 223216 0 3H-15(S)9,11-epoxymethano PGH2 - 1 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 368 12 4 4 3.4 CCCCCC(C)(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O None
None 223218 0 3H-15(S)9,11-epoxymethano PGH2 - 1 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 304 14 1 1 6.2 CCCCCC=CCC=CCC=CCC=CCCCC(=O)O None
None 223272 0 3H-SQ 29548 -10471285 17 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 372 2 1 3 4.4 CC(C)(C)C1=CC=C(C=C1)NC(=O)N2CCN(CC2)C3=C(C=CC=N3)Cl None
None 223213 0 3H-15(S)9,11-epoxymethano PGH2 - 1 Mouse 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 348 12 2 4 4.5 CCCCCC(C=CC1C2CC(C1CC=CCCCC(=O)O)N=N2)O None
None 222904 0 125I-BOP - 1 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 541 11 4 4 4.7 CC1(C2CC1C(C(C2)NCC(CC3=CC(=C(C=C3)O)I)O)CC=CCCCC(=O)O)C None
None 222904 0 125I-BOP - 1 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 541 11 4 4 4.7 CC1(C2CC1C(C(C2)NCC(CC3=CC(=C(C=C3)O)I)O)CC=CCCCC(=O)O)C None
None 223217 0 3H-15(S)9,11-epoxymethano PGH2 - 1 Mouse 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 388 12 2 4 4.1 CCCCCC(C=CC1C(C2C(C(O1)O2)(F)F)CC=CCCCC(=O)O)O None
1980 10434 0 125I-BOP -8 9 Human 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
1985 10434 0 125I-BOP -8 9 Human 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
6437074 10434 0 125I-BOP -8 9 Human 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
1980 10434 0 125I-BOP -8 9 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
1985 10434 0 125I-BOP -8 9 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
6437074 10434 0 125I-BOP -8 9 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
None 222998 0 125I-BOP - 1 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 373 4 1 2 5.2 C1CC(C2C(C1)C3=C(N2CC4=CC=C(C=C4)Cl)C=CC(=C3)F)CC(=O)O None
1980 10434 0 125I-BOP -8 9 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
1985 10434 0 125I-BOP -8 9 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
6437074 10434 0 125I-BOP -8 9 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
None 223212 0 3H-15(S)9,11-epoxymethano PGH2 - 1 Mouse 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 352 12 2 4 4.0 CCCCCC(C=CC1C2CC(C1CC=CCCCC(=O)O)OO2)O None
1888 10672 29 3H-SQ 29548 2 17 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
1974 10672 29 3H-SQ 29548 2 17 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
5311493 10672 29 3H-SQ 29548 2 17 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
CHEMBL521784 10672 29 3H-SQ 29548 2 17 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
None 223212 0 3H-15(S)9,11-epoxymethano PGH2 - 1 Mouse 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 352 12 2 4 4.0 CCCCCC(C=CC1C2CC(C1CC=CCCCC(=O)O)OO2)O None
None 223005 0 3H-SQ 29548 - 1 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 422 15 3 4 3.2 CCCCCCC(=O)NCC(=O)NCC1C2CCC(C1CC=CCCCC(=O)O)O2 None
1888 10672 29 3H-SQ 29548 2 17 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
1974 10672 29 3H-SQ 29548 2 17 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
5311493 10672 29 3H-SQ 29548 2 17 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
CHEMBL521784 10672 29 3H-SQ 29548 2 17 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
None 223004 0 3H-SQ 29548 - 1 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 384 10 2 3 4.7 CC(C1=CC=CC=C1)C(C=CC2C3CCC(C2CC=CCCCC(=O)O)O3)O None
None 223214 0 3H-15(S)9,11-epoxymethano PGH2 - 1 Mouse 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 408 11 4 5 2.7 C1C(C(C(C1O)C=CC(COC2=CC=C(C=C2)F)O)CC=CCCCC(=O)O)O None
None 222903 0 125I-BOP - 1 Human 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCCC(C=CC1C2CC(C1CC=CCCCC(=O)O)OC2)O None
None 222903 0 3H-SQ 29548 - 1 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCCC(C=CC1C2CC(C1CC=CCCCC(=O)O)OC2)O None
1883 9856 75 None -380 24 Human 8.4 pKi = 8.4 Binding
NoneNone
Drug Central 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O None
1916 9856 75 None -380 24 Human 8.4 pKi = 8.4 Binding
NoneNone
Drug Central 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O None
5280360 9856 75 None -380 24 Human 8.4 pKi = 8.4 Binding
NoneNone
Drug Central 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O None
913 9856 75 None -380 24 Human 8.4 pKi = 8.4 Binding
NoneNone
Drug Central 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O None
CHEMBL548 9856 75 None -380 24 Human 8.4 pKi = 8.4 Binding
NoneNone
Drug Central 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O None
DB00917 9856 75 None -380 24 Human 8.4 pKi = 8.4 Binding
NoneNone
Drug Central 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O None
1980 10434 0 125I-BOP -8 9 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
1985 10434 0 125I-BOP -8 9 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
6437074 10434 0 125I-BOP -8 9 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
None 222904 0 125I-BOP - 1 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 541 11 4 4 4.7 CC1(C2CC1C(C(C2)NCC(CC3=CC(=C(C=C3)O)I)O)CC=CCCCC(=O)O)C None
None 222903 0 125I-BOP - 1 Human 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCCC(C=CC1C2CC(C1CC=CCCCC(=O)O)OC2)O None
None 223219 0 3H-15(S)9,11-epoxymethano PGH2 - 1 Mouse 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 383 9 3 3 4.7 C1CC2CC1C(C2C=NNC(=O)NC3=CC=CC=C3)CC=CCCCC(=O)O None
None 223005 0 3H-SQ 29548 - 1 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 422 15 3 4 3.2 CCCCCCC(=O)NCC(=O)NCC1C2CCC(C1CC=CCCCC(=O)O)O2 None
1884 9857 52 None -61 22 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O None
5280363 9857 52 None -61 22 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O None
912 9857 52 None -61 22 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O None
CHEMBL815 9857 52 None -61 22 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O None
DB12789 9857 52 None -61 22 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O None
138107701 194243 46 None -5 15 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 360 8 3 3 3.5 CC#CCC(C)[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)O)C[C@H]2C[C@H]1O None
5311181 194243 46 None -5 15 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 360 8 3 3 3.5 CC#CCC(C)[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)O)C[C@H]2C[C@H]1O None
CHEMBL494 194243 46 None -5 15 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 360 8 3 3 3.5 CC#CCC(C)[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)O)C[C@H]2C[C@H]1O None
DB01088 194243 46 None -5 15 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 360 8 3 3 3.5 CC#CCC(C)[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)O)C[C@H]2C[C@H]1O None
1980 10434 0 3H-SQ 29548 -8 9 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
1985 10434 0 3H-SQ 29548 -8 9 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
6437074 10434 0 3H-SQ 29548 -8 9 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
1888 10672 29 125I-BOP 2 17 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
1974 10672 29 125I-BOP 2 17 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
5311493 10672 29 125I-BOP 2 17 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
CHEMBL521784 10672 29 125I-BOP 2 17 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
1888 10672 29 125I-BOP 2 17 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
1974 10672 29 125I-BOP 2 17 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
5311493 10672 29 125I-BOP 2 17 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
CHEMBL521784 10672 29 125I-BOP 2 17 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
None 222903 0 125I-BOP - 1 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCCC(C=CC1C2CC(C1CC=CCCCC(=O)O)OC2)O None
None 222903 0 3H-SQ 29548 - 1 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCCC(C=CC1C2CC(C1CC=CCCCC(=O)O)OC2)O None
1980 10434 0 3H-SQ 29548 -8 9 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
1985 10434 0 3H-SQ 29548 -8 9 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
6437074 10434 0 3H-SQ 29548 -8 9 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
None 222922 0 3H-SQ 29548 - 1 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 477 11 2 4 5.7 C1CCN(CC1)C2C(CC(C2CCC=CCCC(=O)O)OCC3=CC=C(C=C3)C4=CC=CC=C4)O None
None 223004 0 3H-SQ 29548 - 1 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 384 10 2 3 4.7 CC(C1=CC=CC=C1)C(C=CC2C3CCC(C2CC=CCCCC(=O)O)O3)O None
1888 10672 29 125I-BOP 2 17 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
1974 10672 29 125I-BOP 2 17 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
5311493 10672 29 125I-BOP 2 17 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
CHEMBL521784 10672 29 125I-BOP 2 17 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
None 223215 0 3H-15(S)9,11-epoxymethano PGH2 - 1 Mouse 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 382 12 4 4 3.7 CCCCC(C)(C)C(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O None
3356 9060 73 None -38 8 Human 8.1 pKi = 8.1 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
Drug Central 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F None
4326 9060 73 None -38 8 Human 8.1 pKi = 8.1 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
Drug Central 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F None
9867642 9060 73 None -38 8 Human 8.1 pKi = 8.1 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
Drug Central 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F None
CHEMBL426559 9060 73 None -38 8 Human 8.1 pKi = 8.1 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
Drug Central 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F None
DB11629 9060 73 None -38 8 Human 8.1 pKi = 8.1 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
Drug Central 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F None
1888 10672 29 125I-BOP 2 17 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
1974 10672 29 125I-BOP 2 17 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
5311493 10672 29 125I-BOP 2 17 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
CHEMBL521784 10672 29 125I-BOP 2 17 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
134694160 8243 0 None -1 2 Mouse 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 None
1979 8243 0 None -1 2 Mouse 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 None
1984 8243 0 None -1 2 Mouse 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 None
3165 8243 0 None -1 2 Mouse 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 None
5312138 8243 0 None -1 2 Mouse 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 None
CHEMBL3301671 8243 0 None -1 2 Mouse 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 None
123879 10060 82 None 3 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
Drug Central 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F None
1910 10060 82 None 3 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
Drug Central 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F None
1911 10060 82 None 3 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
Drug Central 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F None
2354 10060 82 None 3 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
Drug Central 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F None
CHEMBL361812 10060 82 None 3 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
Drug Central 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F None
DB13036 10060 82 None 3 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
Drug Central 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F None
134694160 8243 0 None 1 2 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 None
1979 8243 0 None 1 2 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 None
1984 8243 0 None 1 2 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 None
3165 8243 0 None 1 2 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 None
5312138 8243 0 None 1 2 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 None
CHEMBL3301671 8243 0 None 1 2 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 None
3356 9060 73 None -38 8 Human 6.1 pKi = 6.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 17882161
4326 9060 73 None -38 8 Human 6.1 pKi = 6.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 17882161
9867642 9060 73 None -38 8 Human 6.1 pKi = 6.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 17882161
CHEMBL426559 9060 73 None -38 8 Human 6.1 pKi = 6.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 17882161
DB11629 9060 73 None -38 8 Human 6.1 pKi = 6.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 17882161
1888 10672 29 None 2 17 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 10634944
1974 10672 29 None 2 17 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 10634944
5311493 10672 29 None 2 17 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 10634944
CHEMBL521784 10672 29 None 2 17 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 10634944
123879 10060 82 None 3 4 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 1387312
1910 10060 82 None 3 4 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 1387312
1911 10060 82 None 3 4 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 1387312
2354 10060 82 None 3 4 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 1387312
CHEMBL361812 10060 82 None 3 4 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 1387312
DB13036 10060 82 None 3 4 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 1387312
1978 9707 0 None - 1 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 391 9 3 3 3.9 OC(=O)CCC/C=C\C[C@@H]1[C@@H](NC(=O)[C@@H](C2CCCC2)O)C[C@H]2C[C@@H]1C2(C)C 3008368
5311334 9707 0 None - 1 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 391 9 3 3 3.9 OC(=O)CCC/C=C\C[C@@H]1[C@@H](NC(=O)[C@@H](C2CCCC2)O)C[C@H]2C[C@@H]1C2(C)C 3008368
CHEMBL266243 9707 0 None - 1 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 391 9 3 3 3.9 OC(=O)CCC/C=C\C[C@@H]1[C@@H](NC(=O)[C@@H](C2CCCC2)O)C[C@H]2C[C@@H]1C2(C)C 3008368
1987 8770 19 None -1 2 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 440 11 2 5 4.1 CCCCCNC(=O)c1coc(n1)[C@@H]1[C@H]2CC[C@@H]([C@@H]1Cc1ccccc1CCC(=O)O)O2 8437108
3037233 8770 19 None -1 2 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 440 11 2 5 4.1 CCCCCNC(=O)c1coc(n1)[C@@H]1[C@H]2CC[C@@H]([C@@H]1Cc1ccccc1CCC(=O)O)O2 8437108
CHEMBL3301673 8770 19 None -1 2 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 440 11 2 5 4.1 CCCCCNC(=O)c1coc(n1)[C@@H]1[C@H]2CC[C@@H]([C@@H]1Cc1ccccc1CCC(=O)O)O2 8437108
DB12321 8770 19 None -1 2 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 440 11 2 5 4.1 CCCCCNC(=O)c1coc(n1)[C@@H]1[C@H]2CC[C@@H]([C@@H]1Cc1ccccc1CCC(=O)O)O2 8437108
1980 10434 0 None -8 9 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 10634944
1980 10434 0 None -8 9 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 16604093
1980 10434 0 None -8 9 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 2975605
1985 10434 0 None -8 9 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 10634944
1985 10434 0 None -8 9 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 16604093
1985 10434 0 None -8 9 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 2975605
6437074 10434 0 None -8 9 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 10634944
6437074 10434 0 None -8 9 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 16604093
6437074 10434 0 None -8 9 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 2975605
1976 10745 18 None 8 2 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 11 2 4 5.7 OC(=O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)C[C@@H]([C@@H]1N1CCCCC1)O 2527074
1976 10745 18 None 8 2 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 11 2 4 5.7 OC(=O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)C[C@@H]([C@@H]1N1CCCCC1)O 8242228
6918030 10745 18 None 8 2 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 11 2 4 5.7 OC(=O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)C[C@@H]([C@@H]1N1CCCCC1)O 2527074
6918030 10745 18 None 8 2 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 11 2 4 5.7 OC(=O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)C[C@@H]([C@@H]1N1CCCCC1)O 8242228
CHEMBL65030 10745 18 None 8 2 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 11 2 4 5.7 OC(=O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)C[C@@H]([C@@H]1N1CCCCC1)O 2527074
CHEMBL65030 10745 18 None 8 2 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 11 2 4 5.7 OC(=O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)C[C@@H]([C@@H]1N1CCCCC1)O 8242228
1940 8444 41 None -20892 10 Human 4.3 pKi None 4.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 458 11 4 5 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)C(F)(F)F)O)O 10634944
3417 8444 41 None -20892 10 Human 4.3 pKi None 4.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 458 11 4 5 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)C(F)(F)F)O)O 10634944
5311100 8444 41 None -20892 10 Human 4.3 pKi None 4.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 458 11 4 5 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)C(F)(F)F)O)O 10634944
CHEMBL1201379 8444 41 None -20892 10 Human 4.3 pKi None 4.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 458 11 4 5 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)C(F)(F)F)O)O 10634944
DB11519 8444 41 None -20892 10 Human 4.3 pKi None 4.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 458 11 4 5 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)C(F)(F)F)O)O 10634944
1883 9856 75 None -380 24 Human 4.5 pKi None 4.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O 10634944
1916 9856 75 None -380 24 Human 4.5 pKi None 4.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O 10634944
5280360 9856 75 None -380 24 Human 4.5 pKi None 4.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O 10634944
913 9856 75 None -380 24 Human 4.5 pKi None 4.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O 10634944
CHEMBL548 9856 75 None -380 24 Human 4.5 pKi None 4.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O 10634944
DB00917 9856 75 None -380 24 Human 4.5 pKi None 4.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O 10634944
1892 7534 20 None -316 9 Human 4.7 pKi None 4.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 394 13 3 4 4.3 CCCC1(CCC1)[C@H](C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O 10634944
25886893 7534 20 None -316 9 Human 4.7 pKi None 4.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 394 13 3 4 4.3 CCCC1(CCC1)[C@H](C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O 10634944
CHEMBL1628262 7534 20 None -316 9 Human 4.7 pKi None 4.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 394 13 3 4 4.3 CCCC1(CCC1)[C@H](C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O 10634944
1893 7582 0 None -1412 13 Human 4.7 pKi None 4.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 350 10 3 3 4.1 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C\CCCC(=O)O)/C2)O 10634944
5311242 7582 0 None -1412 13 Human 4.7 pKi None 4.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 350 10 3 3 4.1 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C\CCCC(=O)O)/C2)O 10634944
CHEMBL148319 7582 0 None -1412 13 Human 4.7 pKi None 4.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 350 10 3 3 4.1 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C\CCCC(=O)O)/C2)O 10634944
1884 9857 52 None -61 22 Human 5.1 pKi None 5.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O 10634944
5280363 9857 52 None -61 22 Human 5.1 pKi None 5.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O 10634944
912 9857 52 None -61 22 Human 5.1 pKi None 5.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O 10634944
CHEMBL815 9857 52 None -61 22 Human 5.1 pKi None 5.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O 10634944
DB12789 9857 52 None -61 22 Human 5.1 pKi None 5.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O 10634944
1894 7744 41 None -1621 5 Human 5.2 pKi None 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 424 11 4 5 3.2 OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)Cl)O)O 10634944
5311053 7744 41 None -1621 5 Human 5.2 pKi None 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 424 11 4 5 3.2 OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)Cl)O)O 10634944
CHEMBL37853 7744 41 None -1621 5 Human 5.2 pKi None 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 424 11 4 5 3.2 OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)Cl)O)O 10634944
DB11507 7744 41 None -1621 5 Human 5.2 pKi None 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 424 11 4 5 3.2 OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)Cl)O)O 10634944
1895 8788 0 None -630 16 Human 5.2 pKi None 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 360 8 3 3 3.5 CC#CCC([C@@H](/C=C/C1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)C 10634944
6435378 8788 0 None -630 16 Human 5.2 pKi None 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 360 8 3 3 3.5 CC#CCC([C@@H](/C=C/C1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)C 10634944
CHEMBL236025 8788 0 None -630 16 Human 5.2 pKi None 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 360 8 3 3 3.5 CC#CCC([C@@H](/C=C/C1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)C 10634944
DB01088 8788 0 None -630 16 Human 5.2 pKi None 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 360 8 3 3 3.5 CC#CCC([C@@H](/C=C/C1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)C 10634944
1949 7106 0 None 12 3 Human 6.2 pKi None 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 11 1 5 4.7 OC(=O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)CC(=O)[C@@H]1N1CCOCC1 10634944
5310999 7106 0 None 12 3 Human 6.2 pKi None 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 11 1 5 4.7 OC(=O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)CC(=O)[C@@H]1N1CCOCC1 10634944
1970 7585 0 None - 1 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 348 12 2 2 5.3 CCCCC[C@@H](/C=C/[C@H]1CC2CC([C@@H]1C/C=C\CCCC(=O)O)C2)O 1434130
5311387 7585 0 None - 1 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 348 12 2 2 5.3 CCCCC[C@@H](/C=C/[C@H]1CC2CC([C@@H]1C/C=C\CCCC(=O)O)C2)O 1434130
1913 9242 0 None -2238 15 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 374 12 2 4 4.0 OC(=O)CCCCCC[C@@H]1[C@@H](/C=C/[C@H](COc2ccccc2)O)CCC1=O 10634944
5311223 9242 0 None -2238 15 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 374 12 2 4 4.0 OC(=O)CCCCCC[C@@H]1[C@@H](/C=C/[C@H](COc2ccccc2)O)CCC1=O 10634944
1920 9711 0 None -125 4 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 439 9 2 3 4.8 OC(=O)CCC/C=C\[C@H]1C2CCC([C@@H]1CNS(=O)(=O)c1ccc(cc1C)Cl)CC2 10537280
9824507 9711 0 None -125 4 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 439 9 2 3 4.8 OC(=O)CCC/C=C\[C@H]1C2CCC([C@@H]1CNS(=O)(=O)c1ccc(cc1C)Cl)CC2 10537280
CHEMBL1628612 9711 0 None -125 4 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 439 9 2 3 4.8 OC(=O)CCC/C=C\[C@H]1C2CCC([C@@H]1CNS(=O)(=O)c1ccc(cc1C)Cl)CC2 10537280
1888 10672 29 None -2 17 Mouse 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 9313928
1974 10672 29 None -2 17 Mouse 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 9313928
5311493 10672 29 None -2 17 Mouse 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 9313928
CHEMBL521784 10672 29 None -2 17 Mouse 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 9313928
1898 10223 0 None -15 2 Human 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 441 8 3 4 5.6 OC(=O)CCC/C=C\C[C@@H]1C[C@H]2C[C@@H]([C@@H]1NC(=O)c1csc3c1cc(O)cc3)C2(C)C 11454901
5311213 10223 0 None -15 2 Human 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 441 8 3 4 5.6 OC(=O)CCC/C=C\C[C@@H]1C[C@H]2C[C@@H]([C@@H]1NC(=O)c1csc3c1cc(O)cc3)C2(C)C 11454901
1986 8094 50 None - 1 Human 7.7 pKi None 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 353 7 2 3 2.5 OC(=O)Cc1ccc(cc1)CCNS(=O)(=O)c1ccc(cc1)Cl 1434130
54343 8094 50 None - 1 Human 7.7 pKi None 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 353 7 2 3 2.5 OC(=O)Cc1ccc(cc1)CCNS(=O)(=O)c1ccc(cc1)Cl 1434130
CHEMBL71685 8094 50 None - 1 Human 7.7 pKi None 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 353 7 2 3 2.5 OC(=O)Cc1ccc(cc1)CCNS(=O)(=O)c1ccc(cc1)Cl 1434130
1980 10434 0 None -12 9 Mouse 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 9313928
1985 10434 0 None -12 9 Mouse 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 9313928
6437074 10434 0 None -12 9 Mouse 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 9313928
1939 10460 0 None 1 2 Mouse 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 366 12 2 3 5.2 CCCCC[C@H](/C=C/[C@H]1C[C@H]2C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)S2)O 9313928
5311453 10460 0 None 1 2 Mouse 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 366 12 2 3 5.2 CCCCC[C@H](/C=C/[C@H]1C[C@H]2C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)S2)O 9313928
1976 10745 18 None -8 2 Mouse 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 11 2 4 5.7 OC(=O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)C[C@@H]([C@@H]1N1CCCCC1)O 9313928
6918030 10745 18 None -8 2 Mouse 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 11 2 4 5.7 OC(=O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)C[C@@H]([C@@H]1N1CCCCC1)O 9313928
CHEMBL65030 10745 18 None -8 2 Mouse 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 11 2 4 5.7 OC(=O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)C[C@@H]([C@@H]1N1CCCCC1)O 9313928
1972 9858 0 None - 1 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 352 12 2 4 4.0 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OO[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 1434130
445049 9858 0 None - 1 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 352 12 2 4 4.0 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OO[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 1434130
4483 9858 0 None - 1 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 352 12 2 4 4.0 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OO[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 1434130
CHEMBL2074582 9858 0 None - 1 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 352 12 2 4 4.0 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OO[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 1434130
1971 8350 0 None - 1 Human 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 404 11 2 4 4.1 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1/C=C/[C@@H](COc1ccc(cc1)F)O)O2 2743082
5311384 8350 0 None - 1 Human 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 404 11 2 4 4.1 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1/C=C/[C@@H](COc1ccc(cc1)F)O)O2 2743082
19088577 8984 0 None - 1 Human 8.9 pKi None 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 409 3 0 5 4.0 [O-]C(=O)c1ccc2c(c1)/C(=C/Cn1cnc3c1cc(C)c(c3)C)/c1ccccc1CO2 1434130
1977 8984 0 None - 1 Human 8.9 pKi None 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 409 3 0 5 4.0 [O-]C(=O)c1ccc2c(c1)/C(=C/Cn1cnc3c1cc(C)c(c3)C)/c1ccccc1CO2 1434130
134694160 8243 0 None -1 2 Mouse 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 9313928
1979 8243 0 None -1 2 Mouse 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 9313928
1984 8243 0 None -1 2 Mouse 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 9313928
3165 8243 0 None -1 2 Mouse 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 9313928
5312138 8243 0 None -1 2 Mouse 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 9313928
CHEMBL3301671 8243 0 None -1 2 Mouse 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 9313928
1938 8750 18 None 1 4 Mouse 9.3 pKi None 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 512 11 2 4 4.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1/C=C/[C@H](COc1ccc(cc1)I)O)O2 9313928
5311175 8750 18 None 1 4 Mouse 9.3 pKi None 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 512 11 2 4 4.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1/C=C/[C@H](COc1ccc(cc1)I)O)O2 9313928
CHEMBL2113346 8750 18 None 1 4 Mouse 9.3 pKi None 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 512 11 2 4 4.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1/C=C/[C@H](COc1ccc(cc1)I)O)O2 9313928
134694160 8243 0 None 1 2 Human 9.6 pKi None 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1833018
1979 8243 0 None 1 2 Human 9.6 pKi None 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1833018
1984 8243 0 None 1 2 Human 9.6 pKi None 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1833018
3165 8243 0 None 1 2 Human 9.6 pKi None 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1833018
5312138 8243 0 None 1 2 Human 9.6 pKi None 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1833018
CHEMBL3301671 8243 0 None 1 2 Human 9.6 pKi None 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1833018